[
  {
    "id": 2,
    "user_query": "Is the protein Papilin secreted?",
    "text-davinci-003_response": "The answer to this question is yes, the protein Papilin is secreted. Papilin, or Papillon (PapK), is a Family 32 carbohydrate-binding modular protein (CBM32) that is mainly expressed in the plasma membrane and secreted by papillomavirus-infected cells. The exact mechanism and physiological role of PapK secretion are not yet fully understood, however it has recently been suggested that it is involved in virus-host cell interactions, such that it can mediate both virus entry and egress. Further, there is evidence that PapK is required for papillomavirus spread and that it may help the virus to alter the host cell environment to its advantage."
  },
  {
    "id": 8,
    "user_query": "Has Denosumab (Prolia) been approved by FDA?",
    "text-davinci-003_response": "Yes, the U.S. Food and Drug Administration (FDA) approved Denosumab (Prolia) in June 2010. It is indicated for the treatment of postmenopausal osteoporosis and approved for use in both men and women. Denosumab (Prolia) is a monoclonal antibody, a type of biologic molecule that works by specifically targeting and blocking the activity of a protein called RANKL (Receptor activator of nuclear factor-κB ligand). By doing this, it reduces the activity of certain cells that break down bone tissue, which slows down the rate of bone loss and reduces the occurrence of fractures in those with osteoporosis."
  },
  {
    "id": 10,
    "user_query": "Name synonym of Acrokeratosis paraneoplastica.",
    "text-davinci-003_response": "Acrokeratosis paraneoplastica is also known as Bazex Syndrome or Bazex-Dupré-Christol Syndrome."
  },
  {
    "id": 11,
    "user_query": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?",
    "text-davinci-003_response": "Vaughan-Williams (VW) classification is a widely used system for grouping anti-arrhythmic drugs according to the type of action they have on cardiac electrical activity. The current version was published in 1989 and includes four classes, labeled I-IV, with selective agents included in each class.\nClass I: Sodium Channel Blockers\nClass I anti-arrhythmic drugs act by blocking the cardiac action potential, preventing rapid depolarization of the myocardium and slowing conduction velocity. This class is further divided into three subclasses, depending on the specific type of sodium channel they block. \nSubclass IA drugs (Class IA) block the fast sodium channels, including quinidine, procainamide, and disopyramide.\nSubclass IB drugs (Class IB) block the slow sodium channels, including lignocaine (or lidocaine), mexiletine, and tocainide.\nSubclass IC drugs (Class IC) have combined fast and slow sodium channel blocking activity, including flecainide and propafenone.\nClass II: Beta-Adrenoceptor Blockers\nClass II anti-arrhythmic drugs act by blocking the action of the sympathetic nervous system on the heart. This class is further divided into two groups; selective β1-adrenergic receptor blockers (i.e. metoprolol, atenolol) and non-selective β-adrenergic receptor blockers (i.e. propranolol, labetalol).\nClass III: Potassium Channel Blockers\nClass III anti-arrhythmic drugs act by blocking the rapid outward currents that repolarize the myocardium. They slow the rate of repolarization and extend the action potential duration, thus prolonging the refractory period. Examples of this class are amiodarone, sotalol, and ibutilide.\nClass IV: Calcium Channel Blockers\nClass IV anti-arrhythmic drugs are primarily used to slow conduction in the atrioventricular (AV) node. They work by blocking calcium influx through the L-type calcium channels, which decreases the force and velocity of impulse conduction. Examples of this class include verapamil and diltiazem."
  },
  {
    "id": 12,
    "user_query": "Which are the different isoforms of the mammalian Notch receptor?",
    "text-davinci-003_response": "The mammalian Notch receptor is composed of four isoforms: Notch1, Notch2, Notch3 and Notch4. All four of these isoforms are composed of a single extracellular domain, a single transmembrane domain, and a single intracellular domain. The extracellular domain of the Notch receptor is composed of 36 epidermal growth factor repeats. The transmembrane and intracellular domains of Notch1, Notch2, Notch3 and Notch4 are highly conserved.\nNotch1 is expressed in several organs such as heart, brain, liver, kidney, spleen, thymus and testis. It is also expressed in different cell types of the immune system, including T and B cells, dendritic cells, macrophages and monocytes. The role of Notch1 is to stimulate the differentiation and activation of T cells, which in turn is involved in immune system regulation.\nNotch2 is expressed in several tissues including brain and is involved in postnatal and adult neurological processes such as learning and memory. Notch2 has also been found to be involved in several types of cancer, including glioblastoma and medulloblastoma.\nNotch3 is expressed in numerous tissues, including heart, brain, and immune cells. It is believed to regulate angiogenesis, vascular development, and neuronal survival.\nNotch4 is expressed in numerous tissues, such as heart, brain, and immune cells. It plays a role in maintaining stem cell quiescence, vascular development, adipogenesis, and wound healing. It has also been implicated in the pathogenesis of several types of cancer."
  },
  {
    "id": 15,
    "user_query": "Is the monoclonal antibody Trastuzumab (Herceptin) of potential use in the treatment of prostate cancer?",
    "text-davinci-003_response": "No, trastuzumab (Herceptin) is not of potential use in the treatment of prostate cancer. Trastuzumab is a monoclonal antibody that is used to treat certain types of breast and stomach cancer that depend on the HER2/neu gene. This gene is not found in prostate cancer cells, therefore trastuzumab would not be of any use in treating this particular cancer. Instead, other treatments such as chemotherapy, hormone therapy, and radiation therapy may be used to treat prostate cancer."
  },
  {
    "id": 22,
    "user_query": "Are transcription and splicing connected?",
    "text-davinci-003_response": "Yes, transcription and splicing are connected. First, transcribing pre-mRNA in the nucleus takes place and is then spliced in certain places. This splicing process occurs when non-coding segments (introns) are cut out of the pre-mRNA and the coding segments (exons) are spliced together to form mature mRNA which can then be shipped to the cytoplasm. This process is critical for the formation of the two distinct types of RNA—mature mRNA and tRNA—both of which play key roles in gene expression. The splicing process serves as an editing tool, allowing cells to modify gene expression without changing the underlying coding sequence of RNA. Thus, the removal of introns enables proteins to arise from the genetic coding in a process known as gene expression. In this way, transcription and splicing are linked because the transcription of pre-mRNA into mature mRNA requires the splicing process."
  },
  {
    "id": 23,
    "user_query": "What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)?",
    "text-davinci-003_response": "Facioscapulohumeral muscular dystrophy (FSHD) is an inherited muscle disorder, also known as Landouzy-Dejerine muscular dystrophy, that typically becomes evident in early childhood and is marked by progressive muscle weakness and wasting in the face, shoulder girdle, and upper arms.\nThe mode of inheritance of FSHD is autosomal dominant. This means that a single mutated gene is enough to cause the disease, and it can be inherited from either parent. The mutated gene can also arise spontaneously for the first time in a person with no family history of the disease."
  },
  {
    "id": 25,
    "user_query": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?",
    "text-davinci-003_response": "The ryanodine receptor quaternary macromolecular complex is a large structure composed of four main proteins—ryanodine receptor 1 (RyR1), calmodulin (CaM), junctin, and triadin—that are responsible for the regulation of calcium release from the sarcoplasmic reticulum in response to an action potential.\nRyanodine receptor 1 is the most complex of the four proteins and is primarily responsible for controlling the release of calcium ions from the sarcoplasmic reticulum. It is composed of four independent homologous domains that are linked together in a functional tetrameric structure. Each domain contains several transmembrane and cytoplasmic sites that interact with CaM, junctin, and triadin. \nCalmodulin is a widespread calcium binding protein that helps regulate protein activity in response to intracellular calcium signaling. Within the context of the RyR1 quaternary macromolecular complex the CaM binds to several specific sites on the cytoplasmic region of RyR1. This binding reportedly helps to stabilize the complex and facilitates calcium-mediated regulation of ryanodine receptor activity. \nJunctin is a 34 kDa protein that is associated with Ryanodine receptors and Ca2+ channels in the sarcoplasmic reticulum. Junctin binds with high affinity to a specific C-terminal calcium binding site in RyR1, and is thought to help regulate RyR1 activity in response to calcium signals. \nTriadin is an integral membrane protein that is associated with the RyR1 complex, and functions to interact with the Ca2+-CaM complex. Triadin is believed to bridge the gap between RyR1, junctin, and CaM, stabilizing their association and providing regulatory control over RyR1 activity. \nTogether, these four proteins form the ryanodine receptor quaternary macromolecular complex, and function to allow calcium release from the sarcoplasmic reticulum to generate the muscle contractions necessary for muscle movement."
  },
  {
    "id": 26,
    "user_query": "What kind of chromatography is HILIC?",
    "text-davinci-003_response": "HILIC (Hydrophilic Interaction Chromatography) is a type of chromatography that separates molecules based on their hydrophobicity. It is often used to analyze polar compounds and is typically performed on a reversed-phase ion chromatography (RPIC) stationary phase. HILIC utilizes an aqueous mobile phase and a bonded hydrophilic stationary phase composed of silica, diols, or polymeric materials. It works by retaining and separating molecules based on their affinity for the stationary phase. HILIC can provide good retention for polar compounds while being insensitive to changes in the mobile phase. The technique has become popular for use in a variety of applications including the analysis of drugs, metabolites, nucleic acids, peptides, and proteins."
  },
  {
    "id": 27,
    "user_query": "What is the effect of TRH on myocardial contractility?",
    "text-davinci-003_response": "The effect of Thyroid hormone Releasing Hormone (TRH) on myocardial contractility is complex and wide-reaching. Physiologically, TRH acts on the tissues of the heart to stimulate the release of thyroid stimulating hormone (TSH) from the hypothalamus, and, subsequently, an increase in the production of circulating thyroid hormones. This increase in thyroid hormones then causes an increase in circulating calcium, which leads to an increase in myocardial contractility. In simple terms, TRH increases myocardial contractility.\nOn a molecular level, TRH influences the production of several different important proteins involved in intracellular calcium-handling, including, but not limited to, myosin light chain 2 (MLC2), Troponin I, Troponin T, and Calmodulin. The upregulation of these proteins, in response to TRH, can lead to changes in myocardial contractility.\nTRH also has been shown to influence the production and release of norepinephrine (NE) from the adrenal medulla. This increase in NE can lead to increased myocardial contractility, higher heart rate, and more forceful contraction of the myocardium. Increased NE can also lead to increased vascular tone, which can also lead to an increase in myocardial contractility.\nIn summary, the effect of TRH on myocardial contractility can be primarily attributed to an increase in circulating thyroid hormones stimulating an increase in the intracellular concentration of calcium. In addition, increases in NE production and release from the adrenal medulla along with upregulation of proteins involved in intracellular calcium-handling can lead to an increase in myocardial contractility."
  },
  {
    "id": 28,
    "user_query": "Proteomic analyses need prior knowledge of the organism complete genome. Is the complete genome of the bacteria of the genus Arthrobacter available?",
    "text-davinci-003_response": "Yes, the complete genomes of several bacteria of the genus Arthrobacter are available. For example, the genome of Arthrobacter chlorophenolicus A6 has been sequenced and is available through various public databases, such as the NCBI GenBank. Other Arthrobacter species whose genomes have been sequenced and made available include Arthrobacter aurescens TC1, Arthrobacter citreus, Arthrobacter globiformis DSM 20171, Arthrobacter luteolus SB24, Arthrobacter nicotianae A13, and Arthrobacter sp. FB24. Notably, the genomes of these bacteria and others have already been used to generate proteomic datasets for analysis."
  },
  {
    "id": 29,
    "user_query": "What is the structural fold of bromodomain proteins?",
    "text-davinci-003_response": "Bromodomain proteins are a class of enzymes that are primarily found in eukaryotic cells and are known to regulate gene transcription. Structurally, bromodomain proteins typically contain two domains separated by a linker region, with the two domains being the bromodomain and the chromodomain. The bromodomain is an alpha-helix that is typically about 60 amino acid residues in length and consists of three alpha-helices wrapped around a common four-stranded antiparallel beta-sheet. In this structure, the amino-terminal helix binds to a four-stranded peptide. The peptide binds to the chromodomain which contains two alpha-helices and one short connecting loop. The alpha-helices in the chromodomain adopt a coiled-coil structure and bind to specific lysine residues in the linker region. Together, these two domains enable the bromodomain proteins to recognize and bind specific residues in predominantly histone proteins."
  },
  {
    "id": 32,
    "user_query": "Which MAP kinase phosphorylates the transcription factor c-jun?",
    "text-davinci-003_response": "The MAP kinase, c-Jun N-terminal kinase (JNK) is responsible for phosphorylating the transcription factor c-Jun. c-Jun is a member of the family of transcription factors called AP-1, which includes other proteins such as c-Fos and ATF-2. When c-Jun is phosphorylated, it dimerizes with other AP-1 proteins which promotes the activity of target genes. JNK is a member of the MAP kinase family which comprises of three different branches: JNK1, JNK2, and JNK3. Each of these branches is activated through different pathways, such as the p38 MAPK pathway, the stress-activated protein kinase pathway, and the Ras/Raf/MEK pathway."
  },
  {
    "id": 36,
    "user_query": "Which fusion protein is involved in the development of Ewing sarcoma?",
    "text-davinci-003_response": "The fusion protein involved in the development of Ewing sarcoma is called EWS-FLI1. This fusion protein is formed by the fusion of the EWS gene, which encodes the Ewing sarcoma breakpoint region 1 (EWSR1) protein, and the FLI1 gene, which encodes the Friend leukemia virus integration 1 (FLI1) protein. This fusion protein is present in more than 90% of Ewing sarcoma cases, and is thought to be involved in the regulation of tumor-associated pathways and hence the development of Ewing sarcoma."
  },
  {
    "id": 40,
    "user_query": "Treatment of which disease was investigated in the MR CLEAN study?",
    "text-davinci-003_response": "The MR CLEAN study was a randomized clinical trial that investigated the effectiveness of mechanical thrombectomy (reperfusion) for the treatment of acute ischemic stroke. The primary goal of the trial was to determine whether mechanical thrombectomy, when compared with the standard of care, which includes aspirin and intravenous tissue plasminogen activator (tPA), improves functional outcomes in patients with acute ischemic stroke. The MR CLEAN study included 500 patients at 16 centers in the Netherlands. The results of the trial, published in The New England Journal of Medicine in 2015, demonstrated that mechanical thrombectomy significantly improved functional outcomes compared with the standard of care alone."
  },
  {
    "id": 44,
    "user_query": "Does BNP increase after intensive exercise in athletes?",
    "text-davinci-003_response": "Yes, BNP (Brain Natriuretic Peptide) does increase after intensive exercise in athletes. BNP is a peptide hormone that is secreted by the cardiac ventricles in response to increased pressure or volume in the heart. When physical activity is increased, the pressure or volume in the heart increases and thus, BNP increases in response to this heightened activity. A comprehensive review of studies suggests that intensive exercise increases BNP levels in athletes.\nFor instance, one study measured BNP levels after intense exercise in 21 male athletes. The results showed that BNP levels significantly increased after just 10 minutes of intense exercise, and this increase was even more significant after 20 minutes of intense exercise. Another study measured BNP levels in 16 male athletes after moderate intensity exercise and after a period of rest. Again, the results showed that BNP levels increased after just 10 minutes of exercise and continued to increase significantly after 20 minutes of exercise as compared to the period of rest.\nThe results of several studies suggest that BNP increases after intensive exercise in athletes. This increase can be attributed to the increase in the pressure or volume in the heart due to the elevated exercise intensity. Overall, BNP increases in athletes after intensive exercise as a response to the heightened heart activity."
  },
  {
    "id": 47,
    "user_query": "Is Weaver syndrome similar to Sotos?",
    "text-davinci-003_response": "Weaver syndrome and Sotos Syndrome are both rare overgrowth syndromes that affect physical growth and development. However, they do have a few key differences. Both syndromes are caused by genetic mutations, although the exact cause of Weaver Syndrome is unknown.\nIn terms of physical features, Sotos Syndrome is characterized by above-average height, accelerated skeletal maturation, and macrocephaly (an unusually large head size). Other physical features associated with Sotos Syndrome include low muscle tone, an open mouth, and an overall “babyish” facial appearance.\nIn contrast, Weaver Syndrome is characterized by accelerated physical growth (including height and weight), macrocephaly, dysmorphic features (e.g. small eyes, thick ears, wide nasal bridge, etc.), hypotonia (low muscle tone), joint laxity and large lips. Additionally, individuals with Weaver Syndrome may experience developmental delays in language skills, motor skills, and social skills.\nOverall, the main similarity between Weaver Syndrome and Sotos Syndrome is the accelerated physical growth and macrocephaly, although there are several key differences in terms of physical features and associated disabilities."
  },
  {
    "id": 49,
    "user_query": "Are ultraconserved elements often transcribed?",
    "text-davinci-003_response": "Ultraconserved elements (UCEs) are highly conserved, non-coding stretches of DNA that are found across geographic and phylogenetic boundaries in multiple eukaryotic species, and which are thought to be of evolutionary importance. While they are non-coding in the sense that they do not contain instructions for proteins, UCEs may in some cases be transcribed as non-coding RNAs (ncRNAs). This has been found to occur in two ways.\nFirst, evidence suggests that some UCEs may be transcribed as short, stable ncRNA molecules known as small nuclear RNAs (snRNAs). That is, UCEs may act as promoters for transcription of the genomic sequence containing these elements, leading to the production of small groups of ncRNAs. These ncRNAs, which could be involved in gene regulation or even play a direct role in the expression of other non-coding or coding genes, have been identified in several species across phyla.\nSecond, other UCEs may also be processed into larger, more stable ncRNA precursors, referred to as microRNAs or “miRNAs”. MiRNAs are small single-stranded RNAs that bind to the coding strands of mRNA transcripts to regulate the translation of those transcripts into proteins. Recent studies have identified UCE-derived miRNAs in multiple species, suggesting that they may act as transcriptional regulators, in addition to playing a role in other processes such as gene splicing and gene silencing.\nTherefore, while not all UCEs are transcribed, evidence suggests that some UCE elements may be transcribed as both snRNAs and miRNAs. These transcribed UCEs may play a role in gene regulation, or may even directly play a role in the expression of coding genes."
  },
  {
    "id": 54,
    "user_query": "Which DNA sequences are more prone for the formation of R-loops?",
    "text-davinci-003_response": "R-loops, or replicating stress, are regions in the DNA where a single-stranded loop of DNA forms a loop in which a base pair of a double-stranded helix interacts with a single strand. R-loops can arise during transcription, replication, and recombination events. This increases the instability of the DNA structure and leads to potential problems in the cell.\nThe sequences of DNA which are most prone to forming R-loops are those which contain repeat sequences. These repeat sequences can be very short, such as GT or CA, or much longer stretches of nearly identical DNA. The longer repeats are especially prone to forming R-loops, as are sequences which contain inverted repeats, or stretches of DNA which are nearly exactly opposite of each other in the same strand.\nR-loops also form more readily when there are certain conditions present, such as high concentrations of sodium ions and high temperatures. Certain proteins, such as topoisomerases and recombinases, can also increase the formation of R-loops by facilitating the unwinding and re-ligation of DNA strands.\nIn short, any DNA sequences which contain repeat elements, inverted repeats, or expose the strands to high temperatures and/or sodium concentrations are more prone to the formation of R-loops. In addition, proteins which modify DNA structure can also increase the occurrence of R-loops."
  },
  {
    "id": 55,
    "user_query": "Mutation of which gene is implicated in the familial isolated pituitary adenoma?",
    "text-davinci-003_response": "The mutation of the AIP gene (acyl-CoA-independent C-acyltransferase) has been implicated in Familial Isolated Pituitary Adenomas. This gene is located on chromosome 11 and encodes for the enzyme AIP (acyl-CoA-independent C-acyltransferase) which is responsible for synthesizing phospholipids in the pituitary gland. Mutations in the AIP gene can disrupt the synthesis and structure of these important lipids, leading to the formation of pituitary tumors. Additionally, it has been found that the AIP gene can undergo somatic mutations in non-inherited pituitary adenomas, suggesting that this gene may contribute to the development of these tumors as well."
  },
  {
    "id": 56,
    "user_query": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?",
    "text-davinci-003_response": "Troponin C (TNNC1) is a gene that encodes a protein of the same name that is critical for normal heart muscle function. Mutations of this gene have been found to cause hypertrophic cardiomyopathy (HCM), a disease of the heart characterized by thickening of the walls of the heart and an inability of the heart to pump blood effectively.\nStudies have shown that more than 30 specific mutations of the TNNC1 gene have been identified as potential causes of hypertrophic cardiomyopathy. This includes missense mutations resulting in the substitution of one amino acid (the building blocks of proteins) for another in the final protein as well as nonsense mutations resulting in the premature termination of a protein and the subsequent loss of at least some of its functions. There are also non-sense mutations leading to skipped exons that cause the lack of expression of a particular region of the protein. In addition, there are also splice site mutations, changes in the DNA that lead to the abnormal joining of adjacent gene segments. Further, there are large deletions of DNA which can also lead to hypertrophic cardiomyopathy.\nSpecifically, some of the most common and well-studied mutations of the TNNC1 gene that lead to hypertrophic cardiomyopathy are:\n• Glu237Gly (missense mutation)\n• Cys146Arg (missense mutation)\n• Val138Met (splice-site mutation)\n• Leu109Pro (missense mutation)\n• c.201 + 1G>A (splice-site mutation)\n• c.91-92insT (frameshift mutation)\n• c.570delG (small deletion)\n• IVS14 + 2T>G (splice-site mutation)\n• c.258_264del (deletion)\n• IVS14 + 5G>A (splice-site mutation)."
  },
  {
    "id": 58,
    "user_query": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?",
    "text-davinci-003_response": "Histone modifications characteristic of constitutive heterochromatin are primarily repressive. These modifications generally include the addition of methyl groups and acetyl groups, as well as ubiquitination and phosphorylation. \nMethylation of histone lysine residues is the most common modification observed in constitutive heterochromatin. Specifically, methylation of lysine 9 in histone H3 (H3K9me) and lysine 27 in histone H3 (H3K27me) are both typically present. Methylation of lysine 4 in histone H3 (H3K4me) is also present in active euchromatin, but is replaced by H3K9me in constitutive heterochromatin.\nAcetylation of lysine residues in histone tails is also observed in both active and inactive chromatin. However, in constitutive heterochromatin, the acetylation of histone tails is generally lower than in active euchromatin. This difference in acetylation patterns is thought to help contribute to the stable, constitutive heterochromatin structure.\nUbiquitination, or the addition of ubiquitin molecules to lysine residues on histones, is another modification observed in active and inactive chromatin. In constitutive heterochromatin, ubiquitination levels are generally lower than in active euchromatin due to the presence of the other post-translational modifications mentioned above.\nFinally, phosphorylation of serine residues in histones is another post-translational modification observed in active and inactive chromatin. However, in constitutive heterochromatin, phosphorylation is generally lower than in active euchromatin due to the other modifications present."
  },
  {
    "id": 63,
    "user_query": "Are long non coding RNAs as conserved in sequence as protein coding genes?",
    "text-davinci-003_response": "The short answer is no, long non-coding RNAs (lncRNAs) are not as conserved in sequence as protein coding genes. lncRNAs are not under as much selection pressure as protein coding genes; due to their non-coding nature and disordered regions they can tolerate a higher degree of sequence variability than protein coding genes.\nThe long answer is that the degree of sequence conservation between species for lncRNAs is generally less than that observed for protein coding genes. While conservation levels for single lncRNAs across species have been observed to range from 75 to 30%, the average conservation of lncRNAs across species families is closer to 27%. This is well below the average sequence conservation range of 80-90% for protein coding genes across species.\nThis is thought to be due to the fact that lncRNAs are not under the same selection pressure as protein coding genes, and have relatively relaxed evolutionary constraints generally speaking. The lack of a set structure and translational product can allow for variation in the sequence within a lncRNA and still allow for the lncRNA to produce a functional product. As such, lncRNAs are generally less conserved than protein coding genes in terms of sequence, but still can remain functional."
  },
  {
    "id": 65,
    "user_query": "What is clathrin?",
    "text-davinci-003_response": "Clathrin is a protein found in cell membranes, and it plays a critical role in the internalization of substances into many types of cells. It forms giant, three-dimensional structures known as \"clathrin coats\" that are composed of hexagonal grids of three proteins: clathrin heavy chain (CHC), clathrin light chain 1 (CLC1) and adaptor protein 1 (AP-1). Clathrin coats are responsible for the formation of small vesicles known as \"clathrin-coated vesicles\" (CCVs), which act as cargo receptacles for endocytosis, the process by which a cell takes in material from its external environment. Clathrin coats help facilitate the formation of CCVs by assembling around the cell membrane, selectively trapping cargo molecules and providing a structural framework for CCV formation. Clathrin coats play an important role in membrane trafficking, as they facilitate the movement of molecules from the cell surface into the cell. In addition, clathrin is also involved in cell signaling processes such as receptor-mediated endocytosis, synaptic vesicle exocytosis and cytokinesis."
  },
  {
    "id": 66,
    "user_query": "What are the main results of PRKAR1A Knockdown?",
    "text-davinci-003_response": "The main results of PRKAR1A knockdown depend on the context in which it is studied. In some contexts, PRKAR1A knockdown has been associated with reduced cell proliferation, lower adhesion strength, and decreased invasivity of cancer cells, while in other contexts, PRKAR1A knockdown has been associated with increased cell survival and resistance to apoptosis.\nIn cancer cell lines, PRKAR1A knockdown can result in decreased cell proliferation due to attenuation of Cyclin D1. This can actually be beneficial in that it can significantly inhibit tumor growth in preclinical models. Additionally, PRKAR1A knockdown can be used to reduce cell adhesion strength. This can also be beneficial in some contexts since cancer cells typically have increased adhesion, which promotes their ability to spread and metastasize.\nIn some contexts, PRKAR1A knockdown has been associated with decreased invasiveness of cancer cells. This is because PRKAR1A knockdown can impair the ERK1/2 signaling pathway, which has been associated with activated cell migration and invasiveness of cancer cells. In contrast, PRKAR1A knockdown may have the opposite effect in other cell types, leading to increased cell survival and/or resistance to apoptosis. For example, PRKAR1A knockdown in L929 mouse fibroblast cells was found to lead to increased cell survival and decreased apoptosis, likely through an increased expression of BCL-2. \nOverall, the results of PRKAR1A knockdown depend on the context in which it is studied and, while it can inhibit cancer cell growth and invasiveness in some contexts, it can also promote cell survival and increased resistance to apoptosis in others."
  },
  {
    "id": 72,
    "user_query": "Are transcribed ultraconserved regions involved in cancer?",
    "text-davinci-003_response": "Yes, transcribed ultraconserved regions are known to be involved in cancer. Transcribed ultraconserved regions are regions in the genome with high levels of conservation across species, implying a high level of evolutionary importance. This has led researchers to investigate their role in disease processes, including cancer. For example, tandem duplications of the ultraconserved region located at intron 8 of the human Notch3 gene is associated with T-cell acute lymphoblastic leukemia. Additionally, multiple studies have identified significant correlations between mutations in transcribed ultraconserved regions and various types of cancer, including colorectal, breast, ovarian, and lung cancer.\nOverall, transcribed ultraconserved regions provide an interesting focus for researchers to investigate their potential role in the development of various types of cancer. In the future, further research into the implications of mutated or changed transcribed ultraconserved regions for cancer development could improve the prognosis of cancer patients."
  },
  {
    "id": 75,
    "user_query": "List side effects of SGLT2 inhibitors?",
    "text-davinci-003_response": "The most commonly reported side effects of SGLT2 inhibitors include:\n• Urinary tract infections\n• Penile yeast infections\n• Lower blood pressure\n• Increased urination\n• Nausea\n• Diarrhea\n• Constipation\n• Abdominal pain\n• Vomiting\n• Headache\n• Fatigue\n• Dizziness\n• Hypoglycemia\n• Bladder cancer\n• Kidney inflammation\n• Allergic reactions\n• Genital itching or discharge\n• Jaundice\n• Liver enzyme elevation\n• Loss of appetite\n• Weight loss\n• Low blood pressure while standing, especially after the first dose\n• Bloating\n• Joint pain\n• Swelling of the legs or ankles"
  },
  {
    "id": 81,
    "user_query": "List the releases of JASPAR database",
    "text-davinci-003_response": "The JASPAR database is a collection of matrices for the transcription factor (TF) binding sites, used to aid in the understanding of gene regulation. The database has been released periodically since its inception in 2006. Here is a list of the various releases of the database: \n• JASPAR 2006 (ver. 1.0): This was the first release of JASPAR. It contained only vertebrate and plant TFBSs. \n• JASPAR 2020 (ver. 13.0): This is the latest version of the JASPAR database. It contains more than 5,000 position weight matrices for over 1,400 TFs from a variety of species, including mammals, birds, insects, nematodes, and plants. \n• JASPAR 2014 (ver. 6.0): This release provided 40 percent more TFBSs than the 2006 version. It incorporated higher-quality data from several new sources, including a collaboration with the ENCODE project. \n• JASPAR CORE (ver. 11.0): This version included increased coverage of TF binding sites for both vertebrates and plants, incorporating data from hundreds of new sources. \n• JASPAR MA (ver. 1.0): This version released in 2017, provided an improved collection of matrices for mammalian TFs. It featured more detailed annotations and improved accuracy. \n• JASPAR 2016 (ver. 8.0): This release focused on providing additional information about TF binding sites in plants, with an emphasis on regulatory regions associated with gene expression and development in different species. \n• JASPAR 2018 (ver. 10.0): This version incorporated data from many new sources, with a larger focus on regulatory regions related to evolution. It features more detailed annotations and an improved accuracy for both vertebrates and plants."
  },
  {
    "id": 83,
    "user_query": "Which gene is required for the efficient function of clopidogrel?",
    "text-davinci-003_response": "The gene required for the efficient function of clopidogrel is the cytochrome P450 (CYP) 2C19 gene. This gene encodes a liver enzyme responsible for metabolizing clopidogrel into its active form, leading to better efficacy. Various genetic variants of this gene are associated with reduced metabolism and thus decreased effectiveness of clopidogrel. Therefore, knowing the genotype of this gene is important for accurately assessing the treatment response and potentially avoiding adverse events."
  },
  {
    "id": 86,
    "user_query": "Which antibiotics target peptidoglycan biosynthesis?",
    "text-davinci-003_response": "One class of antibiotics that targets peptidoglycan biosynthesis is Beta-Lactam antibiotics, such as penicillin, cephalosporins, and carbapenems.\nPenicillin is a Beta-Lactam antibiotic that targets penicillin-binding proteins (PBPs). PBPs are key enzymes involved in peptidoglycan synthesis in the bacterial cell wall. The inhibition of these PBPs by penicillin disrupts the formation of new peptidoglycan, leading to the death of the bacterial cells.\nCephalosporins are also Beta-Lactam antibiotics that target PBPs. Cephalosporins are structurally similar to penicillin, and thus exhibit similar inhibitory mechanisms on peptidoglycan synthesis.\nCarbapenems are a special class of Beta-Lactam antibiotics that are resistant to Beta-Lactamase enzymes, a type of enzyme that can destroy other Beta-Lactam antibiotics. They are also highly effective at targeting PBPs, making them ideal agents to combat serious bacterial infections.\nIn addition to Beta-Lactam antibiotics, other classes of antibiotics have been developed to target peptidoglycan biosynthesis. Glycopeptides, such as vancomycin, strivecins, and teicoplanin, target the cell wall precursor lipid-II by inhibiting its amino-transferase activity. Daptomycin also binds to the peptidoglycan layer, disrupting its assembly. Lastly, bacitracin and fosfomycin inhibit peptidoglycan biosynthesis by inhibiting the associated enzymes."
  },
  {
    "id": 92,
    "user_query": "What is the mode of action of everolimus?",
    "text-davinci-003_response": "Everolimus (Afinitor) is a drug used to treat patients with cancer. It is a small molecule inhibitor of the mammalian target of rapamycin (mTOR) pathway and works by interfering with cellular signaling pathways that control cell growth and proliferation. The drug blocks mTOR, a protein that plays a central role in tumor cell growth and proliferation. mTOR signals are upregulated in many types of cancers including renal cell carcinoma, hepatocellular carcinoma, neuroendocrine tumors, and pancreatic cancer. By blocking mTOR, everolimus inhibits the production of proteins needed for the growth and survival of cancer cells.\nEverolimus also has immunosuppressive activity, blocking the production of cytokines such as interleukin-2, which are involved in the stimulation of the immune system. By blocking the production of these cytokines, everolimus reduces the immune system’s ability to recognize and attack cancer cells.\nIn addition, everolimus has antitumor activity, leading to the growth inhibition or killing of tumor cells. Several studies have shown that everolimus can reduce the size of tumors and prolong overall survival in patients with advanced cancer."
  },
  {
    "id": 97,
    "user_query": "Which pathological condition of the heart is known as hypertrophic cardiomyopathy (HCM)?",
    "text-davinci-003_response": "Hypertrophic cardiomyopathy (HCM) is a genetic disorder that is characterized by the thickening of the heart muscle, which makes it harder for the heart to pump blood. This thickening causes the walls of the left ventricle to become stiffer than normal. This can cause the left ventricle to become overstretched and enlarged and can also result in the obstruction of the outflow of blood from the heart. This obstruction can cause the heart to work harder to push the blood out of the heart, leading to symptoms such as chest pain, shortness of breath, and fatigue. HCM can also lead to an abnormal heartbeat (arrhythmia) and can cause stroke, heart attack, and sudden cardiac death. It is estimated that hypertrophic cardiomyopathy affects about 1 in 500 people and is considered the most common cause of sudden cardiac death in young adults."
  },
  {
    "id": 99,
    "user_query": "What is the function of the viral KP4 protein?",
    "text-davinci-003_response": "The KP4 protein is a protein found in the parvovirus, which is a member of the family Parvoviridae. It is the main structural protein of the virus and its primary function is to form a protective shell around the virus particles. This shell prevents the virus from being damaged by environmental conditions as well as from being recognized and destroyed by the immune system of its host. The KP4 protein is also involved in the binding of the virus to the host cell surface and its entry into the cell. Furthermore, it assists with virus assembly during its replication and may be involved in the release of the virus particles from the host cell."
  },
  {
    "id": 101,
    "user_query": "What is the principle of the PAR-CLIP methodology?",
    "text-davinci-003_response": "The PAR-CLIP (photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation) method is a technique used to identify protein-RNA binding sites by exploiting UV-induced covalent crosslinking and immunoprecipitation. In the PAR-CLIP procedure, cell lysates are incubated with UV-activated ribonucleoside analogues to enable site-specific formation of covalent protein-RNA complexes. Following the UV exposure, the formed complexes are purified and immunoprecipitated with antibodies specific to the protein of interest, such as RNA-binding domain (RBD)-containing proteins or transcription factors. During the purification process, the crosslinked protein and RNA components of the complexes are digested with appropriate enzymes, such as RNase, DNase, or protease, to isolate the target complexes of interest. After digestion, the resulting products are subjected to reverse transcription and high-throughput sequencing to determine the exact sequences of the protein-RNA crosslinks at the binding sites. This method, thus, enables the identification of proteins that interact with RNA to modulate its metabolism."
  },
  {
    "id": 106,
    "user_query": "Which package is available for analysing genomic interactions in R/Bioconductor?",
    "text-davinci-003_response": "Bioinformaticians use the package Bioconductor/R to analyze genomic interactions. Bioconductor is an open source software that is freely available to biologists and bioinformaticians that allows the analysis of genomic data. \nThe package \"InteractionSet\" from Bioconductor is available for analysing genomic interactions. This package provides integration of genomic data from different sources such as ChIP-Seq, ATAC-Seq, DNase-Seq, Chromatin Interaction Analysis (ChIA-Pet) and Hi-C. It also allows for efficient storage and manipulation of this data. The package can be used to detect significant overlap among different genomic data as well as to identify significant interactions between genomic loci. It provides a variety of graphical representations to visualize findings as well as a wide range of statistical methods to analyse data."
  },
  {
    "id": 107,
    "user_query": "How many clinical trials for off-label drugs in neonates are cited in the literature.",
    "text-davinci-003_response": "It is difficult to answer this question with a precise number because the amount of clinical trials for off-label drugs in neonates that are cited in the literature varies depending on the drug and research that has been conducted. However, we can get an approximate answer by researching published studies and literature reviews related to the topic.\nA literature review published in 2000, for example, included more than 50 clinical trials involving off-label drugs in neonates. A more recent literature review published in 2021 catalogued more than 100 clinical trials and research studies related to the use of off-label drugs in neonates.\nOverall, it is estimated that the amount of clinical trials for off-label drugs in neonates that are cited in the literature is 100 or more; however, this number may fluctuate depending on the drug being studied and the amount of research that has been conducted."
  },
  {
    "id": 112,
    "user_query": "What kind of affinity purification would you use in order to isolate soluble lysosomal proteins?",
    "text-davinci-003_response": "The affinity purification method used to isolate soluble lysosomal proteins involves the use of an immobilized lectin. Lectins are a type of proteins that have specific affinity for particular carbohydrates. For isolating soluble lysosomal proteins, a lectin with affinity for mannose-6-phosphate (M6P) would be most useful. M6P is a common glycosylation found on several lysosomal proteins. The technique involves covalently linking the M6P-binding lectin to a solid support such as agarose beads or a membrane. The purified protein mixture is then passed through the solid support which binds the proteins that contain M6P. The bound proteins can then be eluted with a high concentration of mannose or a calcium ion, depending on the type of lectin used. This affinity purification method has been used successfully for the purification of lysosomal proteins from both mammalian and insect cells."
  },
  {
    "id": 113,
    "user_query": "Which are the genes thought to be regulated by EWS/FLI?",
    "text-davinci-003_response": "The EWS/FLI (Ewing sarcoma Breakpoint Region 1-Friend leukemia integration 1) gene fusion product acts at both the transcriptional and post-transcriptional levels to regulate a subset of genes involved in a variety of cellular processes, such as proliferation, cell cycle progression, and DNA damage response.\nSpecific genes or gene pathways directly regulated by EWS/FLI include:\n1. LMO1 – regulates the transcription of an oncogenic protein that contributes to tumorigenesis in Ewing sarcoma.\n2. NfkB – a master transcription factor activating a variety of genes involved in inflammation, cell cycle and DNA damage response pathways, as well as promoting cell survival and proliferation.\n3. NFAT – modulates cell proliferation, gene expression and apoptosis signaling by controlling the expression of genes involved in cell cycle control.\n4. CCND1 – transcription factor that plays an important role in cell proliferation and oncogenesis.\n5. PTEN – tumor suppressor gene that is involved in negative regulation of cell growth.\n6. CDKN1A – a CDK inhibitor that negatively regulates cell cycle progression, and therefore contributes to regulating cell proliferation.\n7. IGFBP3 – an important regulatory protein in the insulin signaling cascade, and thereby cell growth and survival.\n8. DDX24 – a transcription factor involved in modulating cell cycle and DNA damage response signals."
  },
  {
    "id": 115,
    "user_query": "Which pathological conditions are caused by mutations in the CYLD gene?",
    "text-davinci-003_response": "The CYLD gene encodes a protein called CYLD, or cylindromatosis, which is involved in regulating the recurrence of certain types of tumors. Mutations in the CYLD gene cause a number of different pathological conditions, including:\n1. Familial cylindromatosis: This condition is characterized by noncancerous tumors that grow in the skin and often occur in clusters. Affected individuals may also have tumors that form in the walls of the internal organs.\n2. Multiple familial trichoepithelioma: This condition is characterized by the presence of multiple, small, noncancerous tumors in the skin. Individuals with this condition may have an underlying mutation in the CYLD gene.\n3. Brooke-Spiegler syndrome: This condition is characterized by the presence of multiple noncancerous tumors, typically on the face, scalp, and neck. It is caused by mutations in the CYLD gene.\n4. Multiple familial infundibulocystic basal cell carcinoma: This condition is characterized by the presence of multiple tumors in the skin that may either remain benign, become cancerous, or recur. It is caused by mutations in the CYLD gene.\n5.FLAM syndrome: This condition is characterized by the presence of multiple noncancerous tumors and recurrent dry and scaly skin patches. It is caused by mutations in the CYLD gene."
  },
  {
    "id": 121,
    "user_query": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A).",
    "text-davinci-003_response": "The following genes have been found mutated in CMT1A (Charcot-Marie-Tooth Disease type 1 A):\n-PMP22 (Peripheral Myelin Protein 22)\n-MPZ (Myelin Protein Zero)\n-GJB1 (Gap Junction Protein Beta-1)\n-Egr2 (Early Growth Response Protein 2)\n-NEFL (Neurofilament Light)\n-LITAF (Lipopolysaccharide-Induced TNF-Alpha Factor)\n-SH3TC2 (SH3 Domain and Tetratricopeptide Repeat Containing 2)\n-MGC2745 (Mitochondrial Genome-Encoded Protein 45)\n-MTMR2 (Myotubularin Related Protein 2)\n-HSPB1 (Heat Shock Protein Beta-1)\n-HSPB8 (Heat Shock Protein Beta-8)\n-DYSF (Dysferlin)\n-HSPB3 (Heat Shock Protein Beta-3)\n-GARS (Glycyl-tRNA Synthetase)\n-TRIM2 (Tripartite motif Containing 2)\n-SH3TC1 (SH3 Domain and Tetratricopeptide Repeat Containing 1)\n-CNTNAP2 (Contactin Associated Protein-Like 2)."
  },
  {
    "id": 123,
    "user_query": "Which genes have been associated with Cerebral Cavernous Malformation?",
    "text-davinci-003_response": "Genes associated with Cerebral Cavernous Malformation or CCM include KRIT1, CCM2, PDCD10, CCM3, MGC4607, CSPG4, MAPK1, HIF1A, EPAS1, MKL1, and PTEN.\nKRIT1 stands for Krev Interaction Trapped 1 and is located on chromosome 7q21. It encodes for a protein that functions in cell adhesion and acts as a regulator of angiogenesis.\nCCM2 codes for a protein known as Complement Component C2 that has a role in controlling inflammation. It is located on chromosome 7p14.1-22.\nPDCD10 stands for Programmed Cell Death 10 and is located on chromosome 7p22. It is involved in the regulation of restenosis processes and controls vascular development.\nCCM3 is also known as cerebral cavernous malformation 3 and is located on chromosome 7p14.1-22. It helps regulate endothelial cell organization and cell adhesion in vascular structures.\nMGC4607 is a gene located on chromosome 7q11 and codes for a protein that regulates MAPK signaling pathways in endothelial cells.\nCSPG4 is an abbreviation for Chondroitin Sulfate Proteoglycan 4, a protein that acts as an inhibitor of angiogenesis. It is located on chromosome 7p14.1-22.\nMAPK1 stands for Mitogen-Activated Protein Kinase 1 and is located on chromosome 7p21. It is involved in a variety of cellular processes, including angiogenesis.\nHIF1A stands for Hypoxia-Inducible Factor 1 alpha and is located on chromosome 7p21. It is involved in regulation of angiogenesis and vascular remodeling.\nEPAS1 or the endothelial PAS domain protein 1 is located on chromosome 7q21 and is involved in regulation of vascular growth.\nMKL1 or Megakaryoblastic Leukemia 1 is located on chromosome 7q11 and regulates a broad spectrum of cellular processes, including vasculogenesis and angiogenesis.\nFinally, PTEN stands for phosphatase and tensin homolog and is located on chromosome 10q22. It is involved in the regulation of cell growth and cell proliferation."
  },
  {
    "id": 124,
    "user_query": "Is DITPA a thyroid hormone analog utilized in experimental and clinical studies",
    "text-davinci-003_response": "?\nNo. DITPA (1,3-diisopropyl-8-aziridine-2,4 dicarboxylate) is not a thyroid hormone analog and is not utilized in clinical or experimental studies. DITPA is a compound found in research laboratories, but it does not appear to have any therapeutic uses. It has been studied for its effects on certain receptors, however, these studies do not involve the use of DITPA as a thyroid hormone analog."
  },
  {
    "id": 130,
    "user_query": "What is needed for MMP proteins to be functional?",
    "text-davinci-003_response": "MMP proteins must have the correct composition and folding to be functional. They must include all necessary domains and motifs, such as the pro- and catalytic domains, the double-stranded structure, and the zinc-binding sites. MMPs must have the ability to interact with their substrates and their inhibitors, and be able to cleave these substrates. The enzyme activity of MMPs is also dependent upon each MMP's specific environment, such as pH, ionic strength, temperature, and the presence of ions (e.g., Zn2+, Mn2+). Finally, MMPs must be properly localized in the cell, to ensure that they are in their active sites and that they are able to access their substrates."
  },
  {
    "id": 133,
    "user_query": "Which is the most known bacterium responsible for botulism (sausage-poisoning)?",
    "text-davinci-003_response": "The most commonly known bacterium responsible for botulism (sausage-poisoning) is Clostridium botulinum, a Gram-positive anaerobic bacterium. It is the causative agent of botulism, a severe paralytic disease that can be fatal and is the most toxic substance known to man, with just nanograms of toxin causing symptoms and death. The organism is commonly found in soil and in some foods such as meats, fish, dairy products, and honey. The bacterium produces a toxin that can cause a range of symptoms such as nausea, vomiting, diarrhea, vision and speech impairments, paralysis, and in extreme cases, even death. Botulism can be prevented by proper food handling, refrigeration, and sterilization techniques."
  },
  {
    "id": 138,
    "user_query": "Which are the plant DNA (cytosine-5) methyltransferase families?",
    "text-davinci-003_response": "The plant DNA (cytosine-5) methyltransferase families are a group of enzymes known as DNA methyltransferases (DNMTs). These enzymes catalyze the transfer of a methyl group from a source, such as S-adenosyl-L-methionine (SAM), to the fifth position of a cytosine residue in DNA. Some of the families of plant DNMTs include DNMT1, DNMT3, DNMT4, and DNMTT1/DNMTT2.\nDNMT1, also known as the maintenance DNA methyltransferase, is found primarily in animals and is involved in the maintenance of DNA methylation patterns during cell division. In plants, DNMT1 is involved in transcriptional regulation, DNA replication, transgene silencing, and small RNA-mediated gene regulation.\nDNMT3 is a family of DNA methyltransferases found mainly in plants and fungi that is involved in cytosine methylation in response to environmental or developmental stimuli. DNMT3s have been identified to have roles in various plant developmental processes, such as seedling development and flowering.\nDNMT4 is found primarily in plants and functions as a chromatin-remodeling enzyme. DNMT4 is thought to be involved in epigenetic control of transcription and is proposed to have roles in gene silencing, epigenetic memory, and gene reactivation. \nThe DNMTT1/DNMTT2 family, also known as the terminal cytosine-specific methyltransferases, is a family of small plant enzymes that catalyze the methylation of the fifth position of a cytosine residue in DNA. These enzymes are primarily associated with active gene transcription, and they have been found to be involved in the regulation of developmental processes, such as vernalization and flowering time."
  },
  {
    "id": 139,
    "user_query": "Where is the histone variant CENPA preferentially localized?",
    "text-davinci-003_response": "CENPA (Centromeric Protein A) is a histone variant that is preferentially localized in the centromeres of chromosomes. It is specifically recognized as the major histone H3 variant present at the centromeres of all eukaryotes and is present in all centromeric chromatin as it is critical in promoting proper chromosome segregation during mitosis. It is thought that CENPA helps package centromeric chromatin into an ordered nucleosome array, and that it is involved in regulating the structural organization of the centromere and the inheritance of genetic information. It has also been observed to play a role in chromosome stability and in modulating the structure of chromatin."
  },
  {
    "id": 140,
    "user_query": "In which proteins is the chromodomain present?",
    "text-davinci-003_response": "The chromodomain is a protein domain found in more than 600 proteins across all three domains of life. The domain is about 40-50 amino acids in length, and is composed of two alpha helices joined by a short loop. It usually binds acetylated lysine residues, and is found in proteins such as histones, non-histones, and transcription regulators. Chromodomains are important for chromatin remodeling, epigenetic regulation, transcription, DNA repair, and other processes.\nIn histones, the chromodomain is most commonly found in the linker histones H1 and H5, the protamines P1 and P2, and the histone H3 variant, H3.3. In non-histone proteins, chromodomains are found in the Sp1 transcription factor, transcriptional regulator BPTF, and proteins involved in RNA processing and histone modification including CHD4/Mi-2, CHD1, MBD2/3/4, Chromobox and Chromoshadow. Chromodomain-containing proteins are also found in transposons, retroviruses, and bacterial regulatory systems."
  },
  {
    "id": 142,
    "user_query": "Is amiodarone a class I anti-arrhythmic drug?",
    "text-davinci-003_response": "Yes, amiodarone is a class I anti-arrhythmic drug. Amiodarone belongs to a group of medications known as class I anti-arrhythmic drugs. This class of anti-arrhythmic medications is used to treat and prevent abnormal heart rhythms, or arrhythmias, as well as to improve the effectiveness of other anti-arrhythmic medications. Class I anti-arrhythmic drugs work by blocking the sodium channels in cardiac cells, which reduces the conduction of electrical impulses throughout the heart and suppresses arrhythmias. Amiodarone also prolongs the action potential of cardiac cells, which further decreases the risk of abnormal heartbeats. The most common uses of amiodarone include the treatment of life-threatening arrhythmias, such as ventricular fibrillation and ventricular tachycardia, as well as maintenance of sinus rhythm in patients who have atrial fibrillation or atrial flutter."
  },
  {
    "id": 144,
    "user_query": "What is the COUGER tool?",
    "text-davinci-003_response": "The COUGER (Analysis of Cost and Utilization Geared for Efficiency Results) is a web-based healthcare system analysis tool developed by the Health Resources and Services Administration's (HRSA) Bureau of Primary Health Care. This tool was created to provide primary care providers, health centers, and Public Health Service organizations with a way to better understand how they use personnel, resources, and services to provide care.\nThe goal of COUGER is to accurately identify the cost and utilization of health and human services for an individual health center or multi-site base. It allows users to view reports on cost and utilization information to enhance understanding about their service levels, optimize the efficiency of resources, and manage costs.\nCOUGER also includes a set of additional components to aid in the assessment of data and analysis of data. These components include the Cost Analysis Worksheet, the Utilization Analysis Worksheet, and the Aging Analysis Worksheet. These worksheets are designed to provide users with a comprehensive view of their Center’s use of resources and personnel. These worksheets organize data into multiple categories that can be used to understand associated costs and understand utilization patterns.\nCOUGER also features a web-based interactive dashboard, which allows users to access data from disparate sources, view the data as a single source of information, and establish direct connections to external data sources such as the Area Health Education Center and the Bureau of Primary Health Care. The interactive dashboard also provides users with the ability to filter the data by cost categories, utilization categories, save favorite reports, and access pre-formatted reports."
  },
  {
    "id": 145,
    "user_query": "Are there drugs for Tick-borne Encephalitis?",
    "text-davinci-003_response": "Yes, there are drugs for Tick-borne Encephalitis (TBE). These drugs include antiviral medications, such as acyclovir or valacyclovir, which are typically used to treat infections caused by the herpes virus. Additionally, an immunomodulatory drug, such as interferon, may also be used to treat TBE, as well as other types of viral encephalitis.\nIt is important to note that while these medications can help reduce symptoms and shorten the duration of illness for some individuals with TBE, they are not a cure. Some individuals may also need additional treatment for complications like inflammation of the brain and seizures. Additionally, there is no specific vaccine available to prevent TBE in humans, though some vaccines are available for both humans and animals to reduce their risk of infection."
  },
  {
    "id": 146,
    "user_query": "Is SLC22A3 expressed in the brain?",
    "text-davinci-003_response": "Yes, SLC22A3 (solute carrier family 22, member 3) is expressed in the brain. SLC22A3 is a member of the organic cation transporter (OCT) family and is predominantly expressed in neurons. It has been found to be expressed at high levels in the brain where it is thought to influence neurotransmitter levels in the brain, as well as playing an essential role in maintaining the balance between cations and anions inside the cell. It has also been shown that SLC22A3 expression is linked to Parkinson's disease and Alzheimer's disease, further demonstrating its importance in brain function."
  },
  {
    "id": 151,
    "user_query": "Which genome browser database for DNA shape annotations is available?",
    "text-davinci-003_response": "There are a few different genome browser databases available for DNA shape annotations. The first one that comes to mind is the ENCODE portal (ENCODEproject.org), which houses the Encyclopedia of DNA Elements (ENCODE) public data set. This is a compilation of data sets from over 400 labs around the world, and includes annotations based on chromatin immunoprecipitation, transcriptomics, and structural information such as shape analyses. The ENCODE portal offers a variety of tools and visualizations for exploring DNA shape annotations, such as the strand-biased view and the DNA structure explorer.\nA slightly different option is a Galaxy instance hosted by the National Institutes of Health (NIH) Bioinformatics Resources Portal. This instance includes a tool for exploring and visualizing the shape of DNA sequences. It also allows users to view the structural dynamics and positional frequency of nucleic acids, and to review annotations of DNA structure from a variety of sources such as CpG sites and polymorphic sites.\nFinally, the UCSC Genome Browser is another option for exploring DNA shape annotations. This browser includes a tools known as SAVI (Sequence Analysis Viewer and Integrator) which allows users to view the shape of their DNA sequences, depiciting the bias of nucleotides in different regions of the genome. It also provides a variety of interactive graphical views to help users explore the 3D structure of DNA sequences."
  },
  {
    "id": 153,
    "user_query": "What is the relationship between TailorX and Oncotype?",
    "text-davinci-003_response": "TailorX is a clinical decision tool made by Genomic Health, Inc., which uses the Oncotype DX breast cancer test results to help physicians and patients make more informed and personalized treatment decisions for early-stage breast cancer. The Oncotype DX test is a genomic test developed by Genomic Health, which analyzes the activity of 21 genes associated with disease recurrence and distant metastasis to produce a personalized Recurrence Score result. The TailorX tool helps to bridge the gap between the Recurrence Score result and the individual patient's risk by providing an estimate of how effective adjuvant chemotherapy might be for each individual patient. TailorX is a clinically validated, evidence-based tool that takes into consideration the patient-specific factors specific to each individual, such as age, tumor size, lymph node status, and other factors that may influence a patient's prognosis. Additionally, TailorX helps to provide insight into how specific treatment decisions may affect outcomes in Los Angeles and elsewhere."
  },
  {
    "id": 154,
    "user_query": "Does strenuous physical activity affect thyroid hormone metabolism?",
    "text-davinci-003_response": "Yes, strenuous physical activity can affect thyroid hormone metabolism. When a person engages in prolonged, excessive exercise, the body is put under physiological stress and the sympathetic nervous system is activated which can influence the thyroid hormones. During strenuous exercise, the body uses increased amounts of glucose and lipids as energy sources. This can lead to decreased circulating levels of thyroid hormones, such as triiodothyronine (T3) and thyroxine (T4), which can affect metabolic processes throughout the body.\nFurthermore, when the body is under physical stress, the hypothalamus-pituitary-thyroid (HPT) axis can be suppressed. This occurs when stress hormones, such as cortisol, are released and act directly on the thyroid gland to inhibit the synthesis and release of thyroid hormones. As a result, this can lead to a decrease in thyroid hormones despite the presence of adequate circulating levels.\nSo, in conclusion, strenuous physical activity can affect thyroid hormone metabolism by decreasing circulating levels of thyroid hormones, as well as by suppressing the HPT axis. It is important to note, however, that this effect is usually only temporary, as the body’s hormonal and metabolic systems will adjust and return to normal once the activity is stopped."
  },
  {
    "id": 155,
    "user_query": "Which is the main function of \"RNA sponges\"?",
    "text-davinci-003_response": "RNA sponges are used as a tool to investigate the function of specific genes in cells. They are made from short hairpin RNAs (shRNAs) that are designed to bind to and block the expression of a certain gene. By introducing these RNA sponges into cells, scientists can measure the effect of blocking the expression of the gene on cell growth and development, and investigate its function in the cell. RNA sponges can also be used to uncover the link between a gene and a biological pathway, by playing with different gene variants. For example, RNA sponges can be used to assess the effect of multiple gene mutations on the action of a biological pathway. By combining RNA sponges with other molecular tools, such as gene expression markers, it is possible to accurately measure the effect of blocking the expression of a certain gene on overall gene expression. Hence, RNA sponges offer a powerful tool to investigate gene function in cells."
  },
  {
    "id": 157,
    "user_query": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?",
    "text-davinci-003_response": "Mutations of the phospholamban (PLN) gene have been found in patients with cardiomyopathy. The PLN gene encodes a calcium pump that is essential for the normal functioning of the heart muscle, and mutations of the gene can lead to abnormal calcium cycling, causing alterations in muscle contraction. The common PLN mutations associated with cardiomyopathy include:\n-R14del mutation: This mutation results in the deletion of an arginine residue. It has been reported in many patients with dilated cardiomyopathy (DCM) and is one of the most common variants of the PLN gene associated with cardiomyopathy. \n-R9W mutation: This mutation results in the substitution of the arginine residue with a tryptophan residue. It has been identified in several cases of arrhythmogenic right ventricular cardiomyopathy (ARVC). \n-G57S mutation: This mutation results in the substitution of a glycine residue with a serine residue. It has been associated with familial DCM.\n-I45T and R50C mutations: These mutations result in the substitution of an isoleucine residue with a threonine residue, and of an arginine residue with a cysteine residue respectively. They have been identified in several cases of familial DCM.\n-R12C mutation: This mutation results in the substitution of an arginine residue with a cysteine residue. It has been associated with ARVC."
  },
  {
    "id": 160,
    "user_query": "Is there any software for automated analysis of FISH images?",
    "text-davinci-003_response": "Yes, there are several software programs available for automated analysis of FISH images. Many of them can be used to detect and measure fluorescence intensities, segment and analyze cell populations, and store data for further analysis. Some of the most popular software programs include MetaXpress from Molecular Devices, CellProfiler from the Broad Institute, and Cellomics ArrayScan from Thermo Fisher Scientific.\nAnother option is to use algorithms to detect automatically fused in situ hybridization (FISH) spots. Algorithms such as QMosaic, QFISH, and Spot-FISH are specifically designed for detecting FISH spots. Most of these algorithms use a combination of feature extraction algorithms, machine learning, and advanced image analysis techniques to accurately detect and measure FISH spots.\nFinally, there are software packages available for glycobioanalysis, which can be used to analyze FISH images. These programs typically allow users to overlay images and visualize protein localization in the cell. This type of analysis can provide insights into the pathways involved in cell functions and processes, as well as reveal research into the glycosylation pathways of different organisms."
  },
  {
    "id": 165,
    "user_query": "List markers for autophagy.",
    "text-davinci-003_response": "1. Autophagic cellular markers: Autophagic flux can be monitored by a range of cellular markers, including LC3 (microtubule-associated protein 1, MAP1LC3), p62 (also known as sequestosome 1), beclin 1, Atg5, and Atg7. LC3 is ubiquitously expressed, and it is cleaved and conjugated to phosphatidylethanolamine in the presence of autophagy. The levels of LC3, Atg5, and Atg7 decrease during autophagy, and the p62 levels increase.\n2. Autophagic organelle markers: Autophagy of organelles can be monitored by measuring the levels of lysosomal enzymes or proteins, such as cathepsins, β-hexosaminidase, and BNIP3.\n3. Autophagic substrate markers: Autophagosomes can be packed with specific proteins or lipids, which can be monitored through the detection of these proteins or lipids."
  },
  {
    "id": 169,
    "user_query": "Are there any specific antidotes for rivaroxaban?",
    "text-davinci-003_response": "No, there are no specific antidotes for rivaroxaban. Rivaroxaban is an oral anticoagulant drug used to reduce the risk of stroke and blood clots in people who have atrial fibrillation (an irregular heart rhythm) not caused by a heart valve problem. Rivaroxaban works by blocking blood clot formation, specifically by inhibiting thrombin, a key enzyme responsible for blood clotting. Because of the way that rivaroxaban works, there is no specific antidote to reverse its effects. However, in cases of serious bleeding, medications such as vitamin K, activated prothrombin complex concentrate, and fresh frozen plasma can be used to try to increase clotting and reduce bleeding. Additionally, direct oral anticoagulant-specific antibodies can be given to help reverse the effects of some anticoagulants, including rivaroxaban. These antibodies bind to the anticoagulant, preventing it from binding to its target and theoretically reducing its effects. However, these drugs are expensive and have limited availability in some areas."
  },
  {
    "id": 171,
    "user_query": "What is the function of 6SRNA in bacteria?",
    "text-davinci-003_response": "6S RNA is a small, scaffold-like non-coding RNA molecule found in a variety of bacteria. 6S RNA plays a key role in bacterial gene regulation because it binds to the σ70 subunit of the RNA polymerase, forming a ternary complex that is essential for transcription initiation. It acts as a housekeeping gene and helps in maintaining the stability of the transcription and helps the initiation of transcription. In the absence of 6S RNA, the stability of the transcription complex decreases resulting in reduced transcription. In some bacteria, transcription of 6S RNA is responsive to environmental stimuli and acts as a regulatory gene, suggesting that it is important for the expression of genes involved in adaptation to changing environmental conditions. Additionally, 6S RNA modulates secondary structures within 16S and 23S ribosomal RNAs resulting in alterations in ribosomal conformation, which affects both translation and stability of the ribosomal RNA."
  },
  {
    "id": 172,
    "user_query": "Is cytisine superior to nicotine replacement therapy for smoking cessation?",
    "text-davinci-003_response": "The answer to this question is complicated and requires consideration of several factors when determining whether cytisine is superior to nicotine replacement therapy (NRT) for smoking cessation. \nOverall, there is conflicting research regarding the effectiveness of cytisine compared to NRT in smoking cessation. One study published in New England Journal of Medicine in 2016 showed that in a trial of 831 cigarette smokers, consuming cytisine reduced smoking by almost twice as much as those taking a placebo and was as effective as NRT in terms of all major quit smoking outcomes. A more recent 2019 systematic review indicated that while cytisine was effective as both a first-line treatment and an adjunct treatment to NRT, it was not as efficacious as NRT when used as a monotherapy.\nThe cost of cytisine is substantially lower than NRT, making it an attractive option for some smokers. It is also an easy-to-use oral tablet that could be taken at home, whereas NRT involves using a patch or inhaler. Thus, there are certain advantages to using cytisine over NRT in some cases.\nHowever, when considering the effectiveness of cytisine compared to NRT, it is important to note that it is not suitable for all smokers. Those who experience side effects to cytisine and those who have chronic illnesses or are pregnant may not be able to take the medication. In addition, the available research regarding cytisine is mainly from Eastern European countries, and there is a lack of research regarding its use in the Western world. \nOverall, more research is needed regarding the effectiveness of cytisine relative to NRT as a smoking cessation treatment. The best option for a given individual should be decided by a healthcare provider based on the smoker's health history and preferences."
  },
  {
    "id": 173,
    "user_query": "Which amino acid residue appears mutated in most of the cases reported with  cadasil syndrome?",
    "text-davinci-003_response": "The most common mutation associated with CADASIL Syndrome is a substitution of glutamic acid to either glycine (G4V) or cysteine (G4C) at position 44 in the Notch3 protein. This amino acid residue is located within the Epidermal Growth Factor (EGF)-like repeat segment. Glutamic acid is an acidic (negative) charge on the protein and substitution with glycine and cysteine is resulting in decreased charge, which disrupts the normal function of the Notch3 protein."
  },
  {
    "id": 174,
    "user_query": "Which syndromes are associated with mutations in the EZH2 gene?",
    "text-davinci-003_response": "EZH2 is a gene that is associated with several syndromes, including Weaver syndrome, Bohring–Opitz syndrome, Kabuki syndrome, and Coffin-Siris syndrome.\nWeaver syndrome is a rare genetic disorder caused by a mutation in the EZH2 gene. It is characterized by tall stature, dysmorphic facial features, slow psychomotor development, behavioural problems, and intellectual disability.\nBohring–Opitz Syndrome (BOS) is a rare genetic disorder caused by mutations in the EZH2 gene. It is characterized by distinctive facial features, severe intellectual disability, recurrent infections, and recurrent respiratory problems. \nKabuki Syndrome is a rare genetic disorder caused by a mutation in the EZH2 gene. It is characterized by unique facial features, developmental delay, hypotonia, and skeletal and immunological abnormalities.\nCoffin–Siris Syndrome (CSS) is a rare genetic disorder caused by mutations in the EZH2 gene. It is characterized by distinctive facial features, intellectual disability, coarse facial features, short stature, growth delay, and joint laxity."
  },
  {
    "id": 175,
    "user_query": "Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?",
    "text-davinci-003_response": "A variety of databases exist for experimentally determined topologies of α-helical transmembrane proteins. The comprehensive resource for this information is the MEMSAT3 database, which contains experimentally determined transmembrane α-helical regions from protein sequences in 11 taxonomic kingdoms. Additionally, the Protein Data Bank (PDB) contains a diverse set of experimentally determined transmembrane α-helical regions of proteins. The Transmembrane Proteins Database is a database of experimentally determined topologies, descriptions, and alignments of transmembrane proteins from different organisms. Lastly, the International Protein Index (IPI) Transmembrane Proteins Database provides annotations that integrate known 3D structures as well as experimentally determined topologies of α-helical transmembrane proteins."
  },
  {
    "id": 178,
    "user_query": "How is oprozomib administered?",
    "text-davinci-003_response": "Oprozomib is an oral medication and is typically taken as tablets or oral suspension mixed with a small amount of water or other suitable liquid. The tablets should be taken with food 2 or 3 times a day at least one hour before or two hours after meals or as instructed by your doctor. The oral suspension should be taken two or three times daily with food and the dose mixed with at least three tablespoons of water or other suitable liquid such as juice, soda, or milk. The mixture should be completely consumed after mixing and any remaining mixture should be thrown away after use. Swallowing the tablets or suspension whole without chewing and without food can lead to throat irritation."
  },
  {
    "id": 182,
    "user_query": "Does thyroid hormone regulate calcium transient in the myocardium?",
    "text-davinci-003_response": "Yes, thyroid hormone does regulate calcium transient in the myocardium. The hormone thyroxine (T4) is released by the thyroid gland and increases circulating levels of calcium ions (Ca2+) in the blood, which are necessary for normal contraction and relaxation of cardiac muscle. This regulates the interaction of Ca2+ with calcium-binding proteins, allowing more Ca2+ ions to enter into cardiac muscle cells, causing an increased intracellular concentration of these ions.\nThe influx of Ca2+ into the myocardium is coupled with an efflux of other ions out of the cell, particularly sodium, causing changes in the electrical potential within the cell. These changes cause the opening of specialized channels, such as the L-type Ca2+ channels, which allow even more Ca2+ to enter the cell. In this way, it activates specific proteins, most importantly those of the actin and myosin filaments which are responsible for the contraction and relaxation of cardiac muscle cells. As a result, the balance of intracellular Ca2+ levels is regulated, and eventually a calcium transient is generated within the cardiac muscle cell.\nThe regulation of calcium transients by thyroid hormone is essential for the homeostasis and functioning of the myocardium. In the absence of sufficient thyroid hormone, the calcium transient cannot be generated and the normal contraction and relaxation of cardiac muscle cells is not achieved, leading to a condition known as myocardial hypothyroidism."
  },
  {
    "id": 185,
    "user_query": "The protein NONO forms heterodimers. With which proteins?",
    "text-davinci-003_response": "NONO is a protein known as Nucleolar and Coiled-Body Component Protein. It is a type of Protein Coding Gene found in the human body. NONO has been found to form heterodimers with various other proteins, including U2AF65, PADI6, MBP1, DNAJ, and c-Myc. The NONO-U2AF65 heterodimer is a complex found in the core promoter of human genes and is involved in the transcription of multiple genes. NONO-PADI6 and NONO-MBP1 heterodimers have been found to be involved in the maintenance of the nucleolar structure in the cell. The NONO-DNAJ heterodimer is involved in the gene silencing of human X-chromosome-linked genes. The NONO-c-Myc heterodimer acts as a transcriptional repressor upon many types of genes."
  },
  {
    "id": 188,
    "user_query": "Is there any link between CTF4 and CTF18 during sister chromatid cohesion?",
    "text-davinci-003_response": "Yes, there is a link between CTF4 and CTF18 during sister chromatid cohesion. CTF4 is an evolutionarily conserved protein that is part of the multiprotein cohesin complex. This complex has an essential role in sister chromatid cohesion during mitosis and meiosis. CTF18 is an isoform of CTF4 that is expressed during meiosis specifically. CTF4 and CTF18 are both components of the cohesin complex and have overlapping functions in mediating sister chromatid cohesion. CTF18 is needed for proper meiotic sister chromatid cohesion by specifically mediating the cohesion between unsynapsed chromosomes during prophase I. Thus, CTF4 and CTF18 are linked during sister chromatid cohesion as CTF18 is needed to recruit CTF4 to chromosomes to ensure proper establishment of sister chromatid cohesion during meiosis."
  },
  {
    "id": 193,
    "user_query": "List human proteins that are subject to a dimer-to-tetramer transition.",
    "text-davinci-003_response": "1. Interferon Alpha (IFN-α): This cytokine protein is involved in mediating the antiviral and antitumor response. It is known to exist in a dimeric state but can undergo a transition to tetramers during its activation pathways. \n2. Gamma Interferon (IFN-γ): This cytokine protein activates T cells, natural killer cells, and macrophages and is known to exist in both dimeric and tetrameric forms. \n3. Tumor necrosis factor (TNF): This cytokine protein is involved in apoptosis and inflammation and is known to exist in both dimeric and tetrameric forms depending on its conformation. \n4. Prothymosin Alpha (ProT-α): This small acidic protein is involved in transcription and cell proliferation and is known to exist in both dimeric and tetrameric forms. \n5. Kruppel-like Factor 6 (KLF6): This transcription factor is involved in cell growth and proliferation and is known to exist in both dimeric and tetrameric forms. \n6. Heat Shock Protein 90 (Hsp90): This protein plays an important role in the maturation of other proteins and is also known to exist in both dimeric and tetrameric forms. \n7. Glutathione-S-Transferase (GST): This enzyme protein is involved in detoxification and is also known to exist in both dimeric and tetrameric forms."
  },
  {
    "id": 197,
    "user_query": "Which gene strand is targeted by transcription-coupled repair (TCR)?",
    "text-davinci-003_response": "Transcription-coupled repair (TCR) targets the transcribed strand of a gene, known as the sense strand. The sense strand is the strand of the gene from which proteins are transcribed. During transcription, mRNA is synthesized from this strand, encoding the information to make the protein.  TCR recognizes a stalled RNA polymerase on the sense strand and initiates repair of damage on that same strand. It then repairs the damage through the recognition of the DNA–RNA hybrid, which is formed during transcription. The repair system not only corrects mutations in the transcribed sense strand, it also prevents transcription errors and maintains the integrity of the gene."
  },
  {
    "id": 199,
    "user_query": "Which is the branch site consensus sequence in U12-dependent introns?",
    "text-davinci-003_response": "The branch site consensus sequence in U12-dependent introns is YNYuRYNG, where Y corresponds to a pyrimidine, N stands for any base, and R is a purine. This is typically followed by a GU at the splice site. The YNYuRYNG sequence is found in positions -20 to -13 upstream of the U12-dependent intron. These positions are known as the \"invariant branch site\" and are located specifically within the region of the branch site that's recognized by the U12 snRNP and is essential for proper splicing."
  },
  {
    "id": 201,
    "user_query": "What is the suggested therapy for Mycobacterium avium infection?",
    "text-davinci-003_response": "The recommended therapy for Mycobacterium avium infection includes a combination of antibiotic drugs that are active against the bacteria. Depending on the patient and the specifics of the infection, this may include two or more of the following antibiotics: ethambutol, clarithromycin, azithromycin, rifampin, amikacin, or ciprofloxacin. If the patient is not responding to the initial antibiotics, other drugs may need to be added to the regimen or substituted.\nOther therapies used to treat Mycobacterium avium infection include a combination of surgical procedures, and immunomodulatory agents such as interferon gamma or immunoglobulins. Surgical therapies may include removing any lymph nodes or tissues that are infected and reconstructive surgery to repair damaged organs. Immunomodulatory therapies can help the body to better fight the infection and stimulate the immune system to help clear the bacteria.\nIn addition to antibiotic and other therapies, doctors may also recommend lifestyle modifications to help manage M. avium infection. This may include changing the diet to reduce sugar and fat and eating more fruits and vegetables, avoiding exposure to cigarette smoke and other pollutants, and taking supplements to boost the immune system."
  },
  {
    "id": 210,
    "user_query": "Which protein has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein?",
    "text-davinci-003_response": "The protein that has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein is Bcl-2, or B-cell lymphoma 2. Bcl-2 is an abnormal protein found in some types of leukemia and lymphomas and is known to interfere with cell death (apoptosis) by forming complexes with other apoptotic proteins such as PLN. When complexed with PLN, Bcl-2 can modify the enzyme’s phosphate group, which can lead to either a weakening or a strengthening of PLN’s effect on mitochondrial calcium-related activities. Bcl-2 is also capable of binding to other targets such as Bad, Bax, and Bcl-xL, thus effectively modulating mitochondrial permeabilization. This is why Bcl-2 is considered an anti-apoptotic protein, since its complexing with PLN helps maintain the integrity of cell membranes, preserving cell survival."
  },
  {
    "id": 213,
    "user_query": "Is protein M3/6 a dual specificity phosphatase?",
    "text-davinci-003_response": "No, protein M3/6 is not a dual specificity phosphatase. The M3/6 protein is a human ubiquitin protein isopeptidase which is an enzyme involved in the ubiquitin-proteasome pathway, a process involved in intracellular protein degradation. It is responsible for the removal of ubiquitin from a substrate protein and the resultant peptide bond structure is then excised by ADAM10. By contrast, dual specificity phosphatases are also called dual-specificity tyrosine phosphorylation regulated kinase (DYRK) or dual-specificity tyrosine-regulated kinase (DYRK) as they regulate the activation of tyrosine kinases, a process important for transferring biological signals from the cytokine receptor complex to other proteins in the cell known as effector proteins."
  },
  {
    "id": 218,
    "user_query": "Has vitamin D has been shown to reduce incidence of falls in older people in clinical trials?",
    "text-davinci-003_response": "Yes, vitamin D has been shown to reduce the incidence of falls in older people in clinical trials. A systematic review of 16 randomized controlled trials published in The BMJ in 2019, including over 8,000 participants aged 60 years or older, found that supplementation with vitamin D reduced the incidence of falls across the studies. Specifically, the meta-analysis found that study participants who supplemented with vitamin D had a 9% (95% CI 0.8% to 17.1%) reduction in the risk of falls compared with those who had a placebo or no treatment. Furthermore, the meta-analysis concluded that high-dose supplementation was more effective at reducing rates of falls than low-dose supplementation. This suggests that supplementation with 800-1,000 IU per day of vitamin D may prove to be more beneficial than doses of 400 IU per day."
  },
  {
    "id": 221,
    "user_query": "What is the generic name of Gliolan?",
    "text-davinci-003_response": "The generic name of Gliolan is 5-Aminolevulinic Acid. It is a naturally occurring amino acid derivative that is used as a photosensitizer in photodynamic therapy (PDT). Gliolan is an activated prodrug (a drug which is administered in an inactive form and needs to be activated to start working) that is used in combination with visible light to selectively and non-invasively treat certain types of brain tumors. PDT has successfully been used in clinical trials to treat patients with recurrent glioblastoma (brain tumor). It works by generating cytotoxic singlet oxygen radicals when interaction with tissue occurs. These radicals are responsible for damage to the tumor and triggering the body’s immune response."
  },
  {
    "id": 222,
    "user_query": "Is there any association between Jarid2 and miR-155 in Th17 cells?",
    "text-davinci-003_response": "Yes, there is an association between Jarid2 and miR-155 in Th17 cells. Jarid2 (also known as JARID2 or Jumonji, AT-rich interactive domain 2), is a histone demethylase that plays a role in the development and differentiation of Th17 cells. MiR-155 (also known as MIR17HG or microRNA-155) is an miRNA that helps to regulate the development and differentiation of Th17 cells. Research has shown that Jarid2 is able to bind to the promoter region of miR-155 and is able to downregulate its expression. Furthermore, the knockdown of Jarid2 has been shown to lead to the increased expression of miR-155. Therefore, there is a direct relationship between Jarid2 and miR-155 in Th17 cells, with Jarid2 being able to suppress the expression of miR-155."
  },
  {
    "id": 224,
    "user_query": "How many genes does the human hoxD cluster contain?",
    "text-davinci-003_response": "The human hoxD cluster contains 9 genes. These genes are referred to as HOXD1, HOXD3, HOXD4, HOXD9, HOXD10, HOXD11, HOXD12, HOXD13, and HOXD14."
  },
  {
    "id": 229,
    "user_query": "Which are the human glutamate transporters?",
    "text-davinci-003_response": "The human glutamate transporters are a family of proteins called Solute Carrier Family 1 (SLC1) that are responsible for transporting the excitatory neurotransmitter glutamate from one neuron to another. These transporters belong to three categories based on their molecular structures and physiological activities: sodium-coupled, chloride-coupled, and exchanger-coupled.\nThe sodium-coupled transporters are named excitatory amino acid transporters (EAATs) and are regulatory proteins with a Na+- and Cl--dependent transport activity. The sodium-coupled transporters are EAAT1 to EAAT5.\nThe chloride-coupled transporters, also referred to as glutamate-gated chloride channels, are named chloride channels CLC1 to CLC3, and are anion channels with the glutamate, GABA, and glycine as ion-conducting ligands.\nThe exchanger-coupled transporters are expressed in the brain, heart, and other tissues. They are Vglut1, Vglut2, Vglut3, Vglut4, Vglut5, and Vglut6.\nThe activity of all these transporters is regulated by a variety of different factors, including pH, temperature, membrane potential, intracellular and extracellular ionic concentration, and other hormones and transmitters. Thus, a proper understanding of the molecular basis of their regulation may help researchers to better understand the physiological and pathological roles of these transporters."
  },
  {
    "id": 235,
    "user_query": "What is the causative agent of the \"Panama disease\" affecting bananas?",
    "text-davinci-003_response": "The causative agent of Panama disease, also known as Fusarium oxysporum f.sp. cubense (FOC), is a soil-borne fungus that attacks the banana plant's roots, leaves, and stem. Panama disease is a serious banana plant disease that can lead to plant death if not managed properly. The fungus is spread through soil movement, either through field activities or contaminated pieces of infected plant material such as tools, clothes, and soil. Symptoms of Panama disease include wilting of leaves, yellowing of leaves, and eventually the complete wilting and collapse of the entire banana plant. Once infected, there is no cure and the only option is to uproot the plants, destroy them, and replant with disease-free material. To protect banana plantations, farmers should practice crop rotation and use certified disease-free planting material."
  },
  {
    "id": 237,
    "user_query": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?",
    "text-davinci-003_response": "Mercedes Benz syndrome is a rare disorder characterized by the premature fusion (synostosis) of certain cranial bones. The cranial bones most commonly affected are the coronal, sagittal, and lambdoid sutures. This premature fusion can cause the growth of the skull to be abnormal, resulting in a wide variety of facial deformities including spacing of the eyes, increased size of eyes, small pointed chin, flattened forehead, flattened nose, protuberant forehead, and dolichocephaly, or an elongated skull. Additionally, the individual may have abnormal texture, shape, or sunken eyes. This disorder may also cause mental retardation or other developmental delays."
  },
  {
    "id": 242,
    "user_query": "What is a mitochondrial nucleoid?",
    "text-davinci-003_response": "A mitochondrial nucleoid is a nonmembranous region of the mitochondrion where the mitochondrial DNA is organized and maintained. This region, which is also referred to as a mitochondrial matrix or matrix core, is composed of proteins and double-stranded circular DNA molecules that are bound together to form a tight, condensed structure. The mitochondrial nucleoid is responsible for housing the mitochondrial genome, which is composed of DNA fragments of various sizes that encode a number of essential proteins and enzymes. In addition, the mitochondrial nucleoid plays a role in the maintenance of the mitochondrial genome and in the control of transcription and translation."
  },
  {
    "id": 247,
    "user_query": "What is the effect of ivabradine in heart failure with preserved ejection fraction?",
    "text-davinci-003_response": "Ivabradine is an anti-arrhythmic drug that has been shown to reduce heart rate and improve outcomes in patients with heart failure. It belongs to the class of drugs known as selective sinus node inhibitor (SSNI).\nIn heart failure with preserved ejection fraction (HFpEF), ivabradine reduces the heart rate and increases the time interval between heart beats (called the diastolic time interval), thereby reducing myocardial wall stress. This can reduce the symptoms of HFpEF including breathlessness, fatigue, and reduce the risk of hospitalization and death.\nIvabradine can also reduce the systemic pressure and reduce peripheral resistance. This, in turn, reduces the stress on the heart muscle and reduce the risk of hospitalization. Ivabradine can also help to improve quality of life in HFpEF patients, as well as reduce the risk of cardiovascular mortality.\nOverall, ivabradine has been found to be an effective treatment for heart failure with preserved ejection fraction. In the majority of clinical trials, it has been found to reduce heart rate, increase diastolic time interval, reduce symptoms, and reduce the risk of hospitalization and cardiovascular mortality."
  },
  {
    "id": 248,
    "user_query": "Is low T3 syndrome a prognostic marker in patients with renal insufficiency?",
    "text-davinci-003_response": "Low T3 Syndrome, also known as Euthyroid Sick Syndrome, is hypothesized to be an adaptive mechanism employed by the body to help conserve energy in patients with severe illnesses. It is associated with renal failure, sepsis, congestive heart failure, and various systemic inflammatory conditions. Despite its prevalence among patients with renal insufficiency, the evidence regarding whether or not low T3 Syndrome is a prognostic marker in renal failure is inconclusive.\nStudies have associated low T3 Syndrome with poorer outcomes in renal failure, such as increased mortality, morbidity, need for dialysis, need for transplant, and infection rates. It is also associated with reduced left ventricular ejection fraction, an indicator of heart failure. However, other studies have not found a direct correlation between low T3 and worse outcomes in renal insufficiency.\nIn addition, correlations between low T3 Syndrome and markers of organ dysfunction, such as creatinine, or other markers of disease progression, such as high-sensitivity C-reactive protein, have not been consistently found.\nTherefore, based on the current evidence, it is not possible to definitively conclude that low T3 Syndrome is a prognostic marker in patients with renal insufficiency. Further research is needed to properly evaluate the relationship between low T3 Syndrome and renal function."
  },
  {
    "id": 254,
    "user_query": "Which is the relation between sweating and anaerobic threshold?",
    "text-davinci-003_response": "Sweating and anaerobic threshold have an interdependent relationship. The anaerobic threshold occurs when the body is working hard enough to produce energy without oxygen. This is when lactic acid builds up and causes fatigue. As the intensity of exercise increases and the workload becomes too great for the body to sustain with oxygen alone, the initiative for sweating increases. Sweating is designed to help regulate body temperature and works to cool the body. Allowing for heat to escape faster than it is created helps the body avoid rising temperatures which can hinder performance and cause injury. As the body works harder and energy supply decreases, the cooling effects of sweat becomes even more important. This highlights the relationship between anaerobic threshold and sweating because high intensity exercise requires more sweating in order to maintain performance, and the level of exercise requiring such cooling determines the anaerobic threshold."
  },
  {
    "id": 256,
    "user_query": "What is the mode of action of bedaquiline?",
    "text-davinci-003_response": "Bedaquiline is a newly developed drug which is a synthetic diarylquinoline that acts as a highly selective and reversible inhibitor of the bacterial enzyme ATP synthase. This enzyme plays an essential role in the synthesis of ATP, the main energy-carrying molecule of a cell. By preventing ATP synthesis, bedaquiline interferes with bacterial growth and replication. It also inhibits lipid production, preventing the lipids necessary for forming bacterial cell walls. In other words, bedaquiline blocks the access of essential nutrients to the bacterial cells while also hampering their ability to produce energy and replicate, ultimately killing the bacterial cells. In addition, it is believed that bedaquiline induces oxidative stress in the bacteria leading to its death. Therefore, bedaquiline works by disrupting bacterial metabolism and preventing bacterial growth and replication."
  },
  {
    "id": 259,
    "user_query": "Is oxidative stress affected by FOXO expression?",
    "text-davinci-003_response": "Yes, FOXO expression can affect oxidative stress. FOXO is an acronym for “Forkhead box O” which is a family of transcription factors that are expressed in many tissues of the body and are involved in a variety of physiological processes. Studies have shown that FOXO proteins can regulate the expression of genes that are involved in the production of reactive oxygen species (ROS), an important factor in oxidative stress. This suggests that FOXO protein expression can influence the production of ROS and therefore affect oxidative stress.\nIn addition, the relationship between FOXO and oxidative stress has been extensively studied in model organisms. Experiments in C. elegans have uncovered that FOXO proteins can activate genes involved in the protection of cells from oxidative stress as well as the repair of oxidative damage. A study in yeast found that the activation of FOXO by a specific chemical inducer significantly increased intracellular ROS levels even in the presence of multiple factors that normally counter oxidative damage. These results demonstrate that FOXO expression can affect oxidative stress in different species.\nOverall, FOXO expression has been found to be a significant factor in oxidative stress. Studies have revealed that FOXO proteins can control the expression of genes involved in ROS production as well as regulate cells’ responses to oxidative stress. Therefore, FOXO expression can influence oxidative stress on a systemic level and have implications in a variety of diseases."
  },
  {
    "id": 260,
    "user_query": "Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.",
    "text-davinci-003_response": "The LINX system is a treatment for gastroesophageal reflux disease, or GERD, which helps to reduce the symptoms of acid reflux. The system is placed around the lower end of the esophagus and consists of a series of tiny magnets woven into a flexible ring. The ring works by keeping the junction between the esophagus and the stomach closed. Normally, when a person swallows, the lower esophageal sphincter contracts and relaxes to allow food to pass into the stomach and to keep stomach contents from flowing back up into the esophagus. In GERD, this muscle doesn’t work properly, allowing stomach acid to flow up the esophagus and causing symptoms such as heartburn, regurgitation, and chest pain. \nThe LINX system works by reinforcing the lower esophageal sphincter. The tiny magnets help keep the junction closed when the sphincter is weak or unable to close properly. The magnets create suction and draw the sphincter closed, preventing stomach acid from splashing back up into the esophagus. The supportive force of the magnets is strong enough to keep the junction closed, yet gentle enough to allow food and liquids to pass when needed. The LINX system is also adjustable, so that the esophageal sphincter can expand to its natural size and allow food and drink to move freely into the stomach. With this reinforced support, many patients find that their symptoms of acid reflux are significantly reduced, allowing them to enjoy a greater quality of life."
  },
  {
    "id": 262,
    "user_query": "What is the characteristic feature of the Dyke-Davidoff-Masson syndrome.",
    "text-davinci-003_response": "The characteristic feature of Dyke-Davidoff-Masson Syndrome (DDMS) is the presence of unilateral cerebral hemiatrophy, or an abnormal and asymmetrical decrease in the size of one of the two cerebral hemispheres in the brain. This usually arises due to a focal insult or episode as a result of either infection, trauma, or stroke in early childhood. This condition can lead to a wide range of neurological deficits, including unilateral weakness, sensory deficits, and cognitive delays. Additionally, individuals with DDMS may suffer from seizures, gaze asymmetries, drooling, impaired articulation and speech, and learning deficits."
  },
  {
    "id": 263,
    "user_query": "Which gene is involved in the development of Barth syndrome?",
    "text-davinci-003_response": "The gene involved in the development of Barth syndrome is called TAZ (Tafazzin). It is found on the X chromosome and is responsible for producing the tafazzin protein. The TAZ gene is essential for normal cardiolipin metabolism, which is important for the proper functioning of mitochondria. Mutations in the TAZ gene can lead to the accumulation of abnormal cardiolipin in cells, which can cause a number of symptoms including muscular weakness, growth retardation, neutropenia, cardiomyopathy, and other heart problems."
  },
  {
    "id": 268,
    "user_query": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?",
    "text-davinci-003_response": "The consensus motif for the Casein Kinase 1 (CK1) family is generally referred to as the “SLRRT” motif. This motif, which stands for ss–>S-L-R-R-T, is a recognition site for CK1 enzymes that is composed of 5 amino acids in the following sequence: serine (S), leucine (L), arginine (R), arginine (R), and threonine (T). CK1 phosphorylates both serine and threonine residues within the SLRRT sequence. The SLRRT motif is found in several proteins involved in a variety of cellular functions, including regulation of the cell cycle, metabolism, and apoptosis."
  },
  {
    "id": 273,
    "user_query": "What is the Barr body?",
    "text-davinci-003_response": "The Barr body is a pattern of gene expression named after geneticist Murray L. Barr. It is a condensed region of heterochromatin, located near the nuclear membrane in female mammals, that contains the inactive form of one of two X chromosomes. The active X chromosome is found in the nucleus in a less condensed form called the euchromatin, while the Barr body remains tightly compact and inactive. This chromosome-inactivation phenomenon is known as X-inactivation or Lyonization, and occurs in the early stages of embryonic development. Female mammals have two X chromosomes (XX) while males have one X and one Y (XY). To ensure successful development, one of the two X chromosomes must be deactivated, or silenced. This prevents the cell from having too much of the X chromosome's gene expression. In the Barr body, the X chromosome remains condensed, but is not completely shut off. It has been estimated that about 15% of X chromosome genes are expressed from the Barr body."
  },
  {
    "id": 275,
    "user_query": "Is shotgun lipidomics the direct infusion of a lipid sample into a mass spectrometer?",
    "text-davinci-003_response": "No, shotgun lipidomics is not the direct infusion of a lipid sample into a mass spectrometer. Instead, it is a process in which a lipid sample is subjected to a series of chemical reactions in order to extract, separate and measure the individual lipid molecules. The molecules are then introduced into a mass spectrometer, which is used to detect and quantify the individual molecules. In the shotgun lipidomics approach, the sample is first lysed to extract lipids, then separated by liquid chromatography, and finally ionized and measured with the mass spectrometer."
  },
  {
    "id": 283,
    "user_query": "List functions that are evaluated with the Full Outline of Unresponsiveness score?",
    "text-davinci-003_response": "The key components of the Full Outline of Unresponsiveness (F-O-U-R) score are:\n1. Eye Opening – Evaluates the patient’s ability to open their eyes in response to verbal or physical stimulation.\n2. Motor Response – Tests a patient’s capacity to move in response to a stimulus.\n3. Verbal Response – Assesses a patient’s ability to respond to verbal commands.\n4. Breathing Pattern – Checks for signs of respirations.\nEach component of the F-O-U-R score can be further broken down into four distinct levels. The levels range from 0 to 6, with 0 being no response and 6 being full response.\nThe primary functions evaluated with the F-O-U-R score are:\nEye Opening – Tests whether a patient is able to open their eyes in response to verbal or physical stimulation.\nMotor Response – Assesses the extent to which a patient is able to move in response to a stimulus.\nVerbal Response – Checks a patient’s ability to respond to verbal commands.\nBreathing Pattern – Evaluates the amount of respirations present."
  },
  {
    "id": 285,
    "user_query": "Is ospemifene effective for treatment of dyspareunia?",
    "text-davinci-003_response": "Yes, ospemifene is an effective treatment option for women suffering from dyspareunia, which is defined as painful or uncomfortable sexual intercourse. A number of studies have been conducted to assess the efficacy of the drug in reducing pain symptoms related to dyspareunia. In a randomized, placebo-controlled clinical trial which included over 500 postmenopausal women, ospemifene was found to significantly reduce pain intensity as well as improve sexual functioning and overall satisfaction in women with dyspareunia. Other research has found that ospemifene is associated with fewer adverse effects compared to traditional treatments for dyspareunia, such as hormone therapy. Overall, the evidence indicates that ospemifene may be an effective and safe treatment for dyspareunia."
  },
  {
    "id": 287,
    "user_query": "What is the biological role of expansins in fungi?",
    "text-davinci-003_response": "Expansins are proteins found in fungi (as well as other organisms) that play an important role in the regulation and control of cell wall expansion and cell elongation. They work by breaking and weakening the cell wall by loosening hydrogen bonds between the cell wall polymer molecules. This allows the cell wall to become more elastic, enabling the cell wall to expand and leading to increased cell growth and proliferation. Expansins are also believed to be involved in the formation of plasmodesmata, which are channels connecting different cells in a tissue or organ. Expansins are thus critical in the development of a variety of tissues and organs. As a result, their disruption may lead to a variety of symptoms, such as retarded growth or abnormal shape of organs and cell walls."
  },
  {
    "id": 301,
    "user_query": "Which oncogenes are able to induce cellular senescence?",
    "text-davinci-003_response": "Oncogenes are genes that, when abnormally activated, contribute to the formation and growth of tumors. Oncogenes can induce cellular senescence, which is a protective response that cells enter into when faced with stresses such as telomere shortening, oxidative stress, DNA damage, or growth factor deprivation. When oncogenes are abnormally activated, they can trigger a pro-senescence environment and can lead to the induction of senescence in the cell.\nSome oncogenes that have been associated with the induction of cellular senescence include: KRAS, MYC, PIK3CA, BRAF, RELA, and ESR1. KRAS, MYC, and PIK3CA are members of the oncogenic Ras/PI3K/AKT/mTOR pathway, which is thought to contribute to cellular senescence in a number of ways, including the activation of p53 to cause cell cycle arrest. BRAF and RELA are involved in the MAPK and NF-κB pathways, respectively, and can lead to cell cycle arrest and senescence when abnormally activated. ESR1, which is involved in estrogenic signaling, has been shown to induce senescence in a variety of cell types."
  },
  {
    "id": 305,
    "user_query": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?",
    "text-davinci-003_response": "The ASPH (aspartate beta-hydroxylase) gene in humans encodes two different proteins or isoforms. The first isoform is a full-length protein consisting of 779 amino acid residues known as ASPBH1 (aspartate beta-hydroxylase isoform 1). The second isoform is a shortened protein consisting of 719 amino acid residues known as APSH2 (aspartate beta-hydroxylase isoform 2). \nEach of these two proteins is involved in the metabolism of p-aminobenzoate (PABA) to form 4-hydroxyl p-aminobenzoic acid (4-HPAA), which is a key component of the folic acid cycle. ASPBH1 is known to be involved in the activation of thiamine diphosphate (ThDP)-dependent enzymes, while APSH2 is involved in the oxidation of oxalacetate. Both of these proteins are essential for normal cell growth and development."
  },
  {
    "id": 310,
    "user_query": "Which is the most common measure of differences between dinucleotide relative abundance \"genomic signatures\"",
    "text-davinci-003_response": "(di-nucleotide frequencies)\nThe most common measure of differences between dinucleotide relative abundance “genomic signatures” (di-nucleotide frequencies) is the Dinucleotide Relative Frequency Distance (DRFD). This measure calculates the difference in the relative frequency between two dinucleotide sequences by taking the sum of the absolute values of the differences in the percentages between two dinucleotide sequences. For example, if sequence A has a frequency of 0.7 for dinucleotide TA and sequence B has a frequency of 0.3 for the same dinucleotide then the DRFD is 0.4 (abs(0.7-0.3)). The DRFD, therefore, provides an efficient measure of overall difference between two dinucleotide sequences."
  },
  {
    "id": 312,
    "user_query": "Why do we use \"N-terminal proteomics\"?",
    "text-davinci-003_response": "N-terminal proteomics is a powerful technique used to analyze the primary structure (or sequence) of proteins, often in a qualitative manner. It is used to determine how proteins are synthesized, modified, and degraded in the cell, as well as to map post-translational modifications.\nThe N-terminus is the most variable part of a protein and is often modified to achieve various functional roles. It is also the first amino acid of a protein that is exposed after protein synthesis occurs, making it a valuable target for proteomic analysis.\nN-terminal proteomics is also used to identify changes in protein structure that occur at individual amino acid positions. This is useful for determining the functional role of a protein in the cell, and its potential for regulation.\nBy comparing the N-terminal data to databases of known sequences, proteomics can also be used to distinguish between different isoforms, helping researchers understand how different proteins interact with one another.\nOverall, N-terminal proteomics has enabled us to gain better insight into the structure and function of proteins. By using this technique, researchers are able to find novel ways to manipulate protein function, and to gain a better understanding of how proteins interact and are regulated in the body."
  },
  {
    "id": 317,
    "user_query": "Have mutations in the Polycomb group been found in human diseases?",
    "text-davinci-003_response": "Yes, mutations in the Polycomb group of proteins have been found in human diseases. These mutations can have major and far-reaching implications for the cellular processes of the affected organism. One example of such a mutation is MLL2, a subunit of the Polycomb-group protein MLL1 that is associated with several types of human cancer, including leukemia. Mutations in MLL2 can lead to dysregulation of gene expression and the development of cancer. Another example of a mutation in the Polycomb group of proteins is CBX7, which is linked to the Wiedemann-Steiner Syndrome (WSS). Mutations in CBX7 have been linked to the development of several different types of congenital disorders, including intellectual disability, craniofacial defects, and skeletal abnormalities."
  },
  {
    "id": 318,
    "user_query": "Describe the mechanism of action of drisapersen",
    "text-davinci-003_response": "Drisapersen is a drug that works by targeting a certain type of genetic mutation called a GAA (glucosamine) deficiency. This type of mutation is caused by a lack of the enzyme glycosylated aminotransferase. When this mutation occurs, the glycosylated aminotransferase cannot properly attach the glucosamine molecule to the alpha-dystroglycan protein, which is necessary for building the muscular dystrophy cell membrane. \nThe mechanism of action of drisapersen is to restore the proper functioning of the GAA enzyme, allowing the glucosamine molecule to attach to the alpha-dystroglycan protein. This restores the formation of functional dystrophin protein, leading to restoration of the muscular dystrophy cell membrane. \nIn addition, the drug works to slow the progression of the disease by inhibiting the production of toxic proteins that are known to be involved in the development of the disease. It does this by inhibiting a key enzyme known as Annexin A5, which is responsible for triggering the toxic protein production. When the Annexin A5 enzyme is blocked, the production of toxic proteins is reduced, leading to slower progression of the disease."
  },
  {
    "id": 325,
    "user_query": "How does ranolazine affect calcium handling in the heart",
    "text-davinci-003_response": "?\nRanolazine affects calcium handling in the heart in two ways. One is direct, and one is indirect. \nThe direct effect is modulated through its ability to activate N-type (L-type) calcium channels leading to increased calcium influx into cardiomyocytes during action potential. This increased calcium influx, in turn, increases the force of contraction and has a positive inotropic effect on myocardial contractility.\nThe indirect effect results from the modulation of the Na+/Ca2+ exchanger. This is done through an increase in intracellular Na+ levels, secondary to improved sodium-calcium exchange. This decrease in calcium efflux decreases the intracellular calcium concentration, leading to a lower concentration of calcium in the sarcoplasmic reticular (SR) stores. As a result, the calcium released into the cytosol during the action potential is reduced, resulting in a decrease in the force of myocardial contraction.\nThe result of these two effects is that ranolazine increases the force of myocardial contraction, while simultaneously reducing the amount of cytosolic calcium available for myofilament activation. This reduces the risk of calcium overload in the myocardium, thus contributing to the anti-ischemic effects of ranolazine."
  },
  {
    "id": 326,
    "user_query": "Which is the primary distinction between the Reverse Warburg effect and the conventional Warburg effect?",
    "text-davinci-003_response": "The primary distinction between the Reverse Warburg effect and the conventional Warburg effect is that of the metabolic direction. The Warburg effect, also known as aerobic glycolysis, is a phenomenon seen in many types of cancer cells where, despite their ability to utilize oxygen, they mostly rely on glycolysis to produce energy. In other words, these cancer cells prefer glucose metabolism through glycolysis over the traditional aerobic metabolism despite having oxygen present in the environment. \nOn the other hand, the Reverse Warburg effect is a phenomenon of increased aerobic metabolic activity in cancer cells in order to produce energy. This means that the cancer cells prefer traditional aerobic metabolism over glycolysis to obtain energy. In other words, the cancer cells prefer oxygen-consuming pathways for energy production over glucose-consuming pathways. This mechanism is thought to be more efficient in providing energy to cancer cells in comparison to the traditional Warburg effect."
  },
  {
    "id": 327,
    "user_query": "What is the role of per genes in circadian rhythm control?",
    "text-davinci-003_response": "Per genes are a family of genes that play a major role in circadian rhythm control. They are responsible for producing the molecular machinery necessary to sustain rhythmic activity over 24 hours. The family of Per genes consists of Per1, Per2, Per3, Cry1, and Cry2.\nPer1 gene expression increases during the day and decreases during the night to keep the circadian rhythms running smoothly. In the brain, Per1 activates the production of orexin, a neurotransmitter involved in the control of sleep-wake cycles. In the eyes, Per1 is involved in the detection of light, thereby playing a crucial role in setting the animal’s circadian clock.\nPer2 gene expression increases during the night and decreases during the day. Per2 is involved in resetting our circadian clocks in response to changes in daylight length. It also helps the body prepare for rest, guiding changes in body temperature, hormone levels, and other physiological processes that happen as we transition from day to night.\nPer3 is an important gene that helps regulate the circadian rhythm by determining the length of the cycle. Per3 produces a protein that helps to synchronize the rhythms on a daily basis.\nCry1 and Cry2 are two genes that play a role in the stabilization of the circadian rhythm. Cry1 is responsible for its maintenance by regulating the timing of gene expression while Cry2 helps to keep the clock positioned proper in the long run.\nTogether, the five Per genes form the backbone of the body’s intrinsic circadian rhythm. They are responsible for generating and sustaining the 24-hour daily cycle of activity. This helps to regulate our sleep, mood, hormone levels, metabolism, and other physiological functions."
  },
  {
    "id": 330,
    "user_query": "When was empagliflozin FDA approved?",
    "text-davinci-003_response": "Empagliflozin was approved by the United States Food and Drug Administration (FDA) on August 1, 2014. It is approved for the treatment of adults with type 2 diabetes."
  },
  {
    "id": 331,
    "user_query": "Which R/bioconductor package is used for integrative genomics visualizations?",
    "text-davinci-003_response": "The R/bioconductor package that is used for integrative genomics visualizations is the cummeRbund package. The package provides a set of visualization tools for data generated from RNA-Seq and other experiment types across multiple bioconductor packages. It also contains tools for computing gene-level statistics, such as gene expression, alternative splicing, differential expression, pathways over-representation, network visualization, and annotation linking. Furthermore, it is capable of determining correlations between gene expression and clinical data."
  },
  {
    "id": 333,
    "user_query": "How many genes are imprinted in the human genome?",
    "text-davinci-003_response": "The exact number of imprinted genes in the human genome is not known, as some may still be undiscovered. However, so far, there have been a total of 168 imprinted genes identified in the human genome. These genes come from 56 different families, and some of them are associated with important human traits and disorders."
  },
  {
    "id": 336,
    "user_query": "In which cells are A-type lamins expressed?",
    "text-davinci-003_response": "A-type lamins, also known as type V lamins, are expressed in various mammalian cell types, including epithelial cells, hematopoietic stem cells, mesenchymal stem cells, and differentiated muscle cells. They are also found in embryonic stem cells, neural progenitors, photoreceptor cells, and the nucleus of hepatocytes. In addition, A-type lamins are expressed in certain tumor cells, albeit at slightly lower levels than those found in normal cells. They may also be present in some transit-amplifying cell types and quiescent cells. In simple terms, A-type lamins are expressed in most, if not all, mammalian cell types."
  },
  {
    "id": 338,
    "user_query": "Gene silencing can be achieved by RNA interference (RNAi) in eukaryotic organisms. What is the name of the analogous process in prokaryotic organisms?",
    "text-davinci-003_response": "The analogous process in prokaryotic organisms is known as Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR). CRISPR is a prokaryotic form of gene silencing that involves the use of targeted DNA-cutting enzymes, such as Cas9, to attach small pieces of RNA to specific sections of the targeted gene. These RNAs serve as a guide for Cas9 to locate and delete or inactivate the targeted gene sequence. CRISPR can be used to edit all types of DNA, including prokaryotic and eukaryotic DNA, and can be used to control gene expression levels."
  },
  {
    "id": 339,
    "user_query": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?",
    "text-davinci-003_response": "A mutational bias is an unequal rate of substitution in which some bases are more likely to mutate than others. Mutational biases can be introduced between two types of DNA bases due to directional mutation pressure. For example, in some cases, transitions (e.g. from A to G) are more likely to occur than transversions (e.g. from A to C). Directional mutation pressure is a form of selection that preferentially favors some mutations over others. This type of selection can either act as a selective disadvantage, thus leading to fewer mutations, or as an advantageous factor, leading to more mutations. In some cases, directional mutation pressure has been found to lead to a bias in which transitions are more likely to occur than transversions. This is because transitions maintain the sequence and structure of the DNA while transversions tend to cause more disruption."
  },
  {
    "id": 340,
    "user_query": "Is it feasible to determine the complete proteome of yeast?",
    "text-davinci-003_response": "It is feasible to determine the complete proteome of yeast. Through the use of advanced mass spectrometry techniques, scientists can identify the proteins present in a yeast cell as well as their abundance. For example, MudPIT (multidimensional protein identification technology) utilizes liquid chromatography in combination with electrospray ionization mass spectrometry to achieve a comprehensive understanding of the proteome of a sample. In addition, other techniques such as 2-D gel electrophoresis and Western blotting can be used to identify specific proteins present in a sample. By utilizing these methods, scientists can create detailed profiles of the proteins present in a yeast cell, allowing them to determine the complete proteome of the organism."
  },
  {
    "id": 346,
    "user_query": "Which is the most common cause of sudden cardiac death in young athletes?",
    "text-davinci-003_response": "The most common cause of sudden cardiac death in young athletes is hypertrophic cardiomyopathy (HCM). HCM is a condition of the heart muscle in which the walls of the heart chambers thicken. This thickening can interfere with the normal electrical impulses of the heart and cause an irregular heartbeat, known as an arrhythmia. An arrhythmia can lead to sudden cardiac death in young athletes. Other causes of sudden cardiac death in young athletes include coronary artery disease, valve disease, and myocarditis."
  },
  {
    "id": 347,
    "user_query": "Could the Menzerath-Altmann law be proved mathematically trivial in genomes?",
    "text-davinci-003_response": "No, it cannot. The Menzerath-Altmann law states that sentence meaning is hierarchically organized in terms of syntactic complexity. This law is a well-known empirical law that has been observed through experimental studies, and it cannot be easily quantified or measured mathematically. Furthermore, it does not necessarily apply to all languages or contexts, and so it cannot be generalized across different language systems. Therefore, it cannot be proved mathematically trivial in genomes."
  },
  {
    "id": 350,
    "user_query": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?",
    "text-davinci-003_response": "Lon1 (Lon Protease 1) is a serine protease found in the plant Arabidopsis (the model species for plant genetics research). Loss of Lon1 can lead to abnormal leaf morphology, altered seed arrest, and sterility. \nThe most noticeable change in morphology occurs in the leaves. In mutant plants with no Lon1, the leaves are generally shorter and more narrow than in wild type plants, and the petioles and sepals are also shorter. The end result is a more compact plant. In addition, the shape of the leaves become more pointed at the ends, and the tips can become rolled or curled in certain conditions, resulting in a putative crinkled effect.\nThe lack of Lon1 also affects the arrest of the seeds during development. In Lon1-deficient mutants, the seeds continue to develop past the normal arrest point, resulting in increased seed sizes. This also affects the sterility of the mutant plants. The increased seed sizes makes it difficult for the mutant plant to properly pollinate, resulting in reduced seed-setting rates and decreased fertility.\nOverall, the loss of Lon1 in the plant Arabidopsis results in abnormal leaf morphology, altered seed arrest, and sterility. These changes make it difficult for the mutant plants to survive, indicating the importance of Lon1 in the development and function of this plant species."
  },
  {
    "id": 352,
    "user_query": "Are there studies representing the involvement of Notch mutations in neurodegenerative diseases such as Down syndrome, Pick's and Prion's disease, and cadasil syndrome?",
    "text-davinci-003_response": "Yes, there are studies representing the involvement of Notch mutations in neurodegenerative diseases such as Down syndrome, Pick's and Prion's disease, and CADASIL syndrome. \nDown Syndrome is a genetic disorder caused by an extra copy of chromosome 21 that leads to cognitive disabilities. Studies have found that Notch signaling is involved in the development of the brain in people with Down Syndrome, and that mutations in Notch genes can lead to an increased risk of Down Syndrome. \nPicks Disease is a rare neurodegenerative brain disorder that affects memory and behavior. Several studies have identified mutations in the Notch3 gene that have been associated with the development of PICKs disease, suggesting that Notch3 mutations are involved in the development of the disorder. \nPrion disease is caused by misfolded proteins that accumulate in different areas of the brain, leading to progressive neurological symptoms. In recent years, mutations in the Notch2 gene have been linked to the onset of some forms of Prion disease, suggesting that Notch2 mutations may be associated with the development of this disorder. \nCADASIL Syndrome is a rare neurological disorder caused by mutations in the Notch3 gene. This gene is responsible for the production of the protein Notch2, which plays an important role in the survival of brain cells. Studies have found that Notch3 mutations cause the destruction of the myelin sheath, leading to issues with communication between neurons and the resulting neurological symptoms."
  },
  {
    "id": 353,
    "user_query": "Are there any functional differences between Mfd and its human Cocaine syndrome protein B (CSB) homolog?",
    "text-davinci-003_response": "Yes, there are functional differences between Mfd and its human Cocaine syndrome protein B (CSB) homolog.  \nMfd is a proton-exporting ATPase enzyme involved in DNA transcription and repair, essential for replication, and it functions by unwinding DNA strands. It is found in bacterial cells and is involved in the repair of UV-induced DNA damage. CSB, on the other hand, is a DNA repair protein involved in DNA repair and transcription activation, and it is found in human cells. It is involved in the repair of damaged DNA by a variety of mechanisms, including homologous recombination, nucleotide excision repair, and base excision repair.\nWhile Mfd and CSB share similar functions overall, some functional differences exist. For example, CSB has been found to be involved in the detection of double-stranded DNA breaks, whereas Mfd does not appear to have this ability. Furthermore, CSB has been found to be involved in the transcriptional activation of certain genes, which Mfd does not appear to do. These are examples of some of the functional differences between Mfd and its CSB homolog."
  },
  {
    "id": 354,
    "user_query": "What is membrane scission?",
    "text-davinci-003_response": "Membrane scission is a process in which a cell membrane is physically split apart or cleaved. It can occur naturally or can be the result of an external action on the cell, such as an alteration of its surrounding environment or an injection of certain substances into the cell. During membrane scission, lipid bilayers of the cell envelope are cut apart, forming vesicles and/or larger fragments of membrane. This process is involved in a wide range of biological processes, including cell division, endocytosis, exocytosis, and intercellular signaling. During cell division, membrane scission is responsible for the formation of a new outer membrane around the two daughter cells, allowing them to be separated from one another. Endocytosis is a process in which substances, such as proteins and nutrients, are taken in by the cell through what is known as an invagination of the outer membrane. In this process, the cell membrane will pinch off, forming a vesicle that contains the substances taken in. Exocytosis is the opposite process, in which stored substances, such as proteins and hormones, are released from the cell, through the creation of a pore in the membrane. This process can also involve membrane scission. During intercellular signaling, lipid-based molecules, known as lipids, are released from one cell and taken up by the other. In both of these processes, membrane scission is required for the passage of these molecules from one cell to the other."
  },
  {
    "id": 356,
    "user_query": "Is the yeast Μac1 transcription factor induced upon copper deficiency?",
    "text-davinci-003_response": "Yes, the yeast Mac1 transcription factor is induced upon copper deficiency. It acts as a response regulator, receiving signals from copper signaling proteins to regulate copper acquisition processes in the cell. Mac1 is induced during copper deficiency as part of an adaptive response that increases the efficiency of copper utilization and scavenging. At the molecular level, scaffold proteins, such as Sre1 and Yap6, bridge copper signaling pathways and the Mac1 transcription factor, allowing it to sense changes in copper levels and respond with regulated transcription of copper transporters and other proteins to bring more copper into the cell."
  },
  {
    "id": 357,
    "user_query": "What is the mechanism of DNA replication termination in vertebrates?",
    "text-davinci-003_response": "The mechanism of DNA replication termination in vertebrates is complex and is determined by a number of factors including DNA composition, replication fork stability, and termination proteins.\nThe process begins with the replication forks traveling along the length of the chromosome. At specific origins of replication, DNA helicases will unwind the double stranded DNA to allow for the strands to be copied. As the replication forks continue to travel down the chromosome, another class of protein, known as the termination proteins, will begin to bind onto the strands of DNA. These proteins, as well as their associated activators, will begin to form a complex that will ultimately lead to termination of replication. This complex includes the RecQ-like helicase, the DNA repair helicase, and the RNA helicase.\nOnce these proteins are bound to the DNA, the replication forks will begin to shorten, eventually terminating in the formation of a closed structure called a replication loop or a bubble. This structure is formed due to the termination proteins, as well as other proteins, which bind to the loop and prevent the replication from continuing. In this case, the loop acts as a barrier, which closes and stops the replication forks from progressing and replicating the DNA.\nWhen the loop is formed and the replication of DNA is stopped, the loop is then resected and the strand is completely broken off. This helps in preventing any further replication of the chromosome and thus helps in the termination of DNA replication."
  },
  {
    "id": 360,
    "user_query": "Have thyronamines  effects on fat tissue?",
    "text-davinci-003_response": "Yes, thyronamines do have an effect on fat tissue. Thyronamines are hormones that are produced by the thyroid gland and are responsible for modulating the levels of fat and other energy sources in the body. Thyronamines regulate metabolism, stimulate lipolysis (breakdown of triglycerides into free fatty acids and glycerol), increase the uptake of glucose by the cells, and reduce fat storage. They also have an effect on fat cells, specifically, they can increase the number of adipocytes (fat cells) that exist in the body and also the size of those fat cells. This can lead to an increase in fat accumulation as the triglycerides are not being broken down as quickly as they should be. Thyronamines can also decrease the amount of fat cells that are destroyed, leading to an increase in fat accumulation in the body. Finally, thyronamines can decrease the hormonal signals responsible for controlling the release of fat from stores, making it more difficult for the body to access the energy it needs to fuel its activities."
  },
  {
    "id": 361,
    "user_query": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?",
    "text-davinci-003_response": "The two main anti-CD52 monoclonal antibodies used for treatment of multiple sclerosis patients are Alemtuzumab (Lemtrada) and Rituximab (Rituxan). Alemtuzumab is a monoclonal antibody used for the treatment of patients with active forms of relapsing-remitting multiple sclerosis (RRMS). It works by targeting and depleting a type of immune cell called a T-lymphocyte, which is thought to be involved in the destruction of myelin, the insulation around nerve cells in the brain and spinal cord. Rituximab is also a monoclonal antibody used to treat multiple sclerosis, and it works by targeting a different type of immune cell called a B-cell. Rituximab has been found to reduce symptoms of multiple sclerosis and slow the progression of the disease. Both drugs are given in an outpatient setting through an intravenous infusion."
  },
  {
    "id": 369,
    "user_query": "At which kind of individuals is pharmacological treatment of subclinical hypothyroidism effective in reducing cardiovascular events?",
    "text-davinci-003_response": "Pharmacological treatment of subclinical hypothyroidism (increased thyroid hormones) is only effective at reducing cardiovascular events in individuals with a history of ischemic heart disease, such as an MI (myocardial infarction) or unstable angina. Treatment with levothyroxine, a thyroid hormone replacement, reduces the risk of major cardiovascular events, such as nonfatal myocardial infarction and coronary revascularization, in those at high risk for cardiovascular events. Such individuals should have serum thyrotropin (TSH) concentrations of at least 4.5 milliunits per liter (mU/L) and clinical or subclinical hypothyroidism."
  },
  {
    "id": 372,
    "user_query": "What is known about the association between the use of selective serotonin reuptake inhibitors during pregnancy and risk for autism in offspring?",
    "text-davinci-003_response": "Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed medications used to treat depression, anxiety, and other mood disorders. SSRIs have been in use for decades and have generally been considered to be safe for use in pregnancy. However, in recent years there has been increasing evidence to suggest an association between SSRI use during pregnancy and risk for autism spectrum disorder (ASD) in offspring.\nA number of studies have investigated the potential association between maternal SSRI use during pregnancy and risk for ASD in offspring. A 2017 meta-analysis of nineteen studies evaluating the relationship between SSRI use and ASD found a statistically significant positive association between the two, with children whose mothers used SSRIs during pregnancy being at increased risk of receiving an ASD diagnosis. This meta-analysis concluded that the risk for ASD increased by 87% with SSRI use during pregnancy.\nHowever, several subsequent studies have found a more modest or even nonexistent association between maternal SSRI use and ASD risk. A 2019 study which evaluated data from over 1600 mother-child pairs found a small but statistically significant association (13%) between maternal SSRI use during pregnancy and ASD risk in offspring. The authors of the study noted, however, that the overall effect was small and may be due to other factors such as genetic predisposition or exposures to chemicals or environmental factors. They concluded that while the evidence does suggest some association between maternal SSRI use and ASD risk, the risk is likely small and may be due to other factors. \nOverall, the evidence suggests that there may be an association between maternal use of SSRIs during pregnancy and ASD risk in offspring. However, the strength of this association is uncertain and may be due to other factors such as genetic or environmental influences. Further research is needed to better understand the potential association between SSRI use and ASD risk."
  },
  {
    "id": 374,
    "user_query": "Is desmin an intermediate filament protein involved in Dilated Cardiomyopathy (DCM)?",
    "text-davinci-003_response": "Yes, desmin is an intermediate filament protein involved in Dilated Cardiomyopathy (DCM). Desmin is found in all vertebrate striated muscle cells, where it forms a structural framework, known as a desmin network, which supports the myofibrils. Desmin is a major filament protein that connects the nucleus to the contractile apparatus in the cell membrane. In Dilated Cardiomyopathy (DCM), there is a genetic mutation that causes desmin to become abnormal. This can lead to an accumulation of abnormal desmin proteins, which can interfere with normal sarcomere functioning and lead to DCM. It is also associated with mutations in related proteins, such as vimentin, lamin, and α-tubulin, which can also affect the proper functioning of the desmin network."
  },
  {
    "id": 376,
    "user_query": "List human diseases involving genomic imprinting.",
    "text-davinci-003_response": "1. Prader-Willi Syndrome (PWS): A complex genetic disorder caused by the loss of function of genes in chromosome 15. It is caused by a lack of genomic imprinting, resulting in a wide range of symptoms, including feeding disorder, growth retardation, low muscle tone, cognitive delays, repetitive behaviors, and behavioral problems.\n2. Angelman Syndrome (AS): A rare neuro-genetic disorder caused by the absence of a gene or a mutation on chromosome 15, leading to severe intellectual disability, difficulty with coordination and balance, epilepsy, and behavioral problems.\n3. Beckwith-Wiedemann Syndrome (BWS): A rare disorder caused by the loss of imprinting on chromosome 11. Symptoms include overgrowth, enlarged organs, macrosomy, susceptibility to certain kinds of tumors, and congenital malformations.\n4. Silver-Russell Syndrome (SRS): SRS is a form of growth retardation caused by what is known as \"parental imprinting defects\". This disorder is characterized by facial abnormalities, and a delay in physical growth.\n5. Hypothalamic Obstructive Syndrome (HOS): HOS is caused by a disruption of imprinting on a region of the chromosome known as the human leukocyte antigen (HLA) gene, which is involved in the regulation of immune function. This disorder is characterized by an early onset of hypothyroidism, growth failure and obesity.\n6. Beta-Thalassemia: Beta-thalassemia is an inherited blood disorder caused by an absence of genomic imprinting in the beta-hemoglobin gene. Symptoms include anemia, fatigue, and enlargement of the spleen."
  },
  {
    "id": 378,
    "user_query": "Which deficiency is the cause of restless leg syndrome?",
    "text-davinci-003_response": "Restless leg syndrome (RLS) is a neurological disorder characterized by an overwhelming urge to move the legs, often accompanied by uncomfortable sensations in the legs. There is no single known cause for RLS, however, iron deficiency is the most common underlying deficiency associated with this condition. Iron deficiency can result from lower levels of dietary iron, difficulty absorbing iron, or increased loss of iron from the body, and is responsible for an estimated 25 to 50 percent of RLS cases. Other potential deficiencies that may be associated with RLS include folate, Vitamin D and Vitamin B12 deficiencies."
  },
  {
    "id": 379,
    "user_query": "What histone modification is recognized by the bromodomain?",
    "text-davinci-003_response": "The bromodomain is a specific protein motif, believed to be principally involved in binding acetylated histones and potentially other acetylated proteins. Specifically, it binds to lysine residues that have been modified by the addition of an acetyl group, a type of chemical modification known as histone acetylation. Histone acetylation is regulated by histone acetyltransferases (HATs), which transfer the acetyl group from an acetyl-CoA donor to a lysine residue in the N-terminal region of the histone protein. Histone acetylation is associated with relaxed chromatin structure, generally leading to expression of genes located around the acetylated lysine residues. The bromodomain is one of many domains that has evolved to interact with acetylated lysines, unlock chromatin structure and help regulate gene expression."
  },
  {
    "id": 387,
    "user_query": "What is the methodological principle of ChIA-PET?",
    "text-davinci-003_response": "ChIA-PET (Chromatin Interaction Analysis with Paired-End Tag sequencing) is a method used to study protein-DNA interactions within the nucleus of a cell. It is based on the principle that when two genomic loci interact with each other, the DNA sequence in between them is brought into close proximity.\nChIA-PET uses paired-end tag sequencing methodology to analyze these interactions. In this process, short DNA fragments (or tags) are generated from both ends of the DNA around the regions of interest. The exact DNA sequences of these tags are then determined through high-throughput sequencing techniques such as Solexa or Illumina sequencing. Finally, the data generated in this way can be used to identify interactions between two genomic loci, as well as to accurately map out the 3-D structure of the chromatin within the nucleus."
  },
  {
    "id": 390,
    "user_query": "Does PU.1 (SPI1) affect NF-kB binding?",
    "text-davinci-003_response": "Yes, PU.1 (SPI1) is known to affect NF-kB binding. It is a member of the ets family of transcription factors which is known to interact with NF-kB, and so it can influence the ability of NF-kB to bind to DNA. PU.1 binds to both NF-kB Recognition sites (such as the enhancer sequence kappa B or the inducible promoter NF-kappa B-1-like) as well as to the canonical kappa B site. One study found that PU.1 was able to increase the binding affinity for NF-kB to the canonical kappa B site, suggesting that PU.1 plays an important role in regulating the NF-kB activity. In addition, increased levels of PU.1 have been observed to reduce NF-kB binding to promoters and enhancers, further demonstrating the influence of PU.1 on NF-kB binding."
  },
  {
    "id": 391,
    "user_query": "Does the majority of the mitochondrial genomes abide to the second parity rule (PR2)?",
    "text-davinci-003_response": "The answer to this question depends on the particular species being examined. In general, the majority of mitochondrial genomes do abide by the second parity rule (PR2). This rule states that bases on the two strands of the mitochondrial genome must follow a complementary pattern: A-T and C-G. However, certain species may have mitochondrial genomes that exhibit deviations from the PR2 rule. These deviations can arise as a result of several factors including errors during replication, biochemical modifications of base pairs, or the presence or absence of nucleotide pairs. In addition, certain species may lack certain base pairs altogether, which can also violate the PR2 rule. Therefore, while some species have mitochondrial genomes that follow PR2, others may not, so the answer largely depends on the species in question."
  },
  {
    "id": 396,
    "user_query": "Which hormone abnormalities are common in Williams syndrome ?",
    "text-davinci-003_response": "Williams syndrome is a genetic disorder that causes various physical and developmental issues. Particular hormone abnormalities that are seen in individuals with Williams Syndrome include variations in thyroid hormone (underactive and overactive), spontaneous growth hormone deficiency, adrenal insufficiency (meaning low cortisol levels), and low levels of androgens (male hormones) in males. Additionally, since Williams Syndrome affects development, many patients will be insulin resistant, potentially resulting in high insulin levels. Other hormonal issues associated with Williams Syndrome include high leptin levels, abnormal calcium metabolism, and high levels of serotonin. It is important to note that all of these hormonal abnormalities are highly variable and some individuals with Williams Syndrome may not be affected."
  },
  {
    "id": 398,
    "user_query": "Albumin depletion is a common first step for proteomic analysis of CSF fluid. What is the advantage and disadvantage of this procedure?",
    "text-davinci-003_response": "The advantage of albumin depletion in the first step of proteomic analysis of CSF fluid is that albumin is a highly abundant protein, and thus the depleting it avoids it from masking subtle changes in the concentration of lower abundant proteins. This is especially useful for data analysis when changes in the relative abundance of proteins over time are of interest.\nThe disadvantage of albumin depletion is that it can be expensive and time-consuming to perform. It also results in the loss of information and the potential to miss out on key changes in the relative abundance of proteins in the sample. In addition, it is important to note that the stripping of albumin may lead to a decrease in the detectability of other proteins which are bound to albumin."
  },
  {
    "id": 401,
    "user_query": "Which residue of alpha-synuclein was found to be phosphorylated in Lewy bodies?",
    "text-davinci-003_response": "Research has identified several phosphorylated residues of alpha-synuclein in Lewy bodies. The main ones that have been identified are serines-129, -199, -253, and -396, as well as threonines-30 and -35. These phosphorylated residues have been found in both the wild type and mutated forms of alpha-synuclein and are associated with increased aggregation and toxicity in neurons. Phosphorylation of these residues has also been linked to increased cell death, and increased aggregation of alpha-synuclein in Lewy bodies. In the mutated forms of alpha-synuclein, phosphorylation of these residues has been linked to increased formation of Lewy bodies, as well as decreased proteasomal function. Additionally, some evidence suggests that phosphorylation of alpha-synuclein at threonine-35 may be a potential therapeutic target in the treatment of Parkinson's disease."
  },
  {
    "id": 403,
    "user_query": "What is known about thalidomide therapy and survival of glioblastoma patients?",
    "text-davinci-003_response": "Thalidomide has been studied as a potential treatment for glioblastoma brain tumors, and some research suggests that it may prolong survival for certain patients.\nIn 2012, a double-blind randomized trial of thalidomide in combination with standard chemotherapy was conducted in 95 patients with newly diagnosed glioblastoma. The results of the study showed that the combination treatment significantly prolonged survival compared to standard treatment alone, with a median survival time of 14.4 months for the thalidomide group compared to 11.9 months for the group receiving only chemotherapy.\nAnother randomized controlled trial studied the effects of thalidomide combined with temozolomide – another chemotherapy drug – in 90 patients with newly diagnosed glioblastoma. Results showed that combination therapy resulted in an improved overall survival compared to temozolomide alone, with a median survival time of 14 months compared to 12 weeks in the temozolomide-only group.\nFurthermore, some research has found that adding thalidomide to standard chemotherapy and radiation may improve progression-free survival of glioblastoma patients, though further research is needed to understand the effectiveness of such a combination therapy.\nIn conclusion, current evidence suggests that combining thalidomide with standard chemotherapy treatments may improve overall survival and progression-free survival for glioblastoma patients, but the evidence is far from definitive. Further research is needed to assess the precise benefits of thalidomide therapy and determine which types of patients may benefit the most from this treatment."
  },
  {
    "id": 404,
    "user_query": "Is endostatin a proangiogenic factor?",
    "text-davinci-003_response": "Endostatin is an inhibitor of angiogenesis. It is a member of the powerful class of compounds known as metalloproteinase inhibitors (MMPIs). It works by blocking the activation of certain proteases involved in angiogenesis, specifically the enzyme known as matrix metalloproteinase (MMP). Endostatin is therefore considered an anti-angiogenic factor, not a pro-angiogenic factor. Endostatin has been studied for its potential role in treating many diseases that are associated with excessive blood vessel growth, such as in cancer."
  },
  {
    "id": 407,
    "user_query": "List the off-label use of SSRIs",
    "text-davinci-003_response": "Off-label use of selective serotonin reuptake inhibitors (SSRIs) is common and can apply to various conditions. These include:\n1. Anxiety: SSRIs can be used off-label to treat general anxiety disorder, social anxiety disorder, post-traumatic stress disorder (PTSD), and obsessive-compulsive disorder (OCD).\n2. Chronic Pain: SSRIs can be used to treat chronic pain, specifically nerve-related pain such as diabetic neuropathy or post-herpetic neuralgia.\n3. Migraines: SSRIs can be used off-label for the prevention of headache disorders such as migraines.\n4. Insomnia: SSRIs can be used off-label for the treatment of insomnia, specifically individuals who experience difficulty falling or staying asleep.\n5. Fibromyalgia: SSRIs can be used off-label to treat the symptom of pain in individuals with fibromyalgia.\n6. ADHD: SSRIs can be used off-label to treat adults with attention-deficit hyperactivity disorder (ADHD).\n7. Bipolar Disorder: SSRIs can be used off-label to treat symptoms of mania and depression in individuals with bipolar disorder.\n8. Alcoholism: SSRIs can be used off-label to reduce craving and help individuals maintain abstinence from alcohol.\n9. Eating Disorders: SSRIs can be used off-label to treat bulimia nervosa and binge-eating disorder.\n10. Premature Ejaculation: Some SSRIs can be used off-label for premature ejaculation due to their ability to reduce serotonin levels in the body."
  },
  {
    "id": 408,
    "user_query": "Which is the definition of pyknons in DNA?",
    "text-davinci-003_response": "Pyknons are regions of DNA that contain two or more copies of a short sequence of nucleotides repeated consecutively. These regions are thought to play a role in the way genes are regulated and expressed, meaning they can play a role in the regulation of gene expression. Pyknons can also be used by organisms to create unique genetic elements in a genome, such as islands of genes that have the same sequence and can represent an evolutionary ancestral link that has been conserved over time."
  },
  {
    "id": 409,
    "user_query": "Does a linker histone exist in the yeast genome?",
    "text-davinci-003_response": "Yes, linker histones exist in the yeast genome. Linker histone H1 is found in the chromatin of almost all eukaryotes, including the yeast Saccharomyces cerevisiae. In yeast, the canonical H1, Cse4, is necessary for establishment and maintenance of the inactive X chromosome and heterochromatin formation. It plays a role in databases containing primary DNA sequence information of various species, including yeast. Cse4 is also involved in the establishment and maintenance of facultative heterochromatin. The exact role of Cse4 in yeast chromatin remains unclear, but its presence is necessary for faithful maintenance and assembly of chromatin."
  },
  {
    "id": 410,
    "user_query": "What is the role of deadenylases in the cell?",
    "text-davinci-003_response": "Deadenylases are enzymes responsible for the removal of poly(A) tails from mRNA molecules, which are part of the process of messenger RNA (mRNA) degradation. The role of deadenylases is to catalyze the hydrolysis of the polyadenylated tail of mRNAs, leading to their rapid degradation through the action of downstream exonucleases. Deadenylases play an important role in mRNA turnover and play a critical role in regulating gene expression, as mRNA molecules that remain polyadenylated for too long can become subject to transcriptional gene silencing and interference. Furthermore, deadenylases are involved in the regulation of post-transcriptional gene expression and play a role in determining the rate of mRNA turnover. In this way, deadenylases help to maintain homeostasis in the cell by ensuring that mRNA molecules are turned over at an appropriate rate and remain available for normal gene expression."
  },
  {
    "id": 412,
    "user_query": "How long, in kb (kilobases),  is a \"Long interspersed nuclear element\"?",
    "text-davinci-003_response": "A Long interspersed nuclear element (LINE) is a type of mobile genetic element that can be found in the genome of many eukaryotic organisms. It is estimated to be around 6,000 - 8,000 kb (kilobases) in size, with an average of about 7,000 kb. Each LINE encodes at least two open reading frames (ORF), which are responsible for the element's transposition activity. Additionally, many LINEs contain noncoding RNAs and transposase-like domains that can regulate their activity and/or function."
  },
  {
    "id": 414,
    "user_query": "List receptors of the drug Cilengitide",
    "text-davinci-003_response": "Cilengitide is an anti-angiogenic drug used to treat glioblastoma multiforme (GBM), a type of brain cancer. It binds to and prevents the activity of integrin αvβ3, one of the four major receptors that have been identified as contributing to the pathogenesis of GBM. These receptors have been shown to be essential for the process of angiogenesis, which is the formation of new blood vessels from pre-existing vessels. In addition, Cilengitide also binds to integrin avb5, which is found on tumor cells, and has been shown to inhibit tumor cell migration and invasion. Finally, Cilengitide has shown to inhibit the activity of matrix metalloproteinases (MMPs), which are enzymes involved in the breakdown of extracellular matrix proteins, important in tumor angiogenesis and metastatic cancer progression. Therefore, the receptors of Cilengitide include: \n- integrin αvβ3 \n- integrin avb5 \n- matrix metalloproteinases (MMPs)"
  },
  {
    "id": 415,
    "user_query": "Can protein coding exons originate from ALU sequences?",
    "text-davinci-003_response": "Yes, protein coding exons can originate from ALU sequences. ALU sequences are pieces of DNA, called retrotransposons, that have originated from a process of reverse transcription in which a single-stranded RNA molecule is reverse-transcribed into a double-stranded DNA. As such, ALU sequences can be seen as a type of “jumping gene” which can insert itself into various locations of the genome. Through this process, ALU sequences can become newly acquired exons. It has been suggested that the majority of exons (>80%) present in humans arose from the reverse transcription of Alu sequences. Additionally, it is estimated that approximately one third of Alu sequences are associated with protein coding genes. Differences in codon usage and splicing patterns suggest that Alu sequences can have an influence on spicing and can therefore create novel exons coding for proteins."
  },
  {
    "id": 418,
    "user_query": "Is there evidence that tomato juice lowers cholesterol levels?",
    "text-davinci-003_response": "Yes, some research suggests that tomato juice could lower cholesterol levels. For instance, a study published in the Journal of Nutrition in 2009 showed that people who drank five ounces of tomato juice per day for 12 weeks significantly reduced their levels of “bad” cholesterol (or LDL cholesterol).\nAnother animal study published in the journal Food Science & Biotechnology in 2010 revealed that rats fed a high-fat diet plus tomato juice experienced lower levels of LDL cholesterol, along with a decrease in liver fat and an increase in the “good” type of cholesterol (HDL) – results suggesting that tomato juice can help protect against cardiovascular disease.\nFurthermore, more recent research published in the journal Food & Function in 2018 looked at the effect of tomato juice on the cholesterol levels of hamsters. The authors found that when tomato juice was added to a high-fat diet, the hamsters’ LDL cholesterol levels were significantly reduced. The authors concluded that tomato juice has “protective effects against hypercholesterolemia.”\nIn summary, while more research is needed to fully understand the effects of tomato juice on cholesterol levels, some studies have suggested that it may have beneficial effects against cardiovascular disease in humans and animals."
  },
  {
    "id": 423,
    "user_query": "What is the mode of inheritance of nemaline myopathy?",
    "text-davinci-003_response": "Nemaline myopathy is a rare genetic disorder, meaning that it is inherited in a Mendelian fashion. Specifically, it is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the affected gene in order to develop the disorder. One copy is inherited from each parent, with both parents often being healthy carriers of the condition."
  },
  {
    "id": 432,
    "user_query": "Is it possible to detect survivin protein expression in normal human adult tissues?",
    "text-davinci-003_response": "Yes, it is possible to detect survivin protein expression in normal human adult tissues. Survivin is a protein found in two isoforms – the nuclear and the cytoplasmic. It is found in many human tissues, including both healthy and malignant adult tissues. Survivin has been identified in tumors of various tissues, including colorectal, breast, and prostate cancers, as well as in normal adult tissues. In normal adult tissues, survivin is expressed in small amounts, but its precise levels vary depending on the tissue type and the particular cell type. For example, it can be detected at higher levels in lymphoid tissues than in other tissues. Overall, its levels are relatively low in normal tissues compared to those found in malignant tissues.\nIn order to detect survivin protein expression in normal human adult tissues, researchers typically use Western blotting and immunohistochemistry techniques. In Western blotting, antibodies are used to identify the protein in a sample taken from a tissue lysate. This method allows researchers to measure the absolute or relative amounts of survivin protein in various tissue samples. Immunohistochemistry can be used to pinpoint the exact location of survivin in a sample. With this technique, researchers can locate survivin in a particular type of cell in a given tissue. Both methods have been used to detect survivin expression in normal human adult tissues."
  },
  {
    "id": 433,
    "user_query": "List symptoms of Meigs' Syndrome.",
    "text-davinci-003_response": "Meigs’ Syndrome is a rare disorder characterized by the triad of ovarian fibroma, ascites, and hydrothorax. The disorder primarily affects premenopausal women aged 40 to 50, although adolescents and men can also be affected. \nThe primary symptom of Meigs' syndrome is a large non-cancerous tumor or fibroma that grows on the ovary, usually on the side closest to the abdominal wall. This tumor often leads to abdominal swelling, pelvic pain, and bloating. \nOther symptoms associated with Meigs' syndrome include: \n• Ascites or accumulation of fluid in the abdominal cavity, leading to abdominal distention and difficulty breathing \n• Hydrothorax or accumulation of fluid in the thoracic cavity around the lungs \n• Anemia \n• Pleural effusion or accumulation of fluid in the pleural cavity around the lungs \n• Abdominal pain \n• Uterine atony \n• Low back pain \n• High white blood cell count \n• Elevated levels of serum calcium \n• Elevated levels of serum estradiol \n• Elevated levels of AFP (alpha-fetoprotein)\nIn some cases, Meigs’ syndrome can also cause premature menopause in premenopausal women."
  },
  {
    "id": 435,
    "user_query": "What is the molecular function of psoralen photobinding on DNA?",
    "text-davinci-003_response": "Psoralen photobinding is a cellular process that uses a compound called psoralen to modify DNA. Psoralen binds to, and crosslinks, DNA molecules when it is exposed to ultraviolet (UV) light. This binding is referred to as photobinding. The molecular function of psoralen photobinding is to assist in the repair of damaged DNA. This repair process helps to reduce the risk of mutations in the genetic material. Psoralen binds to the two strands of the DNA double helix in a covalent bond, which creates a photodamage or ‘lesion’ at the interfacial sites where the psoralen has attached itself. This lesion then causes a disruption of the normal replication process, resulting in a disjunction or breakage in the DNA strands. The process of photobinding also helps to stabilize the DNA structure, by preventing the DNA strands from unpairing or denaturation.\nOverall, psoralen photobinding is a vital step in the repair process of damaged DNA, and helps to reduce the risk of genetic mutation."
  },
  {
    "id": 440,
    "user_query": "Which are the main causes of fetal echogenic bowel?",
    "text-davinci-003_response": "The main causes of fetal echogenic bowel (EB) are prenatal exposures, gestational age, placental ischemia, and genetic causes.\nPrenatal Exposures: Certain prenatal exposures, including in utero-exposure to certain chemicals, infections, medications, and genetics have been known to increase the risk of developing fetal EB. In utero exposure to alcohol (FASD), polycyclic aromatic hydrocarbons, and infectious agents such as TORCH pathogens can all lead to the development of the condition. Additionally, certain drugs such as acyclovir, nitrofurantoin, and primidone can also increase the risk of fetal EB.\nGestational Age: Certain studies have found an increased risk of fetal EB in preterm infants. This suggests that the development of EB is linked to gestational age and its associated maturation process.\nPlacental Ischemia: Placental ischemia is a possible cause of fetal EB, as it can lead to the obstruction of flow of oxygen and nutrients to the fetus. Furthermore, placental ischemia is associated with intrauterine growth restriction and other associated fetal morbidities, and can also lead to an increased risk in developing EB.\nGenetic Causes: Lastly, certain genetic causes can increase the risk of developing fetal EB. Certain genetic syndromes are associated with the development of EB, such as Down syndrome and Smith-Lemli-Opitz syndrome. Additionally, chromosomal abnormalities such as trisomy 21, 13, and 18 can also be associated with EB. Furthermore, genetic causes such as chromosomal deletions and microdeletions can also increase the risk of getting fetal EB."
  },
  {
    "id": 442,
    "user_query": "Which is the enzymatic activity of the myotubularin family of proteins?",
    "text-davinci-003_response": "The myotubularin family of proteins is involved in the enzymatic activity of phosphoinositide 3-phosphatase (PI 3-phosphatase). This particular enzyme is involved in the breakdown of phosphoinositides, a class of phospholipids that are produced during cell signaling and cellular growth. The myotubularin family of proteins is necessary for the proper breakdown and utilization of phosphoinositides, and when this enzymatic activity is impaired, it can lead to a number of physiological problems. As a result, the myotubularin family of proteins is critical for maintaining normal cell growth, health, and function."
  },
  {
    "id": 445,
    "user_query": "Is there any relationship between histone ubiquitylation and splicing?",
    "text-davinci-003_response": "Yes, there is a relationship between histone ubiquitylation and splicing. Histone ubiquitylation is the process of adding ubiquitin (a small protein) to histones, which are the proteins that wrap and package DNA into chromosomes. This modifies the structure of chromatin, making it more accessible for transcription and other DNA processes. Splicing, on the other hand, is the process of identifying and combining exons (protein coding DNA segments) within pre-mRNA to produce mRNA. The splicing process requires specific recognition signals within the pre-mRNA and is highly regulated. \nRecent studies have suggested that histone ubiquitylation can play a role in regulating splicing, particularly in the selection of alternative splicing forms. Ubiquitylation of histones can recruit chromatin modifying enzymes such as histone deacetylases and histone methylases, which can modify histones in ways that increase or decrease the accessibility of the genome for a particular transcription process, including pre-mRNA splicing. This process can affect the stability and fidelity of splicing patterns and can determine which exons splice together, thus influencing which proteins are produced. As a result, histone ubiquitylation has the potential to influence splicing patterns and has the potential to play an important role in the regulation of gene expression."
  },
  {
    "id": 448,
    "user_query": "What are the advantages of the top down mass spectrometric analysis of histones?",
    "text-davinci-003_response": "The advantages of top down mass spectrometric analysis of histones are numerous.\nFirst, it is much more sensitive compared to other conventional methods used to analyze histones (e.g. gel electrophoresis or western blotting). By using a top down approach, histones can be analyzed at much more detailed levels, which leads to increased accuracy and resolution in results.\nSecond, the sample preparation and data readout associated with the top down mass spectrometric analysis of histones is much faster than other methods. By using the top down approach, a researcher can achieve results faster and with less effort thus increasing their efficiency.\nThird, top down mass spectrometric analysis of histones can reveal information about post-translational modifications that may have modified the histones. This provides more detailed information about the histone and how it interacts with other molecules.\nFinally, top down mass spectrometry can be used to analyze histones in various configurations, such as modified/non-modified, making it a versatile analysis tool. This flexibility in analysis allows the researcher to assess histones in multiple contexts and consequently gain valuable information about their structure and function."
  },
  {
    "id": 451,
    "user_query": "What is the indication of Daonil (Glibenclamide)?",
    "text-davinci-003_response": "Daonil (Glibenclamide) is an oral antidiabetic medication prescribed to people with Type 2 diabetes. It acts by increasing the secretion of insulin from the pancreas and thus lowering blood sugar levels. It is used to improve glycemic control in people with diabetes who are either insulin-dependent or non-insulin dependent. Daonil is also indicated in the treatment of polycystic ovary syndrome (PCOS), a condition where the body produces high levels of male hormones. It can be useful in managing the hormone imbalance that accompanies this condition."
  },
  {
    "id": 452,
    "user_query": "Which is the most typical peptide sequence responsible for retrieval of endoplasmic reticulum (ER) lumenal proteins from the Golgi apparatus?",
    "text-davinci-003_response": "The most typical peptide sequence responsible for retrieval of endoplasmic reticulum (ER) lumenal proteins from the Golgi apparatus is the KDEL sequence, also known as \"retrieval signal\". It is a tetrapeptide sequence consisting of lysine-aspartic acid-glutamic acid-leucine and is found at the C-terminal end of the ER-retained proteins. This sequence serves as a recognition signal during the retrieval process, and is recognized by the KDEL receptor, which is a member of the family of soluble ER-Golgi transport proteins. The KDEL receptor binds to the KDEL signal and mediates its interaction with the AP-1 adaptor protein complex, which is responsible for binding and retrieving the ER-retained proteins from the Golgi back to the ER lumen. Thus, the KDEL sequence plays an important role in regulating ER-Golgi transport."
  },
  {
    "id": 454,
    "user_query": "List the main proteases used for sample digestion in proteomics.",
    "text-davinci-003_response": "The main proteases used for sample digestion in proteomics include:\n1. Trypsin: This is the most widely used protease in proteomics. It cleaves after the carboxyl side of the amino acids lysine (K) and arginine (R) and preferentially cleaves a peptide bond after the c-terminal residue of the amino acids lysine.\n2. Chymotrypsin: This protease cleaves the peptide bond after the carboxyl side of the amino acid tyrosine (Y), tryptophan (W), or phenylalanine (F), depending on conditions.\n3. Elastase: This protease cleaves after the carboxyl side of the amino acids alanine (A) and glycine (G).\n4. V8 Protease: This protease cleaves the peptide bond after the carboxyl side of the amino acids aspartic acid (D) and glutamic acid (E).\n5. Lys-C: This protease cleaves the peptide bond after the carboxyl side of the amino acid lysine (K).\n6. Glu-C: This protease cleaves the peptide bond after the carboxyl side of the amino acid glutamic acid (E).\n7. Asp-N: This protease cleaves the peptide bond after the amino side of the amino acid aspartic acid (D).\n8. Pepsin: This protease cleaves the peptide bond after the carboxyl side of the amino acid phenylalanine (F)."
  },
  {
    "id": 456,
    "user_query": "What is the association between Generalized anxiety disorder and mortality risk?",
    "text-davinci-003_response": "Generalized anxiety disorder (GAD) is associated with an increased risk of mortality. GAD is the most common type of anxiety disorder and is characterized by persistent feelings of tension, distress, restlessness, irritability, and fear. People with GAD are at a higher risk for death due to both physical conditions such as cardiovascular disease, respiratory problems, and premature death related to suicide.\nDepression is also associated with an increased risk of death. It is believed that the effects of anxiety on the body increase the risk of physical conditions and associated mortality. People with depression, as well as those with GAD, are more likely to engage in unhealthy behaviors such as smoking, alcohol abuse, and drug use. All these factors contribute to a higher risk of death.\nHigher levels of chronic stress and lack of social support also increase the risk of mortality in people with GAD. Chronic stress has been linked to poorer physical and mental health, leading to an increased risk of developing physical illnesses and ultimately death. Studies have also demonstrated that people with GAD are more likely to have less social support, which can further increase the risk of mortality due to the lack of emotional comfort provided by family and friends in times of need.\nIn summary, GAD is associated with higher mortality risk due to its physical and mental health implications, as well as the potential lack of social support experienced by those with the condition. It is important to note that while GAD poses an increased mortality risk, it is also treatable and effective therapy can help reduce the risk."
  },
  {
    "id": 457,
    "user_query": "Which molecule is targeted by a monoclonal antibody Mepolizumab?",
    "text-davinci-003_response": "Mepolizumab is a monoclonal antibody that is directed against the human interleukin-5 (IL-5). It is used to treat a condition called severe eosinophilic asthma, which is characterized by an increased number of eosinophils in the lungs. It works by preventing the secretion of IL-5, a cytokine that plays a role in the development and maturation of eosinophils. As a result, it can reduce the number of eosinophils present in the lungs."
  },
  {
    "id": 461,
    "user_query": "Which genes are affected in ROMANO-WARD syndrome?",
    "text-davinci-003_response": "ROMANO-WARD syndrome is an autosomal dominant condition caused by a mutation in the N-type calcium channel gene, known as CACNA1S. This gene is responsible for the control and regulation of calcium ions (Ca2+) in the cells of the body. This gene is located on the Cav 3.2 subunit and is expressed in a variety of tissues, including the heart, skeletal muscles, and smooth muscles. Mutations in the CACNA1S gene can lead to abnormalities in calcium ion flow, influencing electrical activity in these tissues. This can cause dysrhythmias leading to cardiac symptoms, muscle weakness, and other problems associated with ROMANO-WARD Syndrome."
  },
  {
    "id": 462,
    "user_query": "Does melanoma  occur in people of African origin ?",
    "text-davinci-003_response": "Yes, melanoma can occur in people of African origin. Melanoma is caused by an abnormal growth of melanocytes, which are the cells that produce the pigment melanin and are found in the skin. While people of African origin have darker skin tones due to melanin, they are not necessarily immune to melanoma. In fact, the American Cancer Society notes that melanoma occurs in all races, though it is less prevalent in people of African origin than other races. The risk for melanoma is still present and can even be higher in certain African individuals who have a lot of moles, which can be a risk factor for the disease. It is important for people of African origin, just as it is with other races, to be vigilant about monitoring their skin and consulting a doctor if they notice any changes."
  },
  {
    "id": 463,
    "user_query": "What is the effect of resveratrol on mTOR activity?",
    "text-davinci-003_response": "Resveratrol is a natural polyphenol compound found in some plants, such as grapes. Preliminary research into the effects of resveratrol on mTOR activity suggests that the compound may act as an inhibitor. mTOR, or mammalian Target Of Rapamycin, is a signaling pathway that regulates cell growth and metabolism. When activated, mTOR signals the cell to take up and use nutrients, divide, and grow. Over-activation of mTOR can lead to the uncontrolled growth of cells associated with cancer, whereas its inhibition can reduce this risk.\nA study from 2009 found that resveratrol suppresses mTOR activity in a dose-dependent manner, with higher levels of resveratrol resulting in greater suppression. This effect was demonstrated both in cell cultures and in animal models. Another study from 2014 found that resveratrol can reduce mTOR-dependent cancer cell proliferation.\nIn addition to inhibiting mTOR activity, resveratrol has also been found to activate sirtuins, a type of enzyme involved in the regulation of aging and cellular stress. Increased sirtuin activity may help to reduce the risk of diabetes, cardiovascular disease, and cancer.\nIt is important to note that all of these studies were conducted in laboratory settings, and the effects of resveratrol on mTOR activity have not been demonstrated in humans. As such, it is premature to draw any actual clinical conclusions about the effect of resveratrol on mTOR activity. Further research is necessary to determine its safety in humans."
  },
  {
    "id": 464,
    "user_query": "Are people with blood group O protected against severe Malaria?",
    "text-davinci-003_response": "No, people with blood type O are not protected against severe malaria. Malaria is caused by a group of parasites called Plasmodium, which are acquired through the bite of an infected female Anopheles mosquito. These parasites live and multiply inside human red blood cells, which have A, B, AB, and O blood types. Though studies have demonstrated that people with blood type O have a slightly lower risk of contracting malaria, this does not mean they are completely protected. Furthermore, severity of malaria does not vary among the different blood types. It is worth noting that certain genetic traits may also play a role in how severe the infection will be for an individual regardless of their blood type. For example, a mutation to the G6PD enzyme, which helps the body defend against malaria, increases the risk of severe malaria."
  },
  {
    "id": 467,
    "user_query": "What is the mechanism of action of solanezumab?",
    "text-davinci-003_response": "Solanezumab is a monoclonal antibody, which means it is an antibody that has been designed to target a very specific molecule called amyloid-β proteins. These proteins are linked to Alzheimer's disease, so the goal of solanezumab is to specifically target these molecules and prevent them from accumulating and causing damage in the brain.\nThe exact mechanism of action of solanezumab is not yet fully understood. It is believed that solanezumab binds to the amyloid-β proteins and then triggers an immune system response, which then manges to clear the protein from the brain. It is believed that by doing this the risk of cognitive decline in patients with Alzheimer’s disease is reduced, without causing any other side effects.\nAnother proposed mechanism of action is that solanezumab helps to reduce the rate of amyloid-β formation by preventing the amyloid precursor protein from being converted into amyloid-β. In addition, it is believed that solanezumab is able to stimulate the clearance of existing amyloid-β proteins by binding to them and making them more accessible to the body’s immune system and cellular processes that can remove them."
  },
  {
    "id": 469,
    "user_query": "What is the treatment of neuropathic pain in children?",
    "text-davinci-003_response": "The treatment of neuropathic pain in children typically involves a combination of medical, physical, and psychological therapies. \nMedical treatments for neuropathic pain in children include both over-the-counter and prescription medications. Over-the-counter pain relievers may be used to help relieve mild pain such as ibuprofen or acetaminophen. For more severe pain, prescription medications such as anticonvulsants, tricyclic antidepressants, and antispasmodic drugs may be prescribed.\nPhysical therapies are also used to help reduce neuropathic pain in children. Physical therapies such as massage, heat, cold, electrical stimulation, and ultrasound may be used in combination to reduce pain.\nPsychological therapies are also important for treating neuropathic pain in children. Cognitive-behavioral therapy has been shown to help reduce pain in children, as it helps teach children how to cope with pain and reduce its intensity. Psychotherapy may also be beneficial in helping children learn how to manage stress and anxiety, which can often be associated with neuropathic pain.\nIn some cases, the treatment of neuropathic pain in children may require more invasive treatments such as interventional procedures or surgery. These treatments may include nerve blocks, injections, or implantable devices. It is important to talk to your doctor about all of the options before beginning any treatment."
  },
  {
    "id": 470,
    "user_query": "Which phenomenon is known as the \"calcium paradox\" in the isolated perfused heart?",
    "text-davinci-003_response": "The calcium paradox in the isolated perfused heart is a phenomenon in which an increased amount of intracellular calcium can have an inhibitory effect on cardiac muscle contraction, even though calcium is necessary for heart muscle contraction. This is because, in situations of intense excitation, the influx of calcium from external sources results in a decreased response of the myocardial cells to calcium, resulting in a paradoxical situation in which calcium ceases to be an activator of muscle contraction and instead becomes an inhibitor. This phenomenon has been linked to the presence of calcium-sensitivity of the myofilaments, as well as to alterations in the calcium metabolism such as buffering, reuptake or release of stored calcium. In addition, calcium paradox can be due to the increased sensitivity of calcium channels to various factors such as adenosine or endothelin. Ultimately, this paradoxical phenomenon serves as an important homeostatic mechanism for the cardiac muscle during periods of intense excitation."
  },
  {
    "id": 472,
    "user_query": "How do Hsp70 and Hsp110 affect mRNA stability?",
    "text-davinci-003_response": "Hsp70 and Hsp110 are molecular chaperone proteins which, among other roles, are involved in the regulation of mRNA stability and turnover in eukaryotic cells. Hsp70 binds to the 5' and 3' regions of the mRNA, protecting it from accidental degradation. Hsp110 binds to the 5' end of the mRNA chain, interacting with other proteins to stabilize the mRNA and assist in translocation to the cytoplasm. In some cases, both Hsp70 and Hsp110 play roles in exonucleolytic degradation, where the mRNA chain is specifically broken down by exonucleases. Additionally, the presence of Hsp70 and Hsp110 have been associated with stabilization of mRNAs with high protein translation rates. The chaperone proteins help maintain an optimal mRNA structure which allows the mRNA message to be translated effectively. Without the presence of these two chaperone proteins, mRNA stability and translation efficiency would be greatly reduced."
  },
  {
    "id": 477,
    "user_query": "What is FINDbase?",
    "text-davinci-003_response": "FINDbase is a cloud-based platform designed to provide a single source of truth for customer-facing teams across large companies or organizations. It integrates disparate data sources, such as ERP systems, CRM systems, marketing platforms, and customer sentiment systems, into an AI-driven platform that can be accessed by users in real-time to help them better understand their customers. With FINDbase, businesses are able to access up-to-date customer data in one place, enabling them to make more informed decisions regarding customer segmentation, campaigns, and more. It can also be used for segmentation analysis, customer profiling, and drive personalization efforts. Predictive analytics can be used to detect customer trends, potential opportunities, risks, and alert sales reps and marketers in the event of potential churn."
  },
  {
    "id": 481,
    "user_query": "Which deiodinases are present in skeletal  muscle?",
    "text-davinci-003_response": "The three iodothyronine deiodinases (DIOs) present in skeletal muscle are DIO-1, DIO-2, and DIO-3. DIO-1, which is also known as D1, is a ubiquitous type I enzyme found in all tissues and is responsible for the monodeiodination of T4 to T3, the active form of thyroid hormone. Its activity is inhibited by propylthiouracil and iodothyronine deiodinase inhibitors (IDIs). DIO-2, also known as D2, is a tissue-specific type II enzyme expressed primarily in skeletal muscle and cardiac tissues and is responsible for the inactivation of T4 to inactive rT3. Its activity is inhibited by 3,3',5-triiodothyronine (T3) and propylthiouracil, among other inhibitors. DIO-3, also known as D3, is a tissue-specific type III enzyme expressed primarily in skeletal muscle, especially in red fibers. Its activity is inhibited by 3,5-diiodothyronine (T2) and T3 among other inhibitors."
  },
  {
    "id": 483,
    "user_query": "Which is the molecular weight of the protein angiogenin?",
    "text-davinci-003_response": "The molecular weight of the protein angiogenin is approximately 13,370 g/mol. It is a member of the angiogenin family of proteins found in humans, and is a 421-amino acid residue protein. Angiogenin plays an important role in the formation of new blood vessels from existing vasculature, and is a key regulator of angiogenesis - the process by which blood vessel formation occurs."
  },
  {
    "id": 484,
    "user_query": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment.",
    "text-davinci-003_response": "The sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment are:\n1. Empagliflozin (brand name Jardiance): Approved in 2014, this medication helps lower blood glucose levels by causing the kidneys to excrete more glucose in the urine.\n2. Dapagliflozin (brand name Farxiga): Approved in 2014, this medication helps reduce the amount of glucose that’s reabsorbed by the kidneys, thus reducing blood glucose levels.\n3. Canagliflozin (brand name Invokana): Approved in 2013, this medication helps the kidneys to excrete more glucose in the urine and thus reduce blood glucose levels.\n4. Ertugliflozin (brand name Steglatro): Approved in 2017, this medication helps reduce the amount of glucose that’s reabsorbed by the kidneys, thus reducing blood glucose levels. \n5. Ipragliflozin (brand name Suglat): Approved in 2019, this medication helps the kidneys to excrete more glucose in the urine and thus reduce blood glucose levels."
  },
  {
    "id": 486,
    "user_query": "Why does the prodrug amifostine (ethyol) create hypoxia?",
    "text-davinci-003_response": "Amifostine (ethyol) is a prodrug that is slowly metabolized to its active form, WR-2721. WR-2721 can scavenge free radicals, making it a useful drug in the treatment of radiation-induced tissue damage. It also stimulates the production of cytoprotective enzymes like glutathione, and thus helps protect cells from radiation damage. \nWhen amifostine is metabolized to WR-2721, it releases two sources of oxygen, first CO2 and then molecular oxygen. As CO2 is released there is a decrease in the oxygen concentration in the cells, resulting in hypoxia. This is caused by the fact that the volume of oxygen remains constant, and a decrease in the number of molecules results in a decrease in the oxygen concentration. The hypoxia induced by the release of CO2 serves a protective role, as some cells may be sensitive to the effects of oxygen."
  },
  {
    "id": 493,
    "user_query": "Which disease is included as an additional feature in the Goldberg-Shprintzen syndrome?",
    "text-davinci-003_response": "The Goldberg-Shprintzen syndrome is a rare disorder which affects the growth and development of the bones, muscles, heart, and blood vessels. It is a genetic disorder caused by mutations in the gene BCOR. Symptoms of Goldberg-Shprintzen syndrome can include an abnormally-shaped skull, growth delay, hearing loss, intellectual disability, heart defects, and other issues with bone and muscle development. An additional feature of Goldberg-Shprintzen syndrome is Di George syndrome, also known as 22q11.2 deletion syndrome. Di George syndrome is a disorder caused by the deletion of a small piece of chromosome 22, and can cause physical and developmental delays, as well as abnormalities of the heart, kidneys, and other organs. Symptoms of Di George syndrome can include congenital heart defects, frequent infections, delays in physical and/or behavioral development, learning difficulties, and various facial features."
  },
  {
    "id": 496,
    "user_query": "Which disease of the central nervous system is characterized by the presence of Lewy bodies?",
    "text-davinci-003_response": "The disease of the central nervous system characterized by the presence of Lewy bodies is called Dementia with Lewy Bodies (DLB). DLB is a progressive neurodegenerative disorder that affects the parts of the brain involved in movement, thinking and behavior. Lewy bodies are clumps of proteins that are found in the brain and spinal cord of those with the disorder, and are made up of alpha-synuclein proteins. Symptoms of DLB include memory loss, confusion, visual hallucinations, impaired mobility, and problems with movement and balance. These symptoms can have a profound impact on daily activities and can lead to increased risk of falls, accidents and other medical issues if they are not appropriately treated."
  },
  {
    "id": 501,
    "user_query": "Is Kanzaki disease associated with deficiency in alpha-N-acetylgalactosaminidase?",
    "text-davinci-003_response": "Yes, Kanzaki disease is associated with deficiency in alpha-N-acetylgalactosaminidase. Kanzaki disease is an autosomal recessive disorder caused by a deficiency of the enzyme alpha-N-acetylgalactosaminidase, which is responsible for the breakdown of complex sugar molecules. The deficiency leads to a buildup of these molecules in the body resulting in a range of symptoms. Common symptoms of Kanzaki disease include skeletal deformities due to joint contractures, enlarged liver and spleen, intellectual disability, hearing loss, failure to thrive, seizures, and muscle wasting. Treatment options are limited and primarily involve enzyme replacement therapy or gene therapy."
  },
  {
    "id": 512,
    "user_query": "Is vemurafenib effective for hairy-cell leukemia?",
    "text-davinci-003_response": "Yes, Vemurafenib can be effective for hairy-cell leukemia (HCL). Vemurafenib is an inhibitor of the oncogene BRAF, which is usually the mutated form found in HCL. Studies have shown that Vemurafenib can cause remissions in HCL. In a 2018 systematic review conducted by Theoret et al., the researchers examined fourteen clinical trials that tested the efficacy of Vemurafenib for HCL. The overall response rate was found to be 95.7%, with a median duration of response of 11.5 months. Additionally, in the majority of cases, the response was found to be durable for months to years.\nDespite the positive findings in the Theoret et al. study, it is important to note that Vemurafenib is not curative for HCL; it is only able to control the disease. As such, it is important to monitor patients taking Vemurafenib for signs of disease progression. Additionally, side effects associated with this medication include photosensitivity (an increase in the sensitivity of the skin to light) and rashes. Therefore, it is important to discuss and weigh the potential benefits and side effects with your doctor before beginning Vemurafenib therapy."
  },
  {
    "id": 513,
    "user_query": "Which are the inhibitors of histone methyltransferases?",
    "text-davinci-003_response": "Histone methyltransferases are specialised enzymes that transfer methyl groups to specific amino acids on histones, the basic proteins involved in the structure of chromosomes. Inhibitors of these enzymes are molecules that block or disrupt histone methyltransferase activity. These inhibitors can be divided into two main categories: small molecule inhibitors and genetic disruptors. \nSmall molecule inhibitors are typically chemotherapeutic drugs, specialised proteins, peptides, or other chemical molecules that interfere with histone methyltransferase activity. Examples of these inhibitors include 5-azacytidine, suberoylanilide hydroxamic acid (SAHA), inhibitors of the Enhancer of Zeste 2 (EZH2) enzyme, and others. \nGenetic disruptors are gene-targeted molecules such as siRNA or CRISPR-Cas9 constructs that interfere with the expression or activity of histone methyltransferases. These genetic disruptors can be used to specifically deplete methyltransferase enzymes from the cell, thus inhibiting their function. Examples of these inhibitors include small interfering RNA (siRNA), short-hairpin oligonucleotides (shRNAs), and CRISPR-Cas9 gene-editing complexes."
  },
  {
    "id": 517,
    "user_query": "Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?",
    "text-davinci-003_response": "The JAK inhibitor approved for the treatment of rheumatoid arthritis is baricitinib (Olumiant), which is a once-daily oral medication. It was approved by the U.S Food and Drug Administration (FDA) in 2020 for adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more disease modifying anti-rheumatic drugs (DMARDs). Baricitinib works by blocking signals from the body’s cytokines -- a type of protein that is involved in the inflammatory response in RA -- that then reduces inflammation in the joints and helps protect the tissue from further damage."
  },
  {
    "id": 519,
    "user_query": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?",
    "text-davinci-003_response": "The newly identified DNA nucleases that are being studied for therapeutic applications in the treatment of thalassemia are Endonucleases, Deoxyribonucleases and Zinc Finger Nuclease (ZFN), as well as TALEN (Transcription Activator-Like Effector Nuclease) technology.\nEndonucleases, commonly referred to as restriction enzymes, are enzymes used to cut DNA strands at specific sites. These enzymes require recognition sites on the DNA strand, which may vary in length and sequence, in order to cleave the DNA. Endonucleases can be used to insert, remove, or replace segments of DNA, making them useful in the treatment of various genetic diseases, including thalassemia.\nDeoxyribonucleases are enzymes that can cleave DNA strands in a random manner, without the requirement of recognition sites. Since deoxyribonucleases do not require a target site, they can be used to target any strand of mutated or misplaced DNA, making them an attractive choice for treating genetic disorders, such as thalassemia.\nZinc Finger Nucleases (ZFN) are DNA-cutting enzymes that recognize and cut specific target sites in the genome. These enzymes utilize zinc-finger proteins to recognize and bind to a target DNA sequence, and then cut both strands of the DNA at that site. Since ZFNs are highly specific, they have the potential to be used for insertions, deletions, and repairs of mutations within the DNA.\nTALENs are a form of artificial restriction enzymes that utilize DNA-binding proteins in order to recognize and cleave specific DNA sequences. Similar to ZFNs, TALENs can be used for insertions, deletions, and repairs of mutations within the DNA, making them suitable for the treatment of genetic diseases, like thalassemia."
  },
  {
    "id": 524,
    "user_query": "Is the protein β1-integrin recycled?",
    "text-davinci-003_response": "Yes, β1-integrin (or CD29) is recycled. When β1-integrin is sent out from the endoplasmic reticulum (ER) to the plasma membrane, the protein can be internalized and recycled back to the plasma membrane. This process, known as endocytosis, allows the cell to respond to signals from its environment. The recycling of β1-integrin is necessary for it to maintain its adhesive function, where it can form links between extracellular matrix proteins and intracellular signaling pathways. In particular, β1-integrin can be found on the surface of epithelial and endothelial cells, where endocytosis plays a role in maintaining adhesion so that the cells can withstand mechanical stress. Additionally, β1-integrin recycling allows for the cell to “regulate levels of adhesive signaling and its distribution in the plasma membrane” even in a dynamic environment. Thus, β1-integrin is recycled to ensure its ability to interact with its environment, maintain appropriate adhesive properties, and respond to changes in the outside environment."
  },
  {
    "id": 526,
    "user_query": "Which signaling pathway is activating the dishevelled proteins?",
    "text-davinci-003_response": "The canonical WNT signaling pathway is the primary pathway that activates the dishevelled proteins. This is a signal transduction cascade that is triggered when WNT ligands bind to Frizzled or LRP receptors on the target cell. Upon binding of the WNT ligand, dishevelled proteins are activated via phosphorylation by GSK3-beta which initiates the pathway. Once activated, the dishevelled proteins play an important role in modulating downstream signaling pathways. The canonical WNT signaling pathway is involved in a variety of cellular processes such as cell fate determination, proliferation, stem cell maintenance, and tumorigenesis."
  },
  {
    "id": 533,
    "user_query": "Can a peptide aptamer be used as protein inhibitor?",
    "text-davinci-003_response": "Yes, a peptide aptamer can be used as a protein inhibitor. Peptide aptamers are short, synthetic peptides that have been designed to specifically target a particular protein of interest and interact with it in the same way that antibodies would. By interacting with the protein, the peptide aptamer can block its activity, thus inhibiting its function in the body. By designing the peptide aptamers to be specific for certain proteins, they can be used to selectively target and inhibit those proteins, making them ideal for use as therapeutic agents."
  },
  {
    "id": 534,
    "user_query": "List inflammatory caspase proteins?",
    "text-davinci-003_response": "The inflammatory caspase proteins are a group of proteins that form part of the inflammatory pathway and are part of the inflammatory response to injury or damage to tissues. The inflammatory caspases include:-\n1. Caspase-1: Also known as interleukin-1 beta converting enzyme (ICE). Caspase-1 is an activator of the inflammatory response, which triggers inflammation in the body. It is involved in the processing of pro-inflammatory cytokines such as interleukin-1 beta (Il-1β) and is activated by a complex of molecules including pro-inflammatory mediators.\n2. Caspase-4: Also known as Apoptosis-Associated Speck-Like Protein (ASC) and Interferon-initiated Gene 15. Caspase-4 is mainly expressed in monocytes (macrophages) and is key in the innate immune responses to viral infections. It is also involved in the production of pro-inflammatory cytokines such as IL-6, IL-1β, and TNF-α.\n3. Caspase-5: Also known as Inflammasome-associated protein (IAP) and processing inhibitor of caspase-1 (PIC1). Caspase-5 is expressed in monocytes and plays a role in inducing inflammation. It processes pro-inflammatory cytokines such as IL-1β, and can be activated by a variety of stimuli, including bacterial, viral, and fungal components.\n4. Caspase-11: Also known as Endoplasmic Reticulum-associated Protein (ERAP) and Nod-like Receptor Pyrin Domain-containing 3 (NLRP3). Caspase-11 is expressed in macrophages and plays an important role in the activation of the innate immune response. Upon activation, it cleaves pro-inflammatory cytokines such as IL-1β and IL-18, and plays a role in modulating the production of inflammatory markers and cytokines.\n5. Caspase-12: Also known as Macrophage Caspase-Like (MCL). Caspase-12 is expressed in macrophages and is involved in the production of inflammatory mediators. It can also be involved in the production of inflammatory cytokines such as TNF-α and IL-1β and the processing of these cytokines."
  },
  {
    "id": 538,
    "user_query": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma",
    "text-davinci-003_response": "(SEGA).\n1. Vincristine: This chemotherapeutic agent is often used to treat SEGA and is usually prescribed in combination with other drugs. It is a type of plant alkaloid which works by inhibiting DNA production in rapidly dividing cells, such as cancer cells.\n2. Temozolomide: This is another common chemotherapeutic agent used to treat SEGA. It is a type of alkylating agent and works by forming bulky molecules which interfere with the DNA of cancer cells, causing them to stop dividing."
  },
  {
    "id": 541,
    "user_query": "List available databases containing information about conserved noncoding elements.",
    "text-davinci-003_response": "1. The UCSC Genome Browser Database: The UCSC Genome Browser Database is an integrated genome analysis and annotation resource providing access to a comprehensive suite of genomic data sets including genome sequences, annotations, conservation tracks, and variation data. Its Conservation tracks section offers an overview of label nucleotide positions in the genome with scores for their conservation in other mammalian genomes.\n2. PhiBase: PhiBase is a manually curated, species-centric database for eukaryotic noncoding elements. It stores conservation evidence on a range of elements, including: microRNAs, long noncoding RNAs, promoter sequences, repetitive elements, and epigenetic modifications. \n3. The ENCODE Project: The ENCODE Project is a consortium of scientists working on a five-year project to catalogue all elements of the human genome that are active in selected cell types. Its data includes information about conserved noncoding elements, such as promoters, enhancers, and transcription factor binding sites.\n4. dbSUPER: dbSUPER is a web-based database of super-enhancers, which are large conserved regions of enhancer sequences located upstream of genes. It provides comprehensive information about the genomic locations of super-enhancers and their associated target genes.\n5. 30Way Conservation: The 30Way Conservation database at the UCSC Genome Browser provides a comparison of the human genome with other vertebrates and model organisms. It contains scores for each nucleotide position in the query sequence based on its conservation among the other specified species."
  },
  {
    "id": 546,
    "user_query": "What disease in Loxapine prominently used for?",
    "text-davinci-003_response": "Loxapine is an antipsychotic medication used to treat schizophrenia and other psychiatric disorders. It is used to treat symptoms such as hallucinations, delusions, thoughts of suicide, aggression, and anxiety. It may also be used to treat other mental illnesses such as bipolar disorder and depression. Loxapine works by reducing abnormal excitement in the brain. It can help to improve thinking, mood, and behavior."
  },
  {
    "id": 548,
    "user_query": "Which antibodies cause Riedel thyroiditis?",
    "text-davinci-003_response": "Riedel thyroiditis is a rare form of chronic thyroiditis caused by antibodies that produce an immune response against the patient's own thyroid tissue. The antibodies that cause Riedel thyroiditis are typically antithyroid autoantibodies specific for the thyroid-stimulating hormone receptor (TSHR). These antibodies bind to the TSHR and signal the thyroid to produce too much thyroid hormone, leading to a condition known as hyperthyroidism. In rare cases, these autoantibodies can produce a destructive immune response that leads to the destruction of thyroid tissue and fibroblastic infiltration, causing the thickening and fibrosis of the thyroid gland associated with Riedel thyroiditis. Other antibodies associated with Riedel thyroiditis include antithyroid peroxidase (TPO) and antithyroglobulin (TG)."
  },
  {
    "id": 551,
    "user_query": "Which receptors are bound by Tasimelteon?",
    "text-davinci-003_response": "Tasimelteon is an FDA-approved, small molecule agonist of the melatonin MT1 and MT2 receptors. MT1 and MT2 are two subtypes of the melatonin receptor family, which belongs to the G protein-coupled receptor (GPCR) superfamily. MT1 and MT2 melatonin receptors are expressed in the brain and peripheral tissues, where they mediate the effects of the sleep hormone melatonin. Tasimelteon is an agonist of both MT1 and MT2 receptors and is thought to be a safe and effective short-term treatment for people with insomnia. It has been shown to reduce the time it takes to fall asleep and improve sleep quality in people with difficulty sleeping."
  },
  {
    "id": 552,
    "user_query": "Is zyxin a focal adhesion protein?",
    "text-davinci-003_response": "No, zyxin is not a focal adhesion protein. Focal adhesion proteins are a class of proteins involved in linking the extra-cellular matrix to actin filaments and the cytoskeleton. Zyxin is not involved in any of these activities; rather, zyxin is a member of the LIM domain family which is involved in cytoskeletal organization, cell polarity, and cell proliferation."
  },
  {
    "id": 556,
    "user_query": "Which RNA polymerase is used for the replication of viroids?",
    "text-davinci-003_response": "The RNA polymerase used for the replication of viroids is the rolling circle enzyme (RCE). This enzyme is found in several plant viruses and viroids, and works by recognizing a specific primer sequence in the viroid RNA molecule and using energy from ATP hydrolysis to initiate RNA replication from the primer site. RCE has a key role in replicating viroid genomes, as it is able to recognize the short (−70 nucleotides) single-stranded circular viroid RNA and initiate rolling circle replication. RCE encodes a catalytic core consisting of multiple parts, including multiple ‘helicases’ which are proteins involved in unwinding the many nucleotide strands during replication. RCE is also responsible for supplying the new complementary strands of nucleotides during the replication process. The delivered strands can then form a double helical stucture which resembles the original viroid molecule, and the entire process is essential for viroid replication."
  },
  {
    "id": 559,
    "user_query": "What is known about Vancomycin dosing in neonates?",
    "text-davinci-003_response": "Vancomycin dosing in neonates is highly dependent on the body weight and gestational age of the neonate, which is why the neonatal team must assess and evaluate each infant carefully in order to determine the correct dose. The doses must be monitored closely due to its potential for toxicity, as toxicities have been associated with high serum concentrations. Therefore it is essential that serum concentrations be frequently monitored to ensure adequate dosing without toxicity.\nRecommended vancomycin doses in neonates range from 10-20 mg/kg/day, divided into two or three dosing intervals with the ideal dosing regimen being every 8 to 12 hours, although doses as low as 7.5 mg/kg/day and as high as 25 mg/kg/day have been known to be used in individual cases. \nPreterm neonates are typically given lower doses than term neonates (7.5 to 10 mg/kg/day) due to the slower renal elimination of the drug and an increased risk of nephrotoxicity. Maximum total vancomycin doses used for neonates is dependent on gestational age, with dose ranges of 20-75 mg/kg/day being reported. \nVancomycin dosing in neonates should also incorporate monitoring of serum concentrations as a major factor for dosage decisions. Generally vancomycin trough concentrations of 15 to 20 μg/mL are considered adequate for most indications."
  },
  {
    "id": 562,
    "user_query": "Which antiepileptic drug is most strongly associated with spina bifida?",
    "text-davinci-003_response": "The antiepileptic drug most strongly associated with spina bifida is valproic acid. Valproic acid was commonly prescribed to both pregnant women and women who wished to become pregnant for the treatment of epilepsy during the 1970s and early 1980s. In 1995, a study conducted by the Centers for Disease Control and Prevention (CDC) found that the use of valproic acid during the first trimester of pregnancy was strongly associated with spina bifida. This association has since been reconfirmed in larger studies, and as a result, valproic acid is now rarely prescribed to pregnant women or women planning to become pregnant."
  },
  {
    "id": 564,
    "user_query": "The drug JTV519 is derivative of which group of chemical compounds?",
    "text-davinci-003_response": "JTV519 is a novel, synthetic small molecule drug which is a derivative of a class of compounds called platinum based DNA intercalators. These compounds have shown in pre-clinical studies to bind to and inhibit specific proteins which drive the growth of cancer cells. Platinum-DNA intercalators are recognized as having a unique molecular structure which enables them to bind and intercalate DNA, as well as interact with other cellular targets and modulate their activity."
  },
  {
    "id": 566,
    "user_query": "Oxantel is used for periodontitis treatment. How does it work?",
    "text-davinci-003_response": "Oxantel is a prescription medication used to treat periodontitis in adults. The drug works by activating an enzyme in the body called nitric oxide synthase (NOS). This enzyme helps the body produce nitric oxide, which is a type of gas that relaxes blood vessels, reducing inflammation, and helping the gums and tissues around them to heal. Oxantel also has anti-inflammatory and antibacterial properties, which helps to treat and prevent further gum disease. It is typically used in combination with other periodontitis treatments such as scaling and root planing and medicaments, as well as with regular professional cleaning and maintenance care."
  },
  {
    "id": 568,
    "user_query": "What is the function of the protein encoded by the gene PABPC4?",
    "text-davinci-003_response": "PABPC4 (poly (A) binding protein, cytoplasmic 4) is a protein that plays a role in the regulation of gene expression. It belongs to a family of proteins known as poly (A)-binding proteins, which binds specifically to messenger RNA (mRNA) molecules that have a \"poly A tail\", a portion of the mRNA molecule that consists of multiple adenine nucleotides. PABPC4 plays an important role in the processes of mRNA transcription, processing as well as translation of the mRNA molecules into proteins.\nWithin the cell nucleus, PABPC4 is involved in the transcription of mRNA molecules, by binding to the newly transcribed mRNA as well as aiding in the polymerase elongation and capping of the mRNA molecule. PABPC4 is also involved in the pre-mRNA splicing process, where it helps to regulate the alternative splicing of mRNA molecules. Outside of the nucleus, PABPC4 is involved in the cytoplasmic mRNA stability, by binding to the exposed poly (A) tail and protecting the mRNA molecule from enzymatic degradation and other processes that would stop the protein translation process.\nOverall, PABPC4 plays an important role in the processes of mRNA transcription, processing and translation of the mRNA molecules into proteins. It helps to regulate both nuclear and cytoplasmic mRNA stability and is an important component of the gene expression process."
  },
  {
    "id": 570,
    "user_query": "What is the mode of inheritance of Romano Ward long QT syndrome?",
    "text-davinci-003_response": "Romano-Ward long QT syndrome is an inherited disorder caused by mutations in the gene coding for the ion channel protein, HERG, which is located on the long arm of chromosome 11. The mode of inheritance of Romano-Ward long QT syndrome is autosomal dominant, meaning that the trait is inherited from only one parent, not both, who has a defective gene. Individuals with one copy of the mutation are at risk of having symptoms of long QT syndrome while two copies of the mutation would put a person at a higher risk of having symptoms."
  },
  {
    "id": 571,
    "user_query": "Which histone modifications have been associated to alternative splicing?",
    "text-davinci-003_response": "Histone modifications are chemical modifications of the proteins that package DNA in eukaryotic cells into nucleosomes. Histone modifications have been associated with alternative splicing, with modifications to histones H3 and H4 in particular playing a role. Histone modifications identified in studies of alternative splice sites include acetylation, phosphorylation, ubiquitination, sumoylation, methylation, and crotonylation. Acetylation of histone H3 on lysine 9 and lysine 36 is associated with alternative splicing, while phosphorylation of histone H3 on serine 10 is associated with exon skipping. Ubiquitination of histone H2B facilitates alternative transcription start sites. Methylation of histone H3 on lysine 4 has been associated with both constitutive and alternative splicing, while methylation of histone H3 on lysine 36 and H4 on lysine 5 promotes alternative splicing. Sumoylation of histone H3 has also been implicated in alternative splicing, as well as crotonylation of histone H3 lysine 23, which is associated with the inclusion of alternative exons."
  },
  {
    "id": 575,
    "user_query": "What is the mechanism of action of decitabine?",
    "text-davinci-003_response": "Decitabine (5-azacytidine) is a cytidine analog used in the treatment of myelodysplastic syndromes (MDS). It is part of the class of drugs known as “antimetabolites”, which target metabolic processes within cells. \nOnce decitabine enters a cell, it is converted into its active 5-azadioxol-4-ylmethyl-2'-deoxycytidine triphosphate form. The molecule then inhibits DNA methyltransferase, an enzyme responsible for methylation, the process by which DNA is marked as active or inactive (biologically silenced). This results in reduced methylation of DNA which in turn leads to increased expression of silenced genes. In patients with MDS, this helps to restore the production of normal healthy cells. \nDecitabine has also been suggested to act in other ways. It has been found to help increase the sensitivity of cancer cells to radiotherapy, and has been seen to interfere with other key enzymes involved in DNA, RNA, and protein synthesis, such as ribonucleotide reductase and ribonucleotide polymerase. As a result, it is seen to inhibit transcription and ultimately cell growth."
  },
  {
    "id": 576,
    "user_query": "Which gene is associated with the Mitchell-Riley syndrome?",
    "text-davinci-003_response": "The gene associated with the Mitchell-Riley syndrome is FBXW4 (previously known as Fbxo4). Fbxo4 is part of the F-box family of genes and is located on the human X chromosome. Mutations in FBXW4 are associated with the autosomal recessive disorder Mitchell-Riley Syndrome, which is characterized by developmental delay, intellectual disability, facial features including a broad forehead, deep-set eyes, downturned corners of the mouth, thin upper lip, and skin manifestations including facial cherry red spots, papules, and proliferative cutis vasculosa. Mitochondrial anomalies, seizures, and other physical features can also be seen in Mitchell-Riley Syndrome."
  },
  {
    "id": 579,
    "user_query": "Is there any link between the aurora B kinase and the polycomb protein ring1B?",
    "text-davinci-003_response": "Yes, there is a link between the aurora B kinase and the polycomb protein ring1B. Aurora B is a kinase enzyme found in eukaryotic cells that is involved in the regulation of the cell cycle, mitosis, chromatin remodeling, and DNA replication. Aurora B kinase is responsible for activating the mitotic checkpoints of cell division.\nPolycomb protein Ring1B, on the other hand, is a component of the polycomb repressive complex 1 (PRC1), which serves as a transcriptional repressor during many biological processes including development, stem cell maintenance, and cell differentiation. It is thought that the PRC1 complex functions mainly by mediating the post-translational modification of histone proteins, resulting in the conversion of Ezh2 to H3K27me3. \nThere is mounting evidence that the interaction between Aurora B kinase and Ring1B is of utmost importance for the efficient functioning of the PRC1 complex and proper execution of many cellular processes. Upon phosphorylation by Aurora B kinase, Ring1B is activated and is released from its auto-inhibited state, which is essential for polycomb repression. In a study done using mouse embryonic stem cells, Ring1B phosphorylation by Aurora B was shown to be important for the performance of PRC1-mediated transcriptional repression. In contrast, another study using cultured human embryonic kidney cells reported that Ring1B phosphorylation was not necessary for PRC1 function. Thus, the overall link between the two proteins is complex and requires further research to be fully understood."
  },
  {
    "id": 582,
    "user_query": "Name five programs for transcript quantification from RNASeq experiments",
    "text-davinci-003_response": "1. Cufflinks: An open-source bioinformatics software application used to assemble and quantify transcripts from high-throughput RNA sequencing (RNA-Seq) data. \n2. sailfish: An ultra-fast software for transcript quantification based on k-mer counting, capable of running alignments at speeds 16x faster than traditional methods.\n3. Kallisto: a lightweight, ultra-fast, new method for rapid quantification of gene expression from RNA-Seq. \n4. BitSeq: a toolkit for transcript quantification based on the Bayesian inference framework that enables reliable quantification across different experimental conditions.\n5. Salmon: an open-source tool for ultra-fast approximate transcript quantification using lightweight suffix array data structures."
  },
  {
    "id": 587,
    "user_query": "List variants of the MC1R gene.",
    "text-davinci-003_response": "Variants of the MC1R gene can include any mutation or change in the sequence of the gene. Common MC1R gene variants are A92G, R160W,R151C, D294H, R163Q, R142H, and V60L. Others include R151C/R160W, V60L/D294H, R151C/V60L/D294H, and R163Q/D294H. In some cases, the presence of multiple variants can lead to different clinical phenotypes."
  },
  {
    "id": 589,
    "user_query": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?",
    "text-davinci-003_response": "Heterozygous mutations of the BSCL2 gene are associated with a variety of phenotypes, including infants with severe muscle wasting (infantile-onset generalized lipodystrophy, IGL), psychiatric disorders, and cardiac dysfunction in adults. The IGL phenotypes, caused by a near-total lack of fat, can be life-threatening in the first year of infancy. Even with careful management, life-threatening cardiac arrhythmias and sudden death are known to occur in individuals with IGL. \nPsychiatric disorders linked to BSCL2 mutations include hyperactivity, attention deficit disorder, depression, psychosis, bipolar disorder, and anxiety. These mental health issues may persist into adulthood.\nAdults with heterozygous BSCL2 mutations may also display changes in cardiac rhythm, including prolonged QT intervals, significant ventricular arrhythmias, complete heart block, and high risk of sudden death.\nIn addition to the above-mentioned phenotypes, individuals with heterozygous BSCL2 mutations may present with atypical features, such as obesity, increased triglycerides and cholesterol levels, and hypersomnia."
  },
  {
    "id": 592,
    "user_query": "What is the genomic structure of the FAA (FANCA) gene?",
    "text-davinci-003_response": "The FAA (FANCA) gene is located on chromosome 9 (9q34), and its genomic structure consists of 13 exons that span a total of 57,400 base pairs. It contains two promoter regions located adjacent to the first and last exons. Exons 1 and 2 code for amino acid residues that are part of the initiation region, followed by exon 3 that codes for the start codon and the first 12 amino acids. The remaining 10 exons continue to encode the gene's protein, which consists of 852 amino acids. The FAA (FANCA) gene is also associated with a 51-base intron in exon 8. The gene's mRNA is 1.6kb in size, and 4 isoforms are known to exist."
  },
  {
    "id": 593,
    "user_query": "What is Snord116?",
    "text-davinci-003_response": "Snord116 is a gene located on chromosome 16 of the human genome. It is a type II transmembrane protein that is expressed in the brain and is thought to influence the development of corticobasal degeneration, a rare neurological disorder. The gene codes for a protein that is composed of three distinct domains, an N-terminal signal peptide, a transmembrane domain, and a C-terminal cytoplasmic domain. The protein is believed to play a role in cell attachment and migration. It has been found to be involved in neuron-glia interactions and may control calcium ion concentrations in the brain. The expression of Snord116 is decreased in the brains of individuals with corticobasal degeneration. Studies suggest that mutations in Snord116 are associated with the development of the disorder. Further research is needed to determine the exact role of this gene in neurological diseases."
  },
  {
    "id": 594,
    "user_query": "What is the functional role of the protein Drp1?",
    "text-davinci-003_response": "The functional role of the protein Drp1, or dynamin-related protein 1, is to promote the fission of large membrane organelles such as mitochondria. Drp1 is a peripheral membrane protein that clusters along the membrane of an organelle. It is activated by GTP binding and oligomerizes to form a donut-like structure around the organelle. The donut structure then generates a constriction force that is necessary for the division of the organelle into two. During the division, the cytoskeleton dynamically rearranges itself in a process known as membrane remodeling and Drp1 is the key regulatory protein involved in this process. Drp1 also plays a role in the recycling of mitochondria, the regulation of autophagy, and acts as a signaling molecule in response to various physiological stressors."
  },
  {
    "id": 595,
    "user_query": "Which is the genetic cause for the development of Fanconi anemia complementation group D1?",
    "text-davinci-003_response": "The genetic cause for the development of Fanconi anemia complementation group D1 is a mutation in the gene RPN1. RPN1 stands for “RING-H2 domain-containing-1” and it is a gene that is responsible for the production of an enzyme called a proteasome non-lysosomal component, or PNPC. PNPC is responsible for helping to break down proteins in the cell to prevent them from accumulating and causing harm.\nIn individuals with the Fanconi anemia complementation group D1, there is a mutation in the RPN1 gene that causes it to become inactive. This in turn leads to the creation of a defective proteasome non-lysosomal component, which is unable to effectively break down proteins in the cell. As a result, these proteins accumulate, leading to various cellular abnormalities and the development of Fanconi anemia complementation group D1."
  },
  {
    "id": 596,
    "user_query": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?",
    "text-davinci-003_response": "The most common disease caused by mutations in the Calsequestrin 2 (CASQ2) gene is Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC). ARVC is a rare inherited heart condition characterized by arrhythmias, or irregular heartbeats. Other symptoms include abnormal heart structure, an enlarged right ventricle, heart failure, sudden cardiac arrest, and/or symptoms of syncope (fainting). ARVC occurs primarily in young adults, with some cases reported in infants and children.\nIn addition, mutations in the CASQ2 gene may also cause the following conditions: Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT), Long QT Syndrome (LQTS2), Idiopathic Ventricular Fibrillation (IVF), and Brugada Syndrome (BrS). CPVT is a condition characterized by abnormally fast heart rhythms in response to exercise or intense emotions. LQTS2 is an inherited type of long QT syndrome, a heart rhythm disorder where the ventricles take longer to recharge between beats, thus increasing the risk of episodic heart rhythm disturbances. IVF is a rare condition causing sudden, irregular and chaotic electrical activity in the heart, resulting in fast and chaotic ventricular contractions. Finally, BrS is a condition caused by an electrical disturbance in the heart that can result in syncope (fainting) or sudden death."
  },
  {
    "id": 597,
    "user_query": "What are the most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates?",
    "text-davinci-003_response": "The most frequent non-canonical sequence motifs at donor and acceptor splice sites in vertebrates include the conserved 12/17 base pair motifs. This motif is made up of four parts, three of which are conserved across vertebrate species. The first part is the acceptor splice site, which is composed of two bases, followed by a 5–9 base pair intron and then the donor splice site, which is composed of two more bases. Following the 12–17 base pair motif, other common features usually found at vertebrate splice sites include U-rich regions, usually at the 5' end of the intron for the donor site, and A-rich regions, usually at the 3' end of the intron for the acceptor site. The U-rich region is thought to enhance splicing by favoring base-pairing at the donor splice site, and the A-rich region is believed to be important in intron recognition. In addition, there are other motifs such as polypyrimidine tracts, which can be found in the UTR sequences of both exons, and, in introns, there are often TATA-like elements found near the donor and acceptor splice sites. These elements are considered to be important in post transcriptional splicing."
  },
  {
    "id": 602,
    "user_query": "Which are the Atg8 homologs in human?",
    "text-davinci-003_response": "Atg8 homologs in humans are referred to as LC3 (or light chain 3) proteins. LC3 molecules comprise three family members (LC3A, LC3B, and LC3C) and are primarily involved in the formation of autophagosomes, large intracellular membrane organelles. LC3 proteins are most often characterized by their ability to covalently bind to the lipid phosphatidylethanolamine (PE), and are essential components of the Atg8-PE conjugate involved in the elongation of the forming autophagosome. The Atg8-PE conjugate is composed of LC3, ubiquitin, and two ubiquitin-like proteins (Atg12 and Rubicon),which are vital for the assembly and maturation of autophagosomes. The Atg8-PE conjugates and its various components are essential for the dynamic structural reorganization of the autophagosome membrane and ultimately for the successful completion of autophagy in organisms including humans."
  },
  {
    "id": 606,
    "user_query": "Which is the molecular mechanism underlying K-ras alterations in carcinomas?",
    "text-davinci-003_response": "K-ras alterations in carcinomas refer to changes in the KRAS gene, which is a proto-oncogene that is responsible for encoding the small guanosine triphosphate (GTP) binding protein K-ras, which is involved in signal transduction pathways in cell growth, proliferation, and survival. Mutations in KRAS lead to an oncogenic form of K-ras protein that is hyperactive and which is not regulated properly.\nOnce these mutations occur, several downstream effects and pathways are activated in response. Increased activity of the mutated K-ras protein results in binding to GTP and increased activity of signals such as the ERK, MAPK, JUN and ELK pathways, leading to downstream effects such as increased proliferation, angiogenesis, survival, immune escape, metastasis, and drug resistance. In addition, K-ras mutations can cause dysregulation of hormones involved in cell growth, such as epidermal growth factor, insulin-like growth factor, transforming growth factor-alpha, and Interleukin-6.\nK-ras mutations also lead to the dysregulation of several transcription factors, which can in turn drive the expression of several genes that are known to be involved in cancer development and progression. This includes genes involved in the processes of apoptosis, inflammation, cell cycle progression, and DNA damage and repair, all of which can contribute to the development of malignancies. Other altered expression patterns seen in cases of K-ras mutations include the upregulation of inflammatory cytokines such as IL-6, IL-8, and TNF-alpha, which can contribute to the microenvironment of the malignancy and to further progression of the disease.\nThe end result is the unchecked growth of abnormal cells and tumor formation as a consequence of K-ras mutations in carcinomas."
  },
  {
    "id": 607,
    "user_query": "Is microRNA(miRNA) 30 involved in post-ischemic cardiac remodeling?",
    "text-davinci-003_response": "Yes, microRNA (miRNA) 30 has been found to play a key role in post-ischemic cardiac remodeling. MiRNA-30 has been found to regulate numerous genes and pathways associated with this process. For example, miRNA-30 was found to target genes for apoptosis, fibrosis, and inflammation in post-ischemic cardiac remodeling, indicating it is involved in regulating these processes. Additionally, miRNA-30 has been found to promote angiogenesis, which is necessary for healing and remodeling after ischemia. Interestingly, miRNA-30 has been found to target different genes in pre- and post-ischemic remodeling. This suggests it may play different roles in the two processes. Thus, it is clear that miRNA-30 is involved in post-ischemic cardiac remodeling, and plays an important role in regulating the processes involved in healing and remodeling after ischemia."
  },
  {
    "id": 613,
    "user_query": "How is myotonic dystrophy inherited?",
    "text-davinci-003_response": "Myotonic dystrophy, also known as DM, is a type of degenerative muscle disease that is most commonly inherited in an autosomal dominant fashion. This means that a single copy of the mutated gene is sufficient to cause the disease. In addition, the defective gene can be passed on to subsequent generations and is often inherited from a parent who is affected by the disease. \nMyotonic dystrophy is a multi-system disorder caused by a mutation in a gene located on chromosome 19, the DMPK gene. This mutated gene affects the production of proteins in the body, resulting in various symptoms such as muscle wasting, weakening, and periodically occurring stiffness. In some cases, the disorder can also affect the heart, eyes, and brain.\nThe inheritance pattern of myotonic dystrophy is complex and can vary between individuals. Generally speaking, offspring have a 50% chance of inheriting an affected gene from an affected parent. On rare occasions, the disorder may be inherited in an autosomal recessive fashion, meaning that both copies of the mutated DMPK gene must be inherited in order for the disorder to manifest in the individual. Additionally, myotonic dystrophy can also be inherited in an X-linked pattern in which the mutated gene is located on the X chromosome. This type of inheritance affects males due to the way the disease is transmitted through generations.\nMyotonic dystrophy is not typically inherited in a predictable manner, so it is important to speak with a genetic counselor or healthcare professional for an accurate assessment. Ultimately, your inherited pattern of myotonic dystrophy will depend on your family’s specific genetic information and medical history."
  },
  {
    "id": 615,
    "user_query": "Which are the mammalian orthologs of Drosophila Yki?",
    "text-davinci-003_response": "The mammalian orthologs of Drosophila Yki are Hippo (Hpo) and Warts (Wts) proteins, which make up the mammalian Hippo/Yki signaling pathway. Both proteins are involved in the regulation of organ size, cell growth, death and differentiation. Hpo is a type 1 serine/threonine kinase that promotes cell cycle progression, and Wts is a scaffolding/regulatory protein that binds Hpo. Together, the Hippo/Yki pathway activities control the actin cytoskeleton dynamics, transcriptional regulation as well as cell survival and apoptosis."
  },
  {
    "id": 618,
    "user_query": "Does molindone affect body weight?",
    "text-davinci-003_response": "Molindone is an antipsychotic drug that is used to treat schizophrenia and other psychiatric disorders. While there is limited research on the effects of this medication on body weight, most available evidence suggests that it can cause weight gain in both adults and pediatric patients. In a study of 72 adults with schizophrenia, it was found that 56 percent experienced a weight gain of more than seven percent of their body weight after taking molindone for a period of six months. The average weight gain was 13.1 pounds.\nAnother study of 96 adolescents with schizophrenia and related disorders found that 53 percent had an average weight gain of around 8.2 pounds after taking the drug for eight weeks. In addition, a study of 75 children with autism found that those who were taking molindone experienced an average weight gain of 6.5 pounds over the course of eight weeks.\nGiven the limited research available, it is difficult to definitively say if molindone affects body weight. However, the available evidence does suggest that it can lead to weight gain in some patients. It is important to remember that medication-related weight gain can have a significant impact on overall health, so it is important to work with a physician to determine if molindone is an appropriate treatment for your condition. It is also important to keep an eye on your weight and to talk to your doctor about any changes in your body weight."
  },
  {
    "id": 622,
    "user_query": "Neurostimulation of which nucleus is used for treatment of dystonia?",
    "text-davinci-003_response": "Neurostimulation of the Globus Pallidus Internus (GPi) is the most commonly used treatment for dystonia. It is a form of deep brain stimulation (DBS), in which electrodes, implanted deep into the brain, are used to target a specific part of the brain and deliver electrical stimulation to it in order to modify its firing rate and thus reduce symptoms.\nGPi is the nucleus responsible for the regulation of movement, and in dystonia, it can be dysregulated, resulting in despiteful seizures and dystonic muscle contractions. GPi DBS thereby reduces the abnormal activity in the GPi to normalize the movement thus reducing symptoms.\nWhen considering GPi DBS, physicians may also target the Subthalamic Nucleus (STN) in addition to the GPi. STN DBS is beneficial for primary dystonia due to its efficacy in reducing symptom intensity, particularly in patients with cervical dystonia and blepharospasm.\nAlthough DBS delivers promising outcomes for dystonia, a comprehensive assessment by an expert physician should be done prior to surgery to ensure the best possible outcome. Furthermore, clinicians should always be vigilant about the stimulation parameters and risks related to such neurostimulation."
  },
  {
    "id": 625,
    "user_query": "Where is the angiogenin binding element  located?",
    "text-davinci-003_response": "The angiogenin binding element is located in the untranslated 3' region of human and mouse mRNAs (the end of the gene). It is a G/C-rich sequence, starting with the sequence GCCAGCC, G/C-rich, CCAUGCC, and ends around 200nt downstream. This sequence helps the angiogenin protein, a secreted ribonuclease, to recognize and bind to the mRNA and regulate gene expression."
  },
  {
    "id": 626,
    "user_query": "Which proteins cause cytoplasmic sequestration of NF-kB?",
    "text-davinci-003_response": "NF-kB is a transcription factor that is involved in regulating the expression of genes associated with inflammation, immunity and cell survival. It is found in the cytoplasm of cells, but can be activated when it is released from various proteins that cause cytoplasmic sequestration. These proteins include inhibitory IκBs (the most well-known of which is IκBα) and other associated proteins, such as Carma1, Bcl-3, A20 and several other proteins. These proteins form part of the NF-kB signaling complex and, once activated, allow NF-kB to switch on the expression of target genes. The proteins inhibit NF-kB by sequestering it in the cytoplasm and preventing it from entering the nucleus, where it can stimulate gene expression."
  },
  {
    "id": 627,
    "user_query": "What is the mode of inheritance of Marchesani syndrome?",
    "text-davinci-003_response": "Marchesani syndrome, also known as Marfanoid-progeroid-lipodystrophy syndrome, is an autosomal recessive disorder. This means that the affected individual must inherit two copies of a mutated gene, one from each parent, in order to develop the disorder. If either parent has only one copy of the mutated gene, they will not develop the syndrome but can pass the mutation on to their children. In this situation, the parent is said to be a carrier of the mutation."
  },
  {
    "id": 629,
    "user_query": "Which event results in the acetylation of S6K1?",
    "text-davinci-003_response": "The acetylation of S6K1 is the result of phosphorylation of two closely spaced sites in the Kinase Domain (KD) of S6K1 by the signalling Kinase mTORC2. These sites, T389 and S404, are highly conserved in the KD of S6K1 and in other kinases. The phosphorylation of T389 and S404 activates and increases the catalytic activity of S6K1, leading to its acetylation. Acetylation of S6K1 further increases its activity and enhances its ability to phosphorylate its substrate proteins and regulate cellular processes."
  },
  {
    "id": 630,
    "user_query": "List angiocrine factors",
    "text-davinci-003_response": "that can affect the stock market\nThe angiocrine factors that can affect the stock market include: \n1. Macroeconomic indicators: Major economic indicators like GDP, inflation, unemployment, and interest rates play an important role in shaping stock market performance, as they can signal to investors whether economic conditions are improving or deteriorating.\n2. Political Factors: Political instability, government policies, and news events related to trade wars, terrorism, etc. can have a major impact on investor sentiment.\n3. Global Markets: Global stock markets are highly interconnected. Any news or news about different markets can trigger risk-on or risk-off behavior, affecting the performance of stocks in different markets.\n4. Corporate earnings and news: Stocks react positively or negatively to the earnings announcements and other news related to the companies they are invested in.\n5. Sentiment: Sentiment of investors and the public overall has a huge impact on stock prices. If investors become overly bullish or bearish, prices can be pushed up or down accordingly.\n6. Technical Analysis: Market professionals rely on technical analysis to evaluate the past price movements of securities and predict future price movements. This can lead to buying or selling of certain stocks."
  },
  {
    "id": 631,
    "user_query": "What is protein carbamylation?",
    "text-davinci-003_response": "Protein carbamylation is a process in which proteins become modified after reacting with biochemicals called carbamyls. Carbamyls are organic compounds that contain both carbon and nitrogen atoms, and are the primary offenders when it comes to protein carbamylation. \nWhen a protein comes into contact with either a carbamate-based or a more complex carbamyl-based compound, the chemical reaction binds a carbamate group (what is also known as an isocyanate group) to an amino acid within the protein structure. The result is a chemical modification of the protein known as protein carbamylation.\nThis process can have a significant physiological effect, depending on the chemical composition of the modified protein. When certain proteins react with ionizable groups, they become resistant to enzymatic digestion and lose some of their functional ability. Additionally, protein carbamylation can also trigger a wide range of secondary effects such as glycosylation and oxidation. \nOverall, protein carbamylation is a naturally occurring process that can modify proteins without making any permanent changes to the amino acid sequence. This means that when proteins become chemically modified, a process known as protein revival, can be used to restore the protein back to its original form."
  },
  {
    "id": 632,
    "user_query": "What is the cause of episodic ataxia type 6?",
    "text-davinci-003_response": "Episodic ataxia type 6 (EA6) is a genetic disorder caused by a mutation in the CACNA1A gene. This gene is responsible for encoding a subunit of the voltage-gated calcium channel in the brain, which is important for the regulation of muscle coordination, perception, and learning. \nWhen this gene is mutated, changes occur in the way the body processes calcium. This results in the disruption of regular calcium signaling, leading to a range of symptoms including dizziness, nausea, blurred vision, double vision, ataxia, and seizures. These episodes can range from mild to severely disabling and typically start in late childhood or early adolescence. They are often difficult to control with medications, making lifestyle modifications and understanding triggers helpful in managing the condition."
  },
  {
    "id": 633,
    "user_query": "What is the main role of Ctf4 in dna replication?",
    "text-davinci-003_response": "Ctf4 (Cdc10-Telomere-Factor 4) is a protein involved in the replication of eukaryotic DNA, specifically in the process of telomere maintenance, which is fundamental for genomic stability. Ctf4 has a distinct role throughout different steps of the replication process, but its main role is to coordinate the unidirectional elongation of the lagging strand of the template.\nThe first stage of DNA replication involves the separation of the two DNA strands by a helicase. Ctf4, along with other telomerase-associated proteins, then binds to the stalled replication fork and recruits the necessary replication factors in order to initiate the synthesis of the lagging strand. Ctf4 then acts as a processivity factor, which allows for efficient backtracking of the elongation polymerase, leading to the efficient synthesis of both strands of the template.\nFurthermore, Ctf4 is involved in telomere maintenance by promoting efficient processing of the primers and preventing colliding replication events. Both promote the stability of the chromosome ends, since the activities of these proteins help prevent disruption of the replication fork during lagging strand synthesis. Therefore, the main role of Ctf4 is to contribute to the faithful replication of both strands of the template, while promoting the processing of the primers and preventing colliding replication events."
  },
  {
    "id": 634,
    "user_query": "Could Arimidex (anastrozole) cause hot flashes?",
    "text-davinci-003_response": "Yes, Arimidex (anastrozole) can cause hot flashes. Hot flashes are a common and well-known side effect of taking Arimidex. Although it is not always the case, hot flashes can often start within the first few weeks of taking this medication and may last for three months or longer. Hot flashes can range from mild to very uncomfortable and can include a feeling of warmth spreading through the upper body, profuse sweating, and a rapid heartbeat. It is important to talk to your doctor if you are experiencing hot flashes as they may be able to suggest other treatments for menopausal symptoms or modify your Arimidex dose. There are also additional lifestyle modifications and medications may help reduce or manage hot flashes."
  },
  {
    "id": 635,
    "user_query": "What is the role of Inn1 in cytokinesis?",
    "text-davinci-003_response": "The role of Inn1 in cytokinesis is to help with the formation of the mid-body that divides the two daughter cells after a cell has divided. It accomplishes this by binding to cortical actomyosin cables, which are responsible for scaffolding the mid-body during cytokinesis. Other players in the process of cytokinesis are Inn1’s partner, the formin protein, and the actin and myosin components of the cytoskeletal network. Inn1 helps to bridge the divide between actin and myosin during cytokinesis. This creates a robust mid-body that can't be easily broken. Inn1 has been shown to localize to the midbody within minutes of its formation, indicating that it is a necessary protein in the cytokinesis process."
  },
  {
    "id": 636,
    "user_query": "Which hormone deficiency is implicated in the Costello syndrome ?",
    "text-davinci-003_response": "The Costello syndrome is an autosomal dominant disorder caused by mutations in the gene encoding the RAS-MAPK signal transduction pathway, which is important for normal cellular growth and development. One of the most notable hormone deficiencies associated with Costello syndrome is growth hormone (GH) deficiency. GH deficiency is a potentially serious condition that can lead to short stature and other health problems, including delayed puberty and short-term memory problems. Studies have shown that up to 50% of children with Costello syndrome may have GH deficiency, and as many as 40% of adults with Costello syndrome may be GH deficient. Additionally, some studies have suggested that deficiencies in other hormones like cortisol, prolactin, luteinizing hormone (LH), follicle-stimulating hormone (FSH), and thyroid-stimulating hormone (TSH) may also be more common in this population. As such, hormone deficiencies are an important component of the clinical presentation of Costello syndrome."
  },
  {
    "id": 640,
    "user_query": "Which is the most common CFTR mutation in Caucasians?",
    "text-davinci-003_response": "The most common CFTR mutation in Caucasians is a mutation known as F508del. This mutation is responsible for approximately 70% of all genetic mutations in the CFTR gene in Caucasians, and is the most common CFTR mutation worldwide. F508del causes cystic fibrosis, a genetic disorder that affects primarily the lungs and digestive systems. A person with F508del can have reduced sweat chloride, which is indicative of cystic fibrosis. They may also have difficulty digesting certain foods and develop chronic infections in the lungs. Other symptoms such as salt and water imbalance, weight loss, and increased heart rate may also occur."
  },
  {
    "id": 641,
    "user_query": "Which CDK targets control cytokinesis?",
    "text-davinci-003_response": "Cytokinesis is the process by which the cell divides itself in two and is the final stage of cellular division in both animal and plant cells. In animal cells, cytokinesis is typically controlled by the cell's Contractile Ring, a structure composed of actin filaments, microfilaments, and a variety of proteins including myosin that contracts and causes the cleavage furrow to form and be maintained until the cell is split in two. \nIn plants, however, cytokinesis is controlled by certain plant-specific cytoskeletal components, as well as the plant-specific cyclin-dependent kinases (CDKs), which are a family of cyclin-dependent protein kinases involved in the control of cell cycle progression. Specific CDK targets that control cytokinesis in plants include Cytokinesin-like-Kinesin (KLK) and microtubule-associated proteins (MAPs). KLKs are a family of motor proteins that are involved in cytokinesis in plants and help target specific molecules to the cleavage furrow to facilitate its formation. MAPs help arrange and orient microtubules to enable the formation of the cleavage furrow and organize the newly formed cell membranes surrounding the dividing cell."
  },
  {
    "id": 643,
    "user_query": "In what type(s) of plant organelles we can detect prolamellar bodies?",
    "text-davinci-003_response": "Prolamelar bodies can be detected in the chloroplasts of plants. Chloroplasts are organelles that are found in the cells of plants and photosynthetic algae and are responsible for photosynthesis. Prolamelar bodies are protein complexes that are found in the stromal part of the chloroplast and play an important role in the plant's photosynthesis process. Prolamelar bodies are made up of bundles of actin filaments that are associated with various proteins, such as members of the actin-related protein family and tubulins. They also contain the enzyme RuBisCO, which is responsible for the uptake of carbon dioxide from the atmosphere and the formation of glucose molecules in photosynthesis. Prolamelar bodies have been observed in a wide range of plant species, including Arabidopsis thaliana, Physcomitrella patens, and Chlamydomonas reinhardtii."
  },
  {
    "id": 646,
    "user_query": "Are chromomethylases present in animal genomes?",
    "text-davinci-003_response": "Chromomethylases (CMTs) are DNA methyltransferase enzymes that modify chromatin structure by targeting 5-methylcytosine (5mC) residues. Although 5mC is not typically found in animal genomes, recent studies suggest that CMTs are present in some animals.\nA 2020 study by Blencowe and colleagues identified CMTs from 37 species of birds, including cardinals, hummingbirds, parrots, and macaws. The researchers show that the birds' 5mC residues were targeted by recognized CMTs, suggesting that these enzymes play a role in regulating gene expression and chromatin-based epigenetic regulation. \nStudies have also identified CMT homologs in non-bird animals, including humans, mice, and nematodes. For example, one 2013 study identified a chromatin-modifying enzyme in humans that is homologous to the CMT enzymes present in birds. In humans, the enzyme was found to be involved in regulating gene transcription and chromatin structure; however, the exact role of this enzyme and its homologs is still not well understood. \nStudies have also suggested that CMTs may be present in other vertebrates, including fish, reptiles, and amphibians, although further research is needed to confirm the presence of these methyltransferase enzymes in these species. CMTs have also been identified in some invertebrate species, including the nematode Caenorhabditis elegans.\nIn summary, although 5mC is not typically found in animal genomes, there is evidence suggesting that CMTs are present in some animals. Studies have identified CMT homologs in birds, mice, humans, and nematodes, and evidence suggests that CMTs may be present in other vertebrates and some invertebrates. Further research is needed to better understand the role of CMTs in animals."
  },
  {
    "id": 647,
    "user_query": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?",
    "text-davinci-003_response": "There are over 70 known genes that have been linked to autosomal dominant Charcot-Marie-Tooth (CMT), including ATM, BIG, BICN1, CONNEXIN32, EGR2, GDAP1, HSPB1, HSPB8, IGHMBP2, KARS, LITAF, NDRG1, NEFL, NLN, PMP22, PRX, RAB7A, SH3TC2, SH3TX1, SHT15, TDP1, TTC1, and MYH8. The majority of these genes are associated with the myelin sheath of nerves, and mutations in them can then result in damage to the axons of these nerves, leading to CMT. Symptoms range from mild foot deformities to severe muscle weakness and loss of sensation. Because of its huge gene network, it is difficult to determine which gene is responsible for an individual’s case of CMT. It must be noted that not all CMTs arise due to mutations in the abovementioned genes and further studies are being conducted to understand the other potential genes involved."
  },
  {
    "id": 648,
    "user_query": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?",
    "text-davinci-003_response": "The formation of the IFN-b enhanceosome is a coordinated process that involves several transcription factors. Specifically, the nuclear factor kappa B (NF-kB) and the activator protein-1 (AP-1) complexes are thought to be the most important components of the enhanceosome. NF-kB is a dimeric transcription factor complex composed of RelA, RelB, c-Rel, and p50/p65 subunits. Once activated upon cytokine signaling, NF-kB binds to the IFN-b promoter region and recruits other transcription factors, such as AP-1. The AP-1 family of TFs, composed of c-Jun, c-Myc, ATF-2, and others, is critical for IFN-b expression and its enhanceosome activity. The activity of the enhanceosome is further regulated by some other transcriptional cofactors including STAT proteins, Egr-1, and FoxO family members. Finally, microRNAs can act as modulators of IFN-b enhanceosome formation, in particular miR-155, miR-132, miR-142-3p, and miR-17-92 cluster."
  },
  {
    "id": 650,
    "user_query": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor",
    "text-davinci-003_response": "The bioconductor package OmicCircos provides many useful functions for transcript factor binding sites (TFBS) analysis. It includes an array of methods for motif analysis, including de novo motif discovery, motif comparison, and motif enrichment analysis. The package also provides methods for analyzing gene expression data from TFBS, including gene ontology enrichment analysis, gene set enrichment analysis, and gene mapping. Additionally, OmicCircos can generate various visualizations for further analysis, which include a gene-centered network representation, heatmaps, and Venn diagrams. \nCRISPRcanR is an R/Bioconductor package designed for TFBS analysis. It provides tools for analyzing CRISPR data from a variety of sources, including bulk data from GNF1 and RNA-seq datasets. It enables users to perform TFBS motif discovery, enrichment and comparison analyses, and gene expression analysis. Visualization functionalities include heatmaps, time-series plots, scatter plots, and 3D plots.\nThe rGADEM package is another R/Bioconductor package for transcription factor binding sites (TFBS) analysis. The package can be used to predict TF binding sites from sequence data. It provides analysis functions to detect over-represented motifs, TFBS motif enrichment, TFBS motif comparison, and gene expression profiling. In addition, the package includes several visualization tools, such as heatmaps and 3D plots."
  },
  {
    "id": 651,
    "user_query": "Simpson grading is used to describe resection of which brain tumor?",
    "text-davinci-003_response": "Simpson grading is a pathological based system used to describe resection of Glioblastoma Multiforme (GBM) brain tumors. It is a score system derived from the amount of tumor tissue that is removed during the resection surgery. It is also used as a prognostic tool to assess patient survival. The Simpson grading system includes four categories: G1 (gross total resection, where no tumor tissue is visible to the naked eye and no microscopic tumor remains), G2 (subtotal resection, where some residual tumor is visible to the naked eye and small amounts of tumor remain microscopically), G3 (partial resection, where there is still tumor visible to the naked eye and residual tumor is visible microscopically), and G4 (biopsy only, where only a lesion was biopsied with no attempt to completely remove the tumor)."
  },
  {
    "id": 653,
    "user_query": "Is delayed enhancement documented in patients with non-ischemic dilated cardiomyopathy?",
    "text-davinci-003_response": "Yes, delayed enhancement is documented in patients with non-ischemic dilated cardiomyopathy (DCM). Delayed enhancement is defined as the observation on MRI of a part of the myocardium that does not show an immediate post-contrast wash-in, but appears bright after a delayed interval. Delayed enhancement has been reported in DCM and can be seen in cases of both ischemic and non-ischemic DCM.\nIn non-ischemic DCM, delayed enhancement appears to be due to a combination of diffuse edema in the myocardium, interstitial fibrosis and microvascular dysfunction. Studies have shown that delayed enhancement is significantly correlated with a poor prognosis in patients with non-ischemic DCM, independent of clinical or echocardiographic parameters.\n Delayed enhancement on MRI can provide a valuable tool in the diagnosis and prognostication of non-ischemic DCM. Additionally, it has been suggested that delayed enhancement may be predictive of the need for cardiac transplantation in patients with non-ischemic DCM."
  },
  {
    "id": 654,
    "user_query": "Which enzyme is inhibited by Varespladib?",
    "text-davinci-003_response": "Varespladib is an inhibitor of the Human Secretory Phospholipase A2 enzyme (hsPLA2 or sPLA2). The enzyme is an important mediator of inflammatory processes and it catalyzes the release of free fatty acids from the membrane phospholipids. The inhibition of this enzyme by Varespladib has been shown to reduce inflammation in the body, thus making it useful for a variety of medical conditions."
  },
  {
    "id": 660,
    "user_query": "Which autophagy pathway is trigered by the KFERQ motif of cytosolic proteins?",
    "text-davinci-003_response": "The KFERQ motif of cytosolic proteins is a mechanism that activates the ULK1 (unc-51 like autophagy activating kinase 1) autophagy pathway. This autophagy pathway delivers proteins to lysosomes for degradation and is regulated by the phosphorylation of other proteins such as mTORC1 (mammalian target of rapamycin complex 1). Activation of the ULK1 pathway is the crucial step for the initiation of autophagy work-flow. The KFERQ motif, when encountered by ULK1 in the cytoplasm, binds to the protein and induces its phosphorylation. This in turn activates the ULK1 kinase, and subsequent autophagy processes."
  },
  {
    "id": 665,
    "user_query": "Has overexpression of sirtuins been reported to increase lifespan in budding yeast (Saccharomyces cerevisiae)?",
    "text-davinci-003_response": "Yes, overexpression of sirtuins has been reported to increase lifespan in budding yeast (Saccharomyces cerevisiae). Multiple studies have demonstrated the effect of sirtuins on the lifespan of budding yeast. In one study, it was shown that the overexpression of the silencing information regulator protein Sir2 resulted in a substantial increase in the replicative lifespan of budding yeast. In another study, the overexpression of two sirtuin homologs, Sir2p and Sir4p, was found to double the replicative and chronological lifespan in budding yeast. This effect was further enhanced when combined with forced expression of the life-lengthening transcription factor gene SUI2. Together, these studies demonstrate that overexpression of sirtuins can indeed increase the lifespan of budding yeast."
  },
  {
    "id": 669,
    "user_query": "How does phospholamban affect the biological activity of the calcium ATPase SERCA?",
    "text-davinci-003_response": "Phospholamban (PLB) is a small regulatory protein that is found in the sarcoplasmic reticulum (SR) of muscle cells, and functions to regulate the activity of the SR calcium ATPase (SERCA) in the SR membrane. The SERCA is responsible for controlling the uptake of calcium into the SR during muscle excitation to create the calcium ion gradient that is necessary for muscle contraction. PLB inhibits the SERCA during its \"resting state\", causing it to have a lower turnover rate and therefore reduces the uptake of calcium into the SR.\nWhen PLB binds to the SERCA, the affinity of calcium binding to the enzyme is also reduced. This reduces the ability of the SERCA to bind and pump calcium ions into the SR. Phospholamban also increases the sensitivity of the SERCA to ATP, meaning that it must be bound to ATP to revert to its active state, allowing calcium uptake. Upon activation of the SERCA, PLB can be phosphorylated by CaMK-II, causing it to dissociate from the SERCA and allow calcium to be transported into the SR by way of the SERCA pump.\nThrough this sequence, PLB plays a key role in the regulation of calcium handling by the SR, controlling the rate at which calcium ions are taken up and released. PLB therefore has a profound effect on the biological activity of the SERCA by controlling the rate of calcium uptake, and eventually, muscle contraction."
  },
  {
    "id": 670,
    "user_query": "List the components of mTOR Complex 2 (mTORC2).",
    "text-davinci-003_response": "1. mTOR (mammalian Target of Rapamycin): This is the catalytic subunit of the complex and is responsible for activating downstream effectors of mTORC2.\n2. Rictor (Rapamycin insensitive companion of mTOR): Rictor is a unique subunit of mTORC2 and is responsible for mediating the effects of Akt phosphorylation.\n3. mLST8 (mammalian lethal with Sec13 protein 8): This is a scaffolding subunit which links the mTOR and Rictor portions of the mTORC2 complex.\n4. Sin1 (Stress activated map kinase-interacting 1): Another scaffolding subunit, Sin1 allows the mTORC2 complex to interact with stress signaling pathways.\n5. Protor-1 (protein involved in TOR signaling): A dimeric protein that helps mTORC2 interpret insulin and other growth factor signals. \n6. Dip2B (diphosphoinositide-3-phosphatase-2B): This subunit regulates mTORC2 activity through interacting with its substrates and modulating phosphoinositides signaling.\n7. Protein Kinase N (PKN): PKN is involved in the regulation of Akt phosphorylation and acts as an effector of mTORC2."
  },
  {
    "id": 675,
    "user_query": "Which multiple kinase inhibitors are used in cancer therapy?",
    "text-davinci-003_response": "The most common multiple kinase inhibitors used in cancer therapy are imatinib (Gleevec), sorafenib (Nexavar), erlotinib (Tarceva), lapatinib (Tykerb), dasatinib (Sprycel), sunitinib (Sutent), crizotinib (Xalkori), and ponatinib (Iclusig). Imatinib has been used extensively in the treatment of chronic myeloid leukemia (CML) and other cancers, and is usually taken orally at a daily dose of 400-600 milligrams. Sorafenib is used to treat kidney, liver, and thyroid cancers, and is also taken orally, usually at a daily dose of 400 milligrams. Erlotinib and lapatinib are used to treat advanced forms of non-small cell lung cancer, and are generally taken as a tablet daily at a dose of 150 and 1,250 milligrams, respectively. Dasatinib is usually taken as a tablet once daily at a dose of 70-100 milligrams to treat CML, as well as chronic eosinophilic leukemia, acute lymphoblastic leukemia, and other blood cancers. Sunitinib is used to treat kidney, gastrointestinal stromal tumor, and thyroid cancers. It is taken orally, usually once daily, at a dose of 50-100 milligrams. Crizotinib is primarily used to treat anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer and is taken orally, typically once daily, at a dose of 250 milligrams. Finally, ponatinib is used to treat CML, and is usually taken as a tablet at a dose of 45 milligrams, usually once or twice daily."
  },
  {
    "id": 678,
    "user_query": "List types of avoided words in bacterial genomes",
    "text-davinci-003_response": "Avoided words in bacterial genomes are stretches of adjacent nonsynonymous mutations (mutations that cause amino acid changes) that are more common in bacterial genomes than random mutations would suggest. Such avoided words of nucleotides are generally referred to as domain-specific words as they may have been selected for their biological function or effect. Examples of domain-specific words include: \n1. Codon usage bias: This occurs when neighbouring codons (groups of three nucleotides that encode an amino acid) are more frequently used than expected by random chance. Bacterial genomes have adapted codon usage patterns to optimize the use of transfer RNA (tRNA) molecules in translation. \n2. Gene regulation signals: Phrases of nucleotides downstream of a gene that regulate its expression are also seen as avoided words in a bacterial genome. Such regulated signals can act as either promoters or repressors of gene expression.\n3. Ribosome binding sites: These sites are stretches of nucleotides located upstream of a gene. The ribosome binds to this region, initiating translation of the gene's coding sequence. \n4. Termination signals: These signals are located at the end of a gene, leading to termination of translation and thus the gene's expression.   \n5. Conserved Specialized Patterns: These are stretches of nucleotides that have been conserved over evolutionary time, with statistical probability showing that they are retained because they are either functional or essential for a specific biological process. \nAvoided words in bacterial genomes can help to reveal the evolutionary purpose of a gene as well as the genes’ operational mechanisms. As such, they are a valuable tool for bacterial genomics and comparative genomics."
  },
  {
    "id": 681,
    "user_query": "Which is the physiological target for LeuRS translational quality control?",
    "text-davinci-003_response": "The physiological target for LeuRS translational quality control is the transfer RNA (tRNA) carrying the amino acid leucine. LeuRS is a complex composed of two subunits: the leucyl-tRNA synthetase (LeuS) and the release factor 1 (RF1). Through its enzymatic activity, the LeuS subunit of the complex attaches the amino acid leucine to the correct tRNA, and then RF1 associates to decode and release the mRNA tRNA pair. In this way, LeuRS is involved in the quality control of the translational process, ensuring that the correct amino acid is being incorporated into the polypeptide."
  },
  {
    "id": 685,
    "user_query": "Which is the target of the drug Denosumab?",
    "text-davinci-003_response": "Denosumab is a monoclonal antibody that targets the receptor activator of nuclear factor kappa-B ligand (RANKL), a protein involved in maintaining healthy bone turnover. It is approved by the US Food and Drug Administration (FDA) to treat people with osteoporosis, as well as to prevent skeletal-related events (SREs) in people with bone metastases from certain types of cancer. Denosumab works by binding to RANKL and blocking its activity. This reduces the amount of bone that is lost and helps to protect the bones from fractures. Denosumab also increases bone formation, thereby helping to build up bone density."
  },
  {
    "id": 693,
    "user_query": "Which gene test can be used for the X-linked myotubular myopathy?",
    "text-davinci-003_response": "The genetic test used to diagnose X-linked myotubular myopathy (XLMTM) is an molecular genetic test that is specifically designed to analyze the MTM1 gene. This gene is responsible for producing a protein called myotubularin, which is necessary for the proper functioning of motor neurons that control muscle movement. The test is performed by analyzing the MTM1 gene and determining if there is a mutation present. If a mutation is found, then the person has XLMTM. The test is often done in conjunction with other tests, such as electromyography and nerve strength tests, to help confirm the diagnosis. In addition, the MTM1 gene is also tested in a newborn screening program to detect XLMTM in those individuals who are at risk for the disorder."
  },
  {
    "id": 695,
    "user_query": "What is the association between adiponectin and migraine?",
    "text-davinci-003_response": "Adiponectin is a protein hormone, produced primarily by adipose tissue, which has been found to have associations with migraine. A number of studies have shown a direct relationship between low levels of adiponectin and an increased risk of migraine headache attacks. Low adiponectin has been associated with poorer outcomes in patients with migraine, including increased migraine attack frequency and increased headache severity. Low levels of adiponectin have also been associated with a greater risk of developing chronic migraine. In addition, low levels of adiponectin have been associated with a greater risk of suicide attempts in people with migraine. Moreover, when adiponectin levels are low, the response to migraine medications is also more likely to be reduced. Therefore, it appears there is an association between levels of adiponectin and migraine attack frequency and severity, as well as response to treatment."
  },
  {
    "id": 703,
    "user_query": "Is there an association between FGFR3 mutation and plagiocephaly?",
    "text-davinci-003_response": "Yes, there is an association between FGFR3 mutation and plagiocephaly. Plagiocephaly, or “flat head syndrome”, is a condition where the shape of a baby’s head appears to be abnormally flattened. It is a common congenital abnormality that can be caused by a variety of different factors. One of these potential causes is a mutation in the gene FGFR3, which stands for Fibroblast Growth Factor Receptor 3. \nThis gene is responsible for the production of proteins that are involved in cell growth and division. A mutation in FGFR3 has been associated with several types of craniosynostosis, which is a condition in which the joints between skull bones fuse prematurely. In addition to craniosynostosis, studies have also found that FGFR3 mutation can also cause plagiocephaly.\nSpecifically, FGFR3 mutations can be associated with the form of plagiocephaly known as brachycephaly, which is where an infant's head appears flattened on the back and sides. This is because FGFR3 mutations can cause abnormal closure of the bones at the back of the head, which prevents the head from growing in the normal even pattern.\nUltimately, there is an association between FGFR3 mutation and plagiocephaly, particularly the form of plagiocephaly known as brachycephaly. Therefore, screening for this mutation can be important in diagnosing cases of plagiocephaly in infants."
  },
  {
    "id": 708,
    "user_query": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?",
    "text-davinci-003_response": "The enzymes involved in the addition of 7-methylguanosine (m7G) to the mRNA strand during post-transcriptional modification are guanylyltransferases and methyltransferases. Guanylyltransferases are responsible for the addition of a 5'-guanylate group to the mRNA strand, while methyltransferases catalyze the addition of the 7-methyl group to the 5'-guanylate group. Without these enzymes, mRNA molecules cannot be properly m7G modified."
  },
  {
    "id": 709,
    "user_query": "What is HOCOMOCO?",
    "text-davinci-003_response": "HOCOMOCO is a non-redundant human transcription factor (TF) binding site database. It was created by the Institute of Bioinformatics at the National University of Ox an in 2009 to curate and store information about transcription factor binding sites in the human genome. It provides users with information regarding different types of TFBS, including those located in the promoter regions of genes, and those located in enhancers, silencers, and other regulatory elements. HOCOMOCO also provides a catalogue of experimentally-characterized human transcription factor binding sites, as well as computational predictions, based on a variety of algorithms. Finally, the database provides a summary view of results and allows users to customize their searches."
  },
  {
    "id": 713,
    "user_query": "What is the typical alteration of the thyroid profile metabolism early after coronary artery bypass graft surgery?",
    "text-davinci-003_response": "The typical alteration of thyroid profile metabolism early after coronary artery bypass graft surgery is an increase in thyroid stimulating hormone (TSH). During the surgery, the body's parasympathetic nervous system, which is responsible for regulating the thyroid, is put in a state of shock. As a result, the body's thyroid slows down production of thyroid hormones and increases production of TSH to stimulate the thyroid to increase its hormone production. The elevated TSH level initially seen in the thyroid profile is a normal response to the body's stress of the surgery and usually resolves within a few weeks."
  },
  {
    "id": 715,
    "user_query": "What does the SAGA complex acronym stands for?",
    "text-davinci-003_response": "The SAGA complex acronym stands for SWI/SNF-associated Generation of Activators, a transcriptional regulatory complex initially characterized by the yeast SAGA complex. SAGA is a coactivator complex that works in concert with chromatin remodeling factors to activate transcription and consists of at least 17 multiprotein subunits, including histone acetyltransferases (HATs), histone deacetylases (HDACs), RNA polymerases (pol II, III, IV) and other associated proteins. This complex is required for accurate and efficient gene expression in eukaryotic cells and can facilitate efficient transcriptional activation by regulating chromatin states, stabilizing RNA polymerase (pol) II transcription, recruiting activators, and assembling components of the transcriptional machinery."
  },
  {
    "id": 716,
    "user_query": "What is the result of the interaction between TSC1 and PLK1?",
    "text-davinci-003_response": "The interaction between TSC1 and PLK1 results in the inhibition of the mTORC1-signaling pathway. TSC1 and TSC2 are negative regulators of the mTORC1 pathway, and when TSC1 binds to PLK1, it induces the auto-inhibition of both TSC proteins and prevents the mTORC1 pathway from being activated. The PLK1-TSC1 interaction is also believed to play a role in spindle formation during cell division."
  },
  {
    "id": 717,
    "user_query": "What are the characteristics of the \"Universal Proteomics Standard 2\" (UPS2)?",
    "text-davinci-003_response": "The Universal Proteomics Standard 2 (UPS2) is an open and extensible standard used to represent protein-related information. It is designed to foster data interoperability and facilitate harmonization of protein data across the proteomics field. The standard includes metadata regarding protein experiments, observations, and results.\nSpecifically, the UPS2 is composed of three components: the protein experiment data model, biosample cupping, and analysis results. The protein experiment data model describes experimental conditions, structural information, identified peptides, and post-translation modifications. Biosample cupping is a text-based notation that allows the encoding of detailed sample complexity information, i.e., proteins, subproteomes, single-gene isoforms, and gels. Analysis results capture quantitative and qualitative results of quantitative experiments like label-free and isobaric tag-based quantification.\nThe protein experiment data model and analysis results are expressed as a set of objects and properties within an Extensible Mark-up Language (XML) schema, while the biosample cupping element is expressed as a text-based notation. All of the data components should be interpretable by either a human or a computer program.\nThe UPS2 standard was created to bridge the gap between the various, incompatible formats used by data generators and software in the proteomics field. It allows for data from different experiments to be combined and combined in an efficient and standardized way. Furthermore, the portsability offered by the standard allows for the transmission of protein data among software packages."
  },
  {
    "id": 719,
    "user_query": "Which are the smallest known subviral pathogens of plants?",
    "text-davinci-003_response": "The smallest known subviral pathogens of plants are viroids and satellites. Viroids are a type of pathogen that consists of circular segments of single-stranded RNA. They are only a few hundred nucleotides long, and lack any type of capsid or envelope. Viroids have been known to infect a wide variety of plants, and are responsible for causing diseases such as Potato Spindle Tuber Disease and Oak Decline Disease. \nSatellites are similar to viroids in that they consist of single-stranded RNA, however, they also contain a capsid or envelope, and are typically anywhere from viroid size to a few thousand nucleotides long. Satellites are found in a range of plants, from grasses to legumes, and like viroids, can cause disease in their hosts. An example of a disease caused by satellites is Discoloration Syndrome in cucurbits; this is characterized by discolored lesions on the leaves and stems of the plant."
  },
  {
    "id": 720,
    "user_query": "What causes Katayama Fever?",
    "text-davinci-003_response": "Katayama fever is a parasitic infection caused by the parasite called Schistosoma japonicum, which is a species of blood fluke. This parasite is found in East Asian countries such as China and Japan, and it is typically contracted by humans through contact with freshwater bodies that are heavily infested with its larval stage – such as rivers, swamps, and ponds. The larvae penetrate human skin and migrate to the thoracic cavity where they mature into adult worms and reproduce. These adult worms release eggs, which in turn, release a toxin known as cercarial dermatitis toxin that can cause Katayama fever. This toxin triggers severe inflammation of the skin and is also known to cause fever, malaise, muscle aches, and headaches. In some cases, it can also affect the liver and the kidneys."
  },
  {
    "id": 721,
    "user_query": "List clinical trials for prevention of sarcopenia",
    "text-davinci-003_response": "Clinical trials are ongoing at major medical institutions around the world to test methods of preventing sarcopenia.\n1. The U.K. Sarcopenia Study is a multinational Phase III clinical trial that is designed to investigate the ability of Genexol-PM, an investigational drug, to prevent and treat sarcopenia in older adults.\n2. The GER800 Study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the efficacy, safety, and tolerability of an investigational drug known as Geranium Extract for the prevention of sarcopenia in men and women aged 55 and older.\n3. The LEAP Study (Lifestyle, Exercise, and Protein) is a randomized, double blind, placebo-controlled clinical trial that is assessing whether a lifestyle and exercise regimen combined with a dietary supplement of whey protein isolate can reduce the risk of sarcopenia in elderly people living in Japan.\n4. The SHIELD Trial (Study of Healthy Aging to Improve Elders’ Living with Dietary Supplementation) is a randomized, double-blind, placebo-controlled clinical trial that is assessing whether daily dietary supplementation with whey oil-based emulsion can reduce the risk of sarcopenia in elderly people living in Taiwan.\n5. The ULTRA2 Study is a double-blind, randomized, placebo-controlled trial that is investigating the ability of a dietary supplement of sarcosine and taurine to prevent sarcopenia in older adults in Hungary.\n6. The RESIST Study (REmodeling Skeletal muscle by INTake of supplements in Sarcopenia) is a randomized, double-blind, placebo-controlled clinical trial that is assessing the efficacy and safety of dietary supplementation with whey protein-plus-leucine in reducing the risk of sarcopenia in community-dwelling adults aged 60 and older."
  },
  {
    "id": 722,
    "user_query": "Which is the database of molecular recognition features in membrane proteins?",
    "text-davinci-003_response": "The database of molecular recognition features in membrane proteins is called Membrane Protein Data Bank (mpdb). It is a repository for the three-dimensional structure of proteins which spans a range of topics related to membrane biology, biomedical research, and drug discovery. It is hosted by the Protein Information Resource (PIR).\nThe database aims to provide structural information for membrane proteins, which are proteins that span the lipid bilayer of cells, and support a wide range of biological functions. Membrane proteins are also important from a medicinal standpoint as they are often implicated in diseases, drug receptors, channels, and transporters. \nThe mpdb currently stores 3-D structures of over 1000 membrane proteins, including G-protein coupled receptors (GPCRs), ABC transcription factors, ion channels, and hydrophobic transport proteins, all annotated with their molecular features. It also provides visualization of protein structures and their interactions. Along with the structures, the user is able to access detailed experimental annotations, such as atomic-level information about biological recognition features for each protein. This enables users to accurately analyze the molecular interactions between these proteins and other biomolecules. \nIn addition, this database could be used to gain deeper insights into the protein-ligand recognition process, as well as identify and prioritize drug targets for disease treatment."
  },
  {
    "id": 731,
    "user_query": "What kind of bonds are connecting keratin molecules?",
    "text-davinci-003_response": "Keratin is a protein made up of long chains of amino acids. These chains are held together by various types of covalent bonds. Primary covalent bonds consist of single bonds between the atoms within the same keratin molecule. Secondary and tertiary covalent bonds are formed when two or more amino acids join together. The bonding also consists of hydrogen bonds between adjacent amino acids. Hydrogen bonds are weaker than the other types of covalent bonds, but they help stabilize the overall structural shape of the keratin molecules."
  },
  {
    "id": 734,
    "user_query": "What is the risk of developing acute myelogenous leukemia in Fanconi anemia?",
    "text-davinci-003_response": "The risk of developing acute myelogenous leukemia (AML) in Fanconi anemia (FA) is very high. According to some estimates, up to 10% of people with FA will develop AML within their lifetime. The risk increases with age, with the majority of cases occurring in people over the age of 40.Certain genetic mutations associated with FA may increase the risk of developing AML, but individual factors such as family history and lifestyle can also play a role. In addition, people with FA have a higher risk of developing other blood cancers such as acute lymphoblastic leukemia (ALL). They also have an increased risk of developing other diseases, such as solid tumors and bone marrow failure.\nBecause of the high risk of developing AML in FA, it is important for people with FA to be monitored by their doctors for signs and symptoms of leukemia. Regular check-ups, including blood tests, should be a part of this monitoring. If AML is suspected, further testing should be done to make a diagnosis. Treatment involving chemotherapy or stem cell transplant may then be recommended."
  },
  {
    "id": 735,
    "user_query": "How many different mutations have been associated with Muenke syndrome?",
    "text-davinci-003_response": "Muenke syndrome is a rare genetic disorder in which abnormal development of the skull can occur. This abnormality can lead to hearing loss, facial asymmetry, and other physical and behavioral issues. It is caused by mutations in the FGFR3 gene, located on the 4th chromosome.\nAt least three different mutations have been associated with Muenke Syndrome. One mutation inactivates the gene, while two others create a new protein structure, or phenotype. The inactivating mutation is an A to G transversion, while the two phenotype-creating mutations are deletions and nucleotide substitutions. Deletions are genetic mutations that remove one or more nucleotides from a gene. Nucleotide substitutions are mutations that substitute one or more nucleotides from a gene.\nIt is important to note that mutations associated with Muenke Syndrome are rare, and that hundreds of other mutations are possible in the FGFR3 gene. However, at this time, only these three have been discovered and linked with this syndrome."
  },
  {
    "id": 737,
    "user_query": "Which genes have been proposed as potential candidates for gene therapy of heart failure?",
    "text-davinci-003_response": "A number of genes have been proposed as potential candidates for gene therapy of heart failure, including:\n1. ANGPTL4: ANGPTL4 encodes the angiopoietin-like protein-4 and is involved in lipid metabolism and vascular inflammation. Its overexpression could lead to increased myocardial contractility and attenuation of fibrosis.\n2. SERCA2a: SERCA2a encodes a calcium-handling protein that participates in the calcium-cycling of cardiomyocytes, making it absolutely essential for normal contractility of the heart. Replacement of mutant SERCA2a in patients with genetic heart arrhythmia has been suggested as a possible therapy.\n3. GATA4: GATA4 is a member of the GATA transcription factor family and acts as a master transcriptional regulator of cardiomyocyte development and cardiac gene expression. Overexpression of this gene has been shown to improve cardiac contractility and attenuate remodeling in animal models.\n4. Myosin heavy chain: Myosin heavy chain is a major component of the myofilaments of muscle cells. Its genes have been studied as a potential therapeutic target for improving cardiac muscle function and contractility in animal models.\n5. MEF2A and MEF2C: MEF2A and MEF2C are members of the MADS box transcription factor family that has been implicated in various aspects of cardiac development, such as differentiation and maturation of cardiomyocytes. Overexpression of these genes has been suggested as a potential treatment for heart failure."
  },
  {
    "id": 738,
    "user_query": "DX-88 is investigational name of which drug?",
    "text-davinci-003_response": "DX-88 is the investigational name of Fingolimod, which is a drug used to treat multiple sclerosis (MS). It is believed to work by trapping lymphocytes, or white blood cells, in the lymph nodes so they can't enter the central nervous system and damage it. Fingolimod is taken as a once-daily oral pill and is available as brand-name Gilenya in the United States. It was approved by the Food and Drug Administration (FDA) in 2010."
  },
  {
    "id": 740,
    "user_query": "Which genes have been found to be associated with restless leg syndrome",
    "text-davinci-003_response": "?\nThough the exact cause of restless leg syndrome (RLS) is unknown, a number of different genes have been found to be associated with development of RLS. These include MEIS1, BTBD9, MAP2K5, and GCH1, among others. MEIS1 (Meis Homeobox 1), is a protein-coding gene found primarily on chromosome 2p14.1 and is believed to be involved in limb development and axon guidance, among other processes. Mutations to this gene are associated with an increased risk of developing RLS.\nBTBD9 (BTB/POZ domain-containing protein 9) is a protein-coding gene located on chromosome 6p21.3. This gene is associated with regulation of the circadian rhythms and is linked to iron metabolism. Mutations to BTBD9 increase the risk of developing RLS.\nMAP2K5 (mitogen-activated protein kinase kinase 5) is a protein-coding gene located on chromosome 17q11.2 and is responsible for the activation of a number of other gene pathways. Mutations to this gene have been associated with a higher risk of developing RLS.\nGCH1 (GTP cyclohydrolase 1) is a protein-coding gene located on chromosome 14q22.1 and is responsible for a number of processes, including the production of neurotransmitters in the brain. Mutations to this gene have also been associated with an increased risk of developing RLS.\nWhile the exact mechanism behind developing RLS is still being studied, these four genes have been found to be associated with the condition. It is likely that more genes will be identified as the research into RLS continues."
  },
  {
    "id": 743,
    "user_query": "Do the Sleeping Beauty or the piggyBac transposons have higher transposition efficiency?",
    "text-davinci-003_response": "The sleeping beauty and the piggyBac transposons both have their strengths and weaknesses when looking at transposition efficiency. The Sleeping Beauty transposon is a DNA sequence that consists of a transposase gene, that when activated, connects itself to the target gene and inserts its DNA sequence. It has a moderately high efficiency and works reliably in some cell lines. The piggyBac system, on the other hand, is a transposon composed of an endonuclease gene. Once activated, this system can store itself within the nucleus and cut the target DNA to insert its DNA sequence. It is generally considered to be more efficient than the Sleeping Beauty system, but it is also more difficult to work with. Depending on the specific cell line or type, one system may be more efficient than the other. However, in general, piggyBac tends to have higher transposition efficiency than the Sleeping Beauty."
  },
  {
    "id": 744,
    "user_query": "Where does TORC1 sequester during heat stress?",
    "text-davinci-003_response": "TORC1 is a protein complex involved in the regulation of cell growth and metabolism. During heat stress, TORC1 is sequestered into the cytoplasm. The sequestration of TORC1 is believed to be a protective response in order to prevent cells from undergoing irreparable stress or damage due to heat exposure. Heat shock proteins (HSPs) are thought to be involved in the translocation of TORC1, as HSPs are induced upon heat stress and have the ability to bind to TORC1 and interact with Golgi proteins to initiate TORC1 sequestering. The movement of TORC1 into the cytoplasm prevents its normal activity, thus creating a feedback loop that helps protect cells from further damage due to heat stress."
  },
  {
    "id": 745,
    "user_query": "Is rivaroxaban metabolized in kidneys?",
    "text-davinci-003_response": "Yes, rivaroxaban is metabolized by the kidneys. It is metabolized by hydrolysis of the active hepatic enantiomer to form an inactive carboxylic acid metabolite, and then by conjugation of that metabolite to form inactive glucuronide metabolites. The glucuronide metabolites are mainly eliminated through the kidneys, although they can also be eliminated through biliary excretion. Approximately 86-95% of a radiolabeled dose of rivaroxaban is excreted in the urine, with the remainder excreted in the feces."
  },
  {
    "id": 746,
    "user_query": "What are the side effects of Nalmefene?",
    "text-davinci-003_response": "The most commonly reported side effects of Nalmefene are nausea, dizziness, vomiting, headache, constipation, stomach pain, dry mouth, difficulty sleeping, fatigue, and anxiety. Less common side effects include increased heart rate, flu-like symptoms, increased blood pressure, increased sweating, abnormal dreams, and decreased appetite.\nIn rare cases, Nalmefene may also cause serious side effects such as allergic reactions, confusion, tremors, seizures, chest pain, difficulty breathing, convulsions, and changes in vision. It is important to notify a healthcare professional immediately if any of these reactions occur.\nAlso, Nalmefene may interact with other drugs, so patients should check with their healthcare provider before taking the medication."
  },
  {
    "id": 756,
    "user_query": "Which is the E3 ubiquitin ligase of Hsp90?",
    "text-davinci-003_response": "The E3 ubiquitin ligase of Hsp90 is CHIP, otherwise known as Carboxy-Terminal Hsp70-Interacting Protein. CHIP is a member of the STUbL (STUbL stands for “stable tubulin-binding protein-like”) family of E3 ligases that carry out the specific task of attaching polyubiquitin chains to target proteins. CHIP is responsible for the ubiquitination of Hsp90, a crucial step in its regulation. CHIP binds to and hydrolyzes ATP, allowing it to recognize and interact with Hsp70 substrates. It then adds ubiquitin molecules to Hsp90, leading to its degradation and turnover. The CHIP ubiquitin ligase is essential for the proper regulation of the Hsp90 molecular chaperone complex."
  },
  {
    "id": 757,
    "user_query": "Which are the major phycobiliproteins present in cyanobacteria?",
    "text-davinci-003_response": "The major phycobiliproteins present in cyanobacteria are phycobilisomes, phycocyanin, phycoerythrin, and allophycocyanin. \nPhycobilisomes are a type of light-harvesting antenna complex involved in the harvesting of light energy that contains two main components: core and linker polypeptides. The core consists of the bilin-binding cyanobacterial phycobiliproteins, which are made up of either phycocyanin, phycoerythrin, or both. The linker proteins provide a connection between the core and the cell membrane.\nPhycocyanin and phycoerythrin are two photopigments used by cyanobacteria to absorb light. Phycocyanin absorbs light from the blue to the near infrared range, while phycoerythrin absorbs red to far-red light. Both are part of the phycobiliproteins complexes found in cyanobacteria.\nAllophycocyanin is a third type of phycobiliprotein present in cyanobacteria. Like the other two, it is involved in light harvesting, though it absorbs mainly light in the far-red range. Allophycocyanin is also used to form the linker proteins that connect the phycobiliproteins to the cell membrane."
  },
  {
    "id": 759,
    "user_query": "In which kingdom do microsporidia belong, according to their current classification scheme?",
    "text-davinci-003_response": "Microsporidia belong to the kingdom Fungi, according to their current classification scheme. The kingdom Fungi includes organisms like mushrooms, yeasts, molds, mildews, and rusts, all of which are microorganisms. Microsporidia are unicellular organisms that lack cell walls. They are classified as obligate intracellular parasites, meaning they can only reproduce and live within eukaryotic hosts like animals, protozoa, and fungi. They are often found in the digestive and respiratory systems of their hosts, and some species of microsporidia are capable of causing serious human diseases."
  },
  {
    "id": 763,
    "user_query": "Which genes are regulated by TRalpha2  in the heart?",
    "text-davinci-003_response": "TRα2 is a thyroid hormone receptor that belongs to the nuclear receptor family and plays an important role in cardiac development and physiology. It regulates several genes involved in different aspects of cardiac function. Among the genes regulated by TRα2 in the heart are MYH6 and MYH7 (cardiac myosins), SERCA2 (sarcoplasmic calcium-ATPase), FKBP12 (a peptidyl-prolyl isomerase), ANF (atrial natriuretic factor), and TNNT2 (a member of the cardiac troponin family). Other genes that are regulated by TRα2 in the heart include GJA1 and GJA4 (connexins), JUNB and JUND (transcription factors), GATA4 and GATA6 (transcription factors), and SCN5A and SCN4B (sodium channels). In addition, TRα2 has been shown to positively regulate PPARγ and ABCA1, two genes involved in cholesterol metabolism. Finally, several other metabolic and structural genes are regulated by TRα2 in the heart, including glyceraldehyde-3-phosphate dehydrogenase, pyruvate dehydrogenase, myeloperoxidase, myocardin, and cardiac cdk1 (cyclin-dependent kinase 1)."
  },
  {
    "id": 767,
    "user_query": "Is tubulin acetylation involved in cell motility?",
    "text-davinci-003_response": "Yes, tubulin acetylation is involved in cell motility. Tubulin acetylation regulates the assembly, stability and dynamics of microtubules, which are the polymerized forms of tubulin formed by α- and β-tubulin molecules. Microtubules form the internal scaffolding of the cell that helps to generate force and move cellular components throughout the cell. Tubulin acetylation is important for this process and can regulate the forms of microtubules that form, which will ultimately affect the movement of components within the cell. These microtubules can be utilized in a number of ways to move cells and their contents, such as in cell division, cell migration, and axon guidance. In addition, many of the proteins that are needed for cell motility, such as motors and receptors, interact with tubulin and its acetylation status to drive these processes. Thus, tubulin acetylation plays a key role in the process of cell motility by regulating microtubule assembly, stability, and dynamics."
  },
  {
    "id": 768,
    "user_query": "List available genetic multicolor cell labeling techiniques in Drosophila",
    "text-davinci-003_response": "Cell labeling techniques are invaluable to studies of cell fate, lineage development, and neuronal connectivity in Drosophila.\n1. Immunocytochemistry: This technique involves using fluorescently labeled antibodies to target a specific protein sequence or epitope within a given cell. This technique is used to label cell surfaces, nuclear proteins, and intracellular proteins.\n2. Cell-Type Specific Reporter Lines: With this technique, cells of interest are genetically modified to express fluorescent markers such as GFP, RFP, and YFP. This technique allows researchers to gain spatial resolution and insight into subpopulations of cells.\n3. Gal4/UAS: The Gal4/UAS technique is a powerful method to explore the spatio-temporal regulation of gene expression. Using this technique, researchers can express any fluorescently labeled proteins (e.g. GFP, RFP, or YFP) in specific cell populations of interest.\n4. Fluorescent Proteins: This technique involves directly expressing fluorescent proteins, such as GFP, RFP, or YFP, in the cell, or using a protein fusion of fluorescent proteins to tag proteins of interest. This technique is used to visualize and mark gene products within cells of interest.\n5. Lentiviral Labeling: Using this technique, specific cell types can be labeled with combinations of fluorescent proteins. This technique is particularly useful for labeling neurons and other cell types that cannot be effectively labeled with other methods."
  },
  {
    "id": 769,
    "user_query": "Which growth factors are known to be involved in the induction of EMT?",
    "text-davinci-003_response": "The phenotypic conversion of epithelial cells into mesenchymal cells, known as Epithelial-Mesenchymal Transition (EMT), is a reversible process believed to play a role in the normal development of certain tissues as well as in several pathological processes. The process is stimulated by several growth factors known to be involved in the induction of EMT including the transforming growth factor β (TGF-β), hepatocyte growth factor (HGF), epidermal growth factor (EGF), and vascular endothelial growth factor (VEGF). TGF-β is the strongest inducer of EMT, triggering both morphological changes as well as gene regulation. HGF is also capable of inducing EMT, due to its potent angiogenic activity as well as its ability to regulate the expression of integrins. The fibroblast growth factors (FGFs) are another family of molecules able to stimulate this process by triggering the signaling cascade via tyrosine kinase receptors. In particular, FGF-2 has been found to be an inducer of these morphological changes. Finally, EGF has been described to stimulate EMT by working in concert with other stimuli such as TGF-β, resulting in increased expression of mesenchymal markers."
  },
  {
    "id": 774,
    "user_query": "Which histone modification discriminates between active and poised enhancers?",
    "text-davinci-003_response": "H3K4me1 is the primary histone modification that discriminates between active and poised enhancers. This modification signals active transcription compared to H3K27me3, which is more common in poising and precedes transcriptional activation. H3K4me1 is associated with actively transcribed enhancers, while H3K27me3 is associated with enhancers that are primed for activity but currently silent."
  },
  {
    "id": 776,
    "user_query": "What is the inheritance pattern of Li–Fraumeni syndrome?",
    "text-davinci-003_response": "Li–Fraumeni Syndrome (LFS) is an autosomal dominant disorder caused by a mutation of the tumor suppressor gene p53 (TP53). This mutation has been linked to many types of cancer, and is characterized by an increase in the number of tumors at young ages, and increased risk for multiple primary cancers.\nInheritance of LFS follows an autosomal dominant pattern due to the fact that only one copy of the mutant gene is required for the disorder to manifest. This means that if one of the two copies of the gene is mutated, then the person will have LFS. The mutation can be inherited from a parent or can occur spontaneously as a result of a mutation in the individual’s germline.\nWhen a parent with LFS has a child, the child has a 50% chance of inheriting the genetic mutation and developing the disorder. However, the Li–Fraumeni syndrome can also be passed down by individuals who are carriers of the mutation who do not have the disorder themselves so even if both parents appear to be healthy and without the diagnosis they can still pass on the mutated alleles.\nOverall, individuals who have Li–Fraumeni syndrome have an increased risk for developing cancers at a younger age than those without, and may experience multiple primary cancers during their lifetime. Genetic testing is available for those who have a family history or are symptomatic of Li–Fraumeni syndrome, as well as for those who are at increased risk due to their age or lifestyle."
  },
  {
    "id": 781,
    "user_query": "Which are the synonyms of prostate-specific antigen?",
    "text-davinci-003_response": "Synonyms of prostate-specific antigen include: prostatic acid phosphatase, antigenic glycoprotein, complex-form of alkaline phosphatase, prostate secretory protein, prostate-secreted phosphoprotein, prostate-derived antigen, prostate-related antigen, prostatic acid phosphokinase, and prostatic secretory proteins."
  },
  {
    "id": 783,
    "user_query": "What is the function of circular RNA?",
    "text-davinci-003_response": "Circular RNA (circRNA) is a type of non-coding RNA (ncRNA) that forms a closed loop structure. It is produced from larger pre-mRNA transcripts, which are then spliced in the same way as linear mRNA, but in a circular pattern. CircRNA molecules can have a variety of functions within the cell, including acting as microRNAs (miRNAs), serving as regulatory proteins, and acting as trans-acting small interfering RNAs (siRNAs). Additionally, circRNA is thought to play a role in the regulation of gene expression by providing a stable platform for transcription factors. Research has also shown that circRNA can act as a sponge for miRNAs, inhibiting their activity and affecting gene expression. As the field of circRNA sequencing and research continues to expand, more functions of circRNA are being discovered, including its involvement in diseases such as cancer and Alzheimer’s."
  },
  {
    "id": 786,
    "user_query": "List available biomedical question answering systems.",
    "text-davinci-003_response": "1. DeepDive: Developed by the Stanford AI Lab, DeepDive uses probabilistic graphical models to quickly extract structured knowledge from both structured and unstructured data. It can be used to answer questions from both public and proprietary biomedical databases.\n2. MEDIE: The Medical Information Extraction Engine (MEDIE) is a web-accessible system that enables interactive access to biomedical knowledge. MEDIE allows users to ask questions and receive answers from up-to-date biomedical databases within minutes.\n3. Medscanner: Medscanner is an open source biomedical search engine that provides answers to questions related to medical data and health topics. It uses natural language processing to understand user queries and return an answer from a curated database of medical facts.\n4. BioWTest: BioWTest is a web-based system that enables users to ask questions about biological and medical topics. The system uses natural language processing algorithms to process input queries and return the most relevant sources from a large database.\n5. Doctor Q&A: Doctor Q&A is a question-answering system developed by Microsoft that uses artificial intelligence to answer medical questions. The system uses semantic analysis and natural language processing operations to understand and interpret user queries, and then it provides answers from a database of verified medical information."
  },
  {
    "id": 794,
    "user_query": "Which trancription factor activates the betalain pathway?",
    "text-davinci-003_response": "The transcription factor that activates the betalain pathway is a single protein known as BetA. BetA is a copper-containing transcription factor that binds to specific DNA sequences in regulatory regions, known as the betalain box, and causes the expression of a number of genes in the betalain pathway. BetA activates gene transcription by binding directly to the betalain box and by recruiting activator proteins that increase expression of target genes. BetA is also involved in the regulation of the pigment synthesis pathway in other plant species."
  },
  {
    "id": 796,
    "user_query": "Which is the most well-accepted method for Down syndrome non-invasive prenatal diagnosis?",
    "text-davinci-003_response": "The most well-accepted method for non-invasive prenatal diagnosis of Down syndrome is Cell-Free DNA (cfDNA) Testing. This test has been available since 2011, and is considered the most effective and accurate non-invasive form of prenatal testing for Down syndrome.\nThe test works by analyzing the DNA that is present in a pregnant woman’s bloodstream, which is passed from the placenta into the mother’s bloodstream. This DNA is then analyzed for any missing or extra copies of genetic material associated with Down syndrome.\nThe test can detect about 99% of fetuses with Down syndrome, as well as 98% of fetuses with other genetic conditions. It is also important to note that this test is very effective in detecting Down syndrome in fetuses regardless of their age, and is not associated with any risk of miscarriage or other complications.\nIn comparison, ultrasound and/or other traditional prenatal screenings have a lower accuracy rate, are only effective in detecting Down syndrome in fetuses of certain ages, and may carry a risk of miscarriage. Additionally, these traditional tests cannot detect other genetic conditions, such as trisomy 18.\nOverall, cfDNA testing is considered the most well-accepted method for non-invasive prenatal diagnosis of Down syndrome. It is an incredibly powerful tool for physicians to safely and accurately detect Down syndrome—and other genetic conditions—in the fetal stage."
  },
  {
    "id": 799,
    "user_query": "What is the average diameter of intermediate filaments?",
    "text-davinci-003_response": "The average diameter of intermediate filaments ranges from 8-12nm, although there are some outliers that may be smaller or larger than this range. These filaments are dynamic components of the cell cytoskeleton, and have structural roles in maintaining the shape and form of the cell. An intermediate filament is a type of cytoskeletal protein that provides stability to the microvilli, organelles, and other structures within a cell. In addition, they also assist in cell-to-cell adhesion and play a major role in intracellular communication."
  },
  {
    "id": 805,
    "user_query": "Which intermediate filament (IF) protein can be used as a non-specific marker of the neuronal precursor cells of the subventricular zone?",
    "text-davinci-003_response": "The intermediate filament protein nestin is commonly used as a non-specific marker of neural precursor cells of the subventricular zone. Nestin is a type III intermediate filament protein found mainly in the cytoplasm of cells in the peripheral nervous system and in certain types of stem cells. It is expressed in a variety of cells, including neural stem cells, precursor cells of the neuronal lineage, and astrocytes, specifically in the dividing cells and neuronal progenitor cells in the ventricular zones of the brain. It is also involved in the process of neuronal differentiation and is thought to provide structural stability during neuron migration and axon guidance. As such, nestin can be used to identify neuronal precursor cells in the subventricular zone by specifically labeling these cells."
  },
  {
    "id": 806,
    "user_query": "Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?",
    "text-davinci-003_response": "The enzyme responsible for maintaining DNA (cytosine-5-)methylation is called DNA methyltransferase (DNMT). DNMTs are responsible for recognizing and binding to sites on DNA with unmethylated cytosine nucleotides, and catalyzing the transfer of methyl groups onto these cytosines to produce methylcytosines. DNMTs play a critical role in epigenetic regulation, as methylation levels of cytosines within a gene can act to suppress its expression. They are expressed during various stages of embryonic development and have been linked to various diseases, including cancer."
  },
  {
    "id": 807,
    "user_query": "Is transcapillary  albumin escape altered in diabetic patients?",
    "text-davinci-003_response": "Yes, transcapillary albumin escape is altered in diabetic patients. This is due to the fact that, in diabetics, the capillary walls become leaky and allow increased transcapillary escape of albumin. \nThe increased transcapillary escape of albumin is caused by several factors. First, in diabetes, there is an increase in capillary permeability due to increased expression and activity of vascular endothelial cell receptors, which allow albumin to escape through the capillary walls. Additionally, diabetes is associated with increased deposition of glycosaminoglycans in the vascular basement membrane, which further increases capillary permeability. Finally, altered expression of intercellular adhesion molecules in diabetic vasculature can alter the structure of capillary walls, leading to increased albumin escape.\nThe increased transcapillary escape of albumin can have significant clinical consequences. Firstly, it may lead to edema, a condition in which the body's tissues swell due to the accumulation of excess fluid. It can also lead to hypoalbuminemia, a condition in which the levels of albumin in the blood are abnormally low. Both of these conditions are associated with a higher risk of adverse outcomes in diabetes. Additionally, the altered transcapillary escape of albumin also contributes to an increased risk of diabetic nephropathy, a condition in which the kidneys get damaged due to long-term diabetes."
  },
  {
    "id": 812,
    "user_query": "Which cell type has the protein Chromogranin A as marker?",
    "text-davinci-003_response": "Chromogranin A (CgA) is a neuronal granin protein and strong marker of secretory neuroendocrine cells. It is found in a variety of neuroendocrine cells, including diffuse neuroendocrine cells (DNECs), enterochromaffin cells (ECCs), and various endocrine cells in the pancreas and ovaries. CgA is present in nerve endings, axons of peripheral neurons, and synapses of the autonomic nervous system. CgA is expressed in many solid tissue tumors, including gangliogliomas, neuroblastomas, pheochromocytomas, thyroid tumors, small cell carcinoma of the lung, and gastroenteropancreatic neuroendocrine tumors (GEP-NETs). CgA has been used to confirm the diagnosis of NETs and distinguish them from other types of tumors."
  },
  {
    "id": 813,
    "user_query": "Does a selective sweep increase genetic variation?",
    "text-davinci-003_response": "No, a selective sweep does not increase genetic variation. A selective sweep is the result of natural selection where a single gene variant, or allele, influences the reproductive success of individuals in a population. This one advantageous allele can quickly spread and become fixed in the population, reducing the genetic diversity in that population. In contrast, genetic variation in a population is increased by mutation, gene flow, or recombination of existing alleles. Thus, a selective sweep is not a viable way to increase genetic variation without additional processes that increase the mutation rate or introduce new alleles to the population."
  },
  {
    "id": 814,
    "user_query": "Which disease phenotypes are associated to PRPS1 mutations?",
    "text-davinci-003_response": "Mutations in the PRPS1 gene are associated with several different disease phenotypes. These include X-linked (XL) nonsyndromic intellectual disability, XL sensory and motor neuropathy, and XL)\\ erythrocytosis. Additionally, mutations in PRPS1 are associated with several inherited metabolic diseases, including Charcot–Marie–Tooth Disease type 4H, Shwachman–Diamond Syndrome, DeSanctis–Cacchione Syndrome, and the neurodegenerative disorder X-linked NAD+-glycohydrolase deficiency. Other clinical phenotypes related to PRPS1 mutations include spastic paraplegia, arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome, and adenine phosphoribosyltransferase (APRT) deficiency."
  },
  {
    "id": 815,
    "user_query": "Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?",
    "text-davinci-003_response": "The answer to this question is that it might be beneficial for some patients at risk for coronary artery disease to take antioxidant supplements, but the decision should be made on a case-by-case basis. Antioxidants are substances that can help protect cells from damage caused by free radicals which are compounds that can damage critical cell components. Some studies suggest that antioxidants may help reduce the oxidative stress associated with coronary artery disease and, therefore, help reduce the risk of the disease. However, it is important to note that there is some disagreement in the medical literature regarding the effects of antioxidant supplements on cardiovascular risk. \nIn general, the American Heart Association recommends lifestyle modifications such as getting regular exercise, eating a healthy diet, and not smoking, as the best way to reduce the risk of coronary artery disease. If you are at risk, speak with your healthcare provider to determine whether taking antioxidant supplements would be beneficial on an individual basis. If you do decide to take antioxidant supplements, be sure to ask your healthcare provider what dosage would be appropriate for you, as well as any potential side effects or drug interactions."
  },
  {
    "id": 821,
    "user_query": "Is K-63 linked protein ubiquitination related to proteasomal degradation?",
    "text-davinci-003_response": "Yes, K-63 linked protein ubiquitination is related to proteasomal degradation. K-63 linked protein ubiquitination is a post-translational modification that flags proteins for degradation by the proteasomes. It involves the attachment of multiple chains of a molecule called ubiquitin to lysine residues on the proteins. This modification is recognised by the proteasomes, which carry out their function of degrading the protein and releasing its peptide fragments into the cytosol for recycling. These peptide fragments are recycled by the ubiquitin-proteasome system to create new proteins which can then be used in other cellular processes. In this way, the K-63 linked protein ubiquitination is related to the proteasomal degradation process."
  },
  {
    "id": 822,
    "user_query": "Could transcription factors act as cell-cell signalling molecules?",
    "text-davinci-003_response": "Yes, transcription factors can act as cell-cell signalling molecules. Transcription factors are proteins that bind to specific DNA sequences, helping to regulate the expression of genes by initiating transcription. Through different regulatory pathways, transcription factors can affect the expression of other proteins and can influence both intracellular and intercellular signaling. In fact, transcription factors can serve as cell-cell signaling molecules in many ways.\nOne way in which transcription factors can act as cell-cell signaling molecules is by interacting with target receptors on the surface of the recipient cell. For example, when certain cytokines bind to their receptor on the surface of a recipient cell, the activator transcription factor binds to specific DNA sequences, promoting the expression of genes involved in the target cell’s response. This type of signal transduction leads to a wide range of outcomes in the recipient cell, including changes in gene expression (and thus changes in protein expression) and even cellular differentiation.\nAnother way in which transcription factors can serve as cell-cell signaling molecules is by interacting with signaling molecules such as G-protein coupled receptors and nuclear receptors. For example, when certain G-protein coupled receptors (GPCRs) are activated, the transcriptional activity of the associated transcription factor is triggered. This can lead to changes in gene expression in the recipient cell, and as a result, the protein expression and cellular behavior of the cell can be altered. Similarly, nuclear receptors can bind to specific DNA sequences and alter the expression of genes associated with those sequences. This can also lead to changes in the expression of proteins in the recipient cell, as well as other downstream effects.\nOverall, transcription factors can act as cell-cell signaling molecules by interacting with target receptors on the surface of the recipient cell, by interacting with signaling molecules such as G-protein coupled receptors and nuclear receptors, and by altering gene expression. These effects can lead to a range of outcomes in the recipient cell, including changes in gene expression, protein expression, and even cellular differentiation."
  },
  {
    "id": 828,
    "user_query": "Is muscle lim protein (MLP) involved in cardiomyopathies?",
    "text-davinci-003_response": "Yes, muscle-limiting protein (MLP) is involved in cardiomyopathies. MLP is a protein that is encoded by the gene MYL3 and is essential for the structural integrity of the sarcomere. It is a dominant negative regulator of myosin binding protein C (MyBP-C), a critical contractile protein complex in striated muscle. \nStudies have shown that mutations in the MYL3 gene that result in dysfunctional MLP have been associated with hypertrophic and dilated cardiomyopathy, two of the most common forms of cardiomyopathy. Furthermore, MLP has also been found to play a role in cardioproteostasis, which is associated with cardiomyopathy in various forms. Specifically, MLP is associated with epigenetic remodeling of cardiomyocytes, which can lead to cardiac tissue remodeling and eventual heart failure.\nAll in all, it is clear that MLP is an important factor in cardiomyopathies, especially with regards to its involvement in cardioproteostasis and cardiac-tissue remodeling. Although further scientific studies are needed to fully understand the exact role of MLP in cardiomyopathy, the existing studies suggest that MLP is an important component of the pathogenesis of this condition."
  },
  {
    "id": 834,
    "user_query": "What is Tn-seq?",
    "text-davinci-003_response": "Tn-seq is a sequencing-based technique used to detect changes of gene expression in bacterial species. It was developed to address two challenges associated with measuring gene expression in prokaryotic organisms: (1) the difficulty in measuring mRNA levels in these non-model organisms, and (2) the lack of tools for assessing gene expression at the single-cell level. This technique relies on a transposon insertion mutagenesis approach, where a random insertion of transposons is used to inactivate individual bacterial genes. Tn-seq uses next-generation sequencing to identify the genes that have been affected by the transposon insertion. This method allows researchers to identify genes that are differentially expressed between two different conditions. This technique can be used to detect novel gene functions, investigate gene regulatory networks, and monitor the effects of drugs."
  },
  {
    "id": 836,
    "user_query": "Is there any functional association during viral replication between flaviviridae viral RNA depended RNA polymerase and viral helicase?",
    "text-davinci-003_response": "Yes, there is a definite functional association between flaviviridae viral RNA dependent RNA polymerase and viral helicase during viral replication. The viral replicase-helicase complex, composed of the flaviviridae viral RNA-dependent RNA polymerase and the viral helicase, is responsible for the initiation of viral replication. The helicase, which is part of the replicase-helicase complex, uncoils the double stranded viral RNA into its individual strands. This allows the viral RNA dependent RNA polymerase access to the viral genome, so that it can begin the process of transcription and replication of the viral genomic RNA. The viral RNA dependent RNA polymerase then begins transcription of the viral genome, and the helicase ensures that the strands are separated. During replication of the viral genome, the helicase maintains the separation of the strands while it unwinds the double helix in order to form initiation and termination sites, which are necessary for the production of the viral genomes. In summary, the replicase-helicase complex, with the flaviviridae viral RNA dependent RNA polymerase and the viral helicase, is necessary for initiation and regulation of viral replication."
  },
  {
    "id": 838,
    "user_query": "Which is the prevalence of cystic fibrosis in the human population?",
    "text-davinci-003_response": "The prevalence of cystic fibrosis in the human population is approximately 1 in every 3,500 births. While the exact number of individuals affected by CF is unknown, the best estimates suggest that 1 in 2,500 to 1 in 3,500 people have the condition, which is about 30,000 individuals in the United States. Worldwide, CF is estimated to occur in 1 per 3,000 to 5,000 people."
  },
  {
    "id": 844,
    "user_query": "Is there a genome-wide technique for the detection of R-loop formation?",
    "text-davinci-003_response": "Yes, there is a genome-wide technique for the detection of R-loop formation, known as ‘Genomic R-loop Sequencing’ (RLS). RLS is a high-throughput sequencing-based method that quantifies the formation of RNA-DNA hybrids known as R-loops in the genome. The method is based on the hybridization of a modified RNA targeting probe to an R-loop region and its subsequent capture by a biotin–streptavidin interaction followed by sequencing. This technique can provide quantitative measurements of R-loops in normal and diseased cells or tissues, allowing researchers to not only identify regions of R-loop formation but also to compare R-loop formation across different samples. RLS is a powerful tool for understanding the role of R-loops in gene regulation and the relationship between R-loops and disease."
  },
  {
    "id": 847,
    "user_query": "Is transcription-associated mutagenesis (TAM) related to gene expression levels?",
    "text-davinci-003_response": "Yes, transcription-associated mutagenesis (TAM) is related to gene expression levels. TAM is a type of mutation that occurs during the transcription of genes. These mutations can increase or decrease gene expression levels by altering the formation of transcription factor protein complexes or altering the transcriptional regulatory sequences. For example, TAM can change the amino acid sequence of a transcription factor, leading to increased or decreased gene expression levels. In addition, TAM can alter transcriptional regulatory elements, such as transcription start sites, that can positively or negatively impact gene expression. In summary, TAM is related to gene expression levels through the alteration of transcription factors and transcriptional regulatory elements."
  },
  {
    "id": 848,
    "user_query": "Is there a pharmacogenetic test for trastuzumab?",
    "text-davinci-003_response": "The short answer is no, there is not currently a pharmacogenetic test for trastuzumab. A pharmacogenetic test is a tool used to identify genetic variations that may affect how a person responds to a medication. Trastuzumab is a targeted therapy used to treat HER2-positive breast cancer and is not known to be affected by genetic variations.\nHowever, there are many ongoing research studies in pharmacogenetics and precision medicine that aim to identify genetic variations in patients’ responses to trastuzumab and other targeted therapies for breast cancer. For example, the Cancer Research UK Cambridge Centre has recently initiated a research study to identify genetic variations associated with response to trastuzumab in a large cohort of patients with HER2-positive breast cancer. The results of this research study could potentially lead to the development of a pharmacogenetic test for trastuzumab in the future."
  },
  {
    "id": 849,
    "user_query": "Which calcium channels does ethosuximide target?",
    "text-davinci-003_response": "Ethosuximide is an antiepileptic drug that specifically targets voltage-gated calcium channels. Specifically, it blocks the T-type calcium channel Cav3.2 (also known as alpha 1G), which is highly expressed in thalamic neurons. This inhibition of Cav3.2 causes a decrease in the high-frequency oscillations in thalamic neurons that are associated with absence seizures. Additionally, it has been proposed that ethosuximide may also modulate other calcium channels, including Cav3.1 (also known as alpha1F) and Cav3.3 (also known as alpha 1H)."
  },
  {
    "id": 850,
    "user_query": "What is the sedimentation coefficient of the mammalian mitoribosome?",
    "text-davinci-003_response": "The sedimentation coefficient of the mammalian mitochondrial ribosome has not been determined as of 2017. Mitochondria are cellular organelles found in eukaryotic cells, and their function includes the production of energy. The ribosome of the mitochondria is composed of two subunits: a large and a small subunit, both of which carry out different functions in protein synthesis. Studies have indicated that the structure and composition of the mitochondrial ribosome is dissimilar compared to the prokaryotic ribosome, and its sedimentation coefficient is yet to be accurately measured."
  },
  {
    "id": 852,
    "user_query": "Which proteins act as histone-like molecules in prokaryotes?",
    "text-davinci-003_response": "In prokaryotes, histone-like proteins and/or nucleoid-associated proteins (NAPs) are involved in DNA compaction and organization. These proteins are composed of histone-like domains that bind to DNA and help organize the genome into chromatin-like structures. Some of the most important NAPs are HU, MreB-HU, Fis, IHF, and H-NS. \nHU is the main NAP in the organism Escherichia coli, and is important for gene expression, chromatin packing, DNA reshaping, and the coordination of DNA supercoiling. Fis is another important NAP, and it is important for factors like gene expression, DNA supercoiling, and chromosome segregation. Fis plays a key role in prokaryotic regulation and has been linked to the formation of transcriptional complexes. IHF is also involved in DNA supercoiling, and works with HU to regulate the transcription of some genes.\nH-NS is another important nucleoid-associated protein; it can control the folding, supercoiling, and transcription of DNA. H-NS also seems to be important for coordinating multiple types of DNA compaction in different regions of the genome. These NAPs form complexes that are thought to be involved in shock protection, gene regulation, and DNA segregation.\nIn summary, HU, Fis, IHF, and H-NS are key histone-like proteins that are important for DNA organization, gene expression, and chromatin packing in prokaryotes."
  },
  {
    "id": 860,
    "user_query": "Is hypersensitivity to DNA crosslinking agents a hallmark of Fanconi anemia?",
    "text-davinci-003_response": "Yes. Hypersensitivity to DNA crosslinking agents is a hallmark of Fanconi anemia (FA). FA is an autosomal recessive disorder characterized by hypersensitivity to crosslinking agents, including interstrand DNA crosslinks (ICLs) and less commonly, intrastrand crosslinks (ISCs). The ICLs are further divided into those that involve DNA-protein covalently attached and those that involve DNA-DNA covalently attached crosslinks. In FA, cells affected by crosslinking agents typically demonstrate growth inhibition, chromosome fragility, and are unable to restore normal DNA structure. Many proteins are required to repair these lesions, and mutations in the genes that encode these proteins render FA patients hypersensitive to DNA crosslinking agents."
  },
  {
    "id": 869,
    "user_query": "What is the pyroptotic pathway?",
    "text-davinci-003_response": "The pyroptotic pathway is a form of programmed cell death triggered by the detection of pathogenic microbes, or other forms of damage or stress in the body. It is one of the principal modes of cell death involved in the mammalian immune response. This pathway is significant as it is a primary method by which the mammalian immune system defends itself against infection and other stressors. Essentially, it is a mechanism of programmed cell suicide that plays an essential role in defense against invading pathogens.\nAt the biochemical level, the pyroptotic pathway is initiated by the formation of an \"inflammasome,\" a complex of cytosolic sensors, adaptors, and effector molecules. This inflammasome is usually composed of a receptor protein, an adapter protein, and an effector protein. When the inflammasome detects a stimulus (i.e. a pathogen-associated molecule), it activates a particular series of enzymatic proteolytic cascades, leading to the release of inflammatory cytokines and the disruption of cellular membranes. This is the core of the pyroptotic pathway, and is referred to as \"pyroptosis.\"\nIn the context of the immune system, pyroptosis plays an important part, as it serves to limit the spread of infection. During its execution, a cell bursts and releases pro-inflammatory cytokines that activate other immune cells, such as dendritic cells and macrophages, to help eradicate the infection. In addition, pyroptosis eliminates infected cells before they can replicate, potentially allowing for a smaller amount of pathogen to resist eradication.\nFor its role in both limiting the spread of infective agents and serving as an early warning system for damaging or stress-inducing signals, the pyroptotic pathway is a key part of the immune system."
  },
  {
    "id": 871,
    "user_query": "What are the known families of deadenylases?",
    "text-davinci-003_response": "Deadenylases are enzymes that function to remove the polyadenylate tails from RNA molecules during the process of mRNA decay. The known families of deadenylases include the following: \n1. CAF1/Pop2/NOT deadenylases: These enzymes are typically composed of two subunits: a cassette protein (such as CAF1, Pop2, or NOT) and an endoribonuclease (such as CCR4). They are found in organisms from eukaryotes (such as yeast and humans) to prokaryotes. \n2. PARN family: This family is composed of DEAD-box helicases, paralogs of the human exonuclease Rrp6, and a single unique Paralog, AphB. These enzymes are found in prokaryotes and eukaryotes. \n3. XRN family: This family is composed of XRN-family exonucleases. They are found in multiple eukaryotes. \n4. DCP2 family: This family includes the human decapping enzyme DCP2. They are found in multiple eukaryotes. \n5. PAN2/3 family: This family includes the poly(A)nuclease family of enzymes, composed of PAN2/3 comprised of PAN2, PAN3 and PAN2L proteins. These enzymes are found in multiple eukaryotes. \n6. CCR4-NOT complex: This complex consists of both CCR4 and NOT proteins. It is found in eukaryotes."
  },
  {
    "id": 872,
    "user_query": "Which translocation is harbored in the Askin tumor cells?",
    "text-davinci-003_response": "The translocation harbored in the Askin tumor cells is a result of a balanced reciprocal t(11;17)(q24;p13) translocation. This translocation was first discovered in 2000 in a 7-year-old child with a pontine/paraspinal primitive neuroectodermal tumor. This translocation involves an abnormal fusion between TGFBR3 (transforming growth factor beta-related receptor 3) at 11q24, and ETV6 (ETS transcription factor 6) at 17p13. In more than 95% of Askin tumors, a specific variant of this translocation – t(11;17)(q13;q21) – is found. Mutations involving TGFBR3 and ETV6 can result in altered regulation of genes that play important roles in cell proliferation and apoptosis."
  },
  {
    "id": 875,
    "user_query": "Which R/bioconductor package utilizes the Hilbert curve in order to visualize genomic data?",
    "text-davinci-003_response": "The R/Bioconductor package 'HilbertVis' utilizes the Hilbert curve in order to visualize genomic data. Specifically, HilbertVis allows users to explore large genomic datasets such as copy number variants in a three-dimensional space, powered by the Hilbert curve. Through using the fractal-based mapping, it is possible to reduce dimensions while preserving the inherent spatial relationships within the data, allowing for exploration of large datasets with ease. Additionally, the package offers a variety of interactive visualisation tools such as over-laying tracks and use of colour / gradient to make it easier to identify patterns within the data."
  },
  {
    "id": 876,
    "user_query": "Can fetal aneuploidy be detected with non-invasive prenatal testing?",
    "text-davinci-003_response": "Yes, fetal aneuploidy can be detected with non-invasive prenatal testing. Non-invasive prenatal testing is a type of screening test that is used to detect chromosomal abnormalities in a developing fetus. The test works by analyzing a few small pieces of the mother's blood, which contains some of the baby's DNA. This DNA is then closely analyzed to determine whether there are any anomalies in the number of chromosomes present in the fetus. The test can usually be conducted around 10 weeks into the pregnancy and can detect common forms of fetal aneuploidy, including Down syndrome, Trisomy 18, and Trisomy 13. It is important to note that the test is only used for screening, not for a diagnostic result, and further testing will usually be needed to confirm whether the fetus is in fact aneuploid."
  },
  {
    "id": 877,
    "user_query": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?",
    "text-davinci-003_response": "The GenomicRanges and GenomicAlignments packages, available in the Bioconductor project, are two commonly used packages for performing overlap analysis of genomic regions in R. The GenomicRanges package is a set of utilities for representing and manipulating collections of genomic intervals. It allows users to create and analyze combine data sources from different studies and to store them in an R object. This package provides several functions for calculating various overlap metrics including intersection, union, type of overlap, adjacent overlap and conflict. \nThe GenomicAlignments package is a specialized package for handling and manipulating genomic alignments stored as High-Throughput Sequencing (HTS) data. This package provides general tools for managing paired-end alignments, such as alignment coordinate manipulation and quantification. It also provides more specialized methods such as 50 bp resolution normalization of raw read counts, sliding window analysis, deletion detection, and coverage analysis. GenomicAlignments can be used to perform overlap analysis of genomic regions (e.g. to determine how many reads overlap an annotated gene or region)."
  },
  {
    "id": 878,
    "user_query": "Is dichlorphenamide effective for periodic paralysis?",
    "text-davinci-003_response": "Yes, dichlorphenamide is an effective treatment for periodic paralysis. It is an anticonvulsant medication that has been shown to be effective for those with primary and hyperkalemic periodic paralysis. Studies show that when taken in regular doses, dichlorphenamide can reduce the severity and frequency of attacks and improve muscle strength and function.\nAdditionally, some studies have suggested that dichlorphenamide may decrease the need for potassium supplementation and improve the long-term outlook for those with periodic paralysis. It is important to note, however, that dichlorphenamide is not a cure-all for periodic paralysis. It should be used under the guidance of a medical professional and monitored closely to minimize potential side effects and ensure the best prognosis."
  },
  {
    "id": 881,
    "user_query": "Which pathway is activated by ficolin-3?",
    "text-davinci-003_response": "Ficolin-3 is a type of lectin found in human serum. It is a member of the ficolins family of proteins and is encoded by the FCN3 gene. Ficolin-3 is involved in activating the lectin pathway of complement activation. This pathway is used to protect the body from pathogens and other foreign substances. The first step of this pathway involves the binding of ficolin-3 and mannose-binding lectin (MBL) to the surfaces of microbes. This activates the proteolytic enzymes (MASPs) which break down and degrade microbial components. The next step involves the recruitment of the complement proteins C4 and C2 to the complex, which in turn activate factor B and the protease C3 convertase. This ultimately leads to the formation of the membrane attack complex, which leads to the lysis of the bacteria."
  },
  {
    "id": 883,
    "user_query": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?",
    "text-davinci-003_response": "1. TiO2 (titanium dioxide) chromatography: TiO2 is an insoluble, manufactured form of titanium dioxide which is used for adsorption of phospho-amino acids by their distinct hydrophobic and electrostatic properties.\n2.Phosphocellulose (P11) chromatography: Phosphocellulose is a type of cellulose matrix modified with phosphoryl groups, which can be used for the selective binding of phosphopeptides.\n3.Immobilized metal-ion affinity chromatography (IMAC): This chromatography method involves purifying a phosphopeptide mixture over a column containing immobilized metallic ions that bind to negatively charged groupings of amino acids, such as phosphorylated serines and threonines.\n4.Strong cation exchange (SCX) chromatography: SCX involves the binding and separation of molecules containing positively charged amino acids, such as phosphorylated tyrosine, to a negatively charged desalting column.\n5.Lectin affinity chromatography: This method uses chromatography columns containing immobilized lectin derivatives that bind specifically to modified glycopeptides present in a phosphopeptide mixture."
  },
  {
    "id": 884,
    "user_query": "Which histone modifications are correlated with transcription elongation?",
    "text-davinci-003_response": "The four primary histone modifications associated with transcription elongation are acetylation, phosphorylation, ubiquitination, and sumoylation. \nAcetylation: Acetylation of Histone H3 lysine 9 (H3K9Ac) is correlated with transcription elongation and is observed near active promoters across eukaryotic species. It is associated with the recruitment of paused RNAPII and DNA unwinding near the promoter sites.\nPhosphorylation: The phosphorylation of Histone H2A (H2A.Xph) at serine 129 has been found to be essential for transcription elongation and its presence around the transcription start site (TSS) provides indications that transcriptional initiation has been initiated.\nUbiquitination: Ubiquitination of Histone H2B (H2Bub1) and H3 (H3ub1) are commonly seen in nucleus of elongating promoter-proximal regions, suggesting transcription elongation is initiated. \nSumoylation: Histone H2A sumoylation (H2K20m3) is also observed to be enriched in transcription elongating regions, which is necessary to maintain faithful regulation and proper DNA structure, allowing transcription to continue."
  },
  {
    "id": 885,
    "user_query": "Does  thyroid hormone receptor beta1 affect insulin secretion?",
    "text-davinci-003_response": "Yes, thyroid hormone receptor beta1 (TRβ-1) does affect insulin secretion. TRβ-1 is a hormone receptor that binds to thyroid hormones, which can then act to regulate gene expression and initiate subsequent biochemical activities. TRβ-1 has been found to be involved in the regulation of glucose homeostasis and has been shown to play a role in insulin secretion. In animal and cell culture models, TRβ-1 has been found to modulate insulin secretion via regulation of potassium channels and calcium channels, which are both involved in regulating the amount of insulin released into the blood. TRβ-1 also affects glucose metabolism in the pancreas by regulating the expression of several key genes involved in insulin secretion, such as insulin gene (INS) and glucokinase (GCK) gene. In summary, TRβ-1 plays a role in influencing insulin secretion, and its dysregulation can lead to impaired glucose homeostasis and other health issues."
  },
  {
    "id": 893,
    "user_query": "What is commotio cordis?",
    "text-davinci-003_response": "Commotio cordis is a traumatic cardiac arrest syndrome that occurs due in part to direct blows to the chest. It typically affects adolescents and young adults and can happen exceptionally quickly. It is distinguished from other cardiac arrest conditions in that these individuals are usually healthy and have no underlying cardiac defects. It can occur in anyone regardless of their fitness level or athletic skills. \nCommotio cordis is caused by a single blunt force to the chest at a specific phase of the heartbeat, called the vulnerable period, during which the heart's electrical activity is more vulnerable to disruption. The impact causes electrical disturbances in the normal electrical activity of the heart, resulting in ventricular fibrillation and cardiac arrest. Depending on the timing of the impact, this can cause an individual's heart to quiver, allowing some of the blood to escape and cause other heart rhythm disturbances. \nTreatment involves CPR and immediate defibrillation by an automated external defibrillator (AED). If treated within the first few minutes of the trauma, it is possible to prevent brain damage and death.\nThe prognosis for those affected by commotio cordis is generally favorable with prompt CPR and defibrillation, but the risk of fatality remains higher than with other forms of ventricular fibrillation. The best way to prevent commotio cordis is to use chest protectors when engaging in contact sports and other recreational activities where there is a risk of impact to the chest."
  },
  {
    "id": 894,
    "user_query": "What is the cause of Phthiriasis Palpebrarum?",
    "text-davinci-003_response": "Phthiriasis palpebrarum is an infestation of the eyelashes caused by the human ectoparasite, Phthirus pubis, also known as the \"crab\" louse. This tiny insect primarily transmits through physical contact, so close contact with someone who is infested is the primary cause of phthiriasis palpebrarum. This louse can be spread through sharing items like hats, scarves, and clothes. Additionally, these lice are often found on sheets, carpets, and furniture, and the physical contact associated with those items can cause an infestation as well. In some cases, sexual contact can lead to transmission of Phthirus pubis. Although infestations are considered to be relatively uncommon, poor hygiene and immune suppression can increase the risk of infection."
  },
  {
    "id": 896,
    "user_query": "How are CpG island shores defined?",
    "text-davinci-003_response": "CpG island (CGI) shores are defined as regions of DNA lying adjacent to CpG islands in the genome. Typically, they occupy the region between 2 kb and ~5 kb upstream of a CGI, and between 2 kb and ~3 kb downstream of the CGI. Shores have less CpG frequencies than the CGI core, but more than the flanking sequences. In some studies, a GC content of greater than 50% is required for a region to be classified as a shore."
  },
  {
    "id": 898,
    "user_query": "Which gene is mutated in a subtype of arrhythmogenic right ventricular cardiomyopathy known as Naxos disease?",
    "text-davinci-003_response": "The gene mutated in Naxos Disease is Plakophilin-2 (PKP2). This gene, located on chromosome 17, is responsible for encoding a protein called desmoplakin, which is a component of an intercellular junctional plaque called the desmosome. Mutations in this gene can prevent desmoplakin from interacting with other proteins, causing the desmosomes to be structurally weak and impairing their ability to maintain the structural integrity of the cell. This can lead to irregular electrical stimulus and arrhythmia, causing Naxos Disease."
  },
  {
    "id": 899,
    "user_query": "What is the role of edaravone in traumatic brain injury?",
    "text-davinci-003_response": "Edaravone is a neuroprotective drug used to treat traumatic brain injury (TBI). It works by reducing the production of reactive oxygen species (ROS) which are molecules that are generated as a response to cellular stress, and have been linked to tissue damage in TBI. When edaravone is injected into the brain, it binds to free radicals generated after a traumatic event, preventing them from causing oxidative stress and resulting in decreased levels of ROS. This in turn reduces inflammation, prevents apoptosis (cell death), and can restore the healthy functioning of neural cells and tissues. Additionally, edaravone can protect neurons from the harmful effects of glutamate, an excitatory neurotransmitter that can contribute to the destruction of neurons after TBI. By protecting neurons from the damaging effects of glutamate, edaravone can help to reduce the overall damage to the brain and can even promote the formation of new synapses that can further aid in recovery. Consequently, edaravone may be an effective treatment option for those suffering from TBI."
  },
  {
    "id": 900,
    "user_query": "Are there plasma membrane receptors for thyroid hormones?",
    "text-davinci-003_response": "Yes, there are receptors for thyroid hormones on the plasma membrane. The thyroid hormones T3 and T4 are lipid-soluble molecules and can pass through the plasma membrane, which means they must have specific receptors on the outside of the membrane in order to be sensed and used. The receptors for T3 and T4 on the plasma membrane are known as thyroid hormone receptors (TRs). These receptors can bind with either T3 or T4 and trigger a reaction from the cell by activating or deactivating certain signaling pathways. T3 is more active than T4 and binds with higher affinity to the TRs. These TRs are expressed in certain tissues, such as the thyroid, pituitary, liver, heart, and adipose tissue. When bound to a TR, the thyroid hormone can enter the nucleus and regulate cellular function by affecting gene expression. The binding of these hormones to the TRs on the plasma membrane allows cells to sense and react to changes in the levels of thyroid hormones in the body."
  },
  {
    "id": 901,
    "user_query": "Which disorder is rated by Palmini classification?",
    "text-davinci-003_response": "The Palmini classification is a system used to rate brain tumors based on their movement, size, and location in the brain. It can be used to group tumors into five categories based on the likelihood of successful surgical removal. The five grades for the Palmini classification are I (benign), II (favorable), III (unfavorable), IV (malignant), and V (highly malignant). This system has replaced the traditional system of grading brain tumors based solely on the histological findings, as it allows for a more accurate assessment of the tumor's behavior. Tumors rated I or II usually have a better prognosis than those with higher grades, while those with a grade of IV or V are considered much more aggressive and potentially life-threatening."
  },
  {
    "id": 904,
    "user_query": "Are there any desmins present in plants?",
    "text-davinci-003_response": "Yes, desmins are present in plants. Desmins are a type of intermediate filaments, which are cytoskeletal proteins found in eukaryotic cells. They are present in the form of a network in the cytoplasm of plant cells and are involved in maintaining cell shape, anchoring organelles and maintaining cell-cell junctions. Desmin networks are essential for correct plant cell architecture and organelle arrangement. Desmins also help maintain the shape of complex plant organs such as leaves, flowers, and stems. Desmins are also involved in the cell wall assembly process, as they interact with lignin precursors, pectin, and other components. Additionally, desmins interact with actin filaments and play a role in plant growth and development."
  },
  {
    "id": 905,
    "user_query": "Are viruses involved in the etiology of human subacute thyroiditis?",
    "text-davinci-003_response": "Yes, viruses are involved in the etiology of human subacute thyroiditis. This type of thyroiditis can be caused by an infection from certain viruses, such as adenovirus, Epstein-Barr virus, enterovirus, and rubella virus. Although the exact mechanism of how these viruses cause the condition is not fully understood, it is believed that the virus triggers an immune response in the body that leads to the inflammation of the thyroid gland and thus the thyroiditis. Additionally, the virus can attach itself to the thyroid cells, replicate itself, and damage the cells in the process, leading to further inflammation. This type of virus-induced inflammation of the thyroid gland has been associated with both subacute thyroiditis and the more severe chronic autoimmune thyroiditis, which has genetic elements as well."
  },
  {
    "id": 910,
    "user_query": "Which is the receptor for substrates of Chaperone Mediated Autophagy?",
    "text-davinci-003_response": "The receptor for substrates of Chaperone Mediated Autophagy (CMA) is called the L manifest receptor subunit (LMAN1) or the ER mannosidase-like protein (ERMAN1). It is a multi-domain protein located in the endoplasmic reticulum (ER). It binds substrates, such as proteins, and shuttles them across the membrane for CMA to take place. Its N-terminal domain binds the chaperone protein HCN1 and its C-terminal domain binds the cytosolic chaperone HSC70. Thus, it is involved in the recognition of its substrates and helps in the transportation of these proteins across the membrane for CMA."
  },
  {
    "id": 913,
    "user_query": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?",
    "text-davinci-003_response": "1. Haussen et al., “Compare and Contrast Between Microsurgical Clipping Versus Endovascular Coiling for Ruptured Brain Aneurysms: A Systematic Review,\" Neurosurgery, vol. 62, No. 1 (2008), pp. 35-41.\n2. Brouwer et al., “Endovascular Treatment Versus Clipping for Ruptured Intracranial Aneurysms: A Systematic Review,” PloS Medicine, vol. 8, No. 10 (2011), pp. e1001124.\n3. Santillan et al., “Comparison of Possibility of Poor Outcome after microsurgical Clipping Versus Endovascular Coiling of Ruptured Intracranial Aneurysm in a Clinical Study Including 634 Patients,” Journal of Neurosurgery, vol. 127, No. 4 (2017), pp. 980-991.\n4. Hu et al., “Microsurgical Clipping versus Endovascular Coiling for Management of Ruptured Intracranial Aneurysms: A Systematic Review and Meta-analysis,” PloS One, vol. 11, No. 8 (2016), pp. e0162559.\n5. Patel et al., “Comparison of Clinical Outcomes of Microsurgical Clipping Versus Endovascular Coiling in Treatment of Intracranial Aneurysms: Outcomes of The Veterans Affairs Clinical Trials Registry,” World Neurosurgery, vol. 96 (2016), pp. 287-293.\n6. Lorenzano et al., “Safety Analysis of Statistically Powered Population Based Cohort Study Comparing Surgical and Endovascular Treatment for Ruptured Intracranial Aneurysms,” Acta Neurochirurgica, vol. 160, No. 10 (2018), pp. 1897-1905.\n7. Zhang et al., “Ruptured Intracranial Aneurysms: A Comparison of Clinical and Radiological Outcomes Between Microsurgical Clipping and Endovascular Coiling,\" World Neurosurgery, vol. 113 (2018), pp. e466-e475."
  },
  {
    "id": 919,
    "user_query": "Which are the mutational hotspots of the human KRAS oncogene?",
    "text-davinci-003_response": "The KRAS oncogene plays an important role in cancer, as many mutations of it are associated with tumor formation. Mutational hotspots are those areas of the gene where a single mutation is most likely to occur.\nIn the case of KRAS, there are three major hotspots. These are codons 12, 13, and 61. Codon 12 mutations are seen most commonly in colorectal cancer, and codons 13 and 61 mutations are seen primarily in lung cancer. Mutations in these codons lead to either a gain or loss of function in the KRAS protein, causing uncontrolled cell growth and tumor formation. Other (less common) KRAS hotspots include codons 117 and 146.\nIn addition to these hotspots, other mutational features of KRAS have been observed. This includes non-hotspot mutations, which account for around 30% of all mutations in KRAS. Non-hotspot mutations mostly lead to gene inactivation, resulting in a loss of function. Thus, KRAS hotspot and non-hotspot mutations ultimately lead to different outcomes, and hence, should be examined separately."
  },
  {
    "id": 921,
    "user_query": "What is the mechanism of action of ocrelizumab for treatment of multiple sclerosis?",
    "text-davinci-003_response": "Ocrelizumab is an anti-CD20 monoclonal antibody that is approved for the treatment of relapsing remitting and primary progressive multiple sclerosis (MS). It works by binding to and blocking a key protein on B-cells, CD20, which reduces the number of these cells in circulation. This has an inhibitory effect on the inflammatory cascade that drives inflammation in people with MS.\nIn the relapsing remitting form of MS, ocrelizumab is thought to work by blocking B cells that are involved in the body’s attack on its own nerves and other tissues, known as immune cells, as well as reducing inflammation in the brain. By blocking these proteins, ocrelizumab interferes with the autoimmunity process, reducing inflammation and preventing further nerve damage.\nIn primary progressive multiple sclerosis, ocrelizumab works differently. It does not appear to interfere with the autoimmune process, but instead may work by eliminating some of the more active B cells in the circulation that release factors known to contribute to the progression of the disease. Ocrelizumab has been shown to slow the progression of this form of MS.\nThus, ocrelizumab works by selectively targeting B cells involved in the autoimmune process in relapsing remitting MS, while also targeting active B cells in primary progressive MS, inhibiting or reducing the inflammatory processes that drive these diseases."
  },
  {
    "id": 933,
    "user_query": "Are patients with marfan syndrome at increased risk of arrhythmias?",
    "text-davinci-003_response": "Yes, patients with Marfan syndrome are at an increased risk of developing cardiac arrhythmias. Cardiac arrhythmias are disturbances in the normal rhythm of heartbeats, which can cause the heart to beat too fast, too slow, or irregularly. Patients with Marfan syndrome have a genetic defect that can cause their heart tissue to become weakened, which can lead to the development of arrhythmias. Other risk factors include an enlarged aorta and a weakened mitral valve. The most common arrhythmias linked to Marfan syndrome include bradycardia (when the heart rate slows down), tachycardia (when the heart rate speeds up) and atrial fibrillation (an irregular and fast heart rate). People with Marfan syndrome may also be at a greater risk of developing life-threatening arrhythmias such as ventricular fibrillation and sudden cardiac arrest. It is important for patients with Marfan syndrome to regularly monitor their heart rate and rhythm with a doctor to detect any abnormalities."
  },
  {
    "id": 935,
    "user_query": "List Kartagener Syndrome Triad.",
    "text-davinci-003_response": "Kartagener Syndrome is an inherited disorder associated with abnormalities in strucural development. The syndrome is characterized by a triad of physical features, which include: \n1. Situs Inversus: This is a condition in which the internal organs of the body are abnormally positioned or rotated. This abnormality is usually noticed first by a radiologist, who might observe that the heart is on the right side of the body instead of on the left side. \n2. Bronchiectasis: This is a form of chronic lung disease, in which the airways of the lungs become abnormally widened and thickened. This leads to difficulty with breathing, along with problems with cough and phlegm.\n3. Immotile sperm: This is a condition in which the sperm are unable to swim. This can lead to problems with fertility or conception."
  },
  {
    "id": 936,
    "user_query": "Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?",
    "text-davinci-003_response": "FSH Muscular Dystrophy (FSHD) is a progressive muscle wasting disorder in which the muscles of the face, shoulder, and arm are affected first and the most severely. It is associated with the ectopic expression of the protein encoded by the gene DUX4. DUX4 is normally only active during embryonic development and is typically turned off once the fetal stage is passed, but in FSHD, it remains active in adult muscle cells. This causes abnormal expression of the gene throughout the body, leading to the development of the muscle wasting disorder."
  },
  {
    "id": 938,
    "user_query": "Which are the main functions of the APOBEC3 family of proteins?",
    "text-davinci-003_response": "The APOBEC3 (A3) family of proteins are a group of proteins found in most placental mammals that are involved in host defense against viral infections and, in certain cases, implicated in carcinogenesis. A3 proteins are generally characterized by their presence in the cytoplasm as well as cell membranes, although they can also be found in the nucleus. The A3 family includes several members, of which the most studied are A3A, A3B, A3C, A3F, A3G, A3H, and A3I. These proteins have several important functions: \n1. Antiviral Defense: The A3 proteins protect the host against a variety of viruses by degrading viral DNA or by inhibiting viral reverse transcription. For example, A3G, A3H, and A3F have been shown to inhibit reverse transcription of HIV, while A3A, A3B, and A3C inhibit the retrotransposition of retroviruses. Moreover, A3I and A3G have evolved to have specific activities against hepadnaviruses.\n2. Regulating Gene Expression: A subset of the A3 family, comprising A3A, A3B, and A3C, has been found to form DNA-binding hetero-oligomers, with the capability of regulating gene expression in the host cells. These A3 complexes bind to specific sequences in the genome, resulting in the up- or down-regulation of target genes.\n3. Carcinogenesis: Members of the A3 family have been implicated in human cancer, with some studies finding that overexpression of certain A3 proteins can initiate or accelerate carcinogenesis. For example, A3F has been found to stimulate DNA damage and putatively function in inducing genomic mutations that lead to cancer formation.\nIn summary, the main functions of the A3 family of proteins are antiviral defense, regulation of gene expression, and promoting carcinogenesis."
  },
  {
    "id": 939,
    "user_query": "Which histone modifications are associated with constitutive heterochromatin?",
    "text-davinci-003_response": "Constitutive heterochromatin is localized in the euchromatic segments of the genome and is typically found at the heterochromatic regions of centromeres and telomeres. It is tightly condensed, transcriptionally silent, and is believed to help prevent long-range transcriptional interactions between euchromatic regions and protect the genome from deleterious mutations. The histone modifications associated with constitutive heterochromatin are H3K9me2/3, H4K20me3, H1K26me3, and H4K16ac. H3K9me2/3 is a highly repressive mark and is thought to act as a “marker” to recruit other repressive modifications, such as H1K26me3. H4K20me3 is a heterochromatic mark that interacts with proteins of the SUV39 family, and is responsible for the recruitment of Polycomb Repressive Complex 2 (PRC2). Finally, H4K16ac and H3K27me3 are euchromatic marks associated with transcriptionally active regions, but their expression in constitutive heterochromatin may play a role in transcriptional regulation by forming active chromatin (euchromatin) islands within constitutive heterochromatin."
  },
  {
    "id": 940,
    "user_query": "What is the main application of SWATH-MS in proteomics?",
    "text-davinci-003_response": "SWATH-MS (Sequential Window Acquisition of all Theoretical Fragment Ions Mass Spectrometry) is an approach to proteomics that is becoming increasingly popular. This method is used for measuring the levels of proteins and peptides in a sample or tissue. The main application of SWATH-MS in proteomics is the deep quantification of a wide range of proteins in complex biological samples. This technique can identify and quantify hundreds to thousands of individual peptides from a sample at once, allowing for a comprehensive analysis and characterization of proteins present in a sample. SWATH-MS is highly sensitive and accurate, and can also be used to assess the relative abundance of different post-translational modifications (PTMs) on the same peptide. Furthermore, SWATH-MS is useful for studying biphasic systems, where the components of a sample need to be accurately identified, such as in the study of antibody-drug conjugates or isomeric proteins. Finally, this technique is also being used to identify unknown proteins, allowing for the exploration and better understanding of proteins in complex biological samples."
  },
  {
    "id": 949,
    "user_query": "Do R-loops tend to form at sites of DNA replication?",
    "text-davinci-003_response": "Yes, R-loops tend to form at sites of DNA replication. R-loops, or RNA:DNA hybrids, are formed when ribonucleic acid (RNA) base pairs with basepairs in the double-stranded DNA molecule. This creates a looped structure, where the unwound DNA is inhibitory to the detached RNA strand. During DNA replication, RNA polymerase is used to form an RNA primer that binds to the template DNA strand. This RNA primer is required for the elongation of the newly synthesized DNA strand and the formation of the complete duplex. The hybrid R-loop structure forms when the RNA primer forms base pairs with the newly synthesized template DNA strand and the original template DNA strand, thus creating a loop of RNA:DNA hybrids. This formation of R-loops is important for the process of DNA replication, for it ensures proper copying of the genetic code."
  },
  {
    "id": 951,
    "user_query": "What are the structures formed when keratin molecules come together?",
    "text-davinci-003_response": "When keratin molecules come together, they form a network of microscopic filaments called intermediate filaments. These filaments are joined together with cross-linking proteins to form a strong complex structure. This complex of keratin intermediates forms a robust net-like framework called the cytoskeleton, which gives cells their shape, supports them, and provides a scaffold for other cellular components. Inside these structures, keratins further combine with other proteins to form structures such as hair, nails, and horns, which all have unique shapes and properties."
  },
  {
    "id": 953,
    "user_query": "Which are the main features of CREST and other ALS-linked proteins?",
    "text-davinci-003_response": "CREST is an abbreviation for \"Calcinosis, Raynaud phenomenon, Esophageal Motility Disorders, Scleroderma, and Telangiectasia,\" which are a group of related autoimmune disorders often referred to as the CREST syndrome. Patients with CREST syndrome have abnormalities in their connective tissue, which cause symptoms including fatigue, joint pain, skin thickening, vascular changes, heartburn, and organ damage. \nCREST is most often caused by mutations in an autosomal dominant pattern, meaning that only one mutated copy of the gene is needed for the disorder to manifest itself. This gene is located on chromosome 3 and associated with the gene ALS2, encoding the ALS2 protein.\nThe ALS2 protein is a component of multiple signaling pathways that regulate cellular processes such as cell adhesion, migration, and differentiation, and is thought to be an important factor in the development of CREST syndrome. It is made up of several domains, including three predicted transmembrane regions and a C-terminal GTPase-like domain.\nOther known ALS-linked proteins include SOD1, Tau, TDP-43, c9orf72, and FUS. These proteins are all involved in various cellular processes and perform functions related to protein folding, neuronal development, and protection of neurons from toxic substances. Many of the ALS-linked proteins are involved in more than one of these processes, and their exact roles remain to be determined."
  },
  {
    "id": 955,
    "user_query": "What is the relationship between nucleosomes and exons?",
    "text-davinci-003_response": "Nucleosomes and exons are two distinct components of gene expression. Nucleosomes are the fundamental unit of DNA packaging in eukaryotic cells. They are made up of eight histone proteins wrapped in two extreme lengths of DNA. These nucleosomes act as spools around which the DNA wraps to form a complex that compacts the cell's genetic material into tiny, densely packed bundles called chromatin. \nExons, on the other hand, are coding regions of a gene. They are segments of DNA that contain the code for the production of specific proteins. These regions of coding DNA are located in between segments of noncoding DNA with the exons often being split between segments known as introns. \nThe relationship between nucleosomes and exons is that the arrangement of nucleosomes along DNA strands can greatly affect the expression of exons. For example, when the structure of the nucleosomes is more compact, resulting in the wrapping and condensing of DNA around the histones, the expression of the exon gene is down-regulated, meaning fewer copies of the proteins it specifies are made. Conversely, when nucleosomes are organized in a loose structure, allowing for increased access to the DNA wrapped within them, the expression of the exon gene will be up-regulated, resulting in the production of more of the proteins it specifies. Thus, the relationship between nucleosomes and exons is that the arrangement of nucleosomes along the DNA strands affects the expression of the exons, either positively or negatively."
  },
  {
    "id": 956,
    "user_query": "List programs suitable for pharmacophore modelling",
    "text-davinci-003_response": "There are a variety of programs suitable for pharmacophore modeling, including:\n• MOE (Molecular Operating Environment)\n• LigandScout\n• Accelrys Discovery Studio FlexX\n• DrugScore\n• Glide\n• ICM\n• Polypharma\n• Pipeline Pilot\n• Sybyl\n• PLP2\n• QUip\n• Catalyst\n• Mage\n• ChemAxon\n• Cresset Discovery Studio\n• ChemAxon's Maestro\n• Schrodinger Suite"
  },
  {
    "id": 959,
    "user_query": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?",
    "text-davinci-003_response": "The most common methods for ctDNA detection are based on methods that involve the use of next-generation sequencing (NGS). These methods include digital PCR (dPCR), microfluidic droplet digital PCR (ddPCR), and targeted sequence capture followed by NGS.\nDigital PCR (dPCR): This method works by splitting the reaction into thousands of reactions to accurately determine the absolute number of a sequence of particular interest. This method is highly precise and can detect very small amounts of DNA.\nMicrofluidic droplet digital PCR (ddPCR): This method is similar to dPCR in that it uses a large number of reactions to measure a particular sequence. However, ddPCR uses oil droplets in a microfluidics platform to separate the reactions into individual droplets, which can then be measured for the target sequence.\nTargeted sequence capture followed by NGS: This method involves using a panel of primers to specifically target and capture a known sequence of interest and then sequencing it using NGS. This method is often used to detect mutations in ctDNA and can provide very detailed and accurate results. The only downside to this method is that it is more expensive and time consuming than the other methods."
  },
  {
    "id": 960,
    "user_query": "Which gene is associated with Muenke syndrome?",
    "text-davinci-003_response": "The gene associated with Muenke syndrome is FGFR3, which stands for Fibroblast Growth Factor Receptor 3. This gene affects the production and regulation of signals that control many activities, including skeletal development, chondrocyte differentiation, and cell growth and division. Mutations in this gene can lead to skeletal deformities, intellectual difficulties, and craniofacial abnormalities, which are the main characteristics of Muenke syndrome."
  },
  {
    "id": 963,
    "user_query": "Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?",
    "text-davinci-003_response": "Yes, STAT3 is involved in EIF2AK2-dependent suppression of autophagy. Studies have shown that upon cytosolic accumulation of double-stranded RNA, EIF2AK2 is activated and phosphorylates eIF2α, resulting in the inhibition of mTORC1. mTORC1 has a direct inhibitory effect on autophagy, so its suppression is associated with autophagic induction. However, when EIF2AK2 is blocked, STAT3 is documented to be essential for inhibiting autophagy. It is thought that STAT3 links EIF2AK2 to the inhibition of autophagy. In response to EIF2AK2-mediated inhibition of mTORC1, activated STAT3 is able to promote S6K1-dependent P70S6K1 initiation and negative regulation of autophagy. Thus, STAT3 plays a critical role in EIF2AK2-dependent suppression of autophagy."
  },
  {
    "id": 965,
    "user_query": "What are the Topological Domains (TADs)?",
    "text-davinci-003_response": "Topological Domains (TADs) are regions of the genome that are characterized by large-scale 3-dimensional structures of DNA that are stabilized by the binding of proteins to specific sequence motifs. This is often referred to as chromatin structure, which has been shown to be involved in the regulation of gene expression and disease. TADs are typically defined as regions in which chromatin interactions between adjacent regulatory elements are lineage-specific. It has been suggested that TADs are a major layer of gene regulation and that TAD boundaries may play an important role in different cellular processes such as differentiation, cell cycle regulation, and gene editing."
  },
  {
    "id": 966,
    "user_query": "What is the vibrational theory of olfaction?",
    "text-davinci-003_response": "The vibrational theory of olfaction is a hypothesis that proposes that odour molecules bind to receptors in the nose, and the resulting vibration of the chemical bonds cause a pattern of nerve impulses that the brain can decode. The vibrational theory was first proposed in the early 1970s by biophysicists Luca Turin and Adrian Dyer. It is based on the idea that when different types of molecules interact with olfactory receptors, they interact with specific vibrations associated with each type of molecule.\nFor example, certain molecules have a strong affinity for certain receptor sites, such as carbonyl and alcohol groups, while other molecules have no affinity for certain receptor sites. As such, when a molecule interacts with a receptor, it could produce a distinct pattern of vibrations, which the brain could then detect, process, and interpret.\nThe vibrational theory of olfaction suggests that our sense of smell is based on how well the vibrations of a particular molecule match up with certain receptors in our nasal cavity. Molecules that produce a strong vibrational match can easily be recognized by the brain, while those that only produce a weak match may be unrecognizable or overlooked. Through the vibrational theory of olfaction, we can gain insight into how molecules interact with our receptors to affect our sense of smell."
  },
  {
    "id": 971,
    "user_query": "Which deiodinases are best known to be present in brain?",
    "text-davinci-003_response": "The two deiodinases that are best known to be present in the brain are deiodinase type 1 (D1) and deiodinase type 3 (D3). D1 is primarily involved in the activation of thyroid hormones and D3 is primarily involved in the inactivation of thyroid hormones. Both of these enzymes are known to be highly expressed in the brain and other tissues, and have roles in various aspects of brain development, physiology, and metabolism. D1 is present in the hypothalamus and other brain areas and is involved in transporting thyroid hormones from the circulation to where they can be activated or inactivated. D1 is also involved in the maintenance of energy homeostasis, controlling metabolism, and regulating thermogenesis and other processes. D3 is present in the cerebellum and other brain areas and its activity is involved in the inactivation of thyroid hormones, thus providing a basal level of regulation of the active hormones in circulation. D3 also works in concert with D1 to control the levels of active hormone released from the thyroid gland, and, thus, its activity is important for maintaining normal brain development and physiology."
  },
  {
    "id": 973,
    "user_query": "Describe what is the usage of the Theatre software tool for genomic analysis.",
    "text-davinci-003_response": "Theatre is a software tool used for genomic analysis. It is an open source platform designed to enable for the exploration and visualization of large scale interactions between genomic sequences. It provides a suite of features that enable biologists and researchers to explore genomic data in order to gain insights into genomic structure and function.\nTheatre allows users to manipulate and visualize large datasets from multiple sources such as the Genome Datasets (GDS), the ENCODE Consortium, or even user generated datasets. The data is organized into map view or sequence view, allowing users to view detailed sequences and their corresponding annotations. Theatre provides an intuitive interface for navigation and selection of regions of interest. It also allows users to create visual features such as interactive plots and 3D visualizations.\nUsing Theatre, users can run in-depth analyses on a sequence such as feature annotation, conservation of sequences across species, comparative genomics, or genomic assembly analysis. Users are also able to explore shared transcription factor binding sites and homology prediction, by creating functional groups. Theatre's analysis tools help to identify potential regulatory elements using updated annotation databases (including non-coding RNAs, promoter/repressor regions, epigenetics, etc.). Theatre is an invaluable tool for genome research and analysis."
  },
  {
    "id": 974,
    "user_query": "How are CRM (cis-regulatory modules) defined?",
    "text-davinci-003_response": "CRM (cis-regulatory modules) refer to genetic elements that control gene expression and are found within the non-coding region of a gene's promoter. These modules consist of DNA segments that contain binding sites for specific transcription factors (proteins that control the rate of gene expression). The configuration and arrangement of CRMs determine the amount of gene expression produced due to the composition of transcription factor binding sites within a given module. CRMs can control the expression of single genes or multiple genes, and sometimes include other controlling elements in addition to transcription factors."
  },
  {
    "id": 978,
    "user_query": "Which factor interacts with Treslin/TICRR throughout the cell cycle of human cells?",
    "text-davinci-003_response": "The proteins that interact with Treslin/TICRR throughout the cell cycle of human cells are cyclin-dependent kinases (CDKs). CDKs are nucleotide-binding proteins that help regulate the cell cycle by activating key substrates at specific points in the cell cycle. They do this by binding to cyclins, which are special proteins that control the timing of the cell cycle. Treslin/TICRR has a particular affinity for cyclin-dependent kinase 2 (CDK2), which is active during G1 and S phases of the cell cycle. During G1 phase, CDK2 binds to cyclin E, activating Treslin/TICRR to make sure cells enter into S phase correctly. During S phase, CDK2 binds to cyclin A, further activating Treslin/TICRR to help with progression through the S phase of the cycle. Treslin/TICRR is then turned off when CDK2 binds to a different cyclin at the end of S phase. Thus, CDKs interact with Treslin/TICRR throughout the cell cycle of human cells, helping to ensure cell division is completed successfully."
  },
  {
    "id": 981,
    "user_query": "Which medication should be administered when managing patients with suspected acute opioid overdose?",
    "text-davinci-003_response": "When managing patients with suspected acute opioid overdose, the medication that should be administered is naloxone. Naloxone is an opioid antagonist, meaning it binds to the opioid receptors in the brain and reverses their effects. It is typically given through intramuscular or intravenous injection, and has an onset of action of minutes. Depending on the diagnosis, the dose of naloxone can range from 0.4 mg to 2 mg. Additionally, supplemental oxygen and intravenous fluids should also be administered, as well as other forms of supportive care."
  },
  {
    "id": 982,
    "user_query": "In which nuclear compartments is heterochromatin located?",
    "text-davinci-003_response": "Heterochromatin typically refers to tightly condensed structures found in the nucleus of eukaryotic cells. It is believed to be involved in gene regulation and cell cycle control. Heterochromatin can be found in three nuclear compartments: interchromatin granules, perichromatin fibrils, and heterochromatin domains. \nInterchromatin granules are the most abundant form of heterochromatin in the nucleus. They are composed of an insoluble scaffold of histone proteins that contribute to an overall highly condensed and immobile state. Perichromatin fibrils are thin fibers that bridge separate chromatin domains and interact with enzymes and transcription factors associated with gene expression. Finally, heterochromatin domains are segments of tightly packed chromatin that are usually associated with the nucleolus, the region at the center of the nucleus where ribosomal RNAs are transcribed. \nOverall, heterochromatin is found in three distinct nuclear compartments: interchromatin granules, perichromatin fibrils, and heterochromatin domains."
  },
  {
    "id": 984,
    "user_query": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?",
    "text-davinci-003_response": "In bacteria, GG-NER is primarily carried out by two different enzymes: RecQ subfamily DNA helicases and UvrABC endonucleases. The RecQ subfamily helicases can move along the DNA strand in a 3’-5’ direction and unwind the DNA helix, with some subfamily members being particularly effective in resolving nonhomologous DNA end–joining intermediates during repair. The UvrABC endonucleases cleave the damaged strand of DNA at either side of the lesion, allowing the RecQ helicases to separate the strands. These endonucleases are composed of three proteins, UvrA, UvrB, and UvrC, which work together to recognize, excise, and repair DNA damage."
  },
  {
    "id": 988,
    "user_query": "In which genomic regions are Alu enriched?",
    "text-davinci-003_response": "Alu elements are short interspersed elements that make up the majority of primate-specific DNA. They are commonly found in non-coding regions of the genome, such as introns, intergenic regions, and UTRs. They are also found in gene promoter regions, sometimes disrupting genes. Alus are most frequently found in the 5' and 3' transcribed regions (UTRs) of genes, where they may act as transcriptional regulators. Other regions of the genome frequently inhabited by Alus include intronic regions, intergenic regions, and the long terminal repeat regions of retroviruses. Alu elements are particularly enriched in the human genome, occurring at a frequency of ~17%, and have likely played an important role in the evolution of the human genome."
  },
  {
    "id": 993,
    "user_query": "Are there clinical trials using stem cells for the treatment of cardiac disease?",
    "text-davinci-003_response": "Yes, there are clinical trials using stem cells for the treatment of cardiac disease. Stem cell therapy for cardiac disease is considered an experimental therapy, and is currently being studied in multiple clinical trials. Clinical trials are ongoing in many countries, and have shown some promise in treating heart disease due to damage caused by heart attacks and other conditions. One clinical trial, for example, is testing whether stem cells from bone marrow, when injected in patients with severe coronary artery disease, can improve heart function and quality of life. Other ongoing clinical trials are assessing stem cell therapy for certain types of heart failure. Stem cell therapy is also being studied for other types of heart conditions, such as arrhythmias. The success of stem cell therapy for cardiac disease will depend on many factors, including the type and severity of the disease, the type and amount of stem cells used, and the person's overall health."
  },
  {
    "id": 996,
    "user_query": "Has Revlimid been approved by the US Food and Drug Administration?",
    "text-davinci-003_response": "Yes, Revlimid has been approved by the US Food and Drug Administration (FDA). Revlimid was initially approved by the FDA in December 2005 as a treatment for people with multiple myeloma who had received at least one prior therapy. In December 2015, the FDA approved Revlimid as a combination therapy with dexamethasone for the treatment of patients with multiple myeloma. In December 2019, the FDA expanded the indication for Revlimid to include the treatment of patients with mantle cell lymphoma who had received at least one prior systemic therapy. Revlimid has also been approved by the FDA for the treatment of certain types of anemia and for the treatment of certain types of non-Hodgkin's lymphoma."
  },
  {
    "id": 997,
    "user_query": "Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences",
    "text-davinci-003_response": "?\nThe Smith-Waterman algorithm is an optimal local sequence alignment algorithm, which means it is used to identify the regions of similarity in two sequences. It has a time complexity of O(mn), where m and n are the lengths of the two sequences being compared. Since the algorithm requires two sequences to be compared simultaneously, it is not possible to reduce the time complexity of the algorithm."
  },
  {
    "id": 1003,
    "user_query": "What is Piebaldism?",
    "text-davinci-003_response": "Piebaldism is an inherited genetic disorder characterized by the presence of two different pigmentation patterns on the skin. It is an autosomal dominant trait, meaning that a person only needs one copy of the mutated gene to manifest the condition. The pigmentation patterns can appear as small, white patches on the skin, commonly found on the chest, arms, legs, and head, but can also manifest on the face, hands, and feet. These white patches can range in size and shape. In some cases, the patches of skin can also have areas of dark discoloration. This type of discoloration is referred to as \"pigmentation inversus,\" or the \"reverse polarity\" of the normal pigmentation of the body. Although Piebaldism is usually confined to the skin, it can also affect the hair and other body parts."
  },
  {
    "id": 1004,
    "user_query": "Which SLC family is FLVCR1 a member of?",
    "text-davinci-003_response": "FLVCR1 is a member of the eFilling-Like Vesicle Compartment Receptor (FLVCR) family, a subfamily of the solute carrier (SLC) family. FLVCR1, also known as Proton-coupled Folate Transporter (PCFT), is a membrane protein that plays a key role in mediating Proton-coupled Folate Transporter (PCFT) uptake of dietary and therapeutic folates into cells. Its family members, FLVCR2 and FLVCRs, are believed to be involved in iron homeostasis and in maintaining cellular folate concentrations. FLVCR1 is also a target of the drug edelfosine which has been used to treat various types of cancer."
  },
  {
    "id": 1008,
    "user_query": "Which inherited disorder is known to be caused by mutations in the NEMO gene?",
    "text-davinci-003_response": "The inherited disorder that is known to be caused by mutations in the NEMO gene is called \"Incontinentia Pigmenti Bloch-Sulzberger\" (IPBS) syndrome. It is an X-linked disorder, meaning it is caused by an alteration on the X chromosome and is inherited from the maternal side. It affects both males and females but is more often seen in females due to their having two X chromosomes. Symptoms of IPBS often include a rash, teeth abnormalities, vision problems, intellectual disability and in some cases seizures. The NEMO gene (also known as IKBKG) is the gene responsible for producing a protein called \"nuclear factor-kB essential modulator\" (NF-kB) which is essential for various functions inside cells in the body. Mutations in the NEMO gene can cause it to produce a faulty protein, which leads to IPBS. Treatment typically involves managing the symptoms and genetic counseling can help determine the chance of a person having children with IPBS."
  },
  {
    "id": 1009,
    "user_query": "What is ISMARA?",
    "text-davinci-003_response": "ISMARA (Information Society Monitoring, Awareness and Resources for Affiliate Members) is a program and platform designed to help small- and medium-sized businesses better engage in the digital world and maximize their presence in the information society. It provides them with enhanced access to the tools, resources, events, and programs that are essential for success in the digital age. ISMARA offers training, guidance, and consulting services related to such topics as technology marketing, cloud computing, cybersecurity, social media marketing, mobility, legal and compliance issues, and digital media. ISMARA also provides members with access to a network of technology-savvy professionals who can share their expertise and help small businesses navigate the complexities of expanding their business operations and accessing the web. Additionally, ISMARA offers online guides to help members prepare for various business challenges and issues they may face when operating in the digital environment. ISMARA assists businesses with pursuing technological innovations, developing partnerships, and accessing the global economy. This platform also works to strengthen the relationship between businesses and the information society, enabling increased collaboration and a better understanding of key legal, technological, and social issues."
  },
  {
    "id": 1014,
    "user_query": "What histone variants play a role in the DNA damage reponse?",
    "text-davinci-003_response": "Histone variants, or modified forms of canonical histones, play a role in DNA damage response in two main ways: by regulating chromatin accessibility, and by organizing chromatin structure.\nHistone variants regulate chromatin accessibility in response to DNA damage by either reducing or increasing access. For example, the histone variant H2AX increases accessibility to allow for the recruitment of repair factors, while dimethylated H3K9 at the nuclear periphery prevents access to heterochromatin and therefore restricts damage response proteins from accessing with damage site.\nIn addition, histone variants help to organize chromatin in order to allow for efficient repair of damaged DNA. Histones like H2A.X and H2A.Z, as well as histone variants like CenH3 and chrH3, are known to promote the formation of sister chromatid cohesion and DNA repair enzyme recruitment. In particular, H2A.Z variant is responsible for forming a local chromatin conformational change that helps preserve genomic integrity in the presence of DNA damage.\nThese histone variants play an important role in the DNA damage response, ensuring that DNA repair enzymes can act in a timely manner and that modified chromatin can help prevent the development of mutations that could lead to adverse outcomes."
  },
  {
    "id": 1019,
    "user_query": "Which disease has been associated to a disruptive ALX1 protein?",
    "text-davinci-003_response": "The disease most often associated with a disruptive ALX1 (Arylsulfatase-Like 1) protein is Frontometaphyseal Dysplasia (FMD). FMD is an inherited disorder that is characterized by skeletal malformations, including short stature, decreased linear growth, and premature closure of the growth centers of the long bones. Patients may also experience craniofacial and dental abnormalities, hearing loss, and abnormalities of the head and neck, heart, kidney, and reproductive organs. ALX1 mutations are the primary cause of FMD, and the presentation of these mutations is highly variable."
  },
  {
    "id": 1022,
    "user_query": "In which yeast chromosome does the rDNA cluster reside?",
    "text-davinci-003_response": "The ribosomal DNA (rDNA) cluster is located on chromosome XII in the yeast Saccharomyces cerevisiae, also known as \"baker's yeast\". The rDNA cluster consists of hundreds to thousands of tandemly repeated copies of the ribosomal genes and is located at the telomeric end of the long arm. It contains nine small ribosomal genes (encoding the 18S, 5.8S, and 25S/28S ribosomal RNAs) and one large ribosomal gene (encoding the 5S ribosomal RNA)."
  },
  {
    "id": 1023,
    "user_query": "Which is the underlying mechanism for exon skipping used to treat Duchenne muscular dystrophy?",
    "text-davinci-003_response": "Exon skipping is a potential treatment for Duchenne muscular dystrophy (DMD) that hopes to restore the production of an internally truncated, but partially functional, Dystrophin protein. By bypassing a mutated exon, exon-skipping techniques aim to create a shorter but still functional mRNA molecule.\nThe underlying mechanism of exon skipping is mediated by small double-stranded RNAs called antisense oligonucleotides (ASOs). When delivered to the cytoplasm of a cell containing a DMD-causing mutation, these ASOs bind to the mRNA surrounding the mutated exon and induce exon-skipping by a process known as RNA interference (RNAi). During RNAi, the ASOs catalyze the destruction of the targeted mRNA molecule, thereby preventing its translation into a functional protein. In the case of DMD, this prevents the production of the mutated dystrophin, while still allowing for expression of a lesser, but still functional, form of the protein."
  },
  {
    "id": 1028,
    "user_query": "What is the link between Dax1 and Esrrb?",
    "text-davinci-003_response": "Dax1 (also known as Nuclear Receptor Subfamily 0, Group B, Member 1, or NR0B1) is a nuclear receptor protein that plays a role in sex determination and differentiation. Esrrb (also known as Estrogen-Related Receptor Beta or NR3B2) is a nuclear receptor protein that binds to Dax1 and affects its activity. The interaction between Dax1 and Esrrb is essential for normal development, as it regulates gene expression during gonadal determination andXXmale sex determination. During this process, Dax1 binds to Esrrb on the DNA, which then stops the production of androgens and induces the production of estrogen, allowing for normal XX sex determination. Additionally, Dax1 and Esrrb form a heterodimer that interacts with other co-regulatory proteins to further modulate gene expression, and contribute to early testis development. Dax1 and Esrrb are also important in later stages of embryonic development, such as in the formation of gonadal hormones and maintenance of somatic sex. Together, Dax1 and Esrrb form a complex and interconnected system, with a vital role in sex determination and differentiation."
  },
  {
    "id": 1030,
    "user_query": "Are DNA helicases involved in progeroid syndromes?",
    "text-davinci-003_response": "DNA helicases are enzymes responsible for unwinding double-stranded DNA to make the strands available for replication, repair, or transcription. DNA helicases are involved in a variety of progeroid syndromes, such as Werner syndrome (WS), Bloom Syndrome (BS) and Rothmund-Thomson Syndrome (RTS).\nIn WS, mutations in the WRN protein (which possesses an intrinsic DNA helicase) can cause accelerated aging phenotypes. WRN mutations are also responsible for the loss of DNA repair capacity in WS cells, making them less able to fight genetic damage that arises from exposure to environmental toxins, and hence accelerates aging.\nSimilarly, mutations in the BLM protein (which also possesses an intrinsic helicase) are the major cause of BS, and are thought to lead to progeroid and cancer-causing phenotypes by impairing homologous recombination and/or causing genome instability.\nFinally, RTS is caused by deficiencies in the RecQ protein, another DNA helicase. In RTS, the helicase activity is impaired, causing recombination and double-strand break repair defects, leading to progeroid symptoms.\nIn conclusion, DNA helicases are involved in the progeroid syndromes of WS, BS, and RTS. Mutations in the genes encoding these proteins impair the helicase activity and lead to various defects in DNA repair, causing accelerated aging."
  },
  {
    "id": 1034,
    "user_query": "Which heat shock protein is found to be upregulated during Hsp90 inhibition?",
    "text-davinci-003_response": "The heat shock protein most commonly found to be upregulated during Hsp90 inhibition is Hsp70 (also known as HspA1A or HSPA1A). Hsp70 is one of the most abundant members of the Hsp90 family and has been found to be upregulated in response to a variety of stressors, including Hsp90 inhibition. This induction of Hsp70 has been shown to be both direct and indirect, meaning it can occur through inhibition of Hsp90 functions, or by other independent pathways. Additionally, Hsp70 has also been found to serve a vital role in mediating the response of cells and tissues to Hsp90 inhibition, including providing chaperone activity for misfolded proteins that Hsp90 is no longer able to support."
  },
  {
    "id": 1036,
    "user_query": "What is the name for anorexia in gymnasts?",
    "text-davinci-003_response": "The name for anorexia in gymnasts is gymnast anorexia nervosa. It is a form of anorexia nervosa in which an individual consumes a very low calorie diet, and in some cases may also engage in excessive exercise to maintain a low body weight. They typically strive for a weight that is lower than recommended for their height and age. This can be a dangerous condition as the extreme lack of caloric intake increases the risk of cardiovascular collapse, amenorrhea, brittle bones, and even death."
  },
  {
    "id": 1038,
    "user_query": "What are the indications for alteplase?",
    "text-davinci-003_response": "Alteplase is a thrombolytic medication, commonly known under the brand names Activase and Cathflo, used in the treatment of certain types of blood clots. It works by binding to the clot and breaking it down into smaller components, which can then be more easily broken down and absorbed by the body. The FDA has approved the use of alteplase for the following indications:\n1) Acute Myocardial Infarction (MI): The use of alteplase in patients with acute MI is clinically proven to reduce mortality and morbidity.\n2) Pulmonary Embolism (PE): Alteplase has been shown to reduce mortality in patients with acute PE when used within 6 hours of symptom onset.\n3) Ischemic stroke: Alteplase has been demonstrated to improve functional outcome in certain types of ischemic stroke when used within 4.5 hours of symptom onset.\n4) Central line associated venous thrombosis (coagulopathy): Alteplase can be used to remove a clot that is occluding a central line, thereby restoring venous access and avoiding the need for invasive surgical intervention.\n5) Hemodialysis access thrombosis: Alteplase can be used to remove a clot in a hemodialysis access site, improving upon traditional methods such as thrombectomy.\n6) Deep vein thrombosis (DVT): Alteplase has been demonstrated to reduce mortality and morbidity compared to traditional forms of anticoagulation therapy in the treatment of DVT."
  },
  {
    "id": 1039,
    "user_query": "List scaffold proteins of the ERK signaling pathway.",
    "text-davinci-003_response": "1. RAF (RAF1, ARAF, and BRAF): These proteins are serine/threonine kinases that reside in the cytoplasm and which act as the direct activators of the MAPK cascade.\n2. MEK (MEK1 and MEK2): MEKs are dual specificity (Ser/Thr and Tyr) kinases that are activated by Rafs and are responsible for the transduction of extracellular signals into the nucleus.\n3. ERK (ERK1 and ERK2): ERKs are MAPKs that phosphorylate a diverse array of proteins involved in the regulation of cell cycle progression, proliferation, and differentiation.\n4. Adaptor Proteins (Shc, Grb2, and SOS): Adaptor proteins are implicated in the scaffolding and/or regulation of early signaling components in the MAPK cascade. They are responsible for the assembly of multiple signaling proteins and in some cases serve as a platform to recruit downstream effectors of the MAPK pathway."
  },
  {
    "id": 1041,
    "user_query": "Which classes of endogenous retroelements are known to date?",
    "text-davinci-003_response": "There are three classes of endogenous retroelements known to date:\n1. Long Terminal Repeat retrotransposons (LTR retrotransposons): These retroelements transcribe their own transcript, which is then reverse-transcribed back into the genome. As their name implies, LTR retrotransposons have long terminal repeats at their ends. Examples of these include Ty1-copia, Ty3-gypsy, and BEL/Pao elements.\n2. Non-Long Terminal Repeat retrotransposons (Non-LTR retrotransposons): These retroelements use an RNA intermediate to make copies of themselves. They lack the long terminal repeats present in LTR retrotransposons and are often seen to target specific sites within the genome. Examples of non-LTR retrotransposons include the LINE and SINE elements.\n3. DNA transposons: These retroelements directly transmit a DNA copy of themselves from one part of the genome to another. As such, they do not use an RNA intermediate for their mobile element. Examples of DNA transposons include the Tc1-mariner, hAT, and CACTA families."
  },
  {
    "id": 1047,
    "user_query": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach.",
    "text-davinci-003_response": "1. FANCM (Fanconi anemia type M)\n2. HDAC1 (histone deacetylase 1) \n3. HDAC2 (histone deacetylase 2) \n4. HDAC3 (histone deacetylase 3) \n5. LMO2 (Lim-only 2) \n6. NCOR2 (nuclear receptor corepressor 2) \n7. NFAT1 (nuclear factor of activated T cells) \n8. PEBP2C (polyomavirus enhancer binding protein 2c)\n9. PU.1 (ets transcription factor PU.1) \n10. RUNX1 (runt-related transcription factor 1) \n11. SET (su(var)3-9, enhancer-of-zeste, and trithorax) \n12. STAT3 (signal transducer and activator of transcription 3) \n13. USF1 (upstream transcription factor 1) \n14. USF2 (upstream transcription factor 2)"
  },
  {
    "id": 1053,
    "user_query": "Which proteins are the different members of the NF-kappaB family of transcription factors?",
    "text-davinci-003_response": "The Nuclear Factor Kappa B (NF-κB) family of transcription factors consists of five members, initially discovered in mice and later identified in humans. These proteins are RelA/p65, RelB, c-Rel, NF-κB1 (p50/p105) and NF-κB2 (p52/p100). \nRelA/p65, RelB and c-Rel are the members of the classical NF-κB family, which all contain an N-terminal Rel homology domain (RHD). RelA/p65 and p50/p105 together form the p65/p50 heterodimer, which is the most abundant NF-κB complex in 94% of cells.\nNF-κB1 (also known as p50/p105) is a heterodimer composed of a p50 and p105 subunit while NF-κB2 (also known as p52/p100) is a heterodimer composed of a p52 and p100 subunit. Both proteins regulate gene transcription through DNA binding, as well as via other mechanisms such as histone acetyl transferase activity and microRNA binding. \nThese five proteins all participate in the regulation of genes involved in immune and inflammatory responses, apoptosis, cell proliferation and differentiation, and can act as activators or repressors depending on the specific context."
  },
  {
    "id": 1061,
    "user_query": "Which proteins have been identified as RET ligands?",
    "text-davinci-003_response": "RET (rearranged during transfection) is an established member of the receptor tyrosine kinase family whose ligands have been identified in a number of organisms, including humans. The known human ligands to RET include glial cell line-derived neurotrophic factor (GDNF), neurturin (NTN), artemin (ARTN), and persephin (PSPN).\nIn addition, a number of other proteins have been identified as putative RET ligands, including endothelin-3 (ET3), midkine (MDK), and growth/differentiation factor 11 (GDF11). Studies have also revealed a novel ligand for RET, termed neuwudinnin (NWDN), which is expressed in ovarian granularstroma and appears to have a role in ovarian cancer pathogenesis. A number of other proteins have also been postulated to act as ligands for RET, including hepatocyte growth factor/scatter factor (HGF/SF), sugiokilin (SUGOK), matrilin-2 (MAT2), and pleiotrophin (PTN)."
  },
  {
    "id": 1066,
    "user_query": "List all articles on network meta-analysis for smoking cessation",
    "text-davinci-003_response": "1. Network Meta-Analysis of Psychosocial Interventions for Smoking Cessation: A Systematic Review and Comparison with an Evidence-Based Guideline Recommendation, by M.T. Young, J.L. Pilling, Z.L. Wood et al., in PLoS ONE, March 2020\n2. An Updated Network Meta-Analysis of Smoking Cessation Interventions, by N.V. Beekhuyzen and B.L. Booth-Butterfield, in Nicotine & Tobacco Research, October 2018 \n3. Network Meta-Analysis of Behavioral Interventions for Smoking Cessation among Adults: A Systematic Review and Bayesian Analysis, by T. Petri, B.A. Taylor, C.E. Collins et al., in Annals of Behavioral Medicine, July 2017\n4. A Network Meta-Analysis of Smoking Cessation Interventions, by I.J. Bonevski, P.A. Shelley, S.L. Westbrook et al., in Addiction, February 2014\n5. An Overview of Network Meta-Analysis for Smoking Cessation Interventions, by R.C. West, A.T. Eastwood, and M. Iglesias-Jove, in BMC Public Health, December 2013\n6. A Network Meta-Analysis of Smoking Cessation Interventions for Different Long-term Outcomes, by C.A. Henschke and M.A. Asfar, in Nicotine & Tobacco Research, August 2005\n7. A Bayesian Network Meta-Analysis of Smoking Cessation Interventions, by G.P. Dohorou, G. Magalingam, M. Maglione et al., in BMC Public Health, October 2004"
  },
  {
    "id": 1068,
    "user_query": "Which clotting factor is inhibited by betrixaban?",
    "text-davinci-003_response": "Betrixaban inhibits Factor XI (also known as Plasma Thromboplastin Antecedent). Factor XI is a zymogen that plays an important role in the intrinsic pathway of the coagulation cascade, and is activated by thrombin. Inhibition of Factor XI by Betrixaban interferes with the extrinsic and intrinsic pathways of coagulation and, consequently, halts thrombus formation."
  },
  {
    "id": 1071,
    "user_query": "Are there any specific antidotes for dabigatran?",
    "text-davinci-003_response": "There are no specific antidotes available for dabigatran, a drug used to manage and reduce the risk of stroke and dangerous blood clots. However, there are treatments available that may be able to reverse the drug's effects if needed. The most effective treatment is a combination of treatments such as:\n1. Administration of specific binding agents that bind to dabigatran in the blood and stop it from circulating throughout the body. This option is available as an antidote for dabigatran-mediated bleeding and is used in severe cases when blood thinning medications can't be used.\n2. Prothrombin complex concentrate (PCC). PCC is a type of clotting agent that is often used in emergency situations where the patient is bleeding or is at risk of bleeding due to an anti-coagulant drug, like dabigatran. It can help reverse the effects of the drug by replacing the clotting factors missing from blood due to the drug's action.\n3. Activated charcoal or dialysis. Activated charcoal can be used to absorb dabigatran from the body, while dialysis can help remove dabigatran and other substances from the blood. Both options may be necessary in cases of severe dabigatran toxicity.\nIt is important to note that, although treatments exist for reversing dabigatran's anticoagulant effects, they should only be used in cases of extreme emergency and under the direction of a doctor. In milder cases, restraining from dabigatran use and monitoring the patient for signs of overdosing is the best course of action."
  },
  {
    "id": 1072,
    "user_query": "What is the outcome of TAF10 interacting with the GATA1 transcription factor?",
    "text-davinci-003_response": "TAF10 stands for ‘TATA-binding Protein Associated Factor 10’. It is a subunit of the large transcriptional machinery complex called the general transcription factor (GTF). It is responsible for interacting with RNA polymerase II and other transcriptional regulators in order to regulate gene expression.\nGATA1 stands for ‘GATA binding protein 1’. It is a transcription factor that binds to GATA-binding elements (GATA-boxes) in promoters and enhancers to regulate gene transcription. It is involved in the regulation of development and differentiation in many cell types.\nTAF10 can interact with GATA1 directly or indirectly, and this interaction can lead to a number of different outcomes.\nIf TAF10 and GATA1 interact directly, TAF10 can act as a co-activator, helping to enhance GATA1-mediated gene expression. The interaction can also help recruit other components of the transcriptional machinery complex to the site of transcription, aiding in the efficient transcription of genes that are regulated by GATA1.\nIf TAF10 and GATA1 interact indirectly, it can result in the inhibition of GATA1-mediated gene expression. For example, the TAF10 subunit can bind to a co-repressor and prevent it from interacting with GATA1, or it can interact with an inhibitor of GATA1-mediated transcription, thus blocking GATA1 from binding and regulating gene expression.\nOverall, the outcome of TAF10 interacting with GATA1 depends on whether the interaction is direct or indirect. In either case, it can have an influence on GATA1-mediated gene expression."
  },
  {
    "id": 1073,
    "user_query": "How does TNF affect thyroid hormone receptors?",
    "text-davinci-003_response": "TNF (tumor necrosis factor) is a cytokine (a type of signaling molecule used in cell-to-cell communication). It has the potential to influence the activity of the thyroid hormone receptor (THR). The THR is a type of transcription factor that binds to DNA, allowing for the transcription of genes that are involved in various cellular functions.\nTNF affects THR in several ways. To begin with, it can induce the transcription of certain THR-related genes. For example, it has been shown to increase the expression of multiple THR isoforms, including mRNA transcripts for the beta and gamma receptor subunits. This leads to an increased level of active Thyroid Hormone Receptors in the cell.\nAdditionally, TNF can also affect the structure of the THR itself, possibly altering its binding affinity to other molecules. Such changes could affect how the transmission of messages to the THR is regulated and ultimately how the THR is activated.\nFinally, TNF can also change the phosphorylation status of the THR, which is important for its activity. Phosphorylation is a process where small molecules (called phosphate groups) are added, allowing the receptor to be activated. TNF has been shown to stimulate phosphorylation in both the beta and gamma subunits of the THRs, ultimately leading to increased activity.\nIn summary, TNF affects thyroid hormone receptors (THRs) in several ways. It can induce the transcription of THR-related genes, change the structure of the receptor, and stimulate its phosphorylation. All of these effects can alter the activity of THRs and therefore impact cellular processes."
  },
  {
    "id": 1078,
    "user_query": "What is the action of molindone?",
    "text-davinci-003_response": "Molindone is an antipsychotic drug which works by blocking dopamine receptors in the brain. This helps to reduce the symptoms of psychotic disorders, including schizophrenia, schizoaffective disorder, mania, delusional disorder and depression that does not respond to other treatments. This medication is also used to treat certain behavioral disorders, such as Tourette’s Syndrome or aggression in children. By blocking dopamine receptors in the brain, Molindone increases the amount of serotonin in the brain, which helps to reduce agitation and paranoia. It also helps to improve sleeping patterns and reduce impulsive behaviour."
  },
  {
    "id": 1082,
    "user_query": "Are there any Decision support systems for chronic pain management ?",
    "text-davinci-003_response": "Yes, there are decision support systems for chronic pain management. These systems are designed to provide clinicians with the evidence and tools they need to make informed decisions about treatment options, medication dosing, and lifestyle recommendations for patients with chronic pain conditions. Decision support systems can include: \n- Artificial Intelligence (AI) systems: AI systems can analyze patient data to help identify patients who may be at increased risk for exacerbation or more severe conditions, inform decision making about medications and lifestyle modifications, and help guide patient-specific pain management strategies.\n- Clinical decision support systems: Clinical decision support systems (CDSS) provide clinicians with evidence-based recommendations about medications, lifestyle modifications, physical activity, and pain management strategies. By comparing a patient's individual characteristics to a database of evidence, CDSS can suggest personalized treatment options for the patient. \n- Electronic medical records: Electronic medical records can provide a more comprehensive picture of a patient's medical history, enabling clinicians to view a patient's medical history and track trends over time related to their pain management. \n- Pain management consulting systems: These systems are designed to bridge the gaps in pain care and surgery. The systems provide a platform for surgeons, hospitals, and patient advocates to collaborate in order to develop tailored treatment plans."
  },
  {
    "id": 1084,
    "user_query": "Which is the methyl donor of histone methyltransferases?",
    "text-davinci-003_response": "The methyl donor of histone methyltransferases is the cofactor S-Adenosyl Methionine (SAM), which donates a methyl group to the substrate (usually a histone protein) of the methyltransferase enzyme. SAM, which is derived from the essential amino acid methionine, is synthesized in the cytosol and is the most important methyl donor in all cells, donating methyl groups to hundreds of substrates in numerous biological processes. Histone methyltransferase enzymes are responsible for adding specific methyl groups to a variety of lysine and/or arginine amino acid residues, resulting in various types of epigenetic modifications that affect gene expression and other cellular events."
  },
  {
    "id": 1085,
    "user_query": "How are human accelerated regions (HAR) defined?",
    "text-davinci-003_response": "Human Accelerated Regions (HARs) are stretches of genomic DNA located in the human genome that differ from other primates, and which can be traced back to a single human ancestor living between 460 and 804 thousand years ago. These regions contain gene regulatory elements, which are short stretches of DNA that bind to molecules that control gene expression. These elements have evolved differently from the sequence in primates, which can result in changes in gene expression or regulation. Although these regions are often less than 1,000 base pairs in length, they can have an important role in controlling such diverse traits as height, the immune system, and even brain development. The term \"Human Accelerated Regions\" was designated by John Stamatoyannopoulos in 2005 based in part on the observation that these regions have evolved faster than other parts of the human genome."
  },
  {
    "id": 1091,
    "user_query": "In which genomic positions is the histone variant macroH2A enriched?",
    "text-davinci-003_response": "The macroH2A histone variant is primarily enriched at sites associated with gene transcription, such as gene promoters, enhancers, and termination sites, as well as coding exons, introns, and splice sites. Specifically, macroH2A is enriched at approximately +1 base pair (bp), -1, +2, -2, and +3 bp relative to the transcription start site and at the 3' end of genes. Furthermore, macroH2A is also enriched at sites located upstream of transcription start sites (known as distal enhancers) and at the +1 and +2 positions of alternative first exons."
  },
  {
    "id": 1093,
    "user_query": "From which sequence does the Alu repeat originate from?",
    "text-davinci-003_response": "The Alu repeat originates from a 305 nucleotide (nt) sequence called ALU S. ALU S (also known as SINE-R or reverse SINE) is a short interspersed nuclear element (SINE), which is a type of retrotransposon found in many eukaryotic genomes. It is derived from a 7SL RNA, a non-coding RNA found in the endoplasmic reticulum. ALU S was first discovered in primate genomes in 1979 and is estimated to be over 300 million years old. The exact sequence of ALU S is not known precisely, but it appears to have a conserved core region of around 12-16 nt, with the remainder composed of varying amounts of non-conserved nucleotide sequences. ALU S has been found in numerous other species and is thought to be one of the most widespread and abundant repeats in the genome."
  },
  {
    "id": 1099,
    "user_query": "Are there any HCV replication inhibitors available?",
    "text-davinci-003_response": "Yes, there are several HCV replication inhibitors available today. These drugs work by either blocking the virus' ability to replicate itself or preventing the virus from entering cells.\nExamples of antiviral drugs which are direct inhibitors of HCV replication include simeprevir, sofosbuvir, grazoprevir/elbasvir, and ledipasvir/sofosbuvir. These drugs act by blocking viral proteases, or enzymes which assist the virus in replicating its genetic material. Other drugs, such as interferon alfa-2b, and ribavirin, also target HCV replication, but work by stimulating the body's immune system to put up a fight against the virus.\nThis group of medicines is used for the treatment of chronic HCV infection, often as a combination therapy with other drugs. While these drugs can be effective in treating the disease, they are expensive and not available to all patients, particularly those in developing countries."
  },
  {
    "id": 1108,
    "user_query": "Is PLK2 involved in alpha-synuclein phosphorylation in Parkinson disease?",
    "text-davinci-003_response": "Currently, research into the specific role of PLK2 in the pathogenesis of Parkinson Disease is somewhat limited, leaving the exact role of PLK2 in the phosphorylation of alpha-synuclein unclear. However, evidence suggests that PLK2 may indeed play a role in the phosphorylation of alpha-synuclein in Parkinson Disease.\nA study conducted in 2019 investigated the role of PLK2 in the regulation of alpha-synuclein phosphorylation in Parkinson Disease. Results found that PLK2 is upregulated in animal models of Parkinson Disease, suggesting that it plays a role in the disease’s progression. Furthermore, PLK2 was found to interact with core exclusion bodies (CEBs) in disease-associated states, containing aggregates of misfolded alpha-synuclein. This suggests that PLK2 may be involved in the phosphorylation of alpha-synuclein in Parkinson Disease. Additionally, PLK2 was observed to be targeted to certain areas of the brain in Parkinson Disease, such as the pars reticulata of the substantia nigra, an area known to contain Lewy bodies associated with the disease.\nTherefore, it appears that PLK2 may indeed be involved in the phosphorylation of alpha-synuclein in Parkinson Disease. However, further research is needed to confirm the exact role of PLK2 in the pathogenesis of the disease and its relationship to alpha-synuclein phosphorylation."
  },
  {
    "id": 1111,
    "user_query": "Name five popular  computer  programs used to identify genes in genomic sequences",
    "text-davinci-003_response": ". \n1. RepeatMasker: RepeatMasker is a widely used program for identifying genes by screening repetitive elements in a genomic sequence. It is particularly useful for eukaryotic genomes as it allows for the masking of elements present in genomes which may interfere in downstream analyses. \n2. GeneMark: GeneMark is an application for gene finding that uses ab initio techniques to accurately detect gene locations on a large scale basis. It is commonly used for addressing prokaryotic genomes and it is also capable of gene prediction in human and other vertebrates. \n3. Glimmer: Glimmer is a popular program for predicting genes in both prokaryotic and eukaryotic genomes. It is particularly useful for those working with bacterial and archaea genomes. \n4. BLAST/BLAT: BLAST and BLAT, part of the BLAST family of tools, are some of the most widely used sequence search and alignment tools for the identification of genes and other features in genomic sequences. \n5. GenScan: GenScan is a program used for gene prediction in eukaryotes. It uses a combination of ab initio and comparative techniques in order to predict gene structures in a genome."
  },
  {
    "id": 1112,
    "user_query": "Which are the major transcription factors regulating glycolysis in mammals?",
    "text-davinci-003_response": "The major transcription factors regulating glycolysis in mammals are MondoA, ChREBP, and PGC1-alpha. \nMondoA is a transcription factor that recognizes specific DNA sequences, called MondoAboxes, found in the promoters of several glycolytic gene promoters. It activates genes involved in glycolysis, such as those encoding phosphofructokinase-1, pyruvate kinase, and glyceraldehyde-3-phosphate dehydrogenase. \nChREBP (Carbohydrate Response Element-Binding Protein) is another major transcription factor regulating glycolytic genes. ChREBP binds to promoters that contain carbohydrate response elements (ChREs) and induces glycolytic gene expression.\nPGC1-alpha (Peroxisome Proliferator-Activated Receptor gamma Coactivator 1-alpha) is a transcriptional master regulator of energy metabolism. PGC1-alpha regulates the expression of glycolytic genes by binding to the promoter regions of many glycolytic genes, such as phosphofructokinase-1 and pyruvate kinase. \nThese three transcription factors, MondoA, ChREBP, and PGC1-alpha, are the major regulators of glycolysis in mammals."
  },
  {
    "id": 1113,
    "user_query": "Mutations in which gene determine response to both erlotinib and gefitinib?",
    "text-davinci-003_response": "Mutations in the epidermal growth factor receptor (EGFR) gene can determine a response to both erlotinib and gefitinib. Erlotinib and gefitinib are tyrosine kinase inhibitors (TKIs) that block the EGFR signaling pathway. Mutations in EGFR can lead to overexpression of EGFR, amplified activity of tyrosine kinases such as c-erbb2 and c-kit, increased expression of downstream signaling molecules, and the overexpression of molecules involved in proliferation and survival. Clinical research has shown that mutations in EGFR can determine response to treatment with both erlotinib and gefitinib. Specifically, activating mutations in EGFR such as Exon 19 deletions and L858R result in increased sensitivity to both erlotinib and gefitinib, while other Egfr mutations such as L861Q and T790M confer resistance to them."
  },
  {
    "id": 1114,
    "user_query": "Which protein complexes contain mitofilin?",
    "text-davinci-003_response": "Mitofilin is a key component of the mitochondrial inner membrane protein complex, which is also known as the mitochondrial respiratory chain complex I. This complex is composed of 45 proteins, including 13 mitochondrial and nuclear encoded subunits (NDUFV1, NDUFS1, NDUFS2, NDUFS3, NDUFS4, NDUFS5, NDUFS6, NDUFS7, NDUFS8, NDUFS9, NDUFV2, NDUFA1, and Mitofilin). Mitofilin is one of the nuclear encoded proteins, and it binds to the other nuclear encoded subunits, as well as several mitochondrial encoded subunits, to form the complex. Additionally, Mitofilin interacts with the voltage-dependent anion channel (VDAC) and is linked to the other respiratory complexes (complexes II-IV) through the adenine nucleotide carriers (ANT). It is considered to be essential for both the assembly and functioning of the respiratory chain complexes."
  },
  {
    "id": 1120,
    "user_query": "Which computational frameworks are available for predicting enhancers?",
    "text-davinci-003_response": "1. ChIP-Seq: ChIP-Seq (Chromatin ImmunoPrecipitation sequencing) is a widely used framework for studying the transcriptional regulation of genes by predicting enhancer binding sites. ChIP-Seq combines high-throughput sequencing technologies with chromatin-immuno-precipitation (ChIP), where DNA fragments bound by specific proteins of interest (e.g transcription factors) are identified and quantified.  \n2. epigenetic marks: Epigenetic marks such as post-translational modifications (PTM) and histone modifications of chromatin can provide insights into whether certain regions of the genome are enhancers or promoters. For example, acetylation of lysines in histones is generally associated with enhancers, while methylation of histones is typically associated with promoters.\n3. Machine learning: Machine learning methods have been developed specifically for predicting enhancers. These methods typically use genome sequence features (e.g. GC content, motifs, etc.) as input features to build predictive models or classifiers that can distinguish between enhancers and non-enhancers.\n4. Deep learning: Deep learning methods have recently been used to effectively predict enhancers by using convolutional and recurrent neural networks. These networks can identify enhancer-specific DNA features and perform unsupervised learning to accurately define enhancers."
  },
  {
    "id": 1123,
    "user_query": "What is GRO-seq?",
    "text-davinci-003_response": "GRO-seq (Genome-wide Run-On Sequencing) is a technique used to measure transcription levels across all of the RNA transcripts in a cell. Using GRO-seq, researchers can generate a comprehensive and quantified map of transcriptional activity across a whole genome or cell type. The technique utilizes next-generation sequencing to understand how and when genes are expressed in cells. GRO-seq takes advantage of a specific type of enzyme, named a reverse transcriptase, to generate cDNA strands from all of the RNA transcripts that are present in the sample. These cDNA strands are then sequenced to understand promoter activity, alternative splicing, transcription start sites, and post-transcriptional events, thereby providing a global transcriptional view of the cell."
  },
  {
    "id": 1134,
    "user_query": "Are Drosophila ultraconserved elements candidate ncRNAs?",
    "text-davinci-003_response": "Drosophila ultraconserved elements (DUEs) are short stretches of DNA which are highly conserved across many species, including humans, mice, and other organisms. While it was initially thought that DUEs were proteins-coding regions, the fact that they are conserved in such remote species suggested that these elements must contain a more general functional element. It was thought that these elements might be involved in gene regulation rather than providing the information necessary for the creation of proteins. Recent work has suggested that DUEs are likely to be involved in non-protein-coding functions, primarily focused on regulating gene expression.\nGiven the evidence pointing to a role for DUEs in gene regulation, it is possible that they may be candidate non-coding RNAs (ncRNAs). Non-coding RNAs are molecules involved in many vital functions within cells, including regulation of gene expression. Though there are still numerous questions surrounding the exact roles of DUEs in gene regulation, a recent study showed that they could regulate the expression of certain genes in Drosophila, suggesting a likely ncRNA role. This research also demonstrated that DUEs display properties characteristic of ncRNAs, such as being hypomethylated and binding to the chromosome in a manner consistent with an RNA molecule.\nOverall, the evidence indicates that Drosophila ultraconserved elements are probable candidate ncRNAs, and thus may be involved in a variety of vital regulatory functions. Further study is needed in order to provide more details about the exact role of DUEs and to better elucidate the regulatory mechanisms they may be involved in."
  },
  {
    "id": 1142,
    "user_query": "How are thyroid hormones involved in the development of diabetic cardiomyopathy?",
    "text-davinci-003_response": "Diabetic cardiomyopathy is a condition in which the heart muscle of people suffering from diabetes is weakened and unable to pump effectively. It is caused by long-term exposure to high glucose levels and is associated with an increased risk of heart failure and stroke. Thyroid hormones, specifically, triiodothyronine (T3) and thyroxine (T4), have a complex role in the development of diabetic cardiomyopathy. Thyroid hormones play a role in both carbohydrate and lipid metabolism, and when levels are unbalanced, this can lead to an increase in blood sugar that can damage the cardiovascular system. Studies have found that an overactive thyroid (hyperthyroidism) can cause an increase in leptin, the hormone responsible for regulating fat metabolism, and can lead to increased diabetes risk. In addition, T4 has been found to inhibit the activity of Na+-K+ ATPase, which plays a critical role in cardiac contractility and conduction, and may be a factor in the development of diabetic cardiomyopathy. High levels of T3 have also been linked to an increased risk of excessive arterial stiffness, which can lead to the development of heart failure. Furthermore, thyroid hormones have been found to stimulate the production of certain cytokines and chemokines that can cause inflammation of the cardiovascular system, thus leading to an increased risk of heart failure. Thus, thyroid hormones can contribute to the development of diabetic cardiomyopathy by influencing the metabolism of lipids and carbohydrates and by affecting the contractility of the heart."
  },
  {
    "id": 1149,
    "user_query": "Which is the subcellular localization of the protein angiogenin?",
    "text-davinci-003_response": "The subcellular localization of the protein angiogenin is primarily on the cell surface and in the extracellular space. Angiogenin is found in association with other proteins, like fibronectin, laminin, and collagen, on the cell surface. It is also present in extracellular matrix of the extracellular space between cells, where it is involved in cell-to-cell adhesion. Additionally, angiogenin is found in the cytoplasm of some cells, where it may play a role in mRNA and protein transport."
  },
  {
    "id": 1151,
    "user_query": "Which bone protein is used in archaelogy for dating and species identification?",
    "text-davinci-003_response": "The bone protein most commonly used in archaeology for both dating and species identification is collagen, a structural protein found in the bones of animals. Collagen is made up of long chains of the amino acid, glycine, which makes up about one third of the protein's total structure. In an archaeological context, collagen is useful because it remains for a relatively long time due to its strong resistance to bacterial and chemical breakdown. In addition, collagen is known to have a predictable decay rate, which is why it can be used for calculating the age of archaeological remains. Species identification is also possible with collagen because the amino acid sequence of different animal species can be used to identify them."
  },
  {
    "id": 1156,
    "user_query": "Is armodafinil used for treatment of insomnia?",
    "text-davinci-003_response": "No, armodafinil (Nuvigil) is not used as a treatment for insomnia. It is a wakefulness-promoting stimulant medication that is approved by the US Food and Drug Administration (FDA) to treat excessive sleepiness caused by narcolepsy, obstructive sleep apnea, or shift work disorder. It is also sometimes used off-label to treat attention deficit hyperactivity disorder (ADHD) and other sleep-related issues such as chronic fatigue syndrome. The primary use of armodafinil is to help people stay more awake and alert during the day. For those who do experience insomnia, taking armodafinil will not help and can potentially make the problem worse."
  },
  {
    "id": 1159,
    "user_query": "What is Trypan blue used for?",
    "text-davinci-003_response": "Trypan blue is an aniline dye used primarily in biological research, especially in cell cultures, to assess cell viability. It can also be used to stain dead or dying cells and to determine cell counts when used in a hemocytometer. The dye is taken up by viable cells, but not by nonviable cells. Trypan blue is used to identify dying cells that may exhibit various defects such as apoptosis, necrosis, autophagy or other types of cell death. It is also used to differentiate between live and dead cells, since it will only be taken up by live ones. Trypan blue is also employed in other laboratory techniques such as immunofluorescence and infection assays as well as for research involving stem cells. In addition, this dye has been used to assess viability during cell culture expansion, for evaluating the effects of treatments, and to analyze cell proliferation."
  },
  {
    "id": 1161,
    "user_query": "How does ranolazine affect kinase signaling activation in the heart?",
    "text-davinci-003_response": "Ranolazine is a medication used to treat chronic angina in patients who have had a heart attack. It works by increasing the levels of cardioprotective proteins in the heart, which decreases the amount of energy needed to maintain heart muscle and activate kinase signaling pathways. The most prominent kinase affected by ranolazine is protein kinase C (PKC). Ranolazine decreases the activation of the PKC enzyme, which inhibits the activity of other kinases involved in cardiac ischemia-reperfusion injury (IRI) and ischemic preconditioning. This decreases the amount of calcium entering the cells and increases the amount of potassium exiting, resulting in a more acceptance of calcium to the cells and a reduction in IRI. Additionally, ranolazine has been found to block the activity of other kinases, including cyclin-dependent kinase 5 (CDK5) and protein kinase A (PKA), which helps to promote a more healthy cardiac environment. By decreasing the activity of these kinases, ranolazine helps to maintain the normal rate and rhythm of the heart."
  },
  {
    "id": 1164,
    "user_query": "Pridopidine has been tested for treatment of which disorder?",
    "text-davinci-003_response": "Pridopidine is an investigational medication that has been studied for the treatment of Huntington's disease. It is designed to help improve the movement control and cognitive functioning in people that suffer from this genetic condition. It works by targeting certain serotonin and dopamine (neurotransmitter) receptors in the brain. The drug is currently in clinical trials and has shown promising results in alleviating the debilitating symptoms of Huntington's disease, such as involuntary jerking movements, difficulty with coordination and balance, and speech impairment. Pridopidine has not yet been approved for use in any country."
  },
  {
    "id": 1166,
    "user_query": "Are CpG islands located close to housekeeping genes?",
    "text-davinci-003_response": "Yes, CpG islands are frequently found close to housekeeping genes. CpG islands are stretches of DNA which contain clusters of cytosine guanine (CG) pairs, separated by larger stretches of DNA with few of these CG pairs. Research has suggested that the majority of housekeeping genes are located close to CpG islands. Specifically, 90% of human housekeeping genes are at least partially contained within the CpG island, and most of the remaining 10% are located within 10 kb downstream or upstream of the CpG island. Additionally, of the known housekeeping genes with CpG islands, the majority are located within 500 bp of the CpG island boundary. These observations suggest that there is a tendency for housekeeping genes to be located close to CpG islands, with the upstream and downstream regions within 10 kb being particularly favored."
  },
  {
    "id": 1168,
    "user_query": "Which is the target of bortezomib used in cancer therapy?",
    "text-davinci-003_response": "Bortezomib is a targeted therapy used in the treatment of certain types of cancer. It works by inhibiting the action of proteasomes, which are molecules inside the cell that are responsible for breaking down proteins. Specifically, bortezomib inhibits the enzyme 26S proteasome, which plays an important role in regulating proteins involved in cancer cell growth and survival. By inhibiting this enzyme, bortezomib prevents the cancer cells from growing and spreading. Bortezomib shows efficacy in the treatment of multiple myeloma and mantle cell lymphoma. It is also used to treat patients with recurrent/refractory multiple myeloma who have already been treated with chemotherapy. Bortezomib is typically administered intravenously once a week for two weeks followed by a rest period of two weeks."
  },
  {
    "id": 1178,
    "user_query": "Idarucizumab is an antidote of which drug?",
    "text-davinci-003_response": "Idarucizumab is an antidote for the anticoagulant drug dabigatran. It is a recombinant (genetically engineered) humanized monoclonal antibody fragment that is used to reverse the anticoagulant effects of dabigatran. It works by binding to dabigatran and preventing it from binding to thrombin, a protein in the body that helps to form blood clots. It is mainly used to prevent or treat potentially life-threatening bleeding caused by dabigatran, although it is sometimes used in other situations as well."
  },
  {
    "id": 1179,
    "user_query": "What are the main clinical characteristics of Pendred syndrome?",
    "text-davinci-003_response": "Pendred syndrome is a genetic disorder characterized by hearing loss and an enlarged thyroid gland (goiter). It is an autosomal recessive disorder that occurs when an individual inherits two mutated copies of the gene SLC26A4. Clinical characteristics associated with Pendred syndrome include:\n1. Sensorineural hearing loss: Affected individuals typically have progressive hearing loss, which can range in severity from mild to profound. It often has a greater impact on certain frequency ranges and can cause sound distortion, known as auditory dyssynchrony.\n2. Goiter: An enlarged thyroid gland (goiter) is the primary physical sign of Pendred syndrome. It can occur at any age, although it is more commonly seen in children and adolescents. Goiters can range in size from very small to large enough to be visible and/or palpable on the neck.\n3. Vestibular dysfunction: Those with Pendred Syndrome can have problems with their vestibular system, which helps the brain process movement and balance signals from the body. Symptoms can range from dizziness and vertigo to coordination issues.\n4. Other features: Additional features of Pendred Syndrome can include kidney malformations, premature fusion of certain skull bones (craniosynostosis), speech delay, and inner ear malformations."
  },
  {
    "id": 1181,
    "user_query": "What is a popular mesaure of gene expression in RNA-seq experiments?",
    "text-davinci-003_response": "A popular measure of gene expression in RNA-seq experiments is the “read count.” This measure is based on the number of reads/alignments found to each gene which are considered to be expressed in a given sequenced sample. Read counts are then compared between samples to quantitatively measure changes in gene expression across transcripts, as well as differences in gene expression levels between species or experiment groups. Additionally, read counts can be used to detect differentially expressed genes by comparing the read count of two or more conditions. Read counts are one of the most common metrics used for the analysis of RNA-seq experiments and are frequently used to quantify gene expression levels within a sample or between samples."
  },
  {
    "id": 1182,
    "user_query": "Is macroautophagy a selective degradation process?",
    "text-davinci-003_response": "Yes, macroautophagy is a selective degradation process. Macroautophagy is a type of autophagy, which is a process by which cells degrade and recycle their own cell components. Macroautophagy targets large molecules or entire cell organelles for degradation in order to recycle cellular components. This process is selective in the sense that cells can target specific molecules or organelles for recycling or degradation, rather than indiscriminately breaking down everything within the cell. In human cells, macroautophagy is used to target abnormal protein aggregates, damaged organelles, and extra cellular vesicles. In this way, it helps to maintain a healthy cellular environment."
  },
  {
    "id": 1188,
    "user_query": "Which protein is affected by dusp8 activation?",
    "text-davinci-003_response": "DUSP8, or the dual-specificity phosphatase 8 protein, is an enzyme that is responsible for modulating MAPK (mitogen-activated protein kinase) activity and MAPK- dependent signal transduction pathways. In normal physiological conditions, DUSP8 is active and helps maintain the MAPK signaling balance. However, when DUSP8 is activated, it can disrupt this balance and can cause over-activation of MAPK signaling pathways which can lead to a variety of pathological conditions, depending on which particular MAPK pathway is affected. \nThe most well-known MAPK pathway affected by DUSP8 activation is the ERK1/2 pathway, which is critical in cell cycle regulation, differentiation, proliferation, and apoptosis. When activated, DUSP8 can dephosphorylate and thus inactivate ERK1/2, resulting in reduced activity of this pathway. As a result, cells may become insensitive to certain growth-promoting signals and may be more likely to undergo apoptosis. This can be especially useful in treating certain types of cancer, which often exhibit overexpression of the ERK1/2 pathway. \nIn addition to ERK1/2, there are several other proteins that may be affected by DUSP8 activation, including p38 MAPK, JNK, and RSK1/2. For example, DUSP8 activation can result in dephosphorylation and inactivation of the p38 MAPK pathway, which can be involved in inflammation and immune responses. Similarly, DUSP8 activation can disrupt the JNK pathway, which can affect the transcription of genes involved in stress responses and apoptosis. Finally, DUSP8 activation can also result in dephosphorylation of RSK1/2, which is necessary for normal regulation of gene expression."
  },
  {
    "id": 1191,
    "user_query": "Which drugs are utilized to treat eosinophilic esophagitis?",
    "text-davinci-003_response": "The main drugs used to treat Eosinophilic Esophagitis (EoE) are corticosteroid medications (as pills, liquid, and topical medications) along with other oral medications including proton pump inhibitors (PPIs) and leukotriene receptor antagonists (LTRAs). Corticosteroids, often in the form of fluticasone, can reduce inflammation in the esophagus. PPIs work by reducing stomach acid production, helping to prevent symptoms associated with EoE. LTRAs, such as montelukast and zafirlukast, help to reduce the number of eosinophils in the esophagus. Some people with EoE may be treated with a combination of these medications, or with antireflux surgery. Lifestyle modifications, such as dietary changes, may also help reduce symptoms associated with EoE."
  },
  {
    "id": 1194,
    "user_query": "What is the Her2 status in Li-Fraumeni syndrome?",
    "text-davinci-003_response": "The Her2 status in Li-Fraumeni syndrome depends on the individual. It can be positive or negative. The vast majority of hereditary cancers associated with Li-Fraumeni syndrome are associated with Her2 negativity. However, a very small number (3-5%) of Li-Fraumeni syndrome-associated cancers may be associated with Her2 positivity. In either case, individuals with Li-Fraumeni syndrome have an increased risk of developing tumors regardless of Her2 status."
  },
  {
    "id": 1197,
    "user_query": "Why can't humans synthesize Neu5Gc (N-Glycolylneuraminic acid)?",
    "text-davinci-003_response": "Humans cannot synthesize Neu5Gc (N-Glycolylneuraminic acid) because they lack the CMAH (cytidine monophospho-N-acetylneuraminic acid hydroxylase) enzyme needed to catalyze the reaction. Neu5Gc is a type of monosaccharide, which is an important molecule found in the cell membranes of all human and animal cells. It is also a component of the human blood glycoprotein, explaining why humans have developed an antigenic response to Neu5Gc.\nThe CMAH enzyme is used to convert CMP-Neu5Ac (cytidine monophospho-N-acetylneuraminic acid) to Neu5Gc. Humans lack this enzyme due to a mutation that took place in our genome approximately 2–3 million years ago. This gene encoding the CMAH enzyme is present in all other mammals but has been deleted from the human genome. Therefore, humans are unable to synthesize Neu5Gc from the CMP-Neu5Ac precursor. As a result, humans must obtain their Neu5Gc from dietary sources such as red meat and dairy."
  },
  {
    "id": 1198,
    "user_query": "Which enzyme is inhibited by Orteronel?",
    "text-davinci-003_response": "Orteronel is a drug commonly used to treat advanced prostate cancer. It works by inhibiting an enzyme called 17α-hydroxylase/17,20-lyase (17α-OH/17,20-Lyase). This enzyme is responsible for the production of androgens, or male sex hormones, in the body. By inhibiting the enzyme, Orteronel is able to decrease the amount of androgens in the body, which can slow the growth and spread of prostate cancer."
  },
  {
    "id": 1202,
    "user_query": "Elaborate on the TREAT-NMD initiative for DMD patients",
    "text-davinci-003_response": "TREAT-NMD is an international initiative created to bring together the neuromuscular community in order to develop effective treatments and management strategies for neuromuscular diseases. The initiative was launched in 2003 and is a collaborative network of over 150 patient organizations, academic and research institutions, healthcare providers, industry partners, and regulators from around the world.\nTREAT-NMD works to facilitate and promote the development of safe, effective treatments and management strategies for individuals with neuromuscular diseases, including Duchenne Muscular Dystrophy (DMD). The initiative works to eliminate gaps and disparities in health care access, care delivery, quality of life, and implementation of best-practice standards.\nTREAT-NMD specifically has special programs dedicated to DMD patients and caregivers. Programs include the DMD Registry, the DMD Clinical Trials Network, the DMD Biobank, the DMD Care Standards, and the DMD Outcomes Measures Database.\nThe DMD Registry is an online patient registry that collects information from DMD patients and families about disease progression, treatments, therapies, and clinical trial participation. This data is used to inform DMD research and development and help inform decision-makers about current trends and best practices.\nThe DMD Clinical Trials Network works to make clinical trials more accessible to DMD patients and their families. TREAT-NMD has helped to establish networks of investigators who are experienced in DMD research and care and work closely with niche recruiting sites to help identify prospective participants for DMD clinical trials.\nThe DMD Biobank is a global initiative that collects biological samples from DMD patients that can be used for research and diagnosis. Samples are carefully tissue-typed and collected with accompanying clinical information so they can be used for validation of laboratory results.\nThe DMD Care Standards are guidelines that provide guidance on best practices for the clinical management of DMD patients. They outline comprehensive care standards and protocols that are designed to improve patient outcomes.\n Finally, the DMD Outcomes Measures Database is a comprehensive platform that includes a collection of patient-reported outcomes (PROs) that are specific to the DMD population. PROs are used to measure disease progression, treatment efficacy, and patient-reported benefits. These outcomes measures are used in clinical trials, research, and drug development."
  },
  {
    "id": 1207,
    "user_query": "What is the physiological role of LKB1 involved in Peutz-Jeghers syndrome?",
    "text-davinci-003_response": "LKB1 is a tumor suppressor gene whose mutations are responsible for the genetics of Peutz-Jeghers syndrome (PJS). PJS is an inherited disorder characterized by the development of polyps in the gastrointestinal tract as well as hyperpigmentation of the skin, commonly found on the fingers, toes, and lips. \nThe physiological role of LKB1 is to activate energy-producing metabolic pathways such as AMP-activated protein kinase (AMPK) which is involved in the regulation of cell metabolism. LKB1 also plays a role in the phototransduction-signal pathways important to vision. Furthermore, this gene is known to play a role in DNA repair and chromosome-segregation during cell divisions (i.e. mitosis). \nIn individuals with PJS, mutations of the LKB1 gene are what lead to the formation of polyps and hamper the gene’s ability to regulate cell metabolism. This contributes to the increased risk of developing a variety of cancers, including digestive tract, lung, and breast cancers."
  },
  {
    "id": 1213,
    "user_query": "Which is the major function of sororin?",
    "text-davinci-003_response": "Sororin is a protein that helps regulate chromosome segregation during mitosis. It functions by binding to chromatin and recruiting condensin complexes, which help to organize chromosomes and help them properly line up during the process of cell division. Sororin helps to prevent errors from occurring during chromosome separation, ensuring accurate segregation of genetic material. Additionally, Sororin helps to facilitate proper sister chromatid cohesion during anaphase, which is required for the formation of daughter cells that are genetically identical to their parent cell."
  },
  {
    "id": 1216,
    "user_query": "Can desvenlafaxine be used at a dose of 50mg/day?",
    "text-davinci-003_response": "Yes, desvenlafaxine can be used at a dose of 50mg/day. The usual adult dose of desvenlafaxine is 50–400mg daily. The exact dose recommended by a doctor can vary depending on an individual's response to treatment and medical history. Some clinicians suggest gradually increasing the dose until the desired effect is achieved. \nIt is important to note that desvenlafaxine should be taken with caution in people with pre-existing medical conditions such as kidney and liver diseases, as it can interact with other medications and cause side effects. Additionally, it should not be taken by pregnant women, as it can harm the fetus. \nSince desvenlafaxine is a prescription drug, it is important to always follow the instructions of a healthcare provider. Desvenlafaxine should never be taken in higher or lower doses than recommended, and it should be taken regularly and as instructed."
  },
  {
    "id": 1219,
    "user_query": "Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?",
    "text-davinci-003_response": "Yes, ferric carboxymaltose can be used to treat anemia in inflammatory bowel disease (IBD) patients. Ferric carboxymaltose is a type of iron supplementation and has been shown to be effective in improving hemoglobin levels in anemic IBD patients. Studies have also shown that ferric carboxymaltose can be administered in one or two doses without any major side effects, making it a safe option for treating anemia in IBD patients. \nFerric carboxymaltose can work quickly to treat anemia in IBD patients. The iron is quickly absorbed, meaning it can start to work within 24-72 hours after the first dose. The increased iron levels can help restore hemoglobin levels, leading to improved energy levels and symptom relief.\nFerric carboxymaltose is typically administered at a dose of 1000 to 1500 mg per day, divided into two 50 mg doses administered through intravenous injection. It is commonly recommended to administer the second dose within two to four days of the first. However, in some cases the doses may be increased to up to 2000 mg per day if necessary.\nIn addition to its effectiveness, ferric carboxymaltose also offers the advantage of being well tolerated. Studies have found that the most common side effects of the drug are mild and transient, such as headaches, dizziness, nausea, and flushing. Furthermore, ferric carboxymaltose does not interact with other medications, making it a safe choice to use with other medications. \nOverall, ferric carboxymaltose has been shown to be effective and well tolerated in treating anemia in IBD patients. It offers the advantage of quickly improving hemoglobin levels, and can be used in combination with other medications."
  },
  {
    "id": 1220,
    "user_query": "Which disease is treated with Eliglustat?",
    "text-davinci-003_response": "Eliglustat is a medication used to treat a rare, inherited disorder called Gaucher disease type 1. It works by reducing the production of fatty substances called glucocerobrosides, which are the result of Glucosylceramide synthase (GCS) enzyme. Eliglustat helps to normalize levels of glucocerobrosides in the body, which can help to reduce the signs and symptoms of Gaucher disease type 1. Common signs and symptoms of Gaucher disease type 1 may include an enlarged spleen and liver, anemia, low platelet count, and swollen lymph nodes. Eliglustat has been approved by the Food and Drug Administration for adults with the condition and may help to improve quality of life by reducing the symptoms associated with the disease."
  },
  {
    "id": 1225,
    "user_query": "Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?",
    "text-davinci-003_response": "No, the regulation of Vsr endonuclease is not independent of the growth phase of bacteria. Vsr endonuclease is an enzyme that helps protect bacteria from phage infection. It does this by cutting bacteriophage DNA in bacterial cells, preventing its replication. The level of Vsr endonuclease expression is thought to be regulated by the growth phase of the bacteria. Studies have shown that the expression of Vsr is higher in stationary-phase bacteria compared to log-phase bacteria, suggesting that the activity of Vsr is regulated in response to changes in the growth phase of bacteria. Additionally, studies have illustrated that Vsr expression increases in response to external stress, such as exposure to bacteriophage, and this increase is associated with a shift in the bacterial growth phase from log to stationary phase. In summary, the regulation of Vsr endonuclease is therefore dependent on the growth phase of bacteria."
  },
  {
    "id": 1230,
    "user_query": "What is the life expectancy of professional athletes in respect to the general population?",
    "text-davinci-003_response": "The life expectancy of professional athletes is difficult to determine given a wide range of variables, such as age, gender, activities during and after retirement, etc. However, on average, the life expectancy of professional athletes is slightly higher than the average life expectancy of the general population.\nFor example, one study of former NFL players found that average life expectancy of these players was 78.3 years, which is higher than the U.S. male life expectancy of 76.1 years. Similarly, research on professional tennis players concluded that the lifetime mortality rate was lower than the general population in the same age range. \nIn addition, there are specific factors that can influence the life expectancy of professional athletes. For one, these athletes often have access to better health care and medical attention than the general population, which can have a positive impact on their lifespan. Participation in and regular maintenance of exercise regimens, as well as healthy eating and lifestyle habits, may also increase life expectancy. \nIn short, professional athletes have slightly higher life expectancies than the general population on average, and this can be attributed to lifestyle habits as well as access to better health care so they can beat the odds and live longer."
  },
  {
    "id": 1232,
    "user_query": "How does adrenergic signaling affect thyroid hormone receptors?",
    "text-davinci-003_response": "Adrenergic signaling can affect thyroid hormone receptors by either stimulating or inhibiting them. When activated, sympathetic post-synaptic α- and β-adrenergic receptors both increase the level of thyroid hormone receptors, as well as the level of genes involved in thyroid hormone metabolism. The stimulation of sympathetic post-synaptic β-adrenergic receptors in particular will increase the expression of the sodium-iodide symporter, which is responsible for actively taking up iodide from the bloodstream, thus resulting in higher serum levels of iodide and subsequent higher rates of thyroid hormone synthesis.\nIn contrast, when adrenergic receptors are inhibited, the thyroid hormone receptors become less responsive to thyroid-stimulating hormone. This can lead to a decrease in thyroid hormone metabolism as the decrease in thyroid hormone receptors limits the amount of thyroid hormone available for uptake into cells."
  },
  {
    "id": 1233,
    "user_query": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?",
    "text-davinci-003_response": "There are several different types of computational tools for the prediction of beta-barrel transmembrane proteins. These include: \n1) Neural networks - These are an artificial intelligence model which can predict the transmembrane segments of a protein using the amino acid sequence. Neural networks have been used to develop a variety of transmembrane prediction tools such as TMBetaPred and TMBIPS. \n2) Support Vector Machines - These are machine learning algorithms which can be used to predict the presence of transmembrane domains from protein sequences. Support vector machines can be used to predict beta-barrel transmembrane proteins by training the algorithm on a dataset of known transmembrane proteins. \n3) Hidden Markov Models - These are mathematical models which can be used to detect the secondary structures of proteins such as helices and beta barrels. These models can be used to detect how likely a particular sequence is to form a beta-barrel transmembrane protein. \n4) Biophysical Techniques – These include techniques such as site-directed mutagenesis, circular dichroism, interference reflection microscopy, and phage display. These methods can be used to experimentally detect the presence of transmembrane segments in proteins.\n5) Computer Aided Drug Design - This is a rapidly developing field which uses computational tools to look for potential drug target proteins with transmembrane domains. These tools can be used to identify potential drug targets which have beta-barrel transmembrane proteins."
  },
  {
    "id": 1236,
    "user_query": "Is there any cross-talk between the Wnt and the Akt pathways?",
    "text-davinci-003_response": "Yes, there is cross-talk between the Wnt and Akt pathways. The Wnt pathway controls proliferation, differentiation, and cell fate decisions in a variety of cell types, including stem cells, and plays a critical role in cancer development. The Akt pathway is involved in cell survival. The two pathways interact to regulate the fate of a cell. Specifically, Wnt and Akt signaling can both directly influence each other through transcriptional regulation and post-transcriptional mechanisms. For example, Akt activation can lead to the inhibition of GSK-3β and the upregulation of β-catenin, which allows β-catenin to enter the nucleus and promote the activation of Wnt-responsive genes. Additionally, Wnt signaling can positively regulate Akt activation by upregulating components of the PI3K/Akt/mTOR signaling pathway. Taken together, this cross-talk highlights the importance of the two pathways in regulating multiple cellular processes."
  },
  {
    "id": 1238,
    "user_query": "Is the Snord116 cluster associated with the Prader-Willi syndrome?",
    "text-davinci-003_response": "The Snord116 cluster is a cluster of small nuclear RNAs (snRNAs) that have been identified as playing an important role in the Prader-Willi Syndrome (PWS). The Snord116 cluster is comprised of six small nuclear ribonucleotide (snRNA) genes located on chromosome 15. These genes are required for the normal operation of the Prader-Willi Syndrome network, as mutations in any of them has been shown to cause the disease in humans. Furthermore, several other features of the PWS phenotype, including neonatal hypotonia, macroglossia, and hypogonadotropic hypogonadism, are linked to the small nuclear ribonucleotide (snRNA) gene mutations in Snord116. Therefore, it is clear that the Snord116 cluster is directly associated with the Prader-Willi Syndrome."
  },
  {
    "id": 1242,
    "user_query": "Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?",
    "text-davinci-003_response": "The short answer is “yes”, nimodipine is recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage (SAH) patients. \nNimodipine is a calcium channel blocker that is primarily used in the context of SAH to reduce the risk of cerebral vasospasm and delayed cerebral ischemia. It was developed and approved by the United States Food and Drug Administration (FDA) in 1989, and is the only calcium channel blocker that has been studied for vasospasm prophylaxis in this population. \nThe typical regimen is for SAH patients to receive nimodipine orally at a dose of 30mg every 4 hours for 21 days, with the first dose beginning within 24 hours of aneurysmal SAH diagnosis. Numerous randomized controlled trials have demonstrated the efficacy of nimodipine in preventing vasospasm and improving outcomes in SAH, with studies suggesting a reduction of vasospasm of 40-50% in patients taking nimodipine compared to those taking a placebo. Additionally, in one meta-analysis of 7 randomized control trials, it was demonstrated that nimodipine was associated with a significant reduction in poor outcome in patients after SAH.\nFor these reasons, multiple professional guidelines have recommended the use of nimodipine for prevention of vasospasm in aneurysmal SAH patients, including the American Heart Association and the World Federation of Neurosurgical Societies. \nIn summary, nimodipine is the only calcium channel blocker studied for its efficacy in reducing vasospasm and poor outcomes after aneurysmal SAH. Multiple studies have demonstrated its effectiveness, and it is recommended by a number of professional guidelines. Thus, nimodipine is recommended for prevention of vasospasm in aneurysmal SAH patients."
  },
  {
    "id": 1245,
    "user_query": "Where can we find the protein lacritin?",
    "text-davinci-003_response": "Lacritin is a protein found primarily in human tears. It is produced by the lacrimal gland and is a potential therapeutic agent for many ocular and non-ocular conditions. In tears, lacritin is found in a complex mixture containing, among others, proteins, lipids, electrolytes, and mucins. It is also found in the conjunctival epithelial cells, in the Harderian gland and in corneal epithelial cells. Lacritin is also present in the tear film of most other mammals."
  },
  {
    "id": 1247,
    "user_query": "What is the triple screening test performed during pregnancy measuring?",
    "text-davinci-003_response": "The triple screening test is a prenatal screening test used by healthcare providers to assess an unborn baby's risk of having certain chromosomal and genetic conditions. Specifically, the test measures three substances in the mother's blood: alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and estriol (uE3). AFP is a protein produced by the fetal liver, hCG is produced by the placenta, and estriol is a form of estrogen produced by both the placenta and the fetus. Each of these substances can indicate abnormalities such as Down syndrome (Trisomy 21), open neural tube defects (usually spina bifida or anencephaly), and other rare conditions. The triple screening test typically takes place between 15 and 20 weeks into the pregnancy and is usually done along with an ultrasound to check for any physical abnormalities."
  },
  {
    "id": 1249,
    "user_query": "Which protein interacts with the Ragulator-RAG GTPases to control mTOR activity?",
    "text-davinci-003_response": "The protein that interacts with the Ragulator-RAG GTPases to control mTOR activity is Rheb (Ras homolog enriched in brain). Rheb is a small GTPase of the Ras-like superfamily that binds directly to the Ragulator-RAG complexes, which in turn activate the Rheb-mTORC1 complex by exchanging GDP for GTP. This process then activates mTOR, allowing it to regulate the translation of messenger RNAs into proteins."
  },
  {
    "id": 1251,
    "user_query": "Galassi classification is used for which disorder?",
    "text-davinci-003_response": "The Galassi Classification is a system that was developed by neurosurgeons to classify brain tumors. The Galassi Classification is based on the size, location, and extent of the tumor. It is a method to classify the extent of involvement of brain tumors and their growth patterns. The four types of tumor include: Diffuse, limitary, focal, and extra-axial. Diffuse tumors span several regions of the brain, limitary tumors are confined within a certain area, focal tumors are within a single location, and extra-axial tumors are located outside of the brain tissue. This classification system is used to plan for treatment and to better understand the prognosis of the patient with a brain tumor."
  },
  {
    "id": 1258,
    "user_query": "List fluorescent reporter proteins.",
    "text-davinci-003_response": "Fluorescent reporter proteins are proteins that are engineered to produce some kind of signal in response to a specific stimulus, such as fluorescent proteins, luminescent proteins, and bioluminescent proteins.\n1) Fluorescent Proteins:\nGreen Fluorescent Protein (GFP): a protein isolated from a jellyfish that emits a bright green light.\n\t\nYellow Fluorescent Protein (YFP): a derivative of GFP that emits a yellow light.\nCyan Fluorescent Protein (CFP): a variant of GFP that emits a bright blue-green light.\nRed Fluorescent Protein (RFP): a derivative of GFP that emits a deep red light.\nTeal Fluorescent Protein (TFP): a variant of GFP that emits a teal-colored light.\nPURPLE Fluorescent Protein (PFP): a variant of GFP that emits a deep purple light.\nSplit Fluorescent Proteins: a fused pair of fluorescent proteins that can be separated by a specific enzyme; commonly used for monitoring protein-protein interactions.\nmOrange2: a monomeric version of red fluorescent protein with improved properties.\n2) Luminescent Proteins:\nLuciferase: an enzyme that produces light, popularly used as a reporter gene in laboratories to monitor promoter activity.\nPhotinus pyralis luciferase (PpyLuc): a firefly luciferase commonly used to monitor expression of genes.\nRenilla luciferase: a luciferase found in a sea pansy; it produces light with a lower intensity than firefly luciferase.\n3) Bioluminescent Proteins:\nPhotoprotein Aequorin: a calcium sensor derived from a jellyfish found in the Caribbean; it is often used to follow intracellular calcium in cells.\nFlavin Mononucleotide (FMN): a derivative of Flavin Adenine Dinucleotide (FAD); it emits light when oxidized.\nPhotoprotein Renilla Reniformis: a protein derived from a sea pansy; it produces light when exposed to oxygen and energy in the form of Ca2+ ions."
  },
  {
    "id": 1259,
    "user_query": "By which mechanism MutT proteins act against DNA lesions in bacteria?",
    "text-davinci-003_response": "MutT proteins, also known as 8-oxoguanine glycosylase (OGG) enzymes, act as one of the major defense systems against lesions in bacterial DNA. This enzyme scans the genome for “oxidized” guanine bases, which form when DNA precursor molecules react with environmentally produced reactive oxygen species (ROS). When MutT proteins identify these lesions, they bind to them and catalyze their excision from the strand in a single-step hydrolysis reaction. The cleaved lesion is then odinated by an enzyme called MutY, and then repaired by base-excision repair (BER) pathways. The BER pathway involves additional repair enzymes that further process the oxidized guanine bases, such as DNA glycosylase and DNA polymerase, which further assists in restoring the correct base. Collectively, these proteins play an important role in maintaining bacterial DNA integrity."
  },
  {
    "id": 1269,
    "user_query": "Which is the molecular function of the protein CCDC40?",
    "text-davinci-003_response": "The molecular function of the protein CCDC40 is to act as a transcription factor. CCDC40 is a member of the CREB-binding protein (CBP) family of transcription factors. It binds to a specific DNA sequence known as the cAMP responsive element (CRE) and increases expression of genes that contain CRE boundary elements. CCDC40 is thought to be involved in growth, development, and immunity, but its exact function remains unknown."
  },
  {
    "id": 1273,
    "user_query": "What is Cerebral Cavernous Malformation?",
    "text-davinci-003_response": "Cerebral Cavernous Malformations (CCM) are abnormal clusters of blood vessels that are present in the brain or spinal cord. They are composed of small, thin-walled vessels that are filled with blood and can be found in any part of the brain. These clusters can range in size from a few millimeters to several centimeters and can be single or multi-layered. They can occur without any known cause (idiopathic CCM) or can be associated with inherited genetic defects.\nCCM are vascular lesions and typically do not cause symptoms. However, if the lesion expands and bleeds, it can lead to neurological deficits (neurologically-evident CCM). Symptoms can range from mild headaches and seizure-like activity, to focal neurologic deficits, stroke-like events, hydrocephalus, memory loss, cognitive impairment, coma and death.\nMost people with CCM have no identifiable risk factors, although some people may have a family history or a genetic mutation that can increase the chance of developing CCM. Treatment for CCM depends on the severity of symptoms, the size of the lesion and patient’s age. The main goal of treatment is to reduce the risk of bleeding from the malformation. This can be done through medications or by surgically clipping the lesion. In some cases, radiation therapy may be necessary."
  },
  {
    "id": 1275,
    "user_query": "Which protein pathway is regulating SGK1-mediated phosphorylation of FOXO3a to control cell proliferation?",
    "text-davinci-003_response": "The regulation of SGK1-mediated phosphorylation of FOXO3a to control cell proliferation is predominantly influenced by a variety of protein pathways. Specifically, the Wnt/β-Catenin pathway, Insulin/Insulin-Like Growth Factor-1/AKT/mTOR, and Hippo pathways all contribute to the regulation of this phosphorylation event. \nThe Wnt/ β-Catenin pathway is activated upon binding of Wnt ligands to its receptors, which leads to the activation of Dishevelled, resulting in disruption of the β-catenin destruction complex and subsequent stabilization and nuclear translocation of β-catenin. Nuclear-translocated β-catenin binds to FoxO3a, causing its transcriptional repression. SGK1 subsequently phosphorylates FoxO3a, which causes its translocation to the cytoplasm, away from the transcriptional repression of β-catenin. \nThe Insulin/Insulin-Like Growth Factor-1/AKT/mTOR pathway is activated in response to insulin or insulin-like growth factor-1 binding to its receptor, leading to the activation of AKT downstream. Activated AKT can then phosphorylate and activate SGK1, resulting in the phosphorylation of FOXO3a. Inhibition of this pathway leads to FoxO3a remaining in the nucleus and transcriptionally active. \nLastly, the Hippo pathway is activated via multiple upstream signaling molecules, such as MST1/2 and the Lats kinases, leading to the phosphorylation and inactivation of YAP and TAZ transcriptional co-activators. In the absence of YAP and TAZ, SGK1 is activated, causing phosphorylation of FOXO3a in the cytoplasm. Thus, the Hippo pathway also contributes to the SGK1-mediated phosphorylation of FOXO3a to control cell proliferation."
  },
  {
    "id": 1281,
    "user_query": "Is TNNI3K a cardiac-specific protein?",
    "text-davinci-003_response": "No, TNNI3K is not a cardiac-specific protein; it is a skeletal muscle protein. TNNI3K (a.k.a. tropical myopathyslow skeletal troponin I, slow TnI, or sTnI) is a component of the troponin complex found in skeletal muscle, and is responsible for the regulation of muscle contraction. It is not found in the heart muscle, so it cannot be considered a cardiac-specific protein."
  },
  {
    "id": 1287,
    "user_query": "Can the apoptosis regulator BAX trigger the release of cytochrome c?",
    "text-davinci-003_response": "Yes, BAX, a pro-apoptotic Bcl-2 family member can trigger the release of cytochrome c from mitochondria. BAX is an integral membrane protein located on the mitochondrial outer membrane and can be activated through various pathways to induce apoptosis. Upon its activation, BAX can oligomerize and interact with the voltage-dependent anion channel (VDAC) located on the outer mitochondrial membrane. This interaction forms a pore that causes cytochrome c to be released from the intermembrane space into the cytosol. The release of cytochrome c triggers the formation of apoptosomes, a multi-protein oligomeric complex composed of cytochrome c, Apaf-1, and pro-caspases-9, which sets off the caspase cascade and leads to cell death."
  },
  {
    "id": 1289,
    "user_query": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients",
    "text-davinci-003_response": "BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients include:\n• Vemurafenib: Vemurafenib (Zelboraf, Roche) is a pill used to treat metastatic melanoma with the BRAF V600E mutation. It works by blocking the BRAF enzyme, which in turn should stop or slow the growth of cancer cells.\n• Dabrafenib: Dabrafenib (Tafinlar, Novartis) is a pill used in combination with trametinib to treat BRAF V600E-positive metastatic melanoma. It works by blocking the BRAF enzyme, which in turn should slow the growth of cancer cells.\n• Trametinib: Trametinib (Mekinist, Novartis) is a pill used in combination with dabrafenib to treat BRAF V600E-positive metastatic melanoma. It works by blocking a protein-kinase enzyme that helps control cell growth and division.\n• Cobimetinib: Cobimetinib (Cotellic, Roche) is a pill used in combination with vemurafenib to treat BRAF V600-mutated melanoma. It works by blocking the MEK enzyme, which helps control cell growth and division.\n• Encorafenib: Encorafenib (Braftovi, Pfizer) is a pill used in combination with binimetinib to treat BRAF V600-mutated melanoma. It works by blocking the BRAF enzyme, which in turn should slow the growth of cancer cells.\n• Binimetinib: Binimetinib (Mektovi, Pfizer) is a pill used in combination with encorafenib to treat BRAF V600-mutated melanoma. It works by blocking two protein kinase enzymes that contribute to the unregulated growth of cancer."
  },
  {
    "id": 1292,
    "user_query": "Which are the coactivators of the Yes-associated protein (yap)?",
    "text-davinci-003_response": "The Yes-associated protein (YAP) is part of a complex signaling cascade that is involved in regulating multiple intracellular processes. YAP is a transcriptional co-activator that binds to TEAD family transcription factors, which in turn activate the expression of target genes, including those involved in cell proliferation, differentiation, migration, and invasion.\nYAP can be activated either directly, by phosphorylation, or indirectly through the action of co-activators. Common YAP co-activators include TEAD-interacting proteins (TIPs), which are transcriptional co-activators that interact with TEAD to modulate YAP activity. Other co-activators of YAP include TAZ (transcriptional co-activator with PDZ-binding motif), Hippo (a kinase/phosphatase complex), and WWTR1 (WW domain-containing transcription regulator 1). These co-activators all play important roles in regulating YAP activity and ultimately the expression of target genes."
  },
  {
    "id": 1296,
    "user_query": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?",
    "text-davinci-003_response": "Epithelial-mesenchymal transition (EMT) is a major feature of a wide range of developmental and pathological processes, including wound healing, fibrosis, and cancer. During this process, cell-cell adhesion is lost and cells acquire mesenchymal characteristics. A key mechanism of EMT is the reorganization of adhesion complexes. Several proteins play a role in this reorganization and the subsequent loss of cell-cell adhesion. \nCell adhesion is primarily mediated by the transcriptional regulators Snail, Slug, Twist, and Zeb. These proteins lead to the downregulation or suppression of the expression of several cell-cell adhesion proteins. These include the classic cadherins (E-, P-, N-, and H-cadherin) as well as related cell-cell adhesion molecules, such as desmoglein 1 and 2, occludin, claudins, integrins, and junctional adhesion molecules.\nIn addition, EMT involves the reorganization of the actin cytoskeleton. Proteins like β-catenin, myosin light chain 2 (MLC2), angiotensin II type 1 receptor (AT1R), and transforming growth factor β1 (TGFβ1), amongst others, are involved in this reorganization. \nTogether, the abovementioned proteins serve to disrupt cell-cell adhesion and facilitate the transition from an epithelial to a mesenchymal phenotype during EMT."
  },
  {
    "id": 1300,
    "user_query": "What is known about diseases associated with mutations in the CHCHD10 gene?",
    "text-davinci-003_response": "Mutations in the CHCHD10 (coiled-coil-helix-coiled-coil-helix domain containing 10) gene have been linked to a number of neurological and muscular diseases. Mutations in this gene can result in autosomal dominant spinocerebellar ataxia type 19 (also known as SCA19) and axonal Charcot-Marie-Tooth disease type 4J (CMT4J).\nSCA19 is a late-onset form of ataxia, characterized by muscle weakness, decreased coordination, abnormal gait, and muscle cramps. CMT4J is an inherited disorder involving axonal degeneration of the peripheral nervous system, resulting in impaired movement, poor balance, difficulty walking, abnormal reflexes, and muscle wasting.\nMutations in CHCHD10 have also been associated with Paget's Disease of Bone (PDB). PDB is a disorder of the skeletal system in which the normal life cycle of bone rebuilding and remodeling become distorted, resulting in an increased production of abnormal bone tissue. Symptoms commonly include bone pain and tenderness, fractures, fatigue, joint deformity, and hearing loss.\nAdditionally, mutations in CHCHD10 have been linked to Muscular dystrophy-dystroglycanopathy type B (MDDGB), also known as limb-girdle muscular dystrophy type 2I. MDDGB is an inherited neuromuscular disorder characterized by progressive muscle weakness and wasting. Common symptoms include difficulty walking, waddling gait, and frequent falls.\nFinally, mutations in CHCHD10 have been linked to mitochondrial encephalopathic leukoencephalopathy (MELAS). MELAS is a genetic disorder of the mitochondria, which are involved in energy metabolism, leading to neurological symptoms such as intellectual disability, seizures, recurrent headaches, hearing loss, visual disturbances, and stroke-like episodes."
  },
  {
    "id": 1304,
    "user_query": "List common features of Shapiro syndrome",
    "text-davinci-003_response": "Shapiro syndrome (also known as Alert Brittle Diabetes Syndrome or ABDS) is a rare condition characterized by recurrent episodes of diabetic ketoacidosis, hypoglycemia, and episodes of hypertriglyceridemia. It is caused by a mutation(s) in one of the genes involved in insulin production or insulin action. The following are common features of Shapiro Syndrome:\n1. Recurrent episodes of diabetic ketoacidosis: Shapiro Syndrome is associated with recurrent episodes of diabetic ketoacidosis (DKA). During episodes of DKA, the body breaks down fat into ketones which build up in the blood and urine. Symptoms of DKA include nausea, vomiting, stomach pain, fruity-smelling breath, and high levels of blood glucose. \n2. Hypoglycemia: Shapiro Syndrome is associated with episodes of hypoglycemia, or low blood sugar. Symptoms of hypoglycemia include confusion, lack of coordination, dizziness, headaches, and seizures. \n3. Hypertriglyceridemia: In addition to episodes of DKA and hypoglycemia, Shapiro Syndrome is associated with episodes of hypertriglyceridemia, or high levels of triglycerides in the blood. Hypertriglyceridemia is a risk factor for heart attack and stroke.\n4. Autoimmune disorder: Shapiro Syndrome is often associated with autoimmune disorders such as Hashimoto's thyroiditis or celiac disease.\n5. Genetic mutation: Shapiro Syndrome is caused by a mutation(s) in one of the genes involved in insulin production or insulin action. This genetic mutation is typically inherited from a parent."
  },
  {
    "id": 1309,
    "user_query": "What is the role of the histidine rich calcium binding protein (HRC) in cardiomyopathy?",
    "text-davinci-003_response": "The histidine rich calcium binding protein (HRC) has been identified as a key player in the pathogenesis of cardiomyopathy, a disease affecting the heart muscle that often leads to heart failure. HRC acts as “molecular scaffold” that binds to different proteins in the cell which then modifies their activities, leading to disruptions in calcium homeostasis and ultimately a decrease in the contractility of cardiomyocytes. HRC is also responsible for maintaining cytoskeletal integrity in the heart. In cardiomyopathy, mutations in HRC result in altered calcium handling, increases in reactive oxygen species, and altered cellular signaling leading to cardiac hypertrophy and in some cases, cardiomyocyte death. Furthermore, HRC has been shown to act as an inhibitor of autophagy, a cellular process that is important for regulating the amount of lipids in cardiomyocytes. Thus, HRC’s role in cardiomyopathy is multi-faceted, with its involvement in calcium homeostasis, reactive oxygen species formation, and autophagy all playing a critical role in the development and progression of the disease."
  },
  {
    "id": 1312,
    "user_query": "Which post-translational histone modifications are characteristic of facultative heterochromatin?",
    "text-davinci-003_response": "Facultative heterochromatin is a form of DNA packaging that occurs when histone proteins bind to sections of DNA and form a tight chromatin structure. In this condensed state, the DNA cannot be fully transcribed and is often associated with silenced gene expression. The characteristic post-translational histone modifications of facultative heterochromatin are methylation and acetylation of histones H3 and H4. This creates a highly condensed chromatin structure and can activate silencing of chromosomal elements. Specific modifications associated with facultative heterochromatin are H3K9me3, H3K27me3, H3K36me3, H4K20me2, and H4K20me3. Histone deacetylase activity is also associated with facultative heterochromatin, as it further condenses and silences portions of DNA."
  },
  {
    "id": 1313,
    "user_query": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?",
    "text-davinci-003_response": "Aicardi-Goutieres syndrome (AGS) is a rare disorder that affects the immune system and the nervous system. It is caused by mutations in certain genes. Mutations in the genes TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, IFIH1, and DDX41 have all been associated with AGS. TREX1 mutations are the most commonly seen in AGS patients and are believed to be responsible for up to 80% of cases. RNASEH2A, RNASEH2B, and RNASEH2C mutations make up the second most common type of genetic mutation seen in AGS patients. Mutations in SAMHD1, ADAR, IFIH1, and DDX41 are also found in some cases. All of these genes are related to the development of the immune system and play a role in how the body responds to viral and other infections. Mutations in these genes can cause the body to produce too much of certain types of proteins that lead to an overactive immune system and cause inflammation in the brain, leading to the signs and symptoms of AGS."
  },
  {
    "id": 1317,
    "user_query": "What is the mechanism of action of abiraterone?",
    "text-davinci-003_response": "Abiraterone is a steroidal CYP17A1 inhibitor that is used in the treatment of metastatic castrate-resistant prostate cancer (mCRPC). It acts by competitively inhibiting the activity of CYP17A1 enzyme in the prostate tissue and the tumor associated macrophages.\nCYP17A1 is an enzyme that is involved in the production of testosterone, a hormone that stimulates the growth of prostate cancer cells. Abiraterone inhibits the production of testosterone and other androgens, which leads to a decrease in the growth and metabolism of prostate cancer cells. By interfering with this hormone production, abiraterone decreases the proliferation of prostate cancer cells and reduces a patient’s pain and other symptoms of metastatic prostate cancer.\nAbiraterone also has an additional anti-tumor effect due to its ability to suppress the activity of tumor associated macrophage, an important component of the tumor microenvironment. The inhibition of macrophage activity has been shown to decrease the invasion and progression of metastatic prostate cancer.\nOverall, abiraterone acts on prostate tumors by inhibiting the production of testosterone and other androgens, as well as suppressing the activity of tumor associated macrophages, thereby decreasing the proliferation of prostate cancer cells and reducing a patient’s symptoms."
  },
  {
    "id": 1318,
    "user_query": "The protein neprilysin  has an positive effect on Alzheimer disease, how can it be delivered to the brain?",
    "text-davinci-003_response": "Neprilysin is an enzyme that can break down beta-amyloid, the chief component of amyloid plaques found in the brains of people with Alzheimer's disease. Delivering it to the brain could potentially slow down the progression of the disease.\nThe most common method of delivering neprilysin to the brain is via intravenous injection. A special form of the enzyme is synthesized and formulated, then injected directly into the bloodstream. From there, it is carried by the circulatory system to the brain, where it can be taken up by the neurons and used to break down beta-amyloid plaques. This form of delivery is safe and effective, and may be useful for treating mild to moderate stages of Alzheimer's and other neurodegenerative diseases.\nAnother method of delivery is via nasal spray. This delivery method is designed to deliver neprilysin to the brain more directly than intravenous injection. It is still experimental, but it has been shown to be safe and more effective than intravenous injection in some animal models.\nFinally, alternative delivery methods are being studied, such as the use of viruses and liposomes to deliver neprilysin to the brain. These methods are still experimental, but could potentially prove to be useful for treating Alzheimer's disease in the future."
  },
  {
    "id": 1320,
    "user_query": "Which disease is linked to mutations within BRAG1?",
    "text-davinci-003_response": "Mutations in the BRAG1 gene are linked to Costello syndrome, an extremely rare and congenital multisystem disorder which is associated with several key characteristics. The disorder is characterized by distinct craniofacial features such as facial anomalies including a wide mouth, thick lips, deep-set eyes, and heavy eyebrows. Other notable physical traits can include short neck, low-set ears, short stature, frequent ear and skin infections, widely spaced eyes, and papillomas (lumps under the skin). In terms of cognitive development, patients with Costello syndrome usually experience delay in gross and fine motor skills, as well as mental retardation. There is some variability in how symptoms manifest in individuals."
  },
  {
    "id": 1328,
    "user_query": "What is the effect induced by sympathetic nervous system on pupil size?",
    "text-davinci-003_response": "The sympathetic nervous system has a direct effect on pupil size. It causes the pupillary dilator muscle, which surrounds the pupil, to contract, resulting in the pupil widening and becoming larger. The sympathetic nervous system is activated when the body is under conditions of stress, fear, or excitement. This activation causes the release of neurotransmitters, such as norepinephrine, which trigger the contraction of the pupillary dilator muscle. Therefore, when the sympathetic nervous system is activated, the pupil size increases as a response. \nPupil dilation is a natural part of the fight-or-flight response. Under stress or fear, it helps the body to take in a larger amount of visual input in order to make decisions more quickly and enhance physical performance and reaction time. Pupillary dilation also occurs in response to certain events or stimuli, such as viewing something interesting, exciting, or arousing."
  },
  {
    "id": 1329,
    "user_query": "Is p100 the precursor protein molecule of the NF-kappaB transcription factor subunit p50?",
    "text-davinci-003_response": "No, p100 is not the precursor protein molecule of the NF-kappaB transcription factor subunit p50. While p100 is a component of the NF-kB transcription factor, p50 is actually the product of the cleavage of p100. In the canonical NF-kB pathway, p100 is phosphorylated by an IKK complex due to stimulation of a variety of receptors. This phosphorylation leads to proteasome-mediated cleavage of p100, resulting in the generation of two subunits, p50 and p52. p50 then dimerizes with either p50 or a p52 subunit to form an active NF-kB transcription factor complex. Hence, p100 is not the precursor molecule of p50, but rather the precursor to both p50 and p52."
  },
  {
    "id": 1331,
    "user_query": "Is there a difference in the rate between gene fusion and gene fission?",
    "text-davinci-003_response": "Yes, there is a difference in the rate at which gene fusion and gene fission occur. Gene fusion is slower and occurs at an order of magnitude lower rate than gene fission. This is largely due to the more complex structural rearrangements that must occur for gene fusion to take place. Gene fission, in contrast, occurs much more rapidly, because it involves simpler rearrangement of existing sequences in the genome. \nGene fusion is considered a major source of evolutionary innovation, as it can lead to the development of new gene products and biological pathways. Fission, on the other hand, often just results in variations of existing gene sequences and genomes, which is less useful for evolutionary innovation."
  },
  {
    "id": 1344,
    "user_query": "Which genes were found to be methylated in bladder cancer cells?",
    "text-davinci-003_response": "A 2010 study by Nishiyama et al. found that certain genes were consistently methylated in bladder cancer cells, including cyclin D2, PHF20, the putative TNXB and PMAIP1 genes, and the caspase-9 gene. Other genes found to be methylated in bladder cancer cells included IGF2, VEGF, RASSF1, NOTCH3, DAPK1, and SOX9. These genes were found to be hypermethylated in bladder cancer cells compared to normal urothelial cells. The researchers also found that genes involved in cell growth, apoptosis, and angiogenesis were particularly affected by epigenetic changes in bladder cancer cells."
  },
  {
    "id": 1348,
    "user_query": "What is the characteristic domain of histone methyltransferases?",
    "text-davinci-003_response": "The characteristic domain of histone methyltransferases is the SET domain (Su(var)3-9, Enhancer of zeste and Trithorax domain), which is a highly conserved protein domain responsible for substrate recognition and the catalytic activity of histone methyltransferase proteins. This domain is composed of approximately 120 amino acids and is found at the C-terminus of the histone methyltransferase proteins. The SET domain is responsible for methylation of the ε-amino group of lysines or arginines on histones, which in turn modifies chromatin structure and gene expression. The SET domain acts as a catalyst for the transfer of methyl groups from the cofactor S-adenosyl-L-methionine to the nitrogen atom of the lysine or arginine on the histone, resulting in methylated histones and modified chromatin structure."
  },
  {
    "id": 1350,
    "user_query": "Which are the bioinformatics tools for gene structure prediction?",
    "text-davinci-003_response": "1. Glimmer: Glimmer is a widely used tool for predicting gene structure from DNA sequence. It uses gene-finding algorithms to compare the query sequence to existing databases of known genes, and then uses probabilistic techniques to predict the boundaries of potential genes. Glimmer can be used to predict both protein-encoding and non-coding genes.\n2. GeneMark: GeneMark is a popular gene-finding program that is used to predict genes in prokaryotic and eukaryotic genomes. It uses Markov models to find potential protein-coding genes and discriminator models to distinguish them from non-coding RNA classes. It can also be used to predict potential regulatory regions.\n3. FragGeneScan: FragGeneScan is a tool used for gene structure prediction in microbial genomes. It uses a combination of Hidden Markov Models (HMMs) and gene-finding algorithms to accurately predict the boundaries and splice sites of potential genes. It is an effective choice for gene structure prediction in prokaryotic genomes.\n4. Augustus: Augustus is a powerful program for gene structure prediction in prokaryotic and eukaryotic genomes. It uses a combination of gene-finding algorithms and probabilistic models to accurately identify and annotate genes. Augustus can be used to predict both protein-coding and non-coding genes.\n5. GenScan: GenScan is a tool designed for gene prediction in eukaryotic genomes. It uses a combination of gene-finding algorithms and probabilistic models to accurately detect and annotate protein-coding genes, splice sites, and regulatory regions."
  },
  {
    "id": 1352,
    "user_query": "What is the correlation between SPARC expression and growth inhibition in human cancer?",
    "text-davinci-003_response": "The correlation between SPARC expression and growth inhibition in human cancer is not yet fully understood. However, some studies have demonstrated that an increase in SPARC (Secreted Protein Acidic and Rich in Cysteine) expression can correlate with a reduction of cancer growth and progression. Inhibition of SPARC expression can lead to a more aggressive tumor phenotype and a subsequent increase in tumor growth. SPARC has been found to be upregulated in many different types of cancer, including hematological malignancies such as lymphoma, multiple myeloma, and Hodgkin’s lymphoma, as well as solid tumors such as breast, prostate, and ovarian cancer.\nIn addition, increased expression of SPARC has been linked to cell cycle arrest in cancer cell lines, and can thereby inhibit tumor cell proliferation. SPARC has also been shown to be directly involved in the regulation of cancer cell adhesion to the basement membrane, apoptosis, invasion, and angiogenesis. Therefore, increased SPARC expression can be associated with decreased tumor growth and progression.\nIn summary, the current evidence indicates that the increased expression of SPARC in human cancer may correlate with decreased tumor growth and progression. Further research is required to elucidate the exact mechanisms that are involved."
  },
  {
    "id": 1353,
    "user_query": "Which syndrome is associated with mutations in the LYST gene?",
    "text-davinci-003_response": "The syndrome associated with mutations in the LYST gene is called Chediak–Higashi syndrome (CHS). CHS is an autosomal recessive disorder characterized by a combination of partial albinism, recurrent infections, neurological problems, and marrow defects. Common signs and symptoms of this condition include hypopigmentation (reduced skin and hair coloring), recurrent bacterial and viral infections, impaired wound healing, enlarged lymph nodes, abnormally large platelets, recurrent fever, and neurological symptoms such as seizures and dementia. In rare cases, some affected individuals may also develop kidney problems or neoplasms (a type of tumor). Mutations in the LYST gene have been found to cause CHS. This gene provides instructions for making a protein called lysozyme, which has roles in digestion, immune system activity, and protection from certain bacterial and viral infections. Mutations that interfere with lysozyme production result in the signs and symptoms of CHS."
  },
  {
    "id": 1354,
    "user_query": "Has the presence of delayed enhancement been documented in athletes performing strenuous exercise?",
    "text-davinci-003_response": "Yes, there is evidence that delayed enhancement can occur in athletes performing strenuous exercise. Delayed enhancement, also known as delayed contrast enhancement (DCE) or late enhancement, is a type of MRI enhancement in which an area of interest appears brighter than expected after a period of time has passed following the administration of a contrast agent. This type of contrast enhancement has been documented in athletes engaging in strenuous activities, such as running or weight lifting.\nA 2014 study published in Sports Health, which analyzed image scans of 22 elite middle-distance runners, found that one-third of the athletes showed delayed contrast enhancement within the heart muscle three days after strenuous exercise. It was believed that this delayed contrast enhancement was likely caused by an oxidative stress response to the strain of exercise, leading to temporary increases in inflammation.\nMore recently, a 2020 study published in the Journal of Clinical Imaging Science found that delayed contrast enhancement of varying degrees was present in the muscles of bodybuilders who participated in weight training sessions. It was determined that this delayed enhancement was likely the result of muscle damage, which suggests that it may be a sign of muscle injury or strain that can occur as a result of strenuous exercise.\nOverall, the presence of delayed contrast enhancement has been documented in athletes engaging in strenuous exercise, and it has been linked to temporary increases in inflammation and muscle damage. As such, researchers recommend that physicians and sports doctors be aware of potential signs of delayed contrast enhancement in athletes in order to identify and manage these conditions."
  },
  {
    "id": 1356,
    "user_query": "Name the factors required for selenoprotein synthesis in eukaryotes",
    "text-davinci-003_response": "?\nSelenoproteins are produced by eukaryotic organisms and require a specialized type of translation-dependent protein synthesis that involves the incorporation of the trace element, selenium, into proteins. To accomplish this, the following factors are required: \n1. A functional tRNA-sec (selenocysteine-specific transfer RNA). This complex enzyme tRNA serves as a molecular scaffold for the encoding of selenocysteine during translation.  \n2. A full genetic code: eukaryotic cells require the presence of a full genetic code (including the codon UGA) in order to be able to translate the appropriate sequence of nucleotides to produce a functional selenoprotein. \n3. Selenocysteyl-tRNA synthetase: this enzyme is responsible for the activation of selenocysteine/selenomethionine tRNA molecules in order to facilitate their incorporation into complex eukaryotic proteins. \n4. Selenophosphate synthetase: this enzyme catalyzes the formation of selenophosphate, a critical precursor of both selenocysteine and selenomethionine, which is necessary for selenoprotein synthesis.\n5. Selenophosphate reductase: this enzyme catalyzes the reduction of selenophosphate to selenide, which is necessary for protein translation. \n6. Selenoprotein synthesis factors: these are a group of proteins involved in targeting selenocysteine to the specific proteome of a eukaryotic organism."
  },
  {
    "id": 1359,
    "user_query": "What is the role of TRH in hypertension?",
    "text-davinci-003_response": "TRH (Thyrotropin-Releasing Hormone) is a hormone produced in the hypothalamus in the brain that plays an important role in the regulation of blood pressure and cardiovascular health. TRH stimulates both the release of the hormone thyroxine from the thyroid gland and the activity of the sympathetic nervous system (SNS). Both of these responses result in increased vascular resistance and increased cardiovascular reactivity. Therefore, although TRH does not directly affect blood pressure, it leads to an increase in vascular resistance and ultimately can contribute to the development of hypertension. \nAt the same time, TRH also inhibits the release of certain hormones that can reduce the activity of the SNS, such as oxytocin. This further contributes to the development of hypertension as the SNS remains active for too long, resulting in high blood pressure.\nThe role of TRH in hypertension is complex, as it can both contribute to the development of hypertension and potentially help to reduce it. If the levels of TRH are too low, then this can lead to decreased activity of the SNS and a reduction in blood pressure. Similarly, if levels of TRH are too high then this can lead to increased activity of the SNS and a rise in blood pressure. Therefore, it is important to keep the levels of TRH within a normal range in order to maintain healthy blood pressure."
  },
  {
    "id": 1360,
    "user_query": "Is triadin involved in cardiac function?",
    "text-davinci-003_response": "Yes, triadin is a protein involved in regulating calcium transport during cardiac muscle contraction. It is a protein involved in the calcium-calmodulin-dependent activation of the enzyme calcineurin, which is essential for excitation-contraction (EC) coupling in myocytes. Triadin binds to calmodulin and helps with the release of both intracellular and sarcoplasmic reticulum (SR) calcium for muscle contraction. Furthermore, triadin plays an important role in the regulation of cardiac excitation-contraction (EC) coupling, as it assists in the movement of calcium across the sarcolemma. It is also involved in regulating the rate of calcium cycling within the SR, which helps to control heart rate. Finally, triadin has been shown to play a role in determining calcium sensitivity of the contractile apparatus in cardiac and skeletal muscle."
  },
  {
    "id": 1362,
    "user_query": "Which protein is the main inhibitor of protein phosphatase 1 (PP1)?",
    "text-davinci-003_response": "The main inhibitor of protein phosphatase 1 (PP1) is the regulatory subunit G inhibitor protein, or more commonly known as glycogen-associated protein (GIP). GIP is a member of the regulatory family of phosphoprotein phosphatase inhibitors and this particular subfamily includes the GIPs, the glycogen deposit-associated protein (GRP) and the glycogen-binding protein (GBP). GIP binds to the catalytic subunits of PP1 and inhibits the enzyme's activity. It is essential for controlling the glycogen metabolism and the cellular regulation of phosphorylation pathways. GIP binds to the catalytic subunit of PP1 and inhibits its activity, leading to reduced phosphorylation of its target proteins. GIP is also responsible for recruiting PP1 to specific cellular locations, e.g. the actin cytoskeleton, thus contributing to the coordination of diverse cellular processes."
  },
  {
    "id": 1364,
    "user_query": "Which protein is required for Argonaute 2 recruitment to stress granules and P-bodies?",
    "text-davinci-003_response": "The protein that is required for Argonaute 2 (Ago2) recruitment to stress granules and P-bodies is a GTPase-activating protein (GAP) called Ago2‐Interacting 3’ helicase (AGO2I3H). AGO2I3H is a member of the UPF1 family of proteins, which have homology to the bacterial RecG family. This protein has been shown to be a key mediator of Ago2‐dependent gene silencing via its role in the assembly and activity of replication-dependent stress granules and cytoplasmic P-bodies."
  },
  {
    "id": 1365,
    "user_query": "Is Mammaprint approved by the United States Food and Drug Administration?",
    "text-davinci-003_response": "Mammaprint is not currently approved by the United States Food and Drug Administration (FDA). At this time, Mammaprint is considered “investigational” and is therefore not approved by the FDA for use in any clinical setting. Mammaprint is an experimental gene expression test developed to predict the risk of breast cancer recurrence and is only available through clinical trials in the U.S. It has been used in Europe since 2002, and is now available under specific rules for research purposes in Europe, Canada, and the United States. Currently, Mammaprint is in the process of further research and implementation as part of a larger drug development process. As such, it cannot be formally approved by the FDA."
  },
  {
    "id": 1368,
    "user_query": "Which pharmacogenetic test is available for abacavir?",
    "text-davinci-003_response": "The available pharmacogenetic tests for abacavir include both predictive and response-based tests. The predictive tests are typically run prior to initiation of the drug and involve testing for the presence of the HLA-B*5701 allele, which has been associated with an increased risk of hypersensitivity response to abacavir. The response-based tests are run either to confirm the results of a predictive test or after a patient has already started taking the drug, and these tests involve measuring the level of abacavir in the patient's blood sample as well as assessing the presence of abacavir-induced immunoglobulin E antibodies. Both types of tests can help in assessing a patient's individual risk of developing an adverse reaction to abacavir."
  },
  {
    "id": 1370,
    "user_query": "Are nucleosomes positioned at DNA replication origins?",
    "text-davinci-003_response": "Nucleosomes are the fundamental building blocks of chromatin that can be found throughout DNA in eukaryotic cells. Nucleosomes are composed of histone proteins and are generally positioned around a stretch of DNA. In some cases, they are found in tightly packed nucleosome arrays that can occupy long stretches of DNA.\nRegarding positioning at DNA replication origins, nucleosomes are known to play a role in controlling where replication is initiated and where it proceeds throughout the genome. While nucleosomes can be found in the vicinity of these replication origins, there is still a great deal of debate about exactly how they are positioned. Some studies suggest that they generally occupy the beginnings of replication origins and contours of the replication forks, while other research points to nucleosomes being found in the middle of the origins and at the fork itself.\nIn summary, while nucleosomes are known to affect DNA replication, their positioning relative to replication origins is still up for debate in terms of their exact positioning."
  },
  {
    "id": 1371,
    "user_query": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?",
    "text-davinci-003_response": "The most underrepresented oligonucleotides in higher eukaryote genomes are CpG dinucleotides and poly-A runs, or long stretches of consecutive ‘A’ nucleotides.  CpG dinucleotides are formed when cytosine is followed by guanine on the DNA strand. CpG dinucleotides are important for gene expression, as they often indicate the presence of a gene. However, CpG dinucleotides are generally underrepresented in higher eukaryote genomes. Poly-A runs are stretches of repeated A’s or Adenines that can affect the regulation of gene expression and the function of the mRNA molecule. Lower levels of these repeated A’s can limit the amount of potential regulatory sites in the UTRs (untranslated regions) within higher eukaryote genomes. Taken together, CpG dinucleotides and poly-A runs are the most underrepresented oligonucleotides in higher eukaryote genomes."
  },
  {
    "id": 1374,
    "user_query": "Which mechanisms underlie adaptive mutagenesis (stationary-phase mutagenesis) in Bacillus subtilis?",
    "text-davinci-003_response": "Adaptive mutagenesis (stationary-phase mutagenesis) in Bacillus subtilis is a type of mutagenesis that happens when the bacteria is exposed to stress during stationary phase. Adaptive mutagenesis has been proposed to provide bacterial cells with the options to adapt; allowing the bacteria to optimize the gene expression in view of the respective environmental conditions.\nAt the cellular level, a number of mechanisms underlying adaptive mutagenesis in Bacillus subtilis have been identified.\nThe first mechanism is associated with a specific gradient-sensing response regulator, which functions as a transcriptional activator. This is known as the “GutC” response, which is comprised of the gutC sensor kinase (GutR), the cognate response regulator (GutS) and the transcription factor GutC. GutC is activated by the GutR/GutS cascade, leading to the increased expression of various target genes involved in adaptation.\nThe second mechanism underlying adaptive mutagenesis in this species is the SOS response. SOS is an inducible repair system that increases mutation frequency in bacterial cells. Upon physiological stress, the SOS response is activated by inducing the expression of various deoxyribonucleotides that are necessary for repairing DNA damage. At the same time, these deoxyribonucleotides also reduce the efficiency of proof-reading during DNA replication, thereby increasing the mutation frequency.\nFinally, adaptive mutagenesis in Bacillus subtilis also involves the regulation of the activity of various proteins associated with the cell envelope and electron transport chain. These proteins are involved in maintaining the chemical gradient that is necessary for efficient electron transfer, and their activity is altered in response to stress to ensure the survival of the bacteria.\nIn summary, adaptive mutagenesis in Bacillus subtilis is enabled by several mechanisms that allow the bacteria to influence its gene expression in order to survive in its changing environment. These mechanisms involve the activation of the GutC response; induction of the SOS response; and alteration of the activity of cell wall and electron transport proteins."
  },
  {
    "id": 1375,
    "user_query": "What personality traits can be evaluated with the Ten Item Personality Inventory.",
    "text-davinci-003_response": "The Ten Item Personality Inventory (TIPI) is a psychometric tool designed to assess the Big Five personality traits. The Big Five model of personality is comprised of five different dimensions: Extraversion, Agreeableness, Conscientiousness, Neuroticism, and Openness to Experience.\nExtraversion corresponds to how outgoing and sociable a person is. Agreeableness reflects how kind and cooperative someone is. Conscientiousness is linked to a person’s ability to exhibit self-discipline, dependability, and responsibility. Neuroticism measures a person’s level of anxiety, moodiness, and overall emotional stability. Openness to Experience examines an individual’s creativity and open-mindedness to different ideas. \nThe TIPI evaluates these five dimensions in addition to related traits such as social dominance, emotions experienced, need for others’ approval, and desire for reward. It also measures how a person feels about himself, which can reflect self-esteem. Finally, the TIPI evaluates how a person seeks out new experiences and adventure."
  },
  {
    "id": 1376,
    "user_query": "Which are the enzymes involved in the control of tubulin acetylation?",
    "text-davinci-003_response": "The main enzyme involved in the control of tubulin acetylation is tubulin acetyltransferase (TAT). This enzyme is responsible for introducing acetyl groups into the alpha and beta tubulin subunits of microtubules, thus leading to an increase in the rate of assembly or the stabilization of the microtubules.\nOther enzymes involved in the control of tubulin acetylation include katanin, which is a microtubule severing enzyme capable of cleaving microtubules at predetermined positions, as well as HATs (histone acetyltransferases) which are responsible for acetylation of proteins. Additionally, there are several deacetylases, such as SIRT1, which serve to remove the acetyl groups and thus modulate the levels of tubulin acetylation."
  },
  {
    "id": 1378,
    "user_query": "List all approved indications for Glivec",
    "text-davinci-003_response": "(imatinib).\n1. Newly Diagnosed Philadelphia Chromosome Positive (Ph+ CML) adults in chronic phase: To treat adults with newly diagnosed Philadelphia chromosome-positive (Ph+ CML) chronic phase and reduce the probability of progression to accelerated phase or blast crisis.\n2. Previously Treated Philadelphia Chromosome Positive (Ph+ CML) adults in chronic phase: To treat adults with previously treated Philadelphia chromosome-positive (Ph+ CML) chronic phase and reduce the probability of progression to accelerated phase or blast crisis.\n3. Previously Treated Philadelphia Chromosome Positive (Ph+ CML) adults in accelerated phase or blast crisis: To treat adults with previously treated Philadelphia chromosome-positive (Ph+ CML) accelerated phase or blast crisis.\n4. Newly Diagnosed Adults with Hypereosinophilic Syndrome and/or Chronic Eosinophilic Leukaemia: To treat adults with hypereosinophilic syndrome and/or chronic eosinophilic leukaemia (CEL).\n5. Gastrointestinal Stromal Tumours: To treat adults with unresectable and/or metastatic gastrointestinal stromal tumours (GIST) which are not amenable to local therapy.\n6. Aggressive Systemic Mastocytosis (ASM) and/or Hypereosinophilic Syndrome Without Fusion (HES/FIP1L1-PDGFRα): To treat adults and children from two years of age with the following indications of aggressive systemic mastocytosis (ASM) or hypereosinophilic syndrome (HES) without fusion (FIP1L1-PDGFRα). \n7. Dermatofibrosarcoma Protuberans (DFSP): To treat adults and children from two years of age with recurrent and/or metastatic dermatofibrosarcoma protuberans (DFSP) which is not amenable to local therapy."
  },
  {
    "id": 1379,
    "user_query": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?",
    "text-davinci-003_response": "There are several proteins that can induce the inhibition of LINE-1 and Alu retrotransposition, such as SAM68, FUS, PTBP1, hnRNP K, and TDP-43. \nSAM68 (SRC-associated in mitosis 68 kDa) is a member of the SR family of splicing regulators and has been shown to bind both LINE-1 and Alu elements, leading to their repression. Specifically, SAM68 has been demonstrated to interact with the 3´ UTRs of both LINE-1 and Alu, resulting in inhibition of their transcriptional activity.\nFUS (Fused in Sarcoma) is an RNA-binding protein involved in a wide variety of processes, such as mRNA splicing, transport, translation, and stability. It has also been demonstrated to suppress retrotransposition of both LINE-1 and Alu elements.\nPTBP1 (polypyrimidine tract-binding protein 1) is a RNA-binding protein involved in alternative pre-mRNA splicing. It has also been demonstrated to interact with both LINE-1 and Alu elements, resulting in inhibition of their transcriptional activity.\nhnRNP K (heterogenous nuclear ribonucleoprotein K) is an RNA-binding protein that is involved in the regulation of mRNA stability, splicing, polyadenylation, and translation. It has also been demonstrated to repress LINE-1 retrotransposition. \nTDP-43 (TAR DNA binding protein 43) is an RNA-binding protein that is involved in alternative splicing, transcriptional regulation, and the stabilization of mRNA. It has also been demonstrated to suppress Alu retrotransposition."
  },
  {
    "id": 1382,
    "user_query": "Describe the usefulness of Macrostomum lignano in ion channel and stem cell research",
    "text-davinci-003_response": "Macrostomum lignano is a transparent species of free-living flatworm with a body size of about 2–3 mm long that is widely studied in human biology and neuroscience. It has become a model organism of choice for studies in ion channel and stem cell research due to its simple body structure, transparency, and ease of rear. With its simple nervous system, Macrostomum lignano is an ideal model for the study of neuronal ion channels as its neurons contain ion channels that are very similar to those found in humans.\nIn the field of stem cell research, Macrostomum lignano is used to study the development and behavior of stem cells, as well as their differentiation into specific cell types. These studies can provide valuable insights into the mechanisms underlying cell differentiation, gene expression, and tissue regeneration.\nIn addition, Macrostomum lignano is an ideal model for the study of embryonic and post-embryonic development, providing a powerful tool for the understanding of regenerative processes in higher organisms. Furthermore, its simple nervous system allows researchers to monitor the physiological effects of drugs on ion channel activity and neuronal development.\nThe utility of Macrostomum lignano as an inexpensive and easy to rear model for ion channel and stem cell research is unparalleled. It has become an invaluable tool for neuroscience and stem cell research that relies upon a simple biological system and offers clear insights into the development of cells and nerve cells."
  },
  {
    "id": 1384,
    "user_query": "Which drug is benserazide usually co-administered with?",
    "text-davinci-003_response": "Benserazide is usually co-administered with levodopa (L-dopa). Levodopa is a medication used to treat patients with Parkinson's disease. Benserazide helps to prolong the effect of levodopa by blocking its breakdown in the body. It can also help to decrease the amount of levodopa needed to achieve an optimum therapeutic response. Together, these medications provide an important treatment option for patients with Parkinson's disease."
  },
  {
    "id": 1387,
    "user_query": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?",
    "text-davinci-003_response": "1. KBPfinder: KBPfinder is a text mining tool designed to support the detection of protein-protein interactions and other biological relationships from textual sources. It uses natural language processing techniques to detect entities (proteins, genes, and other biomedical concepts) and to match them with query terms. The results are displayed in a graph-based format. KBPfinder is available as a web application.\n2. Textpresso: Textpresso is a comprehensive text-mining tool for extracting biomolecular information from scientific literature. It is equipped with an ontology of terms that are used to define relationships between terms, such as protein-protein interactions. Textpresso uses natural language processing (NLP) technology to identify and recognize biomedical entities from text. The output includes both the text snippets that contain the PPI and the identified entities.\n3. BioAmber: BioAmber is a proteomics tool designed to identify and extract protein-protein interactions from text. It works by searching through biological corpora for words and phrases associated with PPIs. BioAmber then applies natural language processing (NLP) techniques to extract and classify interactions. The output displays candidate PPIs and provides confidence scores for each prediction.\n4. Vebra: Vebra is a text-mining tool developed to extract protein-protein interactions from the literature. It uses natural language processing techniques to classify and extract data points associated with PPIs. Vebra's output includes a table of relationships and the confidence score of each relation.\n5. MINE: The Database for Interacting Proteins (MINT) provides an online searchable database of experimentally verified protein-protein interactions, which is generated by combining data from manually curated databases and molecular networks mined from the scientific literature. The MINE tool provides an easy-to-use web interface for searching this database using text-based queries. The output is a list of molecular network interactions, along with confidence ratings."
  },
  {
    "id": 1391,
    "user_query": "Can RNASeq be used for the analysis of nascent transcripts?",
    "text-davinci-003_response": "Yes, RNASeq (RNA sequencing) can be used for the analysis of nascent transcripts, which are transcripts that have been newly synthesized and are ready to be exported from the nucleus and translated into a functional protein. RNASeq can be used to detect and quantify the nascent transcripts, providing a comprehensive view of the transcriptome. Furthermore, since RNASeq is an in-depth technology, it can provide insight into the various isoforms of the nascent transcripts, which can give researchers novel insights into the gene expression profile. Additionally, it can also be used to quantify the transcripts from other forms of RNA (such as non-coding RNAs), providing a global picture of the transcriptome. Thus, RNASeq is a powerful tool for the study of nascent transcripts."
  },
  {
    "id": 1392,
    "user_query": "Do RNA:DNA hybrids preferentially form in high or low GC regions?",
    "text-davinci-003_response": "RNA:DNA hybrids, or R-loops, form when the single-stranded RNA found in the transcription process invades the double-stranded DNA. The RNA strand may then hybridize to the non-template strand of DNA, creating an R-loop structure.\nIn general, R-loops are believed to preferentially form in areas of higher GC content. The higher GC content within the DNA sequence creates rigid, more double-stranded regions that can more easily be invaded by the single-stranded RNA. RNA:DNA hybrids are easily stabilized when the interactions between the two strands are stronger, which can be achieved in regions with more GC base pairs. Furthermore, studies suggest that the higher the GC content of the DNA region, the higher the number of R-loop structures that are formed. The formation of R-loops increases with increased GC content until the GC content surpasses 70%. At this level, the same amount of R-loops are formed regardless of the GC content. \nOverall, RNA:DNA hybrids preferentially form in regions of higher GC content due to the improved stability the GC base pairs offer. This is due to increased hydrogen bonding opportunities and increased base stacking energy between the two strands."
  },
  {
    "id": 1397,
    "user_query": "Which drugs are included in TAS-102?",
    "text-davinci-003_response": "TAS-102 (trifluridine and tipiracil hydrochloride) is a combination of two active substances of the antineoplastic class of cytostatics (anti-cancer drugs). The main active substances in TAS-102 are Trifluridine and Tipiracil Hydrochloride. \nTrifluridine is an anti-cancer agent in the class of nucleoside metabolic inhibitors, meaning it blocks the metabolism of nucleic acids. Tipiracil Hydrochloride is also an anti-cancer agent in the same the nucleoside metabolic inhibitor class. Tipiracil hydrochloride inhibits the action of the enzyme thymidine phosphorylase, resulting in increased concentrations of active trifluridine in cancer cells, ultimately leading to cancer cell death."
  },
  {
    "id": 1399,
    "user_query": "What causes erucism?",
    "text-davinci-003_response": "Erucism is an allergic reaction to proteins found in the hairs of certain caterpillars, moths, and other insects. These proteins are known as urticating hairs, and can cause irritation if they come into contact with the skin or eyes. Symptoms of erucism include skin rashes, itching, and burning sensations. In more severe cases, a person may experience breathing problems, nausea, headaches, and fever. The severity of the reaction can also vary, ranging from mild to severe.\nThe primary cause of erucism is contact with the urticating hairs on the body of the insect. These hairs are usually found on the insect’s abdomen or legs and can be released from the hairs when the insect moves or when its body is touched. When a person comes into contact with these hairs, the body releases a mixture of chemicals, such as histamine, to fight off the allergen. This can lead to an allergic reaction in the form of erucism.\nIn addition to direct contact, people can also experience a reaction if they come into contact with the insect’s shed hairs, which can become airborne and be breathed in. This secondary form of erucism is referred to as airborne erupism. People can also experience a reaction after coming into contact with the feces or saliva of the insect, or by eating the food they have contaminated."
  },
  {
    "id": 1400,
    "user_query": "How does Hst5 (histatin 5) affect infections by Candida glabrata?",
    "text-davinci-003_response": "Histatin 5 (Hst5) is a small peptide that is produced by the human salivary glands and naturally present in saliva. It is a major component of the innate immune system's defense against oral pathogens such as Candida glabrata. Hst5 was shown to be fungicidal against C. glabrata as well as other species of candida, including C. albicans, C. tropicalis and C. parapsilosis. Studies showed that Hst5 binds to the cell membrane of C. glabrata, leading to increased potassium efflux and eventual disruption of the cell membrane integrity, allowing for the flux of essential molecules and destruction of the cell. In addition, Hst5 was found to be toxic to ergosterol, a sterol which is an essential component of cell membranes in Candida species. This sterol toxicity can lead to further leakage of metabolites and cell death. Studies have also shown that Hst5 can alter the adhesion capacity of C. glabrata to buccal epithelial cells in vitro, thereby attenuating the biofilm forming capacity of the fungus. In summary, Hst5 plays an important role in restricting the growth and spread of C. glabrata by acting on its cell membrane, altering its adhesion capacity, and eventually leading to cell death."
  },
  {
    "id": 1402,
    "user_query": "Are there Conserved Noncoding Elements (CNEs) in plant genomes?",
    "text-davinci-003_response": "Yes, there are Conserved Noncoding Elements (CNEs) in plant genomes. A CNE is a sequence of about 200-400 base-pairs in length that is usually found at the same location across a variety of species and is highly conserved in sequence. CNEs have been found in plant genomes, and are thought to provide regulation of gene expression. It is believed that CNEs are involved in processes such as the maintenance of spatial patterns of gene expression in plants and that transcription factors may bind to CNEs to regulate gene transcription. In addition, CNEs may have a role in forming chromatin structure, providing a structural basis for genome organization. Recent studies suggest that CNEs are involved in controlling gene expression in a time-limited manner, such as during development or in response to environmental cues. In summary, there is growing evidence that CNEs play an important role in gene expression in plants."
  },
  {
    "id": 1403,
    "user_query": "Which is the localization of the RIFIN family of proteins?",
    "text-davinci-003_response": "RIFIN proteins are located in the apicoplast, a non-photosynthetic organelle of apicomplexan parasites, including the causative agents of malaria and toxoplasmosis. These proteins interact with the endoplasmic reticulum (ER) membrane and appear to be concentrated in the outer membrane of the apicoplast. Additionally, some RIFIN proteins are known to shuttle between the apicoplast and other organelles, suggesting a role in molecular transport and signal transduction."
  },
  {
    "id": 1406,
    "user_query": "Is there any genetic determinant of hair pigmentation that could be useful in forensic analyses?",
    "text-davinci-003_response": "Yes, there is a genetic determinant of hair pigmentation that could be used in forensic analyses. It is based on the presence or absence of the gene that codes for the melanocyte stimulating hormone (MSH). The MSH gene is located on chromosome 18 and its presence is associated with the production of the enzyme tyrosinase. This enzyme is responsible for the conversion of the amino acid tyrosine into the pigment melanin, which is then used to produce different shades of hair colour according to the amount that is produced. In individuals with two copies of the gene, melanin is produced in higher quantities resulting in darker hair pigmentation.\nForensic scientists can use the knowledge of the gene to determine the exact makeup of the melanin in an individual's hair. This knowledge can then be used in comparison studies to match hairs from a crime scene with those of a suspect, as individuals with similar hair pigmentations have similar MSH gene patterns. In addition, a genetic profile of the suspect can be used to assess whether or not their hair pigmentation matches that of a trace piece of evidence."
  },
  {
    "id": 1408,
    "user_query": "Could Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) cause sudden cardiac death?",
    "text-davinci-003_response": "Yes, Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) could cause sudden cardiac death. CPVT is a genetic disorder in which the heart rate accelerates rapidly and erratically, often with exercise, stress, or excitement. This rapid heartbeat (tachycardia) can lead to serious and potentially life-threatening arrhythmias and cause sudden cardiac death.  Although the cause of sudden cardiac death in CPVT remains unclear, it is thought to be due to the development of ventricular tachycardia or ventricular fibrillation. Therefore, CPVT can cause cardiac arrest due to an abnormal heart rhythm which can cause the heart to stop beating. Therefore, the answer to the question is yes, CPVT can cause sudden cardiac death."
  },
  {
    "id": 1411,
    "user_query": "Is the ACE inhibitor indicated for lung cancer treatment?",
    "text-davinci-003_response": "No, ACE inhibitors are not indicated for the treatment of lung cancer. They are used to control high blood pressure and congestive heart failure, but not lung cancer. ACE inhibitors work by blocking the action of the enzyme angiotensin converting enzyme, which allows for the widening of blood vessels to reduce blood pressure."
  },
  {
    "id": 1413,
    "user_query": "What are the indications for hydrochlorothiazide?",
    "text-davinci-003_response": "Hydrochlorothiazide (HCTZ) is an oral diuretic medication that is most commonly used to treat high blood pressure, congestive heart failure, and edema (water retention). It is also sometimes used to treat calcium-containing kidney stones.\nThe main indication for HCTZ is to treat hypertension (high blood pressure) and the complications associated with it, including left ventricular hypertrophy (LVH), stroke, congestive heart failure, and early-stage renal impairment. Hydrochlorothiazide can also be used to treat other conditions such as edema, fluid retention, calcium-containing kidney stones, and premenstrual syndrome.\nIn addition, HCTZ can be used in combination with other medications to treat type 2 diabetes and reduce the risk of heart attack and stroke. HCTZ may also be used off-label to treat other conditions, such as polycystic ovary syndrome, primary hyperaldosteronism, and some types of glaucoma."
  },
  {
    "id": 1418,
    "user_query": "Which genes are thought to be involved in medulloblastoma development?",
    "text-davinci-003_response": "Medulloblastoma is a type of malignant brain cancer that most often affects children. Current research suggests that it is caused by a combination of genetic and environmental factors, and a number of genes have been associated with medulloblastoma development. Specific genetic mutations involved may include mutation or loss of the PTEN gene, alteration of the TP53 gene, mutation or rearrangement of the SMO gene, or amplification of the MYC gene. Other genes known to be involved in medulloblastoma development include BRAF, EGFR, PIK3CA and PTCH. However, further research is required to confirm the involvement of these genes in medulloblastoma development."
  },
  {
    "id": 1425,
    "user_query": "Which diseases can be treated with Afamelanotide?",
    "text-davinci-003_response": "Afamelanotide is a synthetic peptide derived from MSH (melanocyte stimulating hormone). It is currently under clinical investigation as a possible therapy for a variety of skin-related diseases. Some of the major therapeutic indications being explored for Afamelanotide include Solar Urticaria (SU), Erythropoietic Protoporphyria (EPP), actinic keratosis, and vitiligo. \nIn Solar Urticaria, Afamelanotide has been demonstrated to improve the patient's sensitivity to light exposure and reduce pain and skin irritation associated with SU. In Erythropoietic Protoporphyria, clinical studies have shown that Afamelanotide can reduce the painful skin reactions that occur in individuals with EPP when exposed to light. \nAfamelanotide has also been investigated as an alternative therapy for actinic keratosis, a precancerous skin condition caused by sun exposure. Studies have shown that Afamelanotide can improve the appearance of actinic keratosis and reduce the risk of the condition progressing to skin cancer. \nFinally, Afamelanotide has also been studied as a possible treatment for vitiligo, a condition characterized by patches of skin with no or very little pigment. Studies suggest that Afamelanotide can help to stimulate the production of melanin in the skin, resulting in darkened patches of skin over time."
  },
  {
    "id": 1429,
    "user_query": "Which is the main calcium binding protein of the sarcoplasmic reticulum?",
    "text-davinci-003_response": "The main calcium binding protein of the sarcoplasmic reticulum is calmodulin. This protein is responsible for controlling the levels of calcium within the sarcoplasmic reticulum and it binds directly to calcium ions to facilitate their release. In doing so, it plays a key role in the regulation of a variety of cellular processes such as muscle contraction and the metabolism of glucose. Calmodulin is activated when calcium binds to it, which then causes it to change its 3-dimensional shape. This structural change activates other proteins, thereby allowing them to function for calcium-regulated processes."
  },
  {
    "id": 1430,
    "user_query": "Is the UGT1A1*28 polymorphism associated with irinotecan response in Caucasians?",
    "text-davinci-003_response": "Yes, the UGT1A1*28 polymorphism has been associated with the response of irinotecan treatment in Caucasians. Studies have found that individuals with the UGT1A1*28 polymorphism are more likely to have an unfavorable response to irinotecan treatment, leading to earlier toxicity-related treatment termination. This effect has been seen in patients with colorectal cancer, pancreatic cancer, and breast cancer. Furthermore, individuals carrying the UGT1A1*28 polymorphism are at a higher risk of experiencing severe adverse events from irinotecan treatment such as severe neutropenia, nausea, vomiting, and diarrhea."
  },
  {
    "id": 1433,
    "user_query": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease.",
    "text-davinci-003_response": "1. Aducanumab (BIIB037): Aducanumab is a human monoclonal antibody developed by Biogen that targets aggregated forms of amyloid-beta. This antibody has been studied in several clinical trials and has been reported to reduce amyloid-β plaque. \n2. Solanezumab (LY2062430): Solanezumab is a humanized monoclonal antibody developed by Eli Lilly that targets monomeric forms of amyloid-beta. This antibody has been studied in several clinical trials and has been reported to slow cognitive decline in Alzheimer patients. \n3. Gantenerumab (RO548745): Gantenerumab is a humanized monoclonal antibody developed by Roche that targets monomeric and oligomeric forms of amyloid-beta. This antibody has been studied in multiple clinical trials, and has been reported to reduce amyloid-β plaque and astrocytic inflammation in patients with Alzheimer's disease. \n4. Bapineuzumab (AAB-001): Bapineuzumab is a humanized monoclonal antibody developed by Janssen that targets monomeric, oligomeric, and fibrillar forms of amyloid-beta. This antibody has been studied in multiple clinical trials and has been reported to reduce amyloid-β plaque in patients with Alzheimer's disease. \n5. Crenezumab (RO5221273): Crenezumab is a humanized monoclonal antibody developed by Genentech that targets aggregated and monomeric forms of amyloid-beta. This antibody has been studied in several clinical trials and has been reported to reduce amyloid-β plaque and improve cognitive function in patients with Alzheimer's disease."
  },
  {
    "id": 1434,
    "user_query": "Does MVIIA and MVIIC bind to the same calcium channel?",
    "text-davinci-003_response": "No, they do not. MVIIA and MVIIC bind to different calcium channels. MVIIA binds to the L-type calcium channel, while MVIIC binds to the R-type calcium channel. Both of these types of channels are found in the membrane of neurons, and they are involved in the regulation of electrical signals that move throughout the nervous system. While there are many similarities between the two types of channels, MVIIA and MVIIC have different binding sites and are therefore not interchangeable."
  },
  {
    "id": 1437,
    "user_query": "What is SHAPE-Seq?",
    "text-davinci-003_response": "SHAPE-Seq (Selective 2'-Hydroxyl Acylation followed by Primer Extension sequencing) is a high-throughput technique for measuring the formation of RNA secondary structures in a transcriptome. This method involves selectively modifying the 2' hydroxyl group of specific nucleotides in the RNA molecule with a chemical reagent. Upon hybridization of the modified RNA with a complementary RNA oligonucleotide primer, the modified 2' position will introduce a barrier to DNA polymerase extension, thereby providing a measure of the folding of the target RNA. The measurement of the folding can then be accomplished by analyzing the levels of primer extension products obtained from the SHAPE-Seq reaction. The SHAPE-Seq technique has been shown to be both highly sensitive and quantitative, providing a powerful tool for the identification and quantification of RNA secondary structures in a transcriptome."
  },
  {
    "id": 1446,
    "user_query": "Describe Heyde syndrome.",
    "text-davinci-003_response": "Heyde Syndrome (HS) is a rare and life-threatening condition characterized by gastrointestinal bleeding. It is a type of gastrointestinal telangiectasia, which is characterized by dilated and abnormal blood vessels in the walls of the gastrointestinal tract. People with HS typically experience recurrent episodes of gastrointestinal bleeding due to these abnormal vessels, although some may experience no symptoms at all.\nHS can affect any part of the gastrointestinal tract, typically the small intestine and colon, but it may also occur in the esophagus, stomach, and rectum. It is most commonly diagnosed in adults and is estimated to affect about 1 in every million people.\nThe cause of HS is not known, but it is believed to be inherited in some cases. In other cases, HS may be secondary to another condition or due to medications. Risk factors for HS include smoking, polycystic ovary syndrome, use of certain medications, and infection with Helicobacter pylori.\nThe main symptom of HS is recurrent episodes of abdominal pain, nausea, vomiting, and rectal bleeding. Other symptoms can include weight loss, anemia, fatigue, and weakness. Diagnosis of HS is made using endoscopy, which allows the doctor to look for dilated and abnormal blood vessels in the gastrointestinal tract.\nTreatment for HS may include medications to prevent bleeding, as well as lifestyle changes to reduce the risk of develooing the condition. Surgery may also be recommended in severe cases. Most people with HS can live a normal life with proper treatment and follow-up."
  },
  {
    "id": 1447,
    "user_query": "Has silicon been used in treatment of  incontinence ?",
    "text-davinci-003_response": "Yes, silicon has been used in the treatment of incontinence. It is most often used in the form of silicone implants, which are placed surgically below the skin to provide support for weakened or overactive pelvic floor muscles that can be a cause of incontinence. These implants are designed to provide support to the muscles, helping them to remain strong and to properly control the urinary and bowel sphincter muscles, reducing episodes of incontinence. Additionally, silicone can be used in the form of a contoured device that is applied to the perineum via a special adhesive patch. This device helps to create a cushion around the area, providing physical support which helps the muscles to function properly and prevents incontinence. In some cases, silicone gels and sheets are applied to the perineum as well, although this is less common than the use of implants or contoured devices."
  },
  {
    "id": 1448,
    "user_query": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?",
    "text-davinci-003_response": "The GO (8-oxo-G) system in Pseudomonas putida consists of four proteins: DNA glycosylase (GlycN), apurinic/apyrimidinic endonuclease (APE), DNA polymerase I (pol I), and alkB.\nGlycN is a DNA glycosylase that targets 8-oxo-G in DNA and excises it, thereby resulting in a single strand break.\nAPE is an endonuclease that recognizes and repairs DNA damage resulting from a single strand break in the DNA. It can repair 8-oxo purines, as well as other oxidative lesions.\nPol I is a DNA polymerase that can copy the damaged DNA strand at the site of the single strand break, and its 3'-PRoX activity allows it to directly modify the modified bases of 8-oxo-G.\nFinally, alkB is a DNA repair protein that is believed to enhance the ability of Pol I to modify 8-oxo-G. It is thought to bind to the site of damage and promote the repair process."
  },
  {
    "id": 1449,
    "user_query": "List five applications of machine learning algorithms in medical diagnosis.",
    "text-davinci-003_response": "1. Diagnosis of Diseases: Machine learning algorithms can be used to identify specific diseases through analyzing patient data such as medical images, doctor notes, lab tests, etc. Machine learning algorithms can be used to create supervised and unsupervised models that can accurately predict the disease based on the input data.\n2. Patient Monitoring: Machine learning algorithms can also be used to monitor patient vitals, such as heart rate and blood pressure, and alert doctors when abnormalities occur. This can help doctors to detect potential issues early and take immediate action if necessary.\n3. Prescription Recommendation: Machine learning algorithms can be used to recommend proper medication based on patient characteristics and medical history. This can help doctors to make quicker and more informed decisions about how to best treat a particular patient.\n4. Patient Care Automation: Machine learning algorithms can automate many of the tasks that are associated with patient care, such as making appointments, answering questions about medications and treatments, and providing educational information about medical conditions. Automating these tasks can help free up medical staff so they can spend more time providing one-on-one care.\n5. Disease Predict: Machine learning algorithms can be used to predict the potential development of a disease in a patient based on risk factors such as lifestyle, environmental factors, and genetic information. This can help doctors to better target preventive care to those that are most likely to develop a certain disease."
  },
  {
    "id": 1450,
    "user_query": "Does the 3D structure of  the genome remain stable during cell differentiation?",
    "text-davinci-003_response": "The short answer is no, the 3D structure of the genome does not remain stable during cell differentiation. The 3D structure of a cell’s genome changes as it moves through its life cycle. At different stages of development, the 3D configuration will be different. Different cell types have distinct 3D structures in their genomes, called chromatin architecture. \nThis is due to the fact that cell differentiation is closely associated with epigenetic modifications, which involve changes at the molecular level and are heritable. During cellular differentiation, DNA methylation, histone modification, non-coding RNA expression, and other epigenetic modifications affect the 3D structure of the genome. This plays an important role in gene expression regulatory mechanisms on a group of cells.\nThese epigenetic modifications can be stable or dynamic and contribute to the maintenance of distinct chromatin structures and transcriptional programs, and thereby influence the development and the differentiation program of a given cell type. Differentiation of somatic stem cells into cells of a specific lineages, for example, is associated with changes in the 3D structure of the genome. This ensures that gene expression is properly regulated and maintained in order to acquire a more specialized set of cell functions.\nIn summary, the 3D structure of the genome does not remain stable during cell differentiation. Instead, epigenetic modifications play an important role in forming distinct chromatin architecture and regulating appropriate gene expression in each cell type as its develops and matures."
  },
  {
    "id": 1453,
    "user_query": "What is 2d 4d ratio in athletes.",
    "text-davinci-003_response": "The 2D:4D ratio, or second-to-fourth digit ratio, is the ratio of the length of the index finger relative to the length of the ring finger. Studies have suggested a correlation between this digit ratio and physical fitness in athletes.\nPrevious research has indicated that athletes tend to have a lower 2D:4D ratio compared to non-athletes, meaning that their index finger is typically shorter than their ring finger. This has been associated with higher levels of testosterone, which promotes muscle growth and physical performance.\nIn terms of gender, the difference between 2D:4D ratios appears to be more pronounced in males than in females. Male athletes tend to have significantly lower ratios compared to non-athletes, while female athletes tend to have only slightly lower ratios.\nUltimately, the 2D:4D ratio appears to be linked with fitness levels in athletes. While there are still questions that remain to be answered, this ratio could be used as an indicator of physical performance in the future."
  },
  {
    "id": 1454,
    "user_query": "What is the association between moon cycle and rupture risk of intracranial aneurysms?",
    "text-davinci-003_response": "The association between moon cycle and ruptured intracranial aneurysms is still not well understood. Over the years, numerous studies have investigated the matter and the results have been inconclusive. It has been suggested that the changing gravitational pull of the moon could influence the mechanical forces on a hard artery wall that can lead to breakage or rupture of an intracranial aneurysm. Aneurysms are weaker parts of a blood vessel wall which are more prone to breaking and bursting so the idea that moon phases could possibly lead to an increase in aneurysm rupture risk has been explored and studied. \nOne study suggested that the risk of rupture of intracranial aneurysms is lower during a full moon. The study correlated meteorological, gravitational and demographic variables but found no relationship to aneurysm rupture risk. \nOther studies have tended to find no correlation between the moon phases and aneurysm rupture. In a large study of over 5000 symptomatic intracranial aneurysms, the researchers found that the peak of the monthly lunar cycle rarely falls within the time window for ruptures. This could mean that either the links between moon cycles and intracranial aneurysm ruptures are insignificant or else that they are too weak to be observed. \nOverall, the evidence currently does not show a definitive association between moon cycle and intracranial aneurysm rupture risk and further research is necessary to clarify the matter."
  },
  {
    "id": 1461,
    "user_query": "List functional roles of the FtsZ protein.",
    "text-davinci-003_response": "1. FtsZ acts as a molecular scaffold for the assembly of a division machinery. It is responsible for separating the separating the parents’ protoplasts during cytokinesis.\n2. FtsZ organizes the formation of a cytokinetic contractile ring or Z-ring. This structure functions as a scaffold upon which the remaining division machinery is organized.\n3. FtsZ also contributes to the local accumulation of components for the early stages of cell division. In gram-positive bacteria, FtsZ assembles at an invagination from the membrane called the divisome, a site that brings together critical cytokinetic proteins in order to help facilitate the division of the two daughter cells.\n4. FtsZ contributes to the construction of the septum (or division wall) by acting as a tether proteins which recruit proteins for septum formation during cytokinesis.\n5. FtsZ is a major component of the Min system, which is involved in controlling bacterial cell shape and size. FtsZ is required for the localization and production of Min proteins along the cell membrane.\n6. FtsZ has been identified as an important virulence factor as it is necessary for bacterial movement and host colonization."
  },
  {
    "id": 1463,
    "user_query": "Is there any evidence of dysregulated long non coding RNAs and Alzheimer's disease?",
    "text-davinci-003_response": "Yes, there is evidence to suggest that dysregulated long non coding RNAs (lncRNAs) may be associated with Alzheimer's disease (AD). Studies have identified potential roles for lncRNAs in AD, including regulation of gene expression, neuroprotective effects, and regulation of amyloid-beta (Aβ) production. For example, increased expression of lncRNAs TUG1 and ANRIL have been associated with increased expression of genes involved in Aβ production, and upregulation of lncRNA LINC01116 has been linked to the development of genes involved in AD. LncRNAs have also been shown to modulate the expression of genes associated with AD-related oxidative stress, inflammation, and apoptosis, as well as promote the transcription of neuronal survival genes. In addition to these effects, lncRNAs have also been suggested to be involved in the regulation of amyloid precursor protein (APP) processing and autophagy, pathways closely linked to the pathogenesis of AD. Taken together, these results suggest that dysregulation of lncRNAs may be associated with AD pathogenesis and may offer potential therapeutic targets for the prevention of AD."
  },
  {
    "id": 1469,
    "user_query": "What is known about type D personality trait in cancer patients?",
    "text-davinci-003_response": "Type D personality is characterized by a tendency to experience negative affect, high levels of social inhibition, and low levels of optimism and social support. Research has shown that the Type D personality trait is associated with increased risk of depression, anxiety, and stress in the general population.\nWhen considering type D personality traits in cancer patients, research has indicated that this personality type is linked to higher levels of distress, lower quality of life, and poorer psychological well-being in cancer patients. There is also evidence to suggest that patients with a type D personality display more physical problems related to the cancer, are more likely to report health-related distress, and may experience greater fatigue following treatment. In addition, a type D personality trait has been linked to increased risk of depression and anxiety in breast cancer patients. Furthermore, some research suggests that a type D personality is associated with worse psychological and physical outcomes in cancer patients over the long term. Overall, the research indicates that the Type D personality likely carries greater risk of distress and poorer medical outcomes in cancer patients."
  },
  {
    "id": 1471,
    "user_query": "Which species may be used for the biotechnological production of itaconic acid?",
    "text-davinci-003_response": "Bioengineers can use two microbial species for biotechnological production of itaconic acid – Aspergillus terreus and Candida italica. A. terreus is a filamentous fungus that has been used in industrial biotechnology due to its robust growth and capability to secrete itaconic acid at high concentrations. C. italica is a yeast species that is capable of unusually high levels of itaconic acid production. Both species have been used successfully for biotechnological production of itaconic acid through the co-fermentation of simple and inexpensive fermentable substrates such as glucose, sucrose, and glycerol."
  },
  {
    "id": 1474,
    "user_query": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?",
    "text-davinci-003_response": "In bacteria, proteins that make up the methyl-directed mismatch repair system (MMR) are best classified into four categories: mismatch recognition proteins, mismatch-specific helicases, methyl-directed DNA methyltransferases, and helicase-loading proteins.\nMismatch recognition proteins, also known as “MutS” proteins, are responsible for recognizing and binding to mismatched bases. In most species of bacteria, there are two kinds of MutS proteins: MutSα and MutL. MutSα is responsible for binding to single-nucleotide mismatches, while MutL binds to double-nucleotide mismatches.\nMismatch-specific helicases, also known as MutH, are enzymes that recognize the mismatch and separate the two newly-synthesized strands of DNA. MutH is then able to nick the strand that contains the newly-synthesized uracil.\nMethyl-directed DNA methyltransferases are enzymes that add a methyl group to the unmethylated strand of DNA. This methylation prevents the new strand from being replicated, thus ensuring that the original strand is preserved.\nFinally, helicase-loading proteins, also known as MutLγ, are responsible for loading the mismatch-specific helicase onto the DNA. Once MutH is loaded, it is able to cleave the mismatched strand of DNA."
  },
  {
    "id": 1476,
    "user_query": "Which is the vector of Louping ill virus?",
    "text-davinci-003_response": "The vector of Louping ill virus is the tick. This is a arthropod-borne virus that is found in wild and domestic sheep in many parts of the world. The main vector of the virus is the sheep tick (Ixodes ricinus) and it is also found in other species of ticks, including Ixodes scapularis and Ixodes persulcatus. The virus is transmitted when the tick feeds on the blood of an infected sheep and then bites a susceptible animal, typically another sheep. It can also be transmitted between sheep indirectly via contaminated fomites such as shearing instruments, feeding troughs, clothing, and handling of infected sheep."
  },
  {
    "id": 1477,
    "user_query": "Does HuR protein regulate the splicing process?",
    "text-davinci-003_response": "HuR protein does appear to play a role in the regulation of the splicing process. HuR is a member of the Hu protein family, which all have roles in alternative pre-mRNA splicing. Studies have suggested that HuR stimulates the selection of downstream splice sites and stimulates the enzymatic remodeling of spliceosomes to efficiently assemble, leading to splicing of pre-mRNA. \nMore specifically, HuR has two arms that interact with the spliceosome: one binds directly to the selected downstream 3' splice site, and the other to the branch point, or BPS. As HuR approaches the splicing complex, it helps to recruit the U2AF65, a key splicing factor, to the branch point region of the pre-mRNA sequence. This helps to prevent the formation of incorrect lariat structures and ensure that splicing occurs at the correct sites. \nAdditionally, HuR has been shown to have a role in splice site selection by interacting with polypyrimidine-tract-binding-protein (PTB), a protein that binds to intronic sequences that flank splice sites and recruits other splicing factors. HuR appears to bind to PTB and sequester it away from the required splice sites, aiding in the selection of alternative splicing sites. \nOverall, HuR is believed to play a vital role in the formation and shaping of the splicing complex, helping to selectively assemble the correct components for efficient processing, and ultimately to guide the selection of the proper splice sites and ensure correct splicing occurs."
  },
  {
    "id": 1478,
    "user_query": "Is Titin the largest single protein molecule found in Nature?",
    "text-davinci-003_response": "No, Titin is not the largest single protein molecule found in Nature. Titin is a protein found in the cytoskeleton of muscle cells, that helps give muscles their mechanical properties. It is the largest known single protein molecule, with a length of about 34,350 amino acids. However, Titin is not the largest single protein molecule found in Nature. The protein Ribonuclease A (RNase A), which is involved in the digestion of dietary RNA, has been found to have approximately 54,000 amino acids, making it marginally larger than Titin. Additionally, the protein Thaumatin, which is involved in taste perception, has been found to have around 55,000 amino acids and is thus the largest known single protein molecule found in Nature."
  },
  {
    "id": 1481,
    "user_query": "What is the the Menzerath-Altmann law?",
    "text-davinci-003_response": "The Menzerath-Altmann law of language structure is a law of language structure that states the negative correlation between the degree of linguistic complexity and the length of linguistic units. It states that the larger the unit of language, the simpler it is. This principle was proposed by linguists Paul Menzerath and Gertraud Altmann in 1954.\nThe law applies to all levels of language, from words to utterances. It states that a language with large and complex structural units (e.g. longer words) will have shorter, simpler sentences. For example, a language with long words might contain shorter sentences with fewer clauses and simple sentence structures. This law is generally seen as an application of Gestalt psychological principles which states that large and complex objects are broken down into separate parts.\nThe Menzerath–Altmann law also assumes that all languages have evolved into a common form through a common evolutionary process, which is why it is applicable to all languages. Thus, it provides evidence for linguistic universals. Studies have found that the law is applicable to some degree in the majority of the world's languages, suggesting that it may indeed be a universal grammar rule."
  },
  {
    "id": 1482,
    "user_query": "Which receptor(s) recognize lysosomal hydrolases in trans-Golgi network (TGN)?",
    "text-davinci-003_response": "The receptors that recognize lysosomal hydrolases in the trans-Golgi network (TGN) are mannose 6-phosphate and cation-dependent mannose 6-phosphate receptors (M6PR, also known as MPR). These lysosomal hydrolases include proteases, lipases, phosphatases, esterases and glycosidases. They play a vital role in the intracellular trafficking and sorting of lysosomal proteins.\nM6PRs possess a binding site for lysosomal hydrolases and serve as cargo transporters for lysosomal proteins, as well as other macromolecules, moving them through the TGN to their correct destinations. They recognize a motif on the lysosomal proteins called the mannose 6-phosphate (M6P) recognition motif. The M6PR then binds to the motif and triggers recognition and transport of the lysosomal proteins. Once bound by the M6PR, the cargo protein and the M6PR complex moves through the TGN and is finally released in the appropriate lysosomal compartment."
  },
  {
    "id": 1492,
    "user_query": "Describe the known functions for the prothymosin alpha c-terminal peptide?",
    "text-davinci-003_response": "Prothymosin alpha c-terminal peptide (ProTα CT) is a conserved, naturally occurring peptide found in the cytoplasm and nucleus of many different types of cells and organisms. ProTα CT is a small peptide (18-26 amino acid residues in length) derived from the C-terminal end of human prothymosin alpha. Studies have shown that this peptide plays an important role in diverse cellular processes including cell differentiation, gene expression, cell death, and protein folding.\nStudies have shown that ProTα CT has several functions within the cell. It is believed to act as a transcription factor involved in the regulation of gene expression, playing a role in cell differentiation and in the growth and development of cells. In addition, ProTα CT is thought to be involved in the activation of certain apoptotic pathways, in the regulation of cell cycle progression, and in the folding and stabilization of proteins. It has also been demonstrated to have a role in nuclear import, in the regulation of stress responses, and in the organization of chromatin. Finally, ProTα CT has been suggested to have a role in the development of certain diseases such as cancer through epigenetic regulation of gene expression."
  },
  {
    "id": 1494,
    "user_query": "What is the role of the Ada O6-alkylguanine alkyltransferase in bacteria?",
    "text-davinci-003_response": "Ada O6-alkylguanine alkyltransferase (also known Adar or AGT) is an enzyme found in bacteria that plays an important role in DNA repair. The enzyme catalyzes the transfer of an alkyl group from an O6-alkylguanine to an acceptor molecule. This process helps to prevent mutations in bacterial DNA caused by alkylation damage that can be caused by environmental stressors such as UV light, radiation and certain chemicals. Adar prevents the accumulation of alkyl-adenine and alkyl-cytosine residues in DNA, which can lead to mutations if left unchecked. Additionally, Adar helps bacteria maintain their proper genomic structure – thus helping them adapt to certain environmental conditions."
  },
  {
    "id": 1503,
    "user_query": "Which is the clinical meaning of the presence of delayed enhancement in patients with hypertrophic cardiomyopathy?",
    "text-davinci-003_response": "Delayed enhancement is an important sign of hypertrophic cardiomyopathy, which is a condition in which the walls of the heart become abnormally thickened. The presence of delayed enhancement indicates that the heart is not functioning properly and that the patient is at risk of developing serious cardiac complications, such as heart failure or stroke. Delayed enhancement also implies that the patient may have increased fibrosis of the heart muscle, which can further compromise cardiac function. Overall, delayed enhancement is a serious sign of hypertrophic cardiomyopathy that can indicate the need for more extensive diagnostic testing, as well as appropriate management and follow-up care."
  },
  {
    "id": 1509,
    "user_query": "Alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers?",
    "text-davinci-003_response": "Alpha-spectrin and beta-spectrin subunits form HETEROPARAMERIC dimers, which are bundles of two or more individual molecules that are arranged in parallel. In the case of alpha-spectrin and beta-spectrin, the two subunits form parallel dimers, meaning that the two monomers are positioned side-by-side with their polarities pointing in the same direction. These parallel heterodimers are connected by oxygen bridges or disulfide bonds and are stabilized by electrostatic and hydrophobic interactions. The arrangement of the two spectrin subunits is essential to the structure and function of the spectrin molecules as a whole."
  },
  {
    "id": 1510,
    "user_query": "Is gastro esophageal reflux related to burning mouth syndrome?",
    "text-davinci-003_response": "Gastroesophageal reflux (GER) is related to burning mouth syndrome (BMS). GER is the backward movement of stomach acid or bile into the esophagus, causing a sour or acidic taste in the mouth, burping, or pain in the chest or throat. Gastroesophageal reflux can also cause burning sensations in the mouth. Burning mouth syndrome is a chronic (long-term) condition characterized by a burning sensation in the mucous membranes of the mouth and throat. It may be accompanied by a metallic, salty, bitter, or sour taste.\nThe link between GER and BMS is seen in the fact that several studies have found that symptoms of GER, such as increased salivary acidity and pH, were associated with an increased prevalence of BMS. Additionally, in those with GER, acid-suppression therapy with proton-pump inhibitors was shown to improve symptoms of BMS. It is thought that GER-induced alterations in oral microenvironment induce or exacerbate burning mouth symptoms. Thus, it appears that GER and BMS are related, and GER may play a role in the synthesis of BMS."
  },
  {
    "id": 1511,
    "user_query": "Which is the protein (antigen) targeted by anti-Vel antibodies in the Vel blood group?",
    "text-davinci-003_response": "The protein (antigen) targeted by anti-Vel antibodies in the Vel blood group is Tn antigen (or, more technically, triglycosylated polyagglutinable N-acetylgalactosamine or TnGalNAc). This antigen is located on the surface of erythrocytes, and is essentially a sugar molecule (triglycosylated N-acetylgalactosamine) that is attached to carbohydrate structures on the red blood cell. This antigen is believed to be the cause of the antibodies present in the Vel blood group, and as such can be detected with a variety of immunoassay techniques."
  },
  {
    "id": 1516,
    "user_query": "Which peptide plays a pivotal role in human cystatin C fibrillization?",
    "text-davinci-003_response": "The peptide that plays a pivotal role in human cystatin C fibrillization is known as amino acid 128-132, which is a motif at the domain-swapping interface of human cystatin C. This peptide is important for fibrillization because it is critical for forming the dimerization isomer of cystatin C, which is a key step in the fibrillization process. The specific amino acids that make up this motif are Asn-Gly-Gly-Ser-Lys (128-132). The importance of this motif has been demonstrated in other studies, which have shown that mutation of this motif can significantly reduce the propensity of cystatin C for fibrillization."
  },
  {
    "id": 1518,
    "user_query": "What is the use of MammaPrint and Oncotype DX?",
    "text-davinci-003_response": "MammaPrint and Oncotype DX are commercial genomic tests used to aid in the decision-making process of breast cancer treatment. The tests are based on the analysis of gene expression of samples of breast tumor tissue. Both tests are designed to help oncologists make informed decisions when it comes to the risk of the cancer recurring after treatment and the likelihood of chemotherapy being beneficial.\nMammaPrint looks at 70-gene profiles to calculate the risk of recurrence within the first 5 years of diagnosis, while Oncotype DX looks at 21 genes and predicts recurrence within 10 years. Oncotype DX also takes into account other factors such as hormone status, age, and tumor size. \nTogether, these tests provide clinicians with a more comprehensive analysis of a patient’s cancer. This helps clinicians to make more informed decisions about the most suitable treatment plan for a particular patient – in some cases chemotherapy may be recommended for a low-risk patient, and in other cases may be avoided for high-risk patients who can receive more targeted treatments."
  },
  {
    "id": 1520,
    "user_query": "Is there any data to suggest that TRH (thyrotropin releasing hormone) administration can improve symptom severity of amyotrophic lateral sclerosis patients?",
    "text-davinci-003_response": "At this time, there is no conclusive data to suggest that TRH administration can improve symptom severity of amyotrophic lateral sclerosis (ALS) patients. While some studies have suggested potential benefits of TRH treatment for ALS patients, particularly in the areas of motor function and cognitive performance, these studies have been limited in size and scope and more research is needed to confirm any potential benefits. \nThe most recent study published on this topic was conducted in 2020 and looked at whether TRH administration could improve cognition and motor functioning in ALS patients over a 4-month period. The study enrolled six ALS patients who received TRH injections over 4 months. The results showed no significant improvement in cognitive functioning but a small improvement in some motor functions, including muscle strength. However, given the small size of the study and the lack of long-term follow-up data, it is not possible to conclude that TRH administration can improve symptom severity of ALS patients. \nIn summary, there is currently no data to definitively suggest that TRH administration can improve symptom severity of ALS patients. Further research is needed in order to provide more conclusive evidence."
  },
  {
    "id": 1524,
    "user_query": "What is the gold standard treatment for Iatrogenic male incontinence?",
    "text-davinci-003_response": "The gold standard treatment for iatrogenic male incontinence depends on the cause and type of incontinence. Treatment typically begins with behavioral measures including exercise, bladder training, and retaining strategies. In some cases, pharmacotherapy or pelvic floor muscle exercises can also be beneficial.\nIn cases of stress incontinence, the gold standard treatment is the behavior or surgery. Common behavioral strategies include bladder retraining, Kegel exercises, and electrical stimulation. If these methods are ineffective, the most commonly recommended surgery is the tension-free vaginal tape (TVT) procedure.\nFor urge incontinence, anticholinergic medications are the gold standard treatment. These medications help to reduce bladder spasms and can improve bladder control. If these medications are insufficient, then sacral nerve stimulation (SNS) or bladder augmentation may be recommended.\nIn some cases of overflow or mixed incontinence, sacral nerve stimulation or a urinary catheter can be helpful. If the effects of these treatments are not sufficient, surgery to reduce bladder size or urinary diversion may be necessary.\nThe choice of treatment for iatrogenic male incontinence will depend on the underlying cause of the incontinence and the patient’s overall health and preference. It is important to work closely with your healthcare provider to explore all of the options and find the best treatment for your individual situation."
  },
  {
    "id": 1525,
    "user_query": "Which is the main CHEK2 genetic variant, thought to be involved in familial breast cancer?",
    "text-davinci-003_response": "The main CHEK2 genetic variant, thought to be involved in familial breast cancer, is the 1100delC variant (also known as p.Ile357Thrfs*17), which is found most commonly in individuals of Nordic and Eastern European descent and is found less frequently in people of African and Asian descent. The 1100delC variant is a splice-site frameshift mutation in exon 10 of the CHEK2 gene which results in the production of a truncated protein. This truncated protein has been associated with an increased risk of hereditary breast cancer in individuals carrying the variant compared to those who do not carry the variant. However, the exact mechanisms by which the 1100delC variant increases the risk of breast cancer are still not fully understood."
  },
  {
    "id": 1535,
    "user_query": "Are immune cells affected in Amyotrophic Lateral Sclerosis?",
    "text-davinci-003_response": "Yes, immune cells are affected in Amyotrophic Lateral Sclerosis (ALS). In recent years, there has been an increased awareness and understanding of the role that a person's immune system plays in the development and progression of ALS. Research is ongoing to further explain the relationship between ALS and the immune system.\nThere are several ways in which the immune system can influence ALS. First, there is evidence to suggest that the immune system may play a role in the death of motor neurons, which are the cells responsible for muscle control. This is because certain types of immune cells, such as T-cells, can cause damage to motor neurons due to their ability to recognize and attack foreign substances or cells that don't belong in the body. There is also evidence to suggest that the immune system can cause inflammation in motor neurons, which can lead to their death over time.\nIn addition, some immune cells can have a strong influence on the levels of certain neurotransmitters in the brain, such as glutamate. This can disrupt the functioning of the neurons and have a negative effect on their ability to control and communicate with the body. This type of disruption has been linked to the progression of ALS.\nFinally, there is evidence to suggest that certain immune cells can produce toxins that damage the structure of motor neurons. This is thought to be another factor that contributes to the progression of ALS.\nIn summary, immune cells are undoubtedly associated with ALS and can have a significant impact on the progression of the disease."
  },
  {
    "id": 1537,
    "user_query": "What is the mechanism of action of eprotirome?",
    "text-davinci-003_response": "Eprotirome is a drug that binds to thyroid receptor proteins involved in the regulation of the thyroid hormone, triiodothyronine. This binding causes several changes at the molecular and cellular level, including:\n1. Regulation of gene expression: The binding of eprotirome to the thyroid receptor proteins causes a conformational change in the receptor proteins, which allows them to interact with specific regulatory regions on various genes. This interaction then activates or represses the expression of these genes, altering the function of the cells.\n2. Regulation of proteins: The binding of eprotirome to the thyroid receptor proteins also triggers the regulation of specific enzymes and proteins that are involved in metabolism and other cellular processes.\n3. Activation of hormones: The binding of eprotirome to the thyroid receptor proteins also induces the production and/or release of hormones, such as insulin and growth hormone, as well as their receptor molecules.\n4. Modification of receptor proteins: Finally, eprotirome binding may also alter the structure of thyroid receptor proteins, either by enhancing or inhibiting their ability to interact with other molecules or ligands. This, in turn, can further modify the activity of the cell or organism in various ways."
  },
  {
    "id": 1541,
    "user_query": "What is GDF10?",
    "text-davinci-003_response": "GDF10 (Growth Differentiation Factor 10) is a growth factor in the transforming growth factor (TGF) β family. It is essential for proper growth during development, and has been implicated in multiple pathological conditions, including cancer and heart failure. GDF10 is a potent growth stimulator that binds to TGF-β receptors. It targets cell-surface proteins, activating the phosphoinositide 3-kinase and mitogen-activated protein kinase signaling pathways, increasing cell proliferation and survival. GDF10 induces cell and organ regeneration, controls epithelial cell migration, and influences the tissue-remodeling that occurs during embryonic development. It also has potential roles in embryonic and postnatal heart development, neuronal development, bone formation, and inflammation. In addition to its role in development, GDF10 plays a role in pathological conditions, such as cancer. For example, in cases of epithelial cancer, GDF10 induces epithelial-mesenchymal transition, enabling the cancer cells to migrate and invade surrounding tissue. In cases of myocardial infarction and heart failure, GDF10 promotes ventricular remodeling, fibrosis, and cardiac hypertrophy. Thus, GDF10 plays multiple essential roles in both physiological development and pathological conditions, and therefore has great potential as a therapeutic target for multiple diseases."
  },
  {
    "id": 1552,
    "user_query": "Which genetic defects are observed in Prader-Willi syndrome?",
    "text-davinci-003_response": "Prader-Willi syndrome (PWS) is a genetic disorder caused by a chromosomal abnormality. People with PWS have a range of physical and mental symptoms caused by the absence, or inactivation, of several genes on chromosome 15.\nThe most common genetic defect associated with PWS is the deletion of a segment of chromosome 15, known as a “microdeletion”. This microdeletion causes the loss of several genes that play an important role in the normal development of the brain and body. In most cases of PWS, this deletion is caused by a genetic rearrangement called “uniparental disomy”, in which a person has two copies of chromosome 15 from one parent, rather than one from each parent.\nOther genetic defects associated with Prader-Willi syndrome include mutations of the SNORD116 gene (affecting the production of small non-coding RNAs) and mutations of the MAGEL2 gene (affecting the production of the MAGEL2 protein, which is involved in the proper functioning of neurons).\nOther genetic abnormalities associated with PWS include alterations to other chromosomes in addition to chromosome 15, and imprinting defects. Imprinting is an epigenetic process in which parental-specific gene expression is regulated. In some cases, this regulation is disrupted in individuals with PWS, leading to abnormal expression of certain genes."
  },
  {
    "id": 1555,
    "user_query": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?",
    "text-davinci-003_response": "The current state-of-the-art computational tools for gene fusion event prediction are the following:\n1. FusionMap: FusionMap is an automated algorithm by the Broad Institute which integrates genome sequencing and RNA-Seq data to identify possible gene fusion events. It utilizes a range of computing methods such as algorithm-based fusion detection, clustering, and sequence matching to detect fusion sites.\n2. ChimeraScan: ChimeraScan is an open-source computational pipeline program for the discovery and gene annotation of fusion transcripts. It operates by assembling transcript annotations (primers, splicing, polyA sites) and mapping reads to a reference genome.\n3. FusionCatcher: FusionCatcher is a free, easy-to-use, efficient, and sensitive gene fusion detection tool. It integrates different sequencing datasets, including transcriptome sequencing (RNA-Seq), genome sequencing (WGS/WES), and whole chromosome capture (agnostic and targeted approaches).\n4. deFuse: deFuse is an algorithm for the detection of gene fusion events from tumor-normal paired-end RNA-Seq data. It is designed to be sensitive and accurate while being computationally efficient (minimizing false-positive detections) by leveraging the paired-end reads.\n5. FusionFinder: FusionFinder is an algorithm which identifies novel gene fusion events from whole-genome sequencing data. It utilizes a technique which involves mapping reads to within a given distance of a gene and then clustering similar reads in order to identify fused gene points."
  },
  {
    "id": 1559,
    "user_query": "Are the proteins Erbin (LAP2) and Merlin cooperating?",
    "text-davinci-003_response": "The answer to this question is complicated and depends on the context in which it is being asked. If you are referring to the proteins Erbin (LAP2) and Merlin as two different proteins that may be interacting with each other, then it is possible that they are cooperating. Research has shown that LAP2 is thought to interact with Merlin by stabilizing certain conformations of Merlin, leading to its activity. However, more research is needed to determine the exact mechanisms of cooperation between these two proteins. If you are asking whether Erbin and Merlin are working together in some biological process, then it is difficult to answer without further research into the function and mechanism of their interaction."
  },
  {
    "id": 1568,
    "user_query": "Which deficiency is the cause of restless leg syndrome",
    "text-davinci-003_response": "?\nRestless Leg Syndrome (RLS) is a neurological disorder characterized by an irresistible urge to move one's legs, often accompanied by uncomfortable leg sensation. While the exact cause of RLS remains unknown, there is growing evidence that iron deficiency may be involved in many cases. Iron plays an important role in dopamine production, and a deficiency can affect dopamine pathways in the brain and cause RLS symptoms. Additionally, iron helps the body produce adenosine, which increases as the day wears on and can trigger the desire to move one's legs. Thus, it stands to reason that any kind of iron deficiency could potentially at least contribute to RLS symptoms."
  },
  {
    "id": 1572,
    "user_query": "What is the role of eteplirsen in DMD patients?",
    "text-davinci-003_response": "Eteplirsen is a therapy used to treat Duchenne muscular dystrophy (DMD) in patients with a deletion of exon 51 of the dystrophin gene. It is an exon-skipping therapy, which means it employs small stretches of genetic material (exons) that are skipped when a messenger RNA (mRNA) is processed from DNA. By skipping exon 51, the body’s production of dystrophin, a protein involved in muscle strength and function, is restored.\nEteplirsen is delivered as an intravenous (IV) injection, which allows the drug to travel directly to the tissues of interest. The drug is then taken up by muscle cells and is used to rejuvenate the cells and provide them with the protein they need to properly function.\nEteplirsen has been proven to result in significant increases in the production of dystrophin protein in DMD patients. In one study, treatment with the drug over 48 weeks increased the amount of dystrophin produced two-fold over the amount produced before treatment. This increased expression of dystrophin in patients has been linked to improvements in muscle function, making it possible for patients to walk greater distances and maintain the ability to move without use of supportive devices.\nOverall, the use of eteplirsen is a major advancement in the treatment of DMD patients. It has been proven to effectively increase the production of dystrophin proteins in the body and has been linked to improvements in muscle movement and function, allowing patients to remain more independent and improve their quality of life."
  },
  {
    "id": 1573,
    "user_query": "Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.",
    "text-davinci-003_response": "Parkinsonism with dementia of Guadeloupe syndrome (PDDG) is an autosomal dominant disorder caused by a mutation in the GBA gene. It is characterized by the co-occurrence of Parkinson’s-like motor symptoms and Alzheimer’s-like cognitive impairment. Symptoms generally begin in middle age (typically between the ages of 40-60) and progress over time. \nThe motor symptoms of PDDG usually develop gradually and initially include tremor, bradykinesia, and rigidity. Postural instability and gait impairment can also be observed and contribute to balance and mobility issues. \nThe cognitive symptoms of PDDG include memory and language problems, agitation, and behavioural disturbances. Visual-spatial deficits and apraxia are also characteristic of the phenotype. \nThe diagnosis of PDDG is based on a combination of clinical features and genetic testing. It is important to note that while the majority of individuals with PDDG present with motor and cognitive symptoms, only a fraction will develop dementia"
  },
  {
    "id": 1574,
    "user_query": "Does the concentration of protein HIF-1α increase after the administration of the cytoprotective prodrug\"amifostine\" (ethyol) ?",
    "text-davinci-003_response": "Yes, the concentration of the protein HIF-1α does increase after the administration of the cytoprotective prodrug amifostine (ethyol). This has been demonstrated in numerous studies. In particular, a study by Eftim and colleagues evaluated the effect of amifostine on HIF-1α concentrations in cell cultures of mouse fibroblasts. The study found that there was a significant increase in HIF-1α concentrations following the application of amifostine. This was due to a decrease in the enzymatic degradation of HIF-1α caused by the cytoprotective action of amifostine. This study provides strong evidence to support the hypothesis that amifostine increases HIF-1α concentrations."
  },
  {
    "id": 1578,
    "user_query": "Which are the main histone modifications associated with enhancers?",
    "text-davinci-003_response": "The main histone modifications associated with enhancers are histone acetylation, methylation, and ubiquitination. Histone acetylation is an important marker for transcriptional activation of enhancers, as it promotes gene expression by modulating the interactions between enhancers and general transcription factors. Histone ubiquitination is also associated with enhancer activity, and its function is to repress enhancer activity. Finally, histone methylation is important for enhancer activity as it serves as a selective marker for the interaction between enhancers and other proteins."
  },
  {
    "id": 1586,
    "user_query": "What is the principle of ATAC (Assay for Transposase-Accessible Chromatin) technique?",
    "text-davinci-003_response": "ATAC (Assay for Transposase-Accessible Chromatin) is a technique used to detect open and active regulatory regions in the genome. The technique relies on the greeting of short DNA fragments known as “tagmentation” to map the accessibility of chromatin.\nThe tagmentation step involves an enzyme called transposase that cuts sites around the DNA and incorporates dNTPs (the calcium phosphate transfection technique) to bridge the two broken fragments. Next, a sequencing adapter sequence is added to the DNA fragment, which allows for sequencing.\nThe open regulatory regions of chromatin are identified by the insertion of the short DNA fragments resulting from the tagmentation. Uniquely mapped sequence tags are created from the tagmentation reaction, which are then identified by the sequencing readout.\nThe sequencing readouts provide information of the epigenetic marks (DNA methylation, histone modification) associated with these DNA fragments. By comparing the sequencing readouts between two samples (i.e. between a control sample and a treated sample), it can be determined which of the open regulatory regions are associated with higher or lower levels of epigenetic marks.\nSo, the principle of ATAC technique is to use enzymatic tagmentation to map the open regulatory regions in the genome and to sequence the uniquely mapped fragments of chromatin to identify epigenetic marks associated with those regions."
  },
  {
    "id": 1587,
    "user_query": "Which are the main NMD factors in Saccharomyces cerevisiae?",
    "text-davinci-003_response": "The main NMD factors in Saccharomyces cerevisiae are Upf1, Upf2, Upf3, Smg1, Smg5, Smg6, Shk1, Hbs1, Pab1, Nab2, Brr1, and Mft1.\nUpf1 is part of the Upf1-Upf2-Upf3 complex, which is responsible for identifying degraded transcripts. This complex is activated by signaling molecules, such as degradative subunits of the polysome-associated mRNA decay machinery or ribosomal proteins, to unwind and helicase the mRNA. The bound Upf1-Upf2-Upf3 complex then couples the signal with a decay activity.\nSmg1, Smg5, and Smg6 (the SMG1 complex) play important roles in ensuring the correct recognition of transcripts for degradation. The SMG1 complex stimulates Upf1-mediated exonucleolytic degradation of aberrant transcripts. It functions as a nuclear sensor of aberrant mRNAs, recruiting Upf1-Upf2-Upf3 and other NMD factors to transcripts that are prone to be translated incorrectly or contain premature stop codons.\nShk1 is an NMD factor involved in mRNA surveillance and decay. It is a downstream target of SMG1. SHK1 binds to Upf1 and promotes the dissociation of Upf2 from the Upf1-Upf2-Upf3 complex, thus increasing the affinity of Upf1 to mRNAs with premature termination codons.\nHbs1 an is an NMD factor involved in inducing the decay of highly unstable mRNAs. It is known to interact with Upf1 in an RNA-dependent manner to induce mRNA decay and to target aberrant transcripts for NMD.\nPab1, Nab2, and Brr1 are mRNA binding proteins involved in recruiting the Upf1-Upf2-Upf3 complex to aberrant transcripts. PAB1 binds to the Poly(A)-binding protein and thus, it helps recruit the Upf1-Upf2-Upf3 complex to aberrant transcripts. Nab2 and Brr1 are related to PAB1 and are important in the recognition and targeted destabilization of mRNAs lacking a complete 3’ end or containing a stop codon. \nFinally, Mft1 is a ubiqu"
  },
  {
    "id": 1588,
    "user_query": "Which histone marks are deposited by Set7?",
    "text-davinci-003_response": "Set7 is a histone-lysine mono-methyltransferase that deposits the histone mark H3K4me1 at target gene promoters. This specific type of histone mark is known as a \"promoter-associated\" mark because it is found in the regulatory regions of genes. Additionally, Set7 is known to deposit other related histone marks, including H3K4me2, H3K4me3, and H4K20me2, which are associated with transcriptional activation and repression, respectively."
  },
  {
    "id": 1592,
    "user_query": "Which genes are associated with Ehlers-Danlos syndrome type I/II?",
    "text-davinci-003_response": "Ehlers-Danlos syndrome type I and II (previously known as classic and hypermobility) are caused by mutations or defects in certain collagen genes. These genes are COL1A1, COL1A2, COL5A1, COL5A2 and TNXB. COL1A1 and COL1A2 provide instructions for making a part of type 1 collagen, which is an essential component of skin, tendons, and connective tissues. COL5A1 and COL5A2 provide instructions for making type V collagen, which is used to construct the regulation network which controls the structure of collagen and elastin. The TNXB gene provides instructions for making Tenascin-X, which is a protein involved in the assembly and function of collagen and elastin. Mutations in any of these genes can result in an increased susceptibility to the tissue fragility and laxity common to Ehlers-Danlos syndrome type I/II."
  },
  {
    "id": 1593,
    "user_query": "Which factors are considered in the ABCD2 score?",
    "text-davinci-003_response": "The ABCD2 score is a score used for the evaluation of transient ischemic attack (TIA) patients and was developed to predict risk for stroke within a 2-day period. The ABCD2 score is calculated by considering seven factors: Age, Blood pressure, Clinical features, Duration of symptoms, Diabetes, Evidence of carotid artery disease, and 2nd event. \n1. AGE: For a person aged 60-69 years, the score is 1 point; for those aged 70 or over, 2 points are given. \n2. BLOOD PRESSURE: Systolic blood pressure ≥ 140 mmHg is given 1 point.\n3. CLINICAL FEATURES: This focuses on the symptoms shown by the patient, with 3 points for 2 unilateral maifestsations, 2 points for 1 unilateral manifestation, 1 point for 2 gait disturbances, 1 point for monocausal dizziness, 0.5 points for unilateral limb weakness and 0 points for no symptoms manifest. \n4. DURATION OF SYMPTOMS: Patients with symptoms lasting 60 minutes or under score 2 points, those with symptoms lasting longer earn 3 points.\n5. DIABETES: If a patient’s blood glucose level is ≥ 11 mmol/L, the score is 1 point.\n6. EVIDENCE OF CAROTID ARTERY DISEASE: If there is evidence of carotid artery disease, it is given 1 point.\n7. 2ND EVENT: If a patient has a recurrent TIA or stroke within 2 days of the initial symptoms, the score is doubled."
  },
  {
    "id": 1594,
    "user_query": "Is Tuberous Sclerosis a genetic disease?",
    "text-davinci-003_response": "Yes, Tuberous Sclerosis (also known as TSC) is a genetic disease. It is caused by mutations in either the TSC1 or TSC2 gene. These genes normally help regulate the growth of cells and keep them from growing and dividing too quickly, but mutations in them cause uncontrolled growth in some organs and tissues of the body. This abnormal cell growth can cause benign tumors to form, which are known as tubers. These tubers, along with other neurological and non-neurological symptoms, are the hallmarks of TSC. The disease is usually inherited in an autosomal dominant pattern, which means that only one copy of the mutated gene is required to cause the condition in a person. Although it is rare, TSC can also be inherited in an autosomal recessive manner, in which case two mutant copies of the gene must be inherited to cause the disease."
  },
  {
    "id": 1598,
    "user_query": "What type of DNA repair pathways is initiated by AlkA glycosylase?",
    "text-davinci-003_response": "AlkA glycosylase is an enzyme involved in the base excision repair (BER) pathway, which is a key pathway for repairing damaged DNA. In this pathway, AlkA glycosylase recognizes and removes mismatched base-pairs (transitions) caused by errors in replication. Upon recognition of these mismatched base-pairs, AlkA glycosylase cleaves the glycoside linkage of the damaged nucleoside and then a number of successive enzymes from the BER pathway will complete the repair. In addition to mismatched base-pairs, AlkA glycosylase is also involved in the repair of oxidative and other chemical-based base modifications."
  },
  {
    "id": 1605,
    "user_query": "What is the mechanism of cementogenesis in pulp regeneration?",
    "text-davinci-003_response": "Cementogenesis is part of the process of pulp regeneration and is the formation of cementum by new cementoblasts on the root surface of a tooth. It is the final step in the repair process of dental pulp regeneration.\nCementogenesis begins with the recruitment of cementoblasts, which are specialized odontoblasts responsible for the formation of cementum. The chemical and physical stimuli that occur along the dentino-cemental junction stimulate the development of these cementoblasts from progenitor cells. Additionally, further maturation of cementoblasts are promoted by biological mediators including growth factors, cytokines, and chemokines.\nOnce cementoblasts are recruited, they begin to synthesize and secrete collagen fibers and other cellular components, such as glycoproteins and proteoglycans. This collagen fiber-based matrix becomes a scaffold for mineralization associated with root formation. Mineralization occurs via hardening of the collagen matrix by hydroxyapatite crystals and then further hardening with the accumulation of calcium and phosphorus ions. During this process, the collagen fibers are further organized to create an organized layer of cementum that covers and protects the root surface of the tooth.\nCementogenesis is essential for full pulp regeneration and the generation of a healthy and functional tooth. The newly formed cementum provides a strong foundation for the attachment of periodontal ligament fibers, which anchor the tooth in the alveolar bone and enable normal functioning movements. Without cementum, it would not be possible for the pulp regenerated tissue to produce a normal functioning tooth."
  },
  {
    "id": 1606,
    "user_query": "What are the reported adverse effects of gabapentin used in children?",
    "text-davinci-003_response": "Gabapentin is an anticonvulsant medication used to treat seizures and other neurological conditions, and is sometimes prescribed to children for the treatment of epilepsy. It is generally observed as safe, however, some reports of adverse reactions or side effects have been made in children who have taken the medication.\nThe most commonly reported side effects of gabapentin use in children are:\n-Drowsiness and fatigue\n-Unsteady or clumsy movement\n-Feeling wearing or tired\n-Unexplained weight gain\n-Headache\n-Nausea\n-Blurred vision\n-Diarrhea\nLess commonly reported side effects can include anxiety, appetite loss, dizziness, mental confusion, tremors, and changes in mood or behavior. There is also some evidence to suggest that long-term use of the medication can lead to the suppression of growth hormones in some pediatric patients, resulting in delays in the development of secondary sexual characteristics.\nIn extremely rare cases, gabapentin use in a child may increase the risk for certain types of malformations. It is important to note, however, that these malformations have been observed at high doses and after long-term use. If you are considering gabapentin for your child, it is important to speak with a healthcare professional about any potential risks."
  },
  {
    "id": 1617,
    "user_query": "What are the skeletal muscle satellite cells?",
    "text-davinci-003_response": "Skeletal muscle satellite cells are specialized cells found in the skeletal muscle that are involved in the regulation of muscle growth and repair. They are regarded as stem cells and can differentiate into muscle cells. These cells form a single layer around the muscle fibers and divide to replenish themselves and differentiate to form new muscle cells.\nSatellite cells are activated in response to muscle damage and translate into the forming and repairing of muscle fibers. Upon activation, satellite cells undergo proliferation and differentiation to form new myotubules, which replace damaged muscle fibers and enhance muscle growth.\nThese cells also play an important role in the body’s ability to adapt to different physical demands. For example, exercise can result in an increased number of satellite cells and an elevated protein production rate of these cells, leading to increased muscle growth and strength.\nIn conclusion, skeletal muscle satellite cells are a type of specialized stem cell that allows for muscle growth and repair. They are activated when a muscle is injured and are essential for the adaptation of muscles to exercise."
  },
  {
    "id": 1618,
    "user_query": "What is the role of neurogranin in Alzheimer's disease patients?",
    "text-davinci-003_response": "Neurogranin (Ng) is a protein located in the postsynaptic density of neurons and is involved in multiple aspects of neuronal signaling. In Alzheimer's disease (AD), neurogranin levels are significantly altered in the brains of patients. Studies have shown that neurogranin levels are significantly decreased in the hippocampus, amygdala, and frontal cortex of AD patients compared to those of healthy individuals. This suggests that altered neurogranin levels in AD patients may contribute to their cognitive decline and neurodegeneration.\nNeurogranin is associated with the regulation of long-term potentiation of synaptic strength and may play a role in memory formation and memory retrieval. A decrease in neurogranin levels has been associated with decreased cognitive and psychomotor performance, and with increased neuronal damage seen in patients with AD. Neurogranin is also involved in synaptic plasticity and cognitive performance particularly when subject to aging and age-related neurodegenerative diseases such as AD.\nNeurogranin may also be involved in the pathogenesis of AD by interacting with the amyloid precursor protein, which is thought to play a role in the development of AD. It is believed that when neurogranin levels are decreased, this can lead to increased beta-amyloid production and the accumulation of amyloid plaques, one of the hallmarks of AD.\nIt has been shown that neurogranin levels increase in response to chronic treatment with cholinesterase inhibitors as well as with antioxidant therapy. It is hypothesized that this could be related to neurogenesis, synaptic plasticity, and restoration of interactions with other signaling molecules. Therefore, it is possible that an increase in neurogranin levels could be beneficial to AD patients, as it may help in the improvement of cognitive functions and the slow progression of the disease."
  },
  {
    "id": 1619,
    "user_query": "Does triiodothyronine play a regulatory role in insulin secretion from pancreas?",
    "text-davinci-003_response": "Yes, triiodothyronine (T3) plays a regulatory role in insulin secretion from the pancreas. Insulin is a hormone that helps regulate the amount of glucose in the bloodstream. T3, a form of the hormone thyroxine, plays a role in this process as it helps stimulate insulin production in the beta cells of the islets of Langerhans in the pancreas. When glucose levels in the blood are high, T3 acts on two proteins, TRα and TRβ, to stimulate the production of insulin. T3 also plays a role in controlling the activity of molecules involved in the signaling pathways for insulin release from the pancreas. Furthermore, it has been shown that T3 increases the expression of an enzyme involved in pancreatic insulin secretion called Hormone-sensitive Lipase (HSL). This enzyme helps to control insulin release from the beta cells by breaking down fats stored in those cells. Taken together, these findings suggest that T3 plays an important regulatory role in determining the amount of insulin that is secreted from the pancreas in response to fluctuations in blood glucose levels."
  },
  {
    "id": 1620,
    "user_query": "How many disulfide bridges has the protein hepcidin got?",
    "text-davinci-003_response": "Hepcidin is a 25-amino acid peptide with three disulfide bridges. The three disulfide bridges are formed between Cys 2 to Cys 16, Cys 4 to Cys 12, and Cys 9 to Cys 22. Therefore, Hepcidin has three disulfide bridges."
  },
  {
    "id": 1622,
    "user_query": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?",
    "text-davinci-003_response": "The major intramolecular sites of phosphorylation involved in cell cycle control on human Chk2 (also known as CHEK2 or CHK2) are Thr68, Thr25, Ser20 and Ser330. This is because these four residues have been observed to be phosphorylated in vivo, and they are essential for the proper regulation of the protein's activity.\nThr68 is phosphorylated in response to DNA damage, which activates the protein and results in an increase of Chk2-mediated cell cycle arrest and apoptosis.\nThr25 phosphorylation by protein kinase A is involved in Chk2 activation by upstream signal pathways, but the specific role of Thr25 still remains unclear.\nSer20 is phosphorylated by AMPK, which promotes Chk2 inhibition and cell cycle progression.\nSer330 is phosphorylated by Aurora B kinase, which modulates the interaction between Chk2 and the downstream effector Cdc25A and inhibits Chk2 activity. Aurora B-mediated phosphorylation of Ser330 has also been suggested to play a role in Chk2-mediated apoptosis."
  },
  {
    "id": 1628,
    "user_query": "Which receptors can be evaluated with the [18F]altanserin?",
    "text-davinci-003_response": "[18F]Altanserin is a tracer used in positron emission tomography (PET) imaging to evaluate the 5-HT2A serotonin receptor in the brain. The 5-HT2A receptor is believed to play a role in many psychiatric conditions, such as schizophrenia and depression. It is also thought to be involved in the normal sleep-wake cycle and in regulating the release of certain hormones. In addition to researching its role in psychiatric disorders, [18F]altanserin is also used to investigate brain function in healthy people. By identifying brain regions with higher or lower 5-HT2A receptor levels, it can help doctors to identify areas of the brain where further research is needed. In addition, [18F]altanserin can be used to identify changes in receptor function in response to certain medications, providing clues to their effects on the human brain."
  },
  {
    "id": 1630,
    "user_query": "Which extra thyroid tissues have thyrotropin (TSH) receptors?",
    "text-davinci-003_response": "Extra thyroid tissues, such as the ovaries, gut, and adipose tissue, may have thyrotropin (TSH) receptors that can bind to TSH. TSH receptors are G-protein coupled receptors that play an important role in the production of thyroid hormones by mediating the cellular response to TSH stimulation. In extra thyroid tissues, TSH receptors are found in cells such as adipocytes, ovarian granulosa cells, enterocytes and mucosal cells, and Sertoli cells. TSH receptors in extra thyroid tissue serve to regulate the production of hormones involved in ovulation and other metabolic pathways. Additionally, TSH receptors in adipose tissue are thought to be involved in the regulation of body fat composition and energy balance."
  },
  {
    "id": 1631,
    "user_query": "Which histone modifications distinguish between promoters and enhancers?",
    "text-davinci-003_response": "Histone modifications, including acetylation, methylation, phosphorylation,sumoylation, ubiquitination, and ADP-ribosylation, serve as key epigenetic regulators of gene expression. They are involved in establishing chromatin structure that is conducive or permissive for gene transcription and DNA repair processes. In addition to other factors that may influence chromatin structure and gene regulation, certain histone modifications have been associated with either promoter or enhancer functions.\nThe marks distinguishing promoters and enhancers include H3K4 trimethylation (H3K4me3) and H3K27 acetylation (H3K27ac) associated with enhancers, and H3K4 monomethylation (H3K4me1) and H3K27 trimethylation (H3K27me3) associated with promoters. Promoters are associated with an enrichment of H3K4me1 and H3K27me3 patterns and an absence of H3K4me3 and H3K27ac, while enhancers are enriched for H3K4me3 and H3K27ac and depleted of H3K4me1 and H3K27me3. \nIn particular, H3K4me1 is a marker of internal promoter regions and its presence is associated with transcription initiation and elongation. H3K27me3 is strongly associated with gene bodies, and is associated with repression of elongation and subsequently termination of transcription. In contrast, H3K4me3 and H3K27ac are both associated with active enhancers, and have been observed to affect gene expression before the start of transcription. H3K27ac has specifically been associated with active expression from distal regulatory elements. \nCollectively, the profiles of these histone modifications can provide a picture of chromatin compaction that helps to identify promoter and enhancer regions, and may also provide information about the type or strength of transcription from each region."
  },
  {
    "id": 1632,
    "user_query": "Where is the metaxin complex localized?",
    "text-davinci-003_response": "The metaxin complex is a protein complex that is primarily localized to the lysosomes of eukaryotic cells. It consists of a translocon complex, the metaxin-1 homodimer, and a tetramer of its paraorthoblastine homologue (POB). These components are present in the inner membrane of the lysosome as well as in the lysosomal lumen, where they appear to interact with several lysosomal proteins. The metaxin complex also localizes to the ER in eukaryotic cells and has been observed to interact with several ER proteins. It is thought to be involved in several cellular processes, such as protein translocation and autophagy."
  },
  {
    "id": 1633,
    "user_query": "What are the major classes of retrotransposons active in the human genome?",
    "text-davinci-003_response": "Retrotransposons, also known as retrotransposable elements (RTEs), are sequences of DNA that are able to \"jump\" or transpose from one location in the genome to another. They are thought to be responsible for much of the dynamic nature of the human genome. Retrotransposons are divided into two major classes: long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs).\nLINEs are the most numerous and active class of retrotransposons in the human genome. They are comprised of two open reading frames (ORFs) and can be anywhere from 6,000 to 8,000 base pairs long. They are composed of two independent ORFs which encode two proteins: an endonuclease and an RNA-dependent reverse transcriptase. These two proteins allow for the LINE-encoded RTEs to move around the genome and replicate.\nSINEs are much shorter and less abundant retrotransposons in the human genome. They range from 100 to 500 base pairs in length and lack protein coding capacity. SINEs are believed to originate from tRNA molecules and are based on the same reverse transcriptase/endonuclease mechanism of LINEs. However, instead of coding for their own transposase proteins, SINEs rely on the proteins encoded by LINEs.\nThese two classes of retrotransposons are thought to play an important role in genome variation and evolution. By randomly moving around the genome, they are believed to be responsible for the insertion of new genes, and other genetic changes that have enabled humans to rapidly adapt to changing environments."
  },
  {
    "id": 1634,
    "user_query": "Which are the clinical characteristics of Diamond-Blackfan anemia?",
    "text-davinci-003_response": "Diamond-Blackfan anemia (DBA) is a rare inherited red blood cell disorder that impacts the body's ability to produce red blood cells. Individuals with DBA might show a variety of signs or symptoms, which may vary in severity depending on the individual. Some of the common clinical characteristics of DBA include:\n- Low red blood cell count (anemia): In most people with DBA, the bone marrow fails to make enough red blood cells (known as anemia). As a result, individuals may experience symptoms such as fatigue, shortness of breath, pale skin, and weakened immune system.\n- Abnormal red blood cell size: The red blood cells of individuals with DBA are often smaller (microcytic) and paler (hypochromic) than normal, resulting in a low hemoglobin and hematocrit levels.\n- Abnormal chromosome analysis: Individuals with DBA may have an abnormal chromosome analysis, which can range from deletions or abnormalities in particular chromosomes, to a rearrangement of entire chromosomes.\n- Short stature: Most people with DBA have low birth weight, short stature, and delayed growth.\n- Congenital anomalies: Some individuals with DBA may have congenital heart defects, skeletal anomalies, or other congenital anomalies. \n- Increased risk of cancer: DBA may be associated with an increased risk of developing cancer.\n- Increased risk of infections: Due to the low number of red blood cells, DBA individuals may have an increased risk of infection."
  },
  {
    "id": 1638,
    "user_query": "Which is the receptor for the immunosuppressive drug cyclosporin A (CsA)?",
    "text-davinci-003_response": "The receptor for the immunosuppressive drug cyclosporin A (CsA) is a member of the cytoplasmic peptide transporters family, referred to as cyclophilin (CyPs). Cyclophilin belongs to the peptidyl-prolyl cis-trans isomerase family and is the primary target of CsA. It achieves its immunosuppressive effect by inhibiting the T-cell activation pathway via its interaction with calcineurin, an enzyme that is crucial for the activation of T-cells. This interaction between cyclophilin and calcineurin leads to a decrease in the production of various cytokines, such as interleukin-2, and thus to a decrease in the proliferation of T-cells. Thus, cyclophilin is the main receptor of CsA, providing its immunosuppressive effects."
  },
  {
    "id": 1642,
    "user_query": "In which types of DNA repair is the UvrAB complex involved?",
    "text-davinci-003_response": "The UvrAB complex is involved in two distinct types of DNA repair: nucleotide excision repair (NER) and recombination-based replication repair.\nNucleotide excision repair (NER) is a major DNA repair system that involves the UvrAB complex. NER pathways allow cells to identify bulky helix-distorting distortions in the helical structure of DNA, such as bulky adducts and UV-induced damage. Once these damages have been identified, the UvrAB complex coordinates the excision of nucleotides to repair the damage.\nRecombination-based replication repair is another DNA repair system that involves the UvrAB complex. This repair system involves the substrates of UvrA and UvrB recruiting proteins that initiate homologous recombination (HR) between sister chromatids. This process is triggered when the UvrA and UvrB proteins detect a misincorporation of a nucleotide during DNA replication. This recruitment process helps to ensure that the misincorporated nucleotide is removed and replaced by the correct one during replication."
  },
  {
    "id": 1643,
    "user_query": "What is the localization of the protein encoded by the gene DNAJC11?",
    "text-davinci-003_response": "The protein encoded by the gene DNAJC11 is localized to the lysosomal membrane. It is present in lysosomes, which are membrane-enclosed organelles that are present in the cytoplasm of cells and are involved in the degradation of macromolecules. DNAJC11 is a member of the DnaJ heat shock protein family and is involved in the correct transport of lysosomal enzymes to the lysosomal membrane, as well as in the stabilization of the lysosomal membrane. It is also involved in the regulation of the cell cycle and in the maintenance of cell morphology, as well as in the prevention of cellular stress and damage."
  },
  {
    "id": 1646,
    "user_query": "Which hormone abnormalities are characteristic to Pendred syndrome?",
    "text-davinci-003_response": "Pendred syndrome is an autosomal recessive disorder caused by a mutation in the PDS gene, which is involved in the formation of organs and structures in the inner ear and kidney. It is characterized by sensorineural hearing loss, goiter (enlargement of the thyroid gland), and MRI-confirmed vestibular aqueduct enlargement. Hormonal abnormalities are a common feature of Pendred syndrome and can affect many aspects of growth and development, including thyroid hormone and growth hormone production.\nAbnormalities of the thyroid hormone system are the most common hormonal abnormality in Pendred syndrome. A decrease in circulating levels of the thyroid hormones thyroxine (T4) and triiodothyronine (T3), along with elevated levels of TSH (thyroid-stimulating hormone) are often seen in individuals with the syndrome. This type of thyroid abnormality, known as hypothyroidism, can lead to a variety of symptoms ranging from chronic fatigue and muscle aches to goiter and delay in physical and mental development.\nPendred syndrome can also be associated with abnormal production of other hormones by the pituitary gland. A decrease in growth hormone (GH) has been observed in some cases, and abnormalities in cortisol, oxytocin, and antidiuretic hormone (ADH) production have also been reported. Treatment of these hormonal abnormalities often does not improve the underlying hearing loss but can help with physical and cognitive development."
  },
  {
    "id": 1647,
    "user_query": "What is the mode of inheritance of  long QT  Jervell and Lange-Nielsen syndrome?",
    "text-davinci-003_response": "The mode of inheritance of Long QT Jervell and Lange-Nielsen Syndrome is autosomal recessive. This means that in order for an individual to present symptoms of the condition, they must have two mutated copies of the gene – one inherited from each parent. If an individual has only one mutated copy of the gene, they are said to be a carrier of the condition but typically do not present symptoms of the disorder. This autosomal recessive mode of inheritance makes it possible for an individual to be symptom-free, even if their parents both carry the mutated gene."
  },
  {
    "id": 1648,
    "user_query": "List programs suitable for protein docking",
    "text-davinci-003_response": "Protein docking is the process by which two or more molecular structures, such as proteins, RNA, or other small molecules, are configured into a complex to predict how they interact. Some software packages suitable for protein docking are:\n1. Autodock Vina: Autodock Vina is an open-source docking program designed to use a hierarchical, systematic method for docking large molecules into a protein binding site. It is a fast, accurate and user friendly docking program.\n2. Autodock 4: Autodock 4 is a molecular docking and optimization tool which employs evolutionary algorithms for accurate conformational sampling and flexible ligand side chains. It is good for predicting what small and large molecules will bind to or interact with proteins.\n3. Dockbox: Dockbox is an open source, cross-platform protein-protein docking software which utilizes the well-established Shape Complementarity Theory. It is a general-purpose, shape-based protein docking program that can be applied to various types of protein-protein complexes.\n4. FlexX: FlexX is a molecular docking program developed for the purpose of structural biology. It uses the technique of shape complementarity to model protein-protein, protein-DNA, protein-RNA, drug-protein, and other complexes. FlexX is used to predict the preferred binding site on a protein for a ligand, and to predict the binding strength of a ligand to the receptor molecule.\n5. SwissDock: SwissDock is an automated protein-protein docking program developed by the Swiss Institute of Bioinformatics. It uses a force-field-based approach to predict the interaction between two proteins or ligand-receptor complexes. SwissDock produces a ranked list of potential binding poses and can be used for structure-based drug discovery."
  },
  {
    "id": 1649,
    "user_query": "Which genes have been found mutated in Gray platelet syndrome patients?",
    "text-davinci-003_response": "One of the genes found to be mutated in patients with Gray Platelet Syndrome (GPS) is the gene known as RUNX1. RUNX1 is involved in the regulation of hematopoiesis, which is the process of development of blood cells. Mutations to the RUNX1 gene can cause a decrease in the number of megakaryocytes, which are the types of cells responsible for producing platelets. This can lead to low platelet counts, a common symptom of GPS.\nAnother gene that has been found to be mutated in GPS patients is ANKRD26. Mutations to this gene lead to an accumulation of toxic lipids, whichmay disrupt megakaryopoiesis and platelet production.\nFinally, the gene USP9X has also been found to be mutated in some GPS patients. The USP9X gene plays a major role in the development of megakaryocytes and hematopoiesis, so mutations to this gene can result in a decreased number of platelets in the bloodstream."
  },
  {
    "id": 1652,
    "user_query": "Is cardiac magnetic resonance imaging indicated in the pre-participation screening of athletes?",
    "text-davinci-003_response": "Cardiac magnetic resonance imaging (MRI) is not typically indicated in the pre-participation screening of athletes. While cardiac MRI can offer greater sensitivity and specificity than other forms of cardiac screening, such as electrocardiography (ECG), it is less time-efficient and more costly than other non-invasive imaging modalities.\nThe American Heart Association (AHA) has raised the question regarding the involvement of cardiac MRI in the pre-participation screening of athletes. However, the AHA does not recommend cardiac MRI as a general pre-participation screening process for athletes due to the relatively low incidence of cardiovascular abnormalities. Screening athletes with electrocardiograms (ECGs) and echocardiograms (ECHOs) will detect a wide range of potential issues that can be further investigated with further testing, including cardiac MRI, if needed.\nCardiac MRI is indicated in certain specific scenarios in which other cardiac screening techniques, such as ECG or ECHO, are inadequate or not available. This includes athletes with clinical signs or symptoms of an underlying heart condition, with a positive screening ECG, ECHO, or both, or with a personal or family history indicative of an underlying heart condition. In these cases, MRI can be utilized to diagnose or exclude an underlying cardiac condition and provide further information for management and prognosis."
  },
  {
    "id": 1654,
    "user_query": "What is the function of the MTH1 enzyme in cancer cells?",
    "text-davinci-003_response": "MTH1 (mismatch repair exonuclease) is an enzyme that helps repair damaged DNA in cancer cells. This enzyme is involved in the correction of mispaired-base errors, which occur when the nucleotide base sequence of a DNA strand gets disrupted due to genetic damage or replication errors. A mispaired-base pair is a pair of nucleotides that don't match up correctly with the original nucleotide sequence. An example of such a mispair would be a G-G base pair instead of a G-A base pair. MTH1 helps to spot these errors in the DNA sequence, and then helps correct them. \nIn cancer cells, MTH1 plays an important role in helping maintain the genomic stability of the cell. For cancer cells to proliferate rapidly, they must be able to replicate their genetic material with a very low error rate. This is why having an operational MTH1 enzyme is so important. Without it, mutations due to mispaired-base errors would occur, resulting in potentially destructive changes to the cell’s genome. This means that if the MTH1 enzyme is inhibited, it can have a detrimental effect on cancer cells and potentially lead to their death."
  },
  {
    "id": 1655,
    "user_query": "Are ultraconserved elements depleted among copy number variants (CNVs)?",
    "text-davinci-003_response": "The answer to this question is not straightforward, as it will vary depending on the type of CNVs in question. In general, however, ultraconserved elements (UCEs) are not typically depleted among copy number variants (CNVs). UCEs are often used as a tool to detect structural variation, but when it comes to CNVs specifically there is some evidence that suggests that UCEs are not affected. It has been suggested that CNVs may actually increase UCE levels, as they can form a protective barrier that helps to preserve the UCEs. This was seen in a study of CNVs in the mouse genome, which showed that UCEs were not depleted among CNVs and in fact, were actually enriched. Additionally, other studies have reported similar findings in humans, where it was found that UCEs were not depleted in regions of CNV. \nOverall, it appears that UCEs are typically not depleted among CNVs, and may in fact be enriched in some cases. It should be noted, however, that specific types of CNVs may deplete UCEs, so it is important to look at the specific type of CNV in question when considering this question."
  },
  {
    "id": 1660,
    "user_query": "Which population has a high frequency of the HLA-B*1502 allele?",
    "text-davinci-003_response": "The HLA-B*1502 allele is a variant of the human leukocyte antigen (HLA) gene, which plays a critical role in the body's ability to recognize and respond to foreign invaders such as bacteria and viruses. This variant of the gene is most commonly found in Southeast Asian populations such as those in Thailand, Vietnam, and China. It is estimated that 8-12% of those of Han Chinese ancestry are carriers of this gene variant. It has also been found at a much lower frequency in other East Asian populations, including those in Taiwan, Korea, and Japan. Additionally, the allele has been detected at low frequencies throughout other parts of the world, including Africa, Europe, and the Americas."
  },
  {
    "id": 1663,
    "user_query": "What is the role of the Tsix gene during X chromosome inactivation?",
    "text-davinci-003_response": "The Tsix (Xist inactivator) gene is a key regulator of X-chromosome inactivation, an important process during early embryogenesis in mammals. During X-inactivation, oneX chromosome is silenced in female mammals, equalizing the amount of X-linked gene expression between sexes and ensuring a balanced physiological state. Tsix regulates the silencing of the X chromosome as part of an intricate and complex process called X inactivation. In early development, Tsix expression is first set up at the blastocyst stage, but Tsix repression is the main event that initiates X inactivation. Tsix plays a crucial role in the silencing of the X chromosome, as when it is silenced, it is unable to inhibit Xist expression, thus leading to X inactivation. To do this, Tsix binds to a long non-coding RNA called Xist which initiates the X inactivation process. Tsix assists in the binding of Xist to the X chromosome and represses Xist transcription. This allows different alleles from both X chromosomes to be expressed, ensuring chromosomal stability in female embryos."
  },
  {
    "id": 1665,
    "user_query": "Which is the substrate of the haspin kinase during mitosis?",
    "text-davinci-003_response": "The substrate of the haspin kinase during mitosis is histone H3. During mitosis, haspin phosphorylates histone H3 at two distinct sites, Thr11 and Thr14. This phosphorylation leads to changes in the structure of the chromosomes, which allows them to be pulled apart and segregated into two daughter cells."
  },
  {
    "id": 1668,
    "user_query": "What is the advantage of neutral loss detection in phosphoproteomics?",
    "text-davinci-003_response": "Neutral loss detection in phosphoproteomics provides several advantages to increase the coverage of phosphoproteins that can be identified. Neutral loss detection takes advantage of the fact that phosphorylated peptides contain phosphate groups (P) which can be lost from the molecule and produce an ion with the same mass as the parent ion after fragmentation. The loss of the phosphate group often yields a signal with a much higher abundance relative to other fragments that can be used to detect phosphorylation sites. It also reduces sample complexity since phosphorylated peptides can be easily clustered and distinguished from non-phosphorylated peptides. Moreover, the abundance of these fragments, termed neutral losses, can be compared across different samples to determine quantitative differences in the relative frequency of each phosphopeptide. As a result, neutral loss detection can be used to accurately quantify a set of proteins and their phosphorylation state in a sample. Additionally, it can reveal sites that were previously missed using traditional methods. Overall, neutral loss detection is a powerful tool for increasing the accuracy and coverage of phosphoproteomics research."
  },
  {
    "id": 1672,
    "user_query": "Which cyclin- dependent kinase inhibitor is regulated by Bmi-1?",
    "text-davinci-003_response": "Bmi-1 regulates two cyclin-dependent kinase inhibitors, including p15 and p16. Both p15 and p16 proteins are members of the INK4 family of cyclin-dependent kinase inhibitors. Bmi-1 binds to the INK4 site and inactivates p15 and p16, which needs to be inactivated before a cell can proceed through the cell cycle. Bmi-1 is also known to interact with other proteins in the INK4 family, such as p18 and p21, although its full role in the regulation of these proteins has yet to be elucidated."
  },
  {
    "id": 1675,
    "user_query": "List inhibtors targeting the mitochondrial permeability transition pore.",
    "text-davinci-003_response": "The mitochondrial permeability transition pore (mPTP) is a large-pore protein complex located within the inner mitochondrial membrane. It serves as a regulatory gate keeper, playing a key role in regulating the morphology of the mitochondrial inner membrane, mitochondrial energy-producing processes, and programmed cell death pathways. Inhibitors of the mPTP can be used as potential therapies for diseases characterized by uncontrolled mitochondrial permeability transition, such as ischemia-reperfusion injury, neurodegenerative disorders, and cardiovascular diseases. \nInhibitors targeting the mPTP can be broadly classified into two groups: those that target the opening of the pore and those that stabilize the closed state. \nInhibitors that open the mPTP include cyclosporine A, fructose-1,6-bisphosphate, myxothiazol, and peptide aldehyde.\nInhibitors that stabilize the closed state of the mPTP include adenosine diphosphate, carbenoxolone, cyclosporin A, erastin, and hexamethylene bisacetamide."
  },
  {
    "id": 1678,
    "user_query": "Which is the process that Conserved noncoding elements mostly regulate?",
    "text-davinci-003_response": "Conserved noncoding elements (also known as CNEEs) are short segments of non-protein-coding DNA (usually around 50–500 base pairs in length) which are believed to regulate gene expression. They can be found in both invertebrates and vertebrates and are thought to play an important role in development, cell proliferation, and other biological processes. \nThe exact mechanisms by which CNEEs regulate gene expression are not fully understood, but they are believed to act through the formation of chromatin-based regulatory networks. It is thought that these networks enable transcription factors to interact with both the DNA sequence and the chromatin structure to help regulate gene expression. CNEEs may also interact with transcription factors to influence the process of gene activation.\nIn addition to their role in gene expression, CNEEs are also known to bind to and regulate long noncoding RNAs (lncRNAs). lncRNAs are molecules that play an important role in the regulation of gene expression and chromatin remodeling. By binding to specific regions of lncRNA, CNEEs can regulate lncRNA expression, and thus affect transcriptional and epigenetic regulation. \nOverall, CNEEs are believed to act as part of larger networks in order to regulate gene expression and other biological processes at a larger scale."
  },
  {
    "id": 1689,
    "user_query": "Is Achondroplasia associated with hearing loss?",
    "text-davinci-003_response": "Achondroplasia is a genetic condition that causes short stature and disproportionate dwarfism. It is caused by a mutation in the FGFR3 gene. While hearing loss is not a common symptom of Achondroplasia, it can occur. People with Achondroplasia are at an increased risk for developing hearing loss due to deformity in the middle ear, abnormal bony growths which can cause blockage of the ear canal, or enlarged adenoids and tonsils in the throat. These blockages can cause conductive or sensorineural hearing loss. Additionally, certain medications used to treat Achondroplasia can sometimes cause hearing loss as a side effect. It is important for people with Achondroplasia to have their hearing tested periodically to ensure that any potential hearing loss is detected and addressed in a timely manner."
  },
  {
    "id": 1691,
    "user_query": "Is STAT3 transcription factor regulated by mTORC1?",
    "text-davinci-003_response": "Yes, STAT3 transcription factor is regulated by mTORC1. The mammalian target of rapamycin complex 1 (mTORC1) is a master regulator of cell growth and metabolism whose impact is mediated, in part, by a number of downstream targets, including phosphorylation. mTORC1 has been shown to phosphorylate the Signal Transducers and Activators of Transcription 3 (STAT3), a member of the STAT family of transcription factors, which are involved in varying processes such as cellular growth, apoptosis, and the immune response. Signaling proteins, such as mTORC1, regulate intracellular pathways that lead to STAT3 receptors being phosphorylated, causing a subsequent shift in the direction of the transcription and translation of specific genes.\nThe binding partner of mTORC1, Raptor, has been linked to the phosphorylation of STAT3 Serine 727 (Ser727). Specifically, it has been found that the mTORC1 complex, through Raptor activity, is able to mediate post-translational modifications to Ser727 by the action of Akt where Ser727 is phosphorylated. This leads to a shift in the direction of the transcription and translation of specific genes, resulting in the activation of various metabolic pathways. Furthermore, experiments have demonstrated that the amount of Ser727 phosphorylation of STAT3 depends on the presence or absence of mTORC1, further supporting the idea that STAT3 is regulated by mTORC1.\nOverall, these findings suggest that mTORC1 plays a crucial role in regulating the STAT3 transcription factor by controlling the phosphorylation of Ser727. In this way, mTORC1 is able to influence the processes initiated by STAT3, such as cellular growth and metabolism, providing an important regulator of cellular homeostasis."
  },
  {
    "id": 1693,
    "user_query": "List components of the CRSP/Med complex.",
    "text-davinci-003_response": "The CRSP/Med Complex is a network of operational components designed to provide railroads with the equipment and capabilities necessary to meet modern transportation needs. Components of the CRSP/Med Complex include:\n• Railroad Operation Facilities: Railroad operation facilities are the primary structures used to support rail operations. This includes operational buildings, freight yards, repair shops, and signal systems.\n• Real-Time Traffic Management Systems: These systems monitor and control the flow of rail traffic on the system, providing accurate and up-to-date information about train operations and other operations related to the system.\n• Communications and Signal Infrastructure: This includes a variety of communications networks and equipment, both wired and wireless, used to link rail control centers and operations staff. It also includes the secure transmission of messages between rail centers on a real-time basis.\n• Intelligent Vehicle Control Systems: These systems are designed to control and manage the movement of trains, including automatic speed control, automatic train routing, and weight control/distribution.\n• Computerized Track Maintenance and Maintenance Management Systems: These systems are used to manage routine maintenance activities and optimize the use of track resources.\n• Data Centers and Network Management: Data centers are used to store, manipulate, and analyze rail data, while network management is used to manage security and reliability of the rail network.\n• Advanced Train Control Systems: Advanced Train Control Systems are designed to facilitate the integration of the various functions of the CRSP/Med Complex. This includes systems used to enable the integration of on-board train computers, dispatch centers, and remote diagnostics and troubleshooting."
  },
  {
    "id": 1696,
    "user_query": "What is the mechanism of viroid replication?",
    "text-davinci-003_response": "Viroids are pathogenic, non-coding strands of RNA (i.e. without a protein coat) that are comprised of a single circle of ribose nucleotides. The replication of viroid RNA is thought to involve a unique mechanism due to its special form.\nThe replication of viroid RNA follows the principles of RNA Replication, which begins when the viroid RNA genome binds to its replicase enzyme. This enzyme is thought to be a natural RNA polymerase that binds to the RNA molecule and hydrolyzes the phosphodiester bonds between the nucleotides. The replicase enzyme proceeds to break down the complementary strands, allowing for the release of the template strand, and the formation of a new strand from the released RNA. \nAs the replicase enzyme carries out its job, it assembles newly synthesized nucleotides in the 5'→3’ direction, consistent with an RNA-dependent RNA polymerase. When the, the newly synthesized strand constitutes a complementary strand of the viroid, and the formation of a double-stranded viroid RNA is completed. \nThe newly synthesized double-stranded viroid RNA is then either released into the cytoplasm for external infection or re-transcribed within the infected cell, creating multiple progeny molecules which are released and go on to cause further infections. \nThis process of viroid replication is thought to be driven by thermal fluctuations and has limited fidelity compared to the replication of proteins or DNA. This is due to the lack of conformational constraints and the lower energy cost associated with non-coding strand RNA replication."
  },
  {
    "id": 1698,
    "user_query": "Mutation of which gene is associated with McLeod syndrome?",
    "text-davinci-003_response": "McLeod syndrome is a rare X-linked disorder that is caused by mutations in the SH2D1A gene. The SH2D1A gene is located on the long arm (q) of the X chromosome (Xq28.1-q28.2). It encodes a protein known as SLAM-associated protein (SAP) and is involved in several cellular functions, including signaling and antigen presentation. Mutations in this gene are responsible for the abnormal neurologic, hematologic, and muscle signs and symptoms seen in this disorder."
  },
  {
    "id": 1699,
    "user_query": "Is RIP1 (RIP-1) part of the necrosome?",
    "text-davinci-003_response": "No, RIP1 (RIP-1) is not part of the necrosome. The necrosome is a multiprotein complex composed of a variety of pro-apoptotic molecules and is found in mammalian cells. It is associated with caspase activation and the induction of cell death. RIP1 (RIP-1) is a molecule known as the receptor-interacting protein-1, which is a serine/threonine kinase involved in a variety of signaling cascades and pathways, including those that regulate cell death. RIP1 is not part of the necrosome and is in fact typically found outside the necrosome, acting separately from the complex to induce cell death."
  },
  {
    "id": 1700,
    "user_query": "Which is the molecular target of the immunosuppressant drug Rapamycin?",
    "text-davinci-003_response": "The molecular target of the immunosuppressant drug rapamycin is the protein kinase known as mammalian (or mechanistic) target of rapamycin (mTOR). mTOR is a serine/threonine protein kinase that is found within the cell's cytoplasm and is a crucial part of the pathway that is involved in cell growth and proliferation. By binding to mTOR, rapamycin suppresses the activation of this kinase, thus impairing the ability of the cell to synthesize proteins and other molecules involved in the processes of cell growth and proliferation. As a result, rapamycin can be used to suppress the activity of the immune system and thereby reduce the risk of rejection after organ transplantation."
  },
  {
    "id": 1702,
    "user_query": "PBT2 has been tested for which disorder?",
    "text-davinci-003_response": "PBT2 has been tested for Alzheimer's Disease. A Phase 2 clinical trial investigating the effects of PBT2 on Alzheimer's Disease was conducted by Prana Biotechnology in 2004. Results from the trial indicated that PBT2 significantly reduced levels of beta-amyloid (Aβ), thought to be a major cause of Alzheimer's Disease. This trial was the first successful clinical trial of a compound targeting Aβ aggregation, with PBT2 showing promising results compared to a placebo. Subsequent Phase II and Phase III trials also showed that PBT2 was safe and moderately effective in slowing the cognitive decline associated with Alzheimer’s, suggesting further investigation into larger clinical trials and therapies based on PBT2 are warranted."
  },
  {
    "id": 1704,
    "user_query": "How does long-range epigenetic silencing (LRES) occur?",
    "text-davinci-003_response": "Long-range epigenetic silencing (LRES) is a process in which genes in distant regions of the same chromosome or different chromosomes are stably inhibited from being transcribed. This means that the silenced genes cannot be expressed, although the genetic code remains intact. LRES generally occurs via the formation of large, polytene chromatin structures known as higher order chromatin domains. These domains are composed of histone and non-histone proteins and nucleic acids, and they serve to condense and package the DNA to fit inside a nucleus, as well as to restrict or enable the expression of certain genes. In the case of LRES, this large genetic structure prevents certain genes from being transcribed into the RNA molecules that enable gene expression. \nThe formation of higher order chromatin domains is determined by a variety of synaptic structures, including DNA methylation, histone modifications, ATP-dependent remodeling of nucleosomes, and non-coding RNAs. These synaptic structures are believed to create long-range regions of epigenetic repression known as LRES.\nFor example, DNA methylation is a major regulatory system in which specific DNA regions are covalently modified by the addition of methyl groups. These methylated DNA regions are known as heterochromatin, which is a state of highly condensed chromatin that is largely inaccessible to the transcription machinery. Heterochromatin is believed to be important in LRES, as it can spread and repress transcriptional activation of genes that are located far away from the original epigenetic mark.\nIn addition to this, histone modifications also play a role in the formation of higher order chromatin and LRES. Histones or histone-like proteins can be modified in a variety of ways, such as by acetylation, methylation, or ubiquitination. These modifications change the overall conformation of the nucleosome, thereby making it difficult or impossible for transcriptional machinery to access the underlying DNA.\nFinally, ATP-dependent remodeling complexes are also key components in establishing higher order chromatin and long-range epigenetic silencing. These complexes use nucleosomes as a scaffold for specific ATPases, which are enzymes that bind to and displace specific histones that contain activating or repressing chromatin marks. These histone complexes then act to lock in a certain pattern of transcription that will persist over long distances. \nOverall, the process of long-range epigenetic silencing involves diverse synaptic structures"
  },
  {
    "id": 1706,
    "user_query": "Can RNAPolII function as an RNA-dependent RNA-polymerase?",
    "text-davinci-003_response": "No, RNA polymerase II (RNAPolII) cannot function as an RNA-dependent RNA polymerase. RNAPolII is a DNA-directed enzyme that transcribes DNA into messenger RNA (mRNA) molecules containing the genetic instructions for the cell. By contrast, an RNA-dependent RNA polymerase (RdRp) is an enzyme that uses a single-stranded RNA molecule as a template to create a complementary strand. RNAPolII does not have this function, and instead only transcriptionally produces mRNA."
  },
  {
    "id": 1708,
    "user_query": "List sclerostin interaction partners.",
    "text-davinci-003_response": "Sclerostin is a protein specifically expressed in the osteocytes of mammalian bones and is known to be involved in many physiological processes related to bone formation. At the protein-protein level, it has been reported to interact with several other proteins, including:\n1. Dickkopf (DKK) 1 & 3: Sclerostin binds to the ectodomain of DKK1 and to the C-terminal domain of DKK3. DKK1 has been found to inhibit WNT/β-catenin signaling, while DKK3 is thought to affect both WNT and BMP2 signaling pathways.\n2. V-3 Integrin (alpha V): Sclerostin binds to the cytoplasmic domain of alpha V, which is a subclass of integrins that are known to be involved in cell adhesion, migration, and proliferation.\n3. Osteopontin: Sclerostin binds to the C-terminal domain of osteopontin, which plays an important role in bone formation.\n4. Osterix: Sclerostin binds to the C-terminal domain of osterix, a transcription factor that is known to control osteoblast differentiation.\n5. TCF4 (beta-Catenin): Sclerostin has been shown to bind to beta-catenin, a ubiquitous adaptor protein that is known to regulate the canonical Wnt/β-catenin signaling pathway.\n6. Runx2: Sclerostin binds to the C-terminal domain of runx2, a transcription factor that is involved in the regulation of osteoblastogenesis."
  },
  {
    "id": 1711,
    "user_query": "Which are currently available software tools for detecting rare codon clusters in coding sequences?",
    "text-davinci-003_response": "Currently available software tools that can be used for detecting rare codon clusters in coding sequences include:\n1) NCBI Nab3.0: Nab3.0 is a gene finding software from the National Center for Biotechnology Information (NCBI). It identifies rare codon clusters in protein coding regions. Nab3.0 provides features such as codon usage frequency, frame-shifting, and open reading frame (ORF) metrics. It is also able to predict splice signals and check for in-frame stop codons.\n2) iLLumina: iLLumina is a web-based tool developed at the International Institute of Molecular and Cell Biology in Warsaw, Poland. It is designed to help researchers identify rare codon clusters in protein-coding open reading frames. iLLumina uses a machine learning approach that takes into account codon usage bias, mRNA secondary structure, and oligonucleotide composition.\n3) CUPPA2: CUPPA2 is a software tool developed at Emory University School of Medicine. It can be used to identify rare codon clusters or extreme usage of codons in protein-coding open reading frames. CUPPA2 uses an algorithm that takes into account multiple sequence alignments as well as the codon frequency data of multiple organisms.\n4) Rarecodon: Rarecodon is an open source tool developed at the Ohio State University. It is used to detect rare codon clusters in coding sequences. Rarecodon takes into account codon usage frequency, sequence conservation, and mRNA secondary structure to identify rare codon clusters."
  },
  {
    "id": 1714,
    "user_query": "Where does CTCF colocalize with cohesin?",
    "text-davinci-003_response": "CTCF and cohesin colocalize at many sites throughout the nucleus of the cell. CTCF binds to chromatin and recruits cohesin to these sites, which helps to mediate a higher-order structure. Specifically, CTCF and cohesin are both found on chromatin at locations that mark the boundaries between transcriptionally active and inactive regions of the genome. This helps to promote higher-order structures, like looping of chromatin that brings distal DNA elements into contact. Additionally, CTCF and cohesin also colocalize to enhancer elements."
  },
  {
    "id": 1715,
    "user_query": "Name triad of Wernicke encephalopathy.",
    "text-davinci-003_response": "The triad of Wernicke encephalopathy is composed of three main symptoms- oculomotor disturbances, memory impairment, and ataxia. \n1. Oculomotor disturbances are the primary sign of Wernicke encephalopathy. These disturbances are characterized by paralysis of the muscles involved in eye movements, such as the oculomotor nerve. Examples of oculomotor disturbances include nystagmus (involuntary eye movements) and opthalmoplegia (paralysis of the eye muscles).\n2. Memory impairment is the second main symptom of Wernicke encephalopathy. Affected individuals may experience confusion and memory loss due to damage to the hippocampus and other areas of the brain.\n3. Ataxia is the third primary symptom of Wernicke encephalopathy. Ataxia is defined as a lack of coordination and balance due to damage to the cerebellum and its connections. Examples of ataxia include difficulty walking, an unsteady gait, and difficulty picking up objects."
  },
  {
    "id": 1718,
    "user_query": "How many and which are the different isoforms for the ryanodine receptor?",
    "text-davinci-003_response": "The ryanodine receptor (RyR) is a family of calcium ion channels that are present in both animal and plant cells. The RyRs are encoded by three genes: the RyR1, RyR2 and RyR3 genes, each of which encode a number of protein isoforms.\nThe RyR1 gene encodes four isoforms of the RyR: RyR1a, RyR1b, RyR1c and RyR1d.RyR1a is the isoform prevalent in skeletal muscle, while RyR1b is found in cardiac muscle. RyR1c and RyR1d are both restricted to the brain and ovary, respectively.\nThe RyR2 gene encodes two isoforms: RyR2a and RyR2b. RyR2a is the dominant form of RyR found in the heart, while RyR2b is the dominant form of RyR found in the brain.\nThe RyR3 gene encodes a single isoform: RyR3. RyR3 is the predominant form of RyR found in skeletal muscle.\nIn summary, there are seven isoforms of the ryanodine receptor: RyR1a, RyR1b, RyR1c, RyR1d, RyR2a, RyR2b, and RyR3."
  },
  {
    "id": 1723,
    "user_query": "Does fibronectin constitute a serum biomarker for Duchenne muscular dystrophy?",
    "text-davinci-003_response": "Fibronectin is not typically considered a serum biomarker for Duchenne muscular dystrophy. Fibronectin is a protein found in the serum that has binding sites for collagen and connects different types of cells together in structures called extracellular matrices. However, research has shown that there is no significant difference in fibronectin levels between Duchenne muscular dystrophy (DMD) patients and healthy subjects. Therefore, it has not been established as a serum biomarker for the disease. \nOther proteins, such as creatine kinase, have been proposed as serum biomarkers for DMD. For instance, research has shown that there is an increase in serum creatine kinase in DMD patients, suggesting that it could be used as a biomarker for the disease. Therefore, while fibronectin may have other functions related to Duchenne muscular dystrophy, it does not currently constitute a serum biomarker for the disease."
  },
  {
    "id": 1732,
    "user_query": "What is the association between number of pregnancies and rheumatoid arthritis",
    "text-davinci-003_response": "?\nRheumatoid arthritis (RA) is an autoimmune condition that causes inflammation of the joints, leading to pain, stiffness, and swelling. While the exact cause of RA is still unknown, research has identified various risk factors, including gender, genetics, lifestyle, and environmental factors.\nRecent studies have suggested that there is an association between the number of pregnancies a woman has had and the risk of developing RA. Women who have had at least four pregnancies are at an increased risk of developing RA. Studies have found that risk increases with each pregnancy, but the overall risk is still relatively low.\nThe reasons for the link between number of pregnancies and RA are unknown, but researchers believe that it is related to hormones, the immune system, or the physical stress of pregnancy. Hormonal changes during pregnancy might affect RA risk, as could changes in the immune system and the physical stress on the body.\nIt is important to note that having more pregnancies does not guarantee that an individual will develop RA. Rather, pregnancy appears to be a risk factor, which means that individuals with this risk factor are more likely to develop the disease than those without this risk factor."
  },
  {
    "id": 1737,
    "user_query": "Can we use prodrug amifostine to protect healthy cell during chemotherapy?",
    "text-davinci-003_response": "Yes, prodrug amifostine can be used to protect healthy cells during chemotherapy. Amifostine is a prodrug that is converted in the body to an active metabolite (WR-1065) that acts as an osmotic protectant or free radical scavenger. This active metabolite helps to protect healthy cells, especially the cells found in the kidneys, pancreas, and nervous system, from the side effects of chemotherapy. It does this by counteracting the toxic effects of free radicals that are created when chemotherapy drugs are administered. Amifostine helps to reduce cell damage and minimize free radical activity, which can help reduce the side effects of chemotherapy. The benefits of using amifostine to protect healthy cells during chemotherapy include reducing or eliminating the risk of severe side effects, protecting the body from long-term organ damage, and improving overall survival rates."
  },
  {
    "id": 1738,
    "user_query": "Which is the main difference between Alu and B1 repeats?",
    "text-davinci-003_response": "Alu and B1 repeats are both types of transposable elements, which are DNA sequences that can move around to different places in the genome and change its structure and function. The main difference between Alu and B1 repeats is their respective composition. Alu repeats are composed of 300 base pairs of various sequences that can be classified into several subfamilies. B1 repeats, on the other hand, are composed of only 24 base pair direct repeats that have considerable similarity between them. Alu sequences can vary greatly in their exact DNA sequence and location within the genome, whereas B1 repeats are quite consistent in both sequence and location, which makes them more useful in phylogenetic studies."
  },
  {
    "id": 1740,
    "user_query": "What is the frequency of mutations induced spontaneously through Ethylnitrosourea (ENU) mutagenesis?",
    "text-davinci-003_response": "The frequency of mutations induced spontaneously through Ethylnitrosourea (ENU) mutagenesis can vary greatly depending on the organism and the tissues being mutated. Generally, however, the estimated frequency of ENU-induced mutations is between 1x10^-4 and 10x10^-4, meaning that approximately 1 in 10,000 to 1 in 100,000 cells can be successfully mutated with ENU.\nENU is often used in targeted mutagenesis studies in model organisms such as mice, where higher frequencies of mutations can be achieved. For example, in mouse embryonic stem cells, the frequency of genetic mutations induced by ENU can reach up to 1x10^-2 per locus. This is much higher than the background levels of spontaneous mutation, which are typically in the range of 1x10^-7 to 1x10^-9.\nRegardless of the organism or tissue, ENU is typically applied over multiple generations in order to obtain an increased level of mutational effects. The overall frequency of mutations induced by ENU in this manner can vary widely, ranging from low levels (1x10^-5 to 1x10^-6) to high levels (1x10^-2 to 1x10^-3)."
  },
  {
    "id": 1758,
    "user_query": "Has Glucose-6-phosphate dehydrogenase (G6PD) deficiency an X-linked inheritance?",
    "text-davinci-003_response": "Yes, Glucose-6-phosphate Dehydrogenase (G6PD) deficiency is an X-linked inherited disorder. This means that the gene causing G6PD deficiency is located on the X chromosome; one of the two sex chromosomes in humans. X-linked inherited disorders are usually manifested in males more than females because males have only one X chromosome (XY).\nMales inherit the X-linked trait from their mother, who is usually a carrier of the disorder because she has one normal and one abnormal X chromosome. Females, on the other hand, can inherit a G6PD deficiency gene from either their mother or father. If a female inherits the gene from her father, she is likely to show symptoms of the disorder due to having two affected X chromosomes. If she inherits the gene from her mother, then symptoms may be mild or even absent. Males, however, will always show symptoms of G6PD deficiency if they inherit the gene from their mother.\nG6PD deficiency is the most common enzyme deficiency in humans, affecting over 400 million people worldwide. It is an autosomal recessive disorder, which means that an individual must inherit two copies of the defective gene (one from each parent) in order to be affected. If only one copy of the defective gene is inherited, then the individual will not show any symptoms but may still pass the gene on to their children."
  },
  {
    "id": 1760,
    "user_query": "Which mutated genes are associated with the Tourette's syndrome?",
    "text-davinci-003_response": "The Tourette's syndrome is a neurological disorder that is characterized by repetitive and involuntary motor and vocal tics. Individuals with Tourette’s experience varying levels of severity, with some sufferers having mild tics that are hardly noticeable, while others experience more severe physical and vocal tics.\nThe exact cause of Tourette's is not known, however there is likely a combination of genetic and environmental factors involved. Research has identified several gene mutations that are associated with the condition. Most notably, mutations of the SLITRK1 gene, the HDC gene, and the kalirin7 gene are linked to Tourette’s. The SLITRK1 gene is responsible for helping to regulate the pathways of dopamine and glutamate within the brain. The HDC gene is related to the production of histamine, a neurotransmitter that regulates cognitive processes. Finally, the Kalirin7 gene is involved in controlling synaptic communication in the brain.\nOther gene mutations associated with the condition are the deiodinase (DIO) gene and the ANXA2 gene. The DIO gene is responsible for regulating the amount of thyroid hormones in the body, while the ANXA2 gene plays a role in creating neurons in the brain. In addition, mutations of the KMT2A gene and the SLC6A4 gene have also been correlated with Tourette’s. The KMT2A gene helps to regulate gene expression, while the SLC6A4 gene is responsible for transporting serotonin in the brain."
  },
  {
    "id": 1763,
    "user_query": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?",
    "text-davinci-003_response": "The DeepBlue epigenomic data server contains data from four major epigenomic projects: \n1. The Encyclopedia of DNA Elements (ENCODE): This is a comprehensive effort to identify the functional elements of the human genome. This project used sequencing and microarray technologies to map the epigenetic patterns in various regions of the genome. \n2. The NIH Roadmap Epigenomics Mapping Consortium (REMC): This project used advanced sequencing technologies to characterize the epigenome in a range of cell types and tissues.\n3. The Blueprint Epigenome Mapping Consortium (BEMC): This is a Canadian partnership that is characterizing the epigenome in biological samples from healthy and diseased individuals.\n4. The Cancer Genome Atlas (TCGA): This is an International Cancer Genome Consortium effort that has used sequencing technologies to collect epigenetic profiles from various types of tumors."
  },
  {
    "id": 1765,
    "user_query": "Is the toxin produced by Clostridium botulinum always deadly?",
    "text-davinci-003_response": "No, the toxin produced by Clostridium botulinum is not always deadly. The toxin can be used medically in safe amounts to treat muscle spasms, headaches, and a number of other medical conditions. The toxin has also been used in food products to reduce the number of bacteria that cause spoilage. In large doses, however, the toxin is deadly and can lead to botulism, a potentially fatal form of food poisoning. There is no known antidote for the toxin and if treatment is delayed, the person might suffer permanent paralysis, difficulty speaking, breathing, and swallowing, and even death."
  },
  {
    "id": 1771,
    "user_query": "Describe mechanism of action of Eteplirsen?",
    "text-davinci-003_response": "Eteplirsen (also known as AVI-4658) is a phosphorodiamidate morpholino oligomer (PMO) therapy, which works by targeting a mutation (a small genetic change that can result in a disease or genetic disorder) in the dystrophin pre-mRNA (mRNA is a molecule that directs the creation of proteins). Specifically, eteplirsen acts by binding to exon 51 of the dystrophin mRNA to block its skipping during the Capping process. As a result, eteplirsen results in a microdystrophin (a tiny form of the dystrophin protein) being produced which compensates for the lack of full-length dystrophin caused by the exon 51 mutation. The microdystrophin enables Duchenne muscular dystrophy (DMD) patients with the particular mutation to produce a small portion of dystrophin protein, which helps to improve muscle strength and function. \nPMO therapy is unlike other forms of DMD therapy because it does not require the delivery of a foreign gene or nucleic acid. This method is more efficient and less risky than conventional DMD therapies, as injection into the muscle does not lead to the release of toxins, unlike many other treatments. This method of action also has a number of advantages, such as the ability to quickly and accurately target the specific mutation, and the ability to use lower dosages since the PMO therapy is not foreign, nor are there many side effects from its administration."
  },
  {
    "id": 1777,
    "user_query": "Which gene-defect causes the Vel-blood type?",
    "text-davinci-003_response": "Vel blood type is an uncommon blood type. It is characterized by the absence of both the Duffy antigens (FY and FYA) on the surface of red blood cells and the expression of the Junior (J) antigen. The gene-defect responsible for Vel blood type is a mutation in the FYA and FYB genes, which encode the Fya and Fyb glycoproteins located on the surface of red blood cells. The mutation affects the expression of the Duffy antigen on the cell surface, leading to the absence of the antigen from the cell. The genotype of the individual with Vel blood type is FYA*02 and FYB*02, which is caused by the duplication of two nucleotides."
  },
  {
    "id": 1782,
    "user_query": "What are the exonic splice enhancers?",
    "text-davinci-003_response": "Exonic splice enhancers (ESEs) are cis-regulatory elements within exons of pre-mRNA that act as binding sites for proteins involved in the splicing process. These enhancers help to promote efficient and accurate recognition of tissue-specific or developmentally regulated mRNA splice sites. ESEs function as part of a complex of splicing proteins, referred to as “splicing factors”, that bind to specific stretches of DNA known as “splicing enhancer elements” (SEE). When splicing factors bind to SEEs, the pre-mRNA is either included or skipped during the splicing process. ESEs are located within the coding portion of precursor mRNA, and their binding with other associated proteins recognizes, enhances or suppresses the intron-exon processing of pre-mRNA. They play an important role in gene regulation by deciding whether a sequence will be included or not in the mRNA after splicing. As a result, ESE elements are essential for regulating the expression of genes and their protein product."
  },
  {
    "id": 1784,
    "user_query": "What is Neisseria adhesin A?",
    "text-davinci-003_response": "Neisseria adhesin A (NadA) is a cell surface adhesin found on the surface of some Neisseria species, such as Neisseria meningitidis and Neisseria gonorrhoeae. It is involved in mediating the attachment of bacteria to host cells, particularly to epithelial cells, which can provide the bacteria with an efficient pathway for migration and colonization. NadA is a glycosylated, membrane-spanning protein which is composed of two subunits: the conserved N-terminal subunit (NadA1) and the variable C-terminal subunit (NadA2). The NadA2 component is the immunogenic portion of the protein and is capable of eliciting both humoral and cellular immune responses. There are several potential targets for NadA-based vaccine development, including serogroups A, C, W-135, and Y of N. meningitidis, and the X, Y and Z serovars of N. gonorrhoeae. Vaccine strategies are aimed at eliciting antibodies against SardA which would block its ability to bind and support colonization."
  },
  {
    "id": 1785,
    "user_query": "Which R package is used for the detection of chromosomal abnormalities from microarray data?",
    "text-davinci-003_response": "The R package 'affyPara' is typically used for the detection of chromosomal abnormalities from microarray data. This package provides functions for the segmentation and estimation of several parameters of the data, including the estimation of copy number gains and losses, the detection of regions of local aberration using a hidden Markov model, and the detection of abnormal regions in log2-transformed gene expression data. Additionally, 'affyPara' is well-equipped to handle larger datasets, and supports multiple annotation formats, from Ensembl, RefSeq, NCBI to GFF3 and custom annotation formats."
  },
  {
    "id": 1792,
    "user_query": "Which tool employs self organizing maps for analyzing synonymous codon usage?",
    "text-davinci-003_response": "CodonW is a tool that employs self organizing maps for analyzing synonymous codon usage. Using a mathematical scaling algorithm, it can convert codon usage data into a unified matrix or table of codon usage. It then uses a self organizing map algorithm (specifically unsupervised neural network) to arrange codon usage patterns according to similarity. This data is then used to identify codon families whose usage is highly conserved across species or to identify species-specific coding strategies. The software package can also output bias indices of codon usage, compare codon usage between two coding regions, and generate synonymity plots."
  },
  {
    "id": 1793,
    "user_query": "What is MINDY-1?",
    "text-davinci-003_response": "MINDY-1, short for \"Microprocessor INterrupt Driven sYstem,\" is an early computer system designed by IBM. It was introduced in 1974 as one of the first commercial microprocessor-based systems. IBM designed MINDY-1 to be used in a wide array of applications, including data processing, industrial automation, and telecommunications. It was the first microprocessor to incorporate the use of interrupts to manage multiple tasks. The MINDY-1 was composed of the IBM 6501 microprocessor, four ROM chips and 64K of RAM. It had several input and output ports that could be used to interface with various external devices. The MINDY-1 system could be used for a variety of tasks, such as creating flowcharts, manipulating arrays, and performing arithmetic calculations. It was widely used in commercial and industrial applications when it became available."
  },
  {
    "id": 1805,
    "user_query": "What is BioCreative?",
    "text-davinci-003_response": "BioCreative is an international conference and research challenge for the evaluation of text mining (TM) and information extraction (IE) systems applied to the biomedical domain. It is co-sponsored by the National Center for Biotechnology Information (NCBI) at the US National Library of Medicine. BioCreative was founded in 2003 and has been held biennially since 2006. The main objective of this conference is to evaluate the performance of text mining and information extraction systems and to promote interactions between the key researchers in the field. The aim is to increase understanding in the diverse areas of Text Mining, Computational Linguistics, Bioinformatics, and Information Retrieval.\nBioCreative focuses on the use of TM and IE for biomedical literature. This involves the development of systems and algorithms to identify facts or relations between biomedical concepts described within literature. These may include entities such as genes, proteins, diseases, drugs, etc., their features, desired criteria or mentions of interactions between pairs of entities, such as protein-protein interactions or drug-target interactions.\nEach BioCreative challenge includes tasks related to tasks such as entity recognition, relation extraction, sentence classification or document categorization. The challenge is also an effective way to assess the performance of different systems when tested on the same data sets. Participants of the challenge have the opportunity to present their methodologies and discuss different approaches to various TM and IE tasks.\nBioCreative also offers a platform for the exchange and discussion of ideas on how to adapt existing TM and IE systems and develop new ones for application in the biomedical domain. Active sharing of data sets, toolkits, and systems between researchers in the field is encouraged, which should help to speed up the development of more accurate and efficient systems."
  },
  {
    "id": 1808,
    "user_query": "What type of mutation is causing the industrial melanism phenotype in peppered moths?",
    "text-davinci-003_response": "The industrial melanism phenotype in peppered moths is caused by a melanic mutation. This mutation is an example of speciation, which is a change in gene frequencies in a population due to an environmental stressor. The mutation causes the individuals with the mutation to darken. This darkening typically appears in moths living in industrial areas, where the polluting smoke and soot darkens the tree barks, making lighter moths more easily detectable by predators. This mutation is caused by a single base mutation, resulting in a single amino acid switch in the tyrosinase enzyme. This tyrosinase enzyme is responsible for the production of melanin, which has a darkening effect on the color of the moth."
  },
  {
    "id": 1810,
    "user_query": "Which software package is available for the analysis of conserved genomic loci?",
    "text-davinci-003_response": "There are a variety of software packages available for the analysis of conserved genomic loci, including programs such as Glimmer, MGA, Augustus, FGENESH, and GeneMark. Glimmer is a popular program for finding genes in bacterial, archaeal, and even eukaryotic genomes. It is useful for detecting regions of conserved sequence and for discerning genes from non-coding regions of a genome. MGA, or MetaGeneAnnotator, is a program for automated annotation of genetic loci in prokaryotic genomes. It is designed to identify coding regions, as well as protein and regulatory motifs, and is capable of predicting the translation initiation and termination sites of genes. Augustus is a program that combines both ab initio and homology-based predictions for automated annotation of sequenced genomes. It can be used to identify both intron and exon regions of conserved loci, and it is frequently used for eukaryotic genome annotation. FGENESH is another program used for gene discovery in both prokaryotic and eukaryotic genomes. It uses a combination of hidden Markov models and sequence information to detect conserved regions and to localize protein-coding genes. Lastly, GeneMark is a probabilistic gene recognition software that can also be used to detect and identify conserved genomic loci. It typically operates in an automated fashion, using homology information to discover regions of conserved sequence in a genome."
  },
  {
    "id": 1812,
    "user_query": "What is Eteplirsen (Exondys 51)?",
    "text-davinci-003_response": "Eteplirsen (Exondys 51) is a prescription medicine used to treat Duchenne Muscular Dystrophy (DMD) in patients who have a confirmed mutation of the dystrophin gene amenable to exon 51 skipping. It is a type of targeted therapy, which works by “skipping” exon 51 of the dystrophin gene in order to create a shorter and functional dystrophin protein. Dystrophin is a large protein found in muscle cells which is responsible for helping to keep the muscle cell membrane intact. In individuals with DMD, the dystrophin gene is either defective or missing, leading to progressive loss of muscle function, muscle wasting, and eventually disability.\nThe drug is delivered as an injection (similar to an insulin injection) and is meant to be given once a week. Eteplirsen is designed to help the body create the shorter, functional form of dystrophin, which in theory, should result in increased muscle strength, increased muscle function, and possibly improved overall survival and quality of life. While some studies suggest the drug can increase dystrophin production and may have some benefit for individuals with DMD, further controlled studies are needed to determine the efficacy of Eteplirsen for treating DMD."
  },
  {
    "id": 1813,
    "user_query": "What are the SINEUPs?",
    "text-davinci-003_response": "SINEUPs, or Single-Input Nomenclature Enhanced UPcodes, are a unique identification system that are based on standard industry coding systems. These UPcodes provide quick assignment of standard merchandise codes as well as a reliable way to track merchandise in supply chain operations.\nThe code itself is defined by a set of rules, such as; using a mixture of both alphanumeric characters and forward slashes, that allows for quick registration and retrieval of products across different retailers, suppliers, manufacturers, shippers, etc. These codes enable each individual partner to quickly identify a product, no matter its supplier or location, without the need for complicated data-entry.\nBy using SINEUP codes, users are able to bridge data gaps between multiple databases, such as that of a manufacturer and a retailer, and increase accuracy in supply chain operations. Additionally, when products are lost or misplaced in the supply chain process, the use of SINEUPs significantly improves traceability for easier location and retrieval.\nIn short, SINEUPs are a simplified version of complicated inventory system capacity identification codes that provides an easily identifiable and traceable means of tracking products throughout the supply chain."
  }
]